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ABSTRACT	   	  
Biotechnology	   promises	   the	   biologically	   and	   ecologically	   sustainable	   production	   of	  commodity	   chemicals,	   biofuels,	   pharmaceuticals	   and	   other	   high-­‐value	   products	   using	  industrial	   platform	   microorganisms.	   Metabolic	   engineering	   plays	   a	   key	   role	   in	   this	  process,	   providing	   the	   tools	   for	   targeted	   modifications	   of	   microbial	   metabolism	   to	  create	  efficient	  microbial	  cell	  factories	  that	  convert	  low	  value	  substrates	  to	  value-­‐added	  chemicals.	  Engineering	  microbes	  for	  the	  bioproduction	  of	  chemicals	  has	  been	  practiced	  through	   three	   different	   approaches:	   (i)	   optimization	   of	   native	   pathways	   of	   a	   host	  organism;	   (ii)	   incorporation	   of	   heterologous	  pathways	   in	   an	   amenable	   organism;	   and	  finally	   (iii)	   design	   and	   introduction	   of	   synthetic	   pathways	   in	   an	   organism.	   So	   far,	   the	  progress	  that	  has	  been	  made	  in	  the	  biosynthesis	  of	  chemicals	  was	  mostly	  achieved	  using	  the	   first	   two	   approaches.	   Nevertheless,	   many	   novel	   biosynthetic	   pathways	   for	   the	  production	   of	   native	   and	   non-­‐native	   compounds	   that	   have	   potential	   to	   provide	   near-­‐theoretical	   yields	   and	   high	   specific	   production	   rates	   of	   chemicals	   remain	   yet	   to	   be	  discovered.	  Therefore,	   the	   third	  approach	   is	   crucial	   for	   the	  advancement	  of	  bio-­‐based	  production	  of	  value-­‐added	  chemicals.	  	  We	   need	   to	   fully	   comprehend	   and	   analyze	   the	   existing	   knowledge	   of	   metabolism	   in	  order	   to	   generate	   new	   hypotheses	   and	   design	   de	  novo	  pathways.	   Current	   knowledge	  about	  the	  metabolism	  is	  incomplete	  even	  for	  well-­‐studied	  microorganism	  such	  as	  E.	  coli	  and	   S.	   cerevisiae,	   and	   researchers	   keep	   discovering	   and	   characterizing	   new	  biochemistry,	   genes,	   enzymes	   and	   reaction	  mechanisms.	   The	   complexity	   of	  metabolic	  networks	  cannot	  be	  understood	  and	  analyzed	  intuitively;	  thus,	  computational	  methods	  are	  indispensable	  to	  explore	  and	  expand	  the	  present	  knowledge	  of	  metabolism	  in	  order	  to	  unravel	  the	  full	  enzymatic	  potential	  of	  microorganisms.	  In	  this	  thesis,	  through	  development	  and	  application	  of	  efficient	  computational	  methods,	  we	  took	  the	  research	  path	  to	  expand	  our	  understanding	  of	  cell	  metabolism	  with	  the	  aim	  to	  discover	  novel	  knowledge	  about	  metabolic	  networks.	  We	  analyze	  different	  aspects	  of	  metabolism	  through	  five	  distinct	  studies.	  	  In	  the	  first	  study,	  we	  begin	  with	  a	  holistic	  view	  of	  the	  enzymatic	  reactions	  across	  all	  the	  species,	  and	  we	  propose	  a	  computational	  approach	  for	   identifying	  all	   the	  theoretically	  possible	   enzymatic	   reactions	   based	   on	   the	   known	   biochemistry.	   We	   organize	   our	  results	  in	  a	  web-­‐based	  database	  called	  “Atlas	  of	  biochemistry”.	  	  In	   the	   second	   study,	  we	   focus	  on	  one	  of	   the	  most	   structurally	  diverse	   and	  ubiquitous	  constituents	   of	   metabolism,	   the	   lipid	   metabolism.	   Here	   we	   propose	   a	   computational	  framework	   for	   integrating	   lipid	   species	   with	   unknown	  metabolic/catabolic	   pathways	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into	  metabolic	  networks.	  In	  our	  next	  study,	  we	  investigate	  the	  full	  metabolic	  capacity	  of	  
E.	  coli.	  We	   explore	   computationally	   all	   enzymatic	   potentials	   of	   this	   organism,	   and	  we	  introduce	   the	   “Super	   E.	   coli”,	   a	   new	   and	   advanced	   chassis	   for	   metabolic	   engineering	  studies.	  Our	  next	  contribution	  concentrates	  on	  the	  development	  of	  a	  new	  method	  for	  the	  atom-­‐level	   description	   of	   metabolic	   networks.	   We	   demonstrate	   the	   significance	   of	   our	  approach	  through	  the	  reconstruction	  of	  atom-­‐level	  map	  of	  the	  E.	  coli	  central	  metabolism	  and	   we	   show	   how	   a	   comprehensive	   atom-­‐level	   metabolic	   analysis	   can	   guide	   the	  experimental	  design	  to	  obtain	  more	  precise	  biological	  information.	  In	  the	  last	  study,	  we	  turn	  our	  focus	  on	  studying	  the	  thermodynamics	  of	  metabolism	  and	  we	  present	   our	   original	   approach	   for	   estimating	   the	   thermodynamic	  properties	   of	   an	  important	   class	   of	  metabolites.	   So	   far,	   the	   available	   thermodynamic	   properties	   either	  from	   experiments	   or	   the	   computational	   methods	   are	   estimated	   with	   respect	   to	   the	  standard	   conditions,	   which	   are	   different	   from	   typical	   biological	   conditions.	   Our	  proposed	  workflow	  paves	  the	  way	  for	  reliable	  computing	  of	  thermochemical	  properties	  of	  biomolecules	  at	  biological	  conditions	  of	  temperature	  and	  pressure.	  Finally,	  in	  the	  conclusion	  chapter,	  we	  discuss	  the	  outlook	  of	  this	  work	  and	  the	  potential	  further	  applications	  of	  the	  computational	  methods	  that	  were	  developed	  in	  this	  thesis.	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RÉSUMÉ	  
Les	   biotechnologies	   portent	   la	   promesse	   d’une	   production	   biologiquement	   durable	   et	  responsable	   de	   composés	   chimiques	   de	   base,	   biocarburants,	   médicaments	   ou	   autres	  produits	   à	   haute	   valeur	   ajoutée,	   grâce	   à	   l’utilisation	   de	   micro-­‐organismes	   comme	  plateforme	   industrielle.	   L’ingénierie	   métabolique	   joue	   un	   rôle	   clef	   dans	   ce	   schéma,	  puisqu’elle	  fournit	  les	  outils	  nécessaires	  à	  une	  modification	  ciblée	  du	  métabolisme	  des	  micro-­‐organismes	   afin	   de	   créer	   des	   usines	   microbiennes	   capables	   de	   convertir	   un	  substrat	   primaire	   en	   un	   produit	   chimique	   à	   haute	   valeur	   ajoutée.	   Actuellement,	   on	  observe	   l’utilisation	  de	   trois	   approches	  pour	  modifier	  un	  micro-­‐organisme	  et	   lui	   faire	  produire	   une	   molécule	   d’intérêt	  :	   (i)	   L’optimisation	   des	   voies	   métaboliques	  préexistantes	   chez	   l’hôte,	   (ii)	   l’incorporation	   de	   voies	  métaboliques	   appartenant	   à	   un	  autre	   organisme,	   (iii)	   la	   construction	   et	   l’introduction	   de	   voies	   métaboliques	  synthétiques	   dans	   ledit	   organisme.	   Jusqu’à	  maintenant,	   les	   deux	   premières	  méthodes	  ont	  été	  les	  plus	  explorées	  et	  utilisées.	  Toutefois,	  il	  existe	  encore	  de	  nombreux	  composés	  pour	   lesquels	   il	  n’y	  a	  pas	  de	  voie	  métabolique	  connue	  présentant	  hauts	   rendement	  et	  productivité.	   C’est	   pourquoi	   la	   troisième	   approche,	   la	   construction	   de	   voies	  synthétiques,	  reste	  primordiale	  afin	  d’assurer	  le	  développement	  de	  la	  bio-­‐production	  de	  produits	  chimiques	  à	  haute	  valeur	  ajoutée.	  Afin	  de	  créer	  et	  construire	  de	  nouvelles	  voies	  métaboliques,	  il	  est	  nécessaire	  d’avoir	  une	  compréhension	   exhaustive	   du	   métabolisme.	   Pour	   le	   moment,	   même	   des	   organismes	  pourtant	   très	   étudiés	   comme	  Saccharomyces	  Cerevisiae	   ou	  Escherichia	  Coli	   présentent	  des	   lacunes	  dans	   leurs	  modèles	  métaboliques,	   et	   les	   chercheurs	   continuent	  encore	  de	  découvrir	   et	   caractériser	   de	   nouveaux	   gènes,	   enzymes,	   interactions	   biochimiques	   et	  mécanismes	  réactionnels.	  La	  complexité	  des	  réseaux	  métaboliques	  n’est	  pas	  intuitive,	  et	  c’est	  pourquoi	  des	  méthodes	  computationnelles	  sont	   indispensables	  pour	   l’explorer	  et	  améliorer	  la	  connaissance	  actuelle	  du	  métabolisme	  en	  général,	  afin	  d’être	  en	  mesure	  de	  maximiser	  l’impact	  du	  potentiel	  enzymatique	  des	  micro-­‐organismes.	  Dans	   cette	   thèse,	   à	   l’aide	   du	   développement	   et	   de	   l’application	   de	   méthodes	  computationnelles	   de	   pointe,	   j’ai	   oriente	   ma	   recherche	   vers	   la	   compréhension	   du	  métabolisme	   cellulaire,	   dans	   le	   but	   d’en	   découvrir	   plus	   sur	   les	   réseaux	  métaboliques.	  J’analyse	  différents	  aspects	  du	  métabolisme	  via	  cinq	  études	  distinctes.	  La	  première	  adopte	  un	  point	  de	  vue	  holistique,	  et	  s’intéresse	  à	  l’ensemble	  des	  réactions	  enzymatiques	   connues.	   J’y	   propose	   une	   approche	   computationnelle	   permettant	  d’identifier	   toutes	   les	   réactions	   enzymatiques	   théoriquement	   possibles,	   à	   partir	   des	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interactions	  biochimiques	  déjà	  connues.	  Les	  résultats	  sont	  organisés	  dans	  une	  base	  de	  donnée	  appelée	  Atlas	  de	  la	  biochimie.	  La	  seconde	  étude	  s’intéresse	  à	  un	  des	  systèmes	  les	  plus	  structurellement	  versatiles,	  et	  néanmoins	  indispensables,	  du	  métabolisme	  :	  le	  métabolisme	  des	  lipides.	  J’y	  propose	  une	  méthodologie	  computationnelle	  permettant	  d’intégrer	  dans	  un	  réseau	  métabolique	  des	  lipides	  n’ayant	  pas	  de	  voie	  métabolique	  ou	  catabolique	  connue.	  Le	  chapitre	  suivant	  porte	  sur	   l’exploration	  de	   la	  totalité	  de	   la	  capacité	  métabolique	  de	  
Escherichia	   Coli.	   J’y	   recense	   tout	   le	   potentiel	   enzymatique	   de	   cet	   organisme,	   et	   y	  introduis	  «	  Super	  E.	  Coli	  »,	  un	  nouveau	  châssis	  servant	  de	  cadre	  d’étude	  pour	  l’ingénierie	  métabolique	  de	  cet	  organisme.	  La	  pénultième	  contribution	  s’attache	  au	  développement	  d’une	  méthode	  de	  description	  atomique	   des	   réseaux	  métaboliques.	   J’y	   démontre	   la	   pertinence	   de	  mon	   approche	   en	  reconstruisant	  une	   carte	  métabolique	  à	   l’échelle	   atomique	  du	  métabolisme	  central	  du	  carbone	  chez	  Escherichia	  Coli,	  et	  explique	  comment	  une	  analyse	  métabolique	  exhaustive	  à	  cette	  échelle	  peut	  guider	  la	  conception	  de	  nouveaux	  protocoles	  expérimentaux	  visant	  à	  obtenir	  des	  données	  biologiques	  plus	  détaillées	  Enfin,	  La	  dernière	  étude	  s’intéresse	  à	   l’étude	  thermodynamique	  du	  métabolisme,	  et	   j’y	  présente	  une	  approche	  originale	  estimant	  les	  propriétés	  thermodynamiques	  d’un	  grand	  nombre	   de	   métabolites.	   Jusqu’à	   présent,	   les	   données	   thermodynamiques	   provenant	  d’expériences	   ou	   bien	   de	   méthodes	   computationnelles	   sont	   estimées	   dans	   l’état	  thermodynamique	  standard,	  qui	  est	  typiquement	  différent	  des	  conditions	  cellulaires.	  La	  méthodologie	   présentée	   établit	   les	   bases	   d’un	   calcul	   précis	   des	   propriétés	  thermochimiques	   des	   métabolites,	   dans	   des	   conditions	   de	   pression	   et	   température	  physiologiques.	  En	  conclusion,	  je	  récapitule	  les	  implications	  de	  ces	  différents	  projets,	  et	  élabore	  sur	  les	  applications	   potentielles	   des	   méthodes	   computationnelles	   développées	   dans	   cette	  thèse.	  	  













LIST	  OF	  FIGURES....................................................................................................................................................................11	  




Graphical	  description	  of	  thesis	  structure....................................................................................................................15	  	  
Chapter	  1	   BACKGROUND	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  17	  
1.1	   Metabolism,	  from	  metabolic	  pathways	  to	  metabolic	  networks	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  17	  
1.2	   Lipid	  metabolism	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  19	  
1.3	   Atom	  transition	  in	  metabolism	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  20	  
1.4	   Bioenergetics	  of	  metabolism	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  21	  
1.5	   Systems	  biology	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  24	  
1.6	   Synthetic	  biology	  and	  metabolic	  engineering	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  24	  
1.7	   Data	  organization	  in	  biological	  and	  chemical	  databases	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  25	  
Chapter	  2	   METHODOLOGY	  &	  THEORY	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  27	  
2.1	   Computational	  methods	  for	  metabolic	  network	  analysis	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  27	  
2.1.1	   Genome-­‐scale	  metabolic	  models	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  28	  
2.1.2	   In	  silico	  pathway	  design	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  29	  
2.1.3	   Retrobiosynthesis	  for	  de	  novo	  pathways	  design	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  30	  
2.2	   BNICE.ch	  framework	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  32	  
2.2.1	   Internal	  and	  external	  databases	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  33	  
2.2.2	   Metabolic	  network	  generation	  in	  BNICE.ch	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  36	  
2.2.3	   Pathway	  enumeration	  algorithm	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  39	  
2.2.4	   Pruning	  the	  generated	  data	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  39	  
2.2.5	   BridgIt	  analysis	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  45	  
2.2.6	   Scoring	  and	  ranking	  the	  biosynthetic	  pathways	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  49	  
2.3	   In	  silico	  atom	  mapped	  network	  integrated	  computational	  explorer	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  50	  
2.4	   Biothermochemical	  computations	  for	  studies	  of	  metabolism	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  53	  
2.4.1	   Overview	  of	  high-­‐level	  quantum	  chemical	  calculations	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  54	  
2.4.2	   Computational	  tools	  used	  for	  high-­‐level	  quantum	  calculations	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  55	  
Chapter	  3	   ATLAS	  of	  BIOCHEMISTRY	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  59	  
3.1	   Introduction	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  60	  
3.2	   Methods	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  61	  
3.2.1	   Preprocessing	  of	  KEGG	  compounds	  and	  reactions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  61	  
3.2.2	   Reconstructing	  KEGG	  reactions	  and	  predicting	  de	  novo	  reactions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  62	  
	   8	  
3.2.3	   BridgIt	  Analysis	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  63	  
3.3	   Results	  and	  discussions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  64	  
3.3.1	   KEGG	  reactions	  covered	  by	  BNICE	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  64	  
3.3.2	   Multi-­‐step	  reactions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  65	  
3.3.3	   Exploring	  the	  potential	  enzymatic	  capacity	  of	  biological	  compounds	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  65	  
3.3.4	   Validating	  the	  action	  of	  generalized	  reaction	  rules	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  66	  
3.3.5	   BridgIT	  analysis	  of	  novel	  reactions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  66	  
3.4	   Conclusions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  68	  
Chapter	  4	   NICELips	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  69	  
4.1	   Introduction	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  70	  
4.2	   Methods	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  73	  
4.2.1	   Generalized	  reaction	  rules	  in	  glycerophospholipid	  metabolism	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  73	  
4.2.2	   Forward	  network	  generation	  within	  NICELips	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  76	  
4.2.3	   Retrobiosynthesis	  algorithm	  within	  NICELips	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  79	  
4.2.4	   Pathway	  enumeration	  algorithm	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  79	  
4.2.5	   Thermodynamic	  studies	  of	  the	  generated	  pathway	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  80	  
4.3	   Results	  and	  discussion	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  80	  
4.3.1	   Exploring	  glycerophospholipid	  metabolism	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  80	  
4.3.2	   Expansion	  of	  the	  glycerophospholipid	  KEGG	  pathway	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  85	  
4.3.3	   Retrobiosynthesis	  of	  bis(monoacylglycero)phosphate	  (BMP)	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  86	  
4.3.4	   Thermodynamic	  feasibility	  studies	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  89	  
4.4	   Conclusions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  90	  
Chapter	  5	   SUPER	  E.	  coli	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  93	  
5.1	   Introduction	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  94	  
5.2	   Methods	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  95	  
5.2.1	   Construction	  of	  a	  “super”	  metabolic	  network	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  96	  
5.2.2	   Integration	  of	  novel	  reactions	  in	  genome	  scale	  model	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  98	  
5.2.3	   Identifying	  sets	  of	  reactions	  that	  increase	  the	  biomass	  yield	  in	  E.	  coli	  network	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐	  99	  
5.2.4	   Thermodynamic-­‐Based	  Flux	  Balance	  Analysis	  (TFBA)	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  100	  
5.2.5	   Gap-­‐filling	  analysis	  by	  using	  novel	  reactions	  in	  E.	  coli	  network	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  100	  
5.2.6	   BridgIt	  analysis	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  101	  
5.3	   Results	  and	  discussions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  101	  
5.3.1	   E.	  coli	  super	  metabolic	  network	  reconstruction	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  101	  
5.3.2	   Characteristics	  of	  de	  novo	  metabolic	  network	  of	  E.	  coli	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  102	  
5.3.3	   Sets	  of	  reactions	  that	  increase	  the	  biomass	  yield	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  103	  
5.3.4	   TFBA	  of	  E.	  coli	  metabolic	  network	  along	  with	  different	  sets	  of	  reactions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  104	  
5.3.5	   Analysis	  of	  dead-­‐end	  metabolites	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  105	  
5.3.6	   BridgIt	  analysis	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  106	  
5.4	   Conclusions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  106	  
Chapter	  6	   iAM.NICE!	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  107	  
6.1	   Introduction	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  108	  
6.2	   Methods	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  108	  
6.2.1	   In	  silico	  atom	  labelling	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  108	  
6.2.2	   Atom-­‐mapped	  reactions:	  transferring	  labelled	  substrates	  to	  labelled	  products	  -­‐-­‐-­‐-­‐-­‐	  110	  
6.2.3	   Atom-­‐mapped	  pathways	  and	  networks	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  111	  
6.3	   Results	  and	  discussion	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  113	  
6.3.1	   Atom	  mapping	  for	  single	  enzymatic	  reactions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  113	  
6.3.2	   Atom	  mapping	  for	  metabolic	  pathways	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  113	  
6.3.3	   Atom	  mapped	  E.	  Coli	  core	  metabolic	  network	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  116	  
	   9	  
6.4	   Conclusions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  123	  
Chapter	  7	   THERMODYNAMICS	  of	  METABOLISM	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  125	  
7.1	   Introduction	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  126	  
7.2	   Methods	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  127	  
7.2.1	   Accounting	  for	  conformers,	  anomers	  and	  tautomers	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  127	  
7.2.2	   Selection	  of	  isodesmic	  reactions	  for	  calculation	  of	  heats	  and	  Gibbs	  free-­‐energies	  of	  
formation	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  131	  
7.2.3	   Thermochemical	  calculations	  for	  neutral	  metabolites	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  136	  
7.2.4	   Thermochemical	  calculations	  for	  ionic	  metabolites	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  136	  
7.3	   Results	  and	  discussion	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  138	  
7.3.1	   Thermochemical	  properties	  of	  neutral	  metabolites	  in	  ideal	  gas	  phase	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  138	  
7.3.2	   Thermochemical	  properties	  of	  ionized	  metabolites	  in	  ideal	  gas	  phase	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  143	  
7.4	   Conclusions	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  150	  




















	   	  
	  10	  
	  
	   	  
	  11	  
LIST	  of	  FIGURES	  
FIGURE	  2-­‐1:	  OUR	  PROPOSED	  WORKFLOW	  FOR	  A	  RETROBIOSYNTHESIS	  FRAMEWORK	  .................................................................	  32	  
FIGURE	  2-­‐2:	  WORKFLOW	  OF	  THE	  BNICE.CH	  FRAMEWORK	  ............................................................................................................	  34	  
FIGURE	  2-­‐3:	  EXAMPLE	  OF	  THE	  ACTION	  OF	  A	  GENERALIZED	  REACTION	  RULE	  ................................................................................	  35	  
FIGURE	  2-­‐4:	  FORWARD	  NETWORK	  GENERATION	  WITH	  BNICE.CH	  ................................................................................................	  42	  
FIGURE	  3-­‐1:	  A	  TWO-­‐STEP	  REACTION	  OF	  KEGG	  DATABASE	  THAT	  DO	  NOT	  HAVE	  A	  CORRESPONDING	  ENZYME	  FOR	  CATALYZING	  IT	  ...............................................................................................................................................................................	  65	  
FIGURE	  3-­‐2:	  THE	  DISTRIBUTION	  OF	  THE	  HIGHEST	  SIMILARITY	  SCORE	  THAT	  DIFFERENT	  METHODS	  OF	  BRIDGIT	  ....................	  67	  
FIGURE	  3-­‐3:	  COMPARING	  THE	  SIMILARITY	  OF	  THE	  CLOSET	  KEGG	  REACTION	  THAT	  EACH	  METHOD	  PREDICTS	  FOR	  NOVEL	  REACTIONS	  .....................................................................................................................................................................................	  68	  
FIGURE	  4-­‐1:	  GENERAL	  STRUCTURE	  OF	  GLYCEROPHOSPHOLIPIDS	  ...................................................................................................	  70	  
FIGURE	  4-­‐2:	  THE	  NICELIPS	  FRAMEWORK	  .........................................................................................................................................	  74	  
FIGURE	  4-­‐3:	  (A)	  COMPOUNDS	  GENERATED	  THROUGH	  THE	  RECONSTRUCTION	  OF	  GLYCEROPHOSPHOLIPID	  PATHWAY	  USING	  NICELIPS.	  THE	  NUMBER	  OF	  COMPOUNDS	  INCREASES	  IN	  EACH	  ITERATION.	  (B)	  TOTAL	  NUMBER	  OF	  REACTIONS	  AND	  KEGG	  REACTIONS	  GENERATED	  IN	  EACH	  ITERATION.	  ..............................................................................................................	  86	  
FIGURE	  4-­‐4:	  THE	  DE	  NOVO	  PATHWAY	  FOR	  PG	  BIOSYNTHESIS	  .........................................................................................................	  87	  
FIGURE	  4-­‐5:	  THE	  RESULTS	  OF	  THE	  RETROSYNTHESIS	  ALGORITHM	  APPLIED	  FOR	  BMP	  ..............................................................	  88	  
FIGURE	  4-­‐6:	  PATHWAY	  RECOSNTRUCTION	  FOR	  BMP	  .......................................................................................................................	  88	  
FIGURE	  5-­‐1	  :	  THE	  WORKFLOW	  FOR	  GENERATING	  THE	  “SUPER	  E.	  COLI”	  METABOLIC	  NETWORK	  ................................................	  96	  
FIGURE	  5-­‐2	  :	  THE	  CORE	  METABOLIC	  NETWORK	  OF	  E.	  COLI	  ..............................................................................................................	  97	  
FIGURE	  5-­‐3:	  TOTAL	  NUMBER	  OF	  GENERATED	  COMPOUNDS	  ...........................................................................................................	  102	  
FIGURE	  5-­‐4:	  TOTAL	  NUMBER	  OF	  REACTIONS	  ....................................................................................................................................	  102	  
FIGURE	  6-­‐1:	  DEPENDING	  ON	  THE	  PURPOSE	  OF	  THE	  IN	  SILICO	  LABELING	  STUDY,	  WE	  CHOOSE	  A	  DIFFERENT	  ISOTOPOMER	  AS	  STARTING	  COMPOUND.	  ...............................................................................................................................................................	  110	  
FIGURE	  6-­‐2:	  BEM	  REPRESENTATION	  OF	  AN	  ATOM-­‐MAPPED	  EXAMPLE	  REACTION	  ....................................................................	  112	  
FIGURE	  6-­‐3:	  AN	  EXAMPLE	  OF	  A	  CARBON	  ATOM-­‐MAPPED	  REACTION	  IS	  GIVEN	  FOR	  EACH	  EC	  CLASS.	  .......................................	  114	  
FIGURE	  6-­‐4:	  GLYCOLYSIS	  PATHWAY	  RECONSTRUCTED	  FROM	  A	  FULLY	  CARBON-­‐LABELLED	  GLUCOSE	  .....................................	  115	  
FIGURE	  6-­‐5:	  ALTERING	  THE	  POSITION	  OF	  THE	  LABEL	  (FROM	  C1	  TO	  C6)	  INFLUENCES	  THE	  SIZE	  OF	  THE	  NETWORK	  ............	  118	  
FIGURE	  6-­‐6:	  SECTION	  OF	  THE	  ATOM-­‐MAPPED	  E.	  COLI	  CORE	  METABOLISM	  IS	  PRESENTED	  FOR	  SINGLE	  IN	  SILICO	  LABELLED	  CARBON	  OF	  GLUCOSE,	  CHANGING	  FROM	  C1	  TO	  C6.	  ................................................................................................................	  123	  
FIGURE	  7-­‐1:	  A:	  COMPARISON	  OF	  MOST	  STABLE	  STRUCTURES	  .......................................................................................................	  128	  
FIGURE	  7-­‐2:	  THE	  MOLE	  FRACTION	  OF	  CONFORMERS	  AT	  EQUILIBRIUM	  AS	  A	  FUNCTION	  OF	  THE	  CORRESPONDING	  RELATIVE	  GIBBS	  FREE	  ENERGY	  OF	  FORMATION	  FOR	  ASPARTIC	  ACID.	  ...................................................................................................	  129	  
FIGURE	  7-­‐3:	  THE	  TAUTOMERS	  OF	  HYPOXANTHINE	  ....................................................................................................................	  130	  
FIGURE	  7-­‐4:	  CONFORMERS	  OF	  GLYCEROL	  AND	  ETHYLENE	  GLYCOL	  WITH	  AND	  WITHOUT	  INTRAMOLECULAR	  HYDROGEN	  BONDS.	  ..........................................................................................................................................................................................	  132	  
FIGURE	  7-­‐5:	  FORMATION	  FREE	  ENERGY	  OF	  PROTONATED	  AND	  DEPROTONATED	  AMINOACIDS	  VS.	  THE	  FORMATION	  FREE	  ENERGY	  OF	  THEIR	  NEUTRAL	  COUNTERPARTS	  .........................................................................................................................	  147	  
FIGURE	  7-­‐6:	  FORMATION	  ENTHALPIES	  OF	  PROTONATED	  AND	  DEPROTONATED	  AMINOACIDS	  VS.	  THE	  FORMATION	  ENTHALPY	  OF	  THEIR	  NEUTRAL	  COUNTERPARTS.	  .......................................................................................................................................	  147	  
FIGURE	  7-­‐7:	  FORMATION	  FREE	  ENERGIES	  OF	  PROTONATED	  AND	  DEPROTONATED	  COMPOUNDS	  (INCLUDING	  AMINOACIDS)	  VS.	  THE	  FORMATION	  ENTHALPY	  OF	  THEIR	  NEUTRAL	  COUNTERPARTS.	  THE	  LINES	  ARE	  LINEAR	  FITS.	  ............................	  149	  




LIST	  of	  TABLES	  
TABLE	  2-­‐1:	  AVAILABLE	  DE	  NOVO	  PATHWAY	  RECONSTRUCTION	  TOOLS	  AND	  THEIR	  AVAILABILITY	  ............................................	  30	  
TABLE	  2-­‐2:	  5	  LEVELS	  OF	  SUPERVISION	  IN	  BNICE.CH.	  ......................................................................................................................	  43	  
TABLE	  3-­‐1:	  THE	  LEVEL	  OF	  SUPERVISIONS	  THAT	  IS	  APPLIED	  IN	  THIS	  STUDY	  FOR	  THE	  GENERALIZED	  REACTION	  RULES,	  COMPOUNDS	  AND	  REACTIONS.	  .....................................................................................................................................................	  63	  
TABLE	  4-­‐1:	  THE	  SET	  OF	  ENZYME	  RULES	  INVOLVED	  IN	  KNOWN	  GLYCEROPHOSPHOLIPID	  PATHWAYS	  ........................................	  75	  
TABLE	  4-­‐2:	  APPLIED	  LEVELS	  OF	  SUPERVISION	  FOR	  THE	  ANALYSIS	  OF	  THE	  SCHEME	  1.	  ...............................................................	  77	  
TABLE	  4-­‐3:	  APPLIED	  LEVELS	  OF	  SUPERVISION	  FOR	  THE	  ANALYSIS	  OF	  THE	  SCHEME	  2&3.	  .........................................................	  77	  
TABLE	  4-­‐4:	  STATISTICS	  OF	  COMPOUNDS	  AND	  REACTIONS	  GENERATED	  IN	  THE	  FIRST	  SCHEME	  OF	  NICELIPS	  ALGORITHM.	  ..	  82	  
TABLE	  4-­‐5:	  RESULTS	  OF	  THE	  CLASSIFICATION	  OF	  THE	  NOVEL	  COMPOUNDS	  .................................................................................	  83	  
TABLE	  4-­‐6:	  A	  CLOSER	  LOOK	  THE	  COMPOUNDS	  OF	  THE	  PG	  CLASS.	  ..................................................................................................	  84	  
TABLE	  4-­‐7:	  A	  SUMMARY	  OF	  RESULTS	  OF	  THERMOYNAMICS	  FEASIBILITY	  STUDIES	  OF	  BMP.	  ......................................................	  90	  
TABLE	  5-­‐1:	  THE	  SUPERVISION	  LEVEL	  FOR	  THE	  REACTIONS	  RULES	  IS	  ON	  THE	  NETWORK	  LEVEL,	  FOR	  THE	  COMPOUNDS	  ON	  THE	  DATABASE	  (KEGG)	  LEVEL	  AND	  THERE	  WAS	  NO	  CONSTRAINT	  FOR	  THE	  REACTIONS	  AND	  ALL	  THE	  POSSIBLE	  REACTIONS	  (KNOWN	  AND	  NOVEL)	  ARE	  ALLOWED	  IN	  THE	  NETWORK	  GENERATION	  PROCESS	  ................................................................	  98	  
TABLE	  5-­‐2:	  TOTAL	  NUMBER	  OF	  GENERATED	  SETS	  OF	  REACTIONS	  THAT	  INCREASE	  THE	  YIELD	  	  ...............................................	  104	  
TABLE	  5-­‐3:	  LIST	  OF	  METABOLITES	  THAT	  WERE	  DEAD-­‐END	  METABOLITES	  IN	  THE	  NATIVE	  E.	  COLI	  AND	  ARE	  NOT	  DEAD-­‐END	  IN	  THE	  DE	  NOVO	  METABOLIC	  NETWORK.	  ..................................................................................................................................	  105	  
TABLE	  6-­‐1:	  THE	  LEVEL	  OF	  SUPERVISION	  THAT	  WE	  APPLIED	  FOR	  THE	  RECONSTRUCTION	  OF	  THE	  ATOM-­‐MAPPED	  CORE	  METABOLIC	  NETWORK	  OF	  E	  .COLI	  .............................................................................................................................................	  117	  
TABLE	  7-­‐1:	  THE	  PREDICTED	  THERMOCHEMICAL	  QUANTITIES	  FOR	  GLYCEROL	  BASED	  ON	  QUANTUM	  CHEMICAL.	  ..................	  133	  
TABLE	  7-­‐2:	  THE	  ISODESMIC	  REACTIONS	  FOR	  NEUTRAL	  METABOLITES	  ........................................................................................	  133	  
TABLE	  7-­‐3:	  ESTIMATED	  STANDARD	  THERMOCHEMICAL	  PROPERTIES	  (IDEAL	  GAS	  PHASE).	  .....................................................	  139	  
TABLE	  7-­‐4:	  ESTIMATED	  GAS-­‐PHASE	  ACIDITIES	  AND	  STANDARD	  THERMOCHEMICAL	  PROPERTIES	  OF	  IONIC	  METABOLITES.	  CALCULATIONS	  AS	  IN	  TABLE	  8.3.	  ALL	  QUANTITIES	  ARE	  GIVEN	  IN	  KJMOL-­‐1.	  ......................................................................	  143	  
TABLE	  7-­‐5:	  ESTIMATED	  STANDARD	  THERMOCHEMICAL	  QUANTITIES	  (IDEAL	  GAS	  PHASE)	  OF	  IONIC	  METABOLITES	  FROM	  CORRESPONDING	  PROPERTIES	  FOR	  NEUTRAL	  METABOLITES.	  ..............................................................................................	  145	  
	  
TABLES	  IN	  THE	  APPENDIX	  
TABLE	  A1:	  PROPOSED	  EC	  CLASSIFICATION	  NUMBER	  UP	  TO	  THE	  THIRD	  LEVEL	  BY	  BNICE.CH	  FOR	  178	  KEGG	  REACTIONS	  THAT	  ARE	  MISSING	  AN	  EC	  NUMBER.	  
TABLE	  A2:	  LIST	  OF	  THE	  81	  NOVEL	  REACTIONS	  OF	  BNICE.CH	  IN	  2012	  THAT	  BECAME	  KNOWN	  IN	  KEGG	  2014	  
TABLE	  A3:	  THERMOCHEMICAL	  DATA	  FOR	  THE	  REACTANTS	  OF	  ISODESMIC	  REACTIONS	  
TABLE	  A4:	  THERMOCHEMICAL	  QUANTITIES	  OF	  NEUTRAL,	  DEPROTONATED,	  AND	  PROTONATED	  AMINOACIDS.	  AND	  COMPARISON	  WITH	  LITERATURE	  VALUES	  	  
TABLE	  A5:	  PARAMETERS	  OF	  LINEAR	  FITS	  IN	  FIGURES	  7.5	  AND	  7.6	  
TABLE	  A6:	  PARAMETERS	  OF	  LINEAR	  FITS	  IN	  FIGURES	  7.7	  AND	  7.8	  	  
	  13	  
INTRODUCTION	  
Motivation	  For	   the	   first	   time	   ever,	   half	   of	   the	   people	   living	   on	   earth	   are	   urban	   residents	   and	   by	  2050,	  it	  is	  expected	  that	  70%	  of	  the	  global	  population	  will	  live	  in	  the	  cities	  [1].	  Rural	  to	  urban	   migration	   brings	   forward	   new	   challenges	   relevant	   to	   the	   urban	   population	  growth	   in	   the	   future.	   Urban	   communities	   are	   facing	   two	   big	   challenges:	   (i)	   limited	  energy	   and	   food	   resources	   and	   (ii)	   unsustainable	   consumption	   of	   these	   resources,	  which	  result	  in	  increasing	  waste	  streams	  production	  and	  CO2	  emissions.	  These	  are	  two	  of	  the	  most	  critical	  issues	  for	  the	  next	  generations	  and	  are	  tightly	  linked	  to	  the	  fact	  that	  the	  world’s	  population	  is	  extremely	  fossil	  fuel	  dependent	  [2].	  	  The	  creation	  of	  sustainable	  “white”	  cities	  would	  be	  the	  ultimate	  solution	  and	  is	  pictured	  as:	  cities	  that	  exploit	  the	  benefits	  of	  white	  biotechnology.	  	  We	  can	   imagine	   future	  urban	  habitations	  where	  the	  city	  powers	   itself	  with	  renewable	  sources	  of	  energy,	  recycles	  material	  at	  various	  levels	  (food,	  clothing,	  objects	  of	  daily	  use,	  etc.),	   converts	   non-­‐recyclable	   waste	   to	   energy,	   and	   thereby	   reduces	   the	   ecological	  footprint.	  White	  biotechnology	  promises	  the	  biologically	  and	  ecologically	  sustainable	  production	  of	   valuable	   chemicals,	   fuels	   and	   other	   high	   value	   products	   using	   “modified”	  microorganisms	  known	  as	  Synthetic	  Microbial	  Cell	  Factories	  (SMCFs),	  which	  serve	  as	  a	  substitution	   to	   the	   unsustainable	   petrochemical-­‐based	   processes	   [3,4].	   These	   robust	  biological	   machines	   are	   designed	   as	   revolutionary	   platforms	   to	   produce	   valuable	  chemicals	  and	  biofuels	  (to	  address	  the	  limited	  sources	  of	  fossil	  fuels)	  using	  sustainable	  resources	  and	  waste	  biomass	   (to	  address	  environmental	   concerns).	  Therefore,	   SMCFs	  are	   the	   ideal	  means	   for	  building	  and	   supporting	  white	   cities	   through	   closing	   the	   loop	  cycle	  of	  waste	  being	  turned	  into	  valuable	  products	  and	  sustainable	  energy	  sources.	  	  However,	  most	  of	  natural	  organisms	  cannot	  directly	   serve	  as	  MCF	   to	  produce	  desired	  compounds	  or	   to	  decompose	  man-­‐made	  material	   used	   in	  modern	   lifestyle.	  Therefore,	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prior	  to	  their	  application	  as	  MCFs,	  the	  platform	  microorganisms	  need	  to	  be	  adapted	  and	  genetically	   modified	   through	   retrofitting	   and	   optimization	   processes	   introduced	   in	  
synthetic	  biology	  and	  metabolic	  engineering	  disciplines.	  The	  very	  important	  question	  is	  how	  to	  manipulate	  and	  harness	  the	  metabolic	  capabilities	  of	  organisms.	  To	  do	  such	  modifications	   through	  metabolic	  engineering,	  one	  should	  have	  a	   complete	  understanding	  of	  metabolism	  across	  different	  organisms	  and	  how	  metabolic	  processes	  determine	   and	   regulate	   the	   physiological	   and	   biochemical	   properties	   of	   a	   cell.	  Metabolism	   comprises	   all	   the	   biochemical	   transformations	   that	   occur	   in	   living	  organisms,	   and	   is	   organized	   through	   interconnected	   metabolic	   and	   regulatory	  networks.	  	  Metabolism	   is	   extremely	   complex	   and	   requests	   a	   systems	   approach	   towards	  understanding	  the	   involved	  metabolic	  processes	   for	  delivering	  solutions	   for	  metabolic	  engineering	   applications.	   With	   the	   emergence	   and	   current	   progress	   made	   in	   high	  throughput	   technologies,	   great	   quantities	   of	   biochemical	   and	   biological	   data	   are	  generated	   in	   genomics,	  metabolomics	   and	   proteomics	   studies	   that	   help	   elucidate	   the	  constituents	  of	  metabolic	  and	  regulatory	  networks	  and	  their	  interactions.	  Mathematical	   approaches	   are	   proven	   to	   be	   imperative	   for	   organizing	   and	   integrating	  the	  generated	  “omics”	  data	  into	  metabolic	  models	  and	  to	  enhance	  our	  understanding	  of	  metabolism	   and	   uncovering	   its	   complexity.	   Mathematical	   descriptions	   of	   metabolism	  (metabolic	  models)	   allow	   a	   systematic	   compilation	   of	   the	   generated	  omics	   data	   of	   an	  organism	   and	   their	   analysis	   allows	   acquiring	   significant	   knowledge	   about	   the	   entire	  metabolic	  network.	  Understanding	  the	  metabolism	  is	  not	  only	  crucial	  for	  the	  success	  of	  metabolic	   engineering	   through	   design	   and	   delivering	   microbial	   platforms	   for	   white	  biotechnology,	   but	   also	   has	   important	   implications	   for	   discovering	   novel	   therapeutic	  approaches	   by	   unraveling	   the	   complicated	   mechanisms	   leading	   to	   diseases	   where	  metabolism	  plays	  a	  critical	  role.	  The	   aim	   of	   this	   thesis	   is	   the	   development	   of	   a	   suite	   of	   computational	   methods	   to	  investigate	  metabolic	  networks	  and	  to	  gain	  novel	  biological	  perceptions	  of	  metabolism.	  We	  apply	  our	  methods	  in	  a	  diverse	  range	  of	  problems	  in	  systems	  biology.	  Doing	  so,	  we	  demonstrate	   how	   computational	   approaches	   coupled	   with	   the	   engineering	  fundamentals	  of	  process	  design	  can	  explore	  and	  expand	  the	  potential	  of	  metabolism.	  As	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such,	  the	  outcome	  of	  this	  thesis	  highlights	  the	  importance	  of	  computational	  approaches	  in	  accelerating	  metabolic	  engineering	  studies	  and	   in	  providing	  guidance	   for	  designing	  therapeutic	  interventions.	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Chapter	  ) 	  
BACKGROUND	  
In	   this	   chapter	   we	   review	   essential	   biological	   and	   chemical	   notions	   and	   definitions	  important	   for	   this	   thesis	   including	   metabolism	   and	   its	   relevant	   subjects	   such	   as	  metabolic	   pathways,	  metabolic	   network	   and	  metabolic	  models.	  We	   further	   focus	   our	  attention	   on	   the	   lipid	   metabolism	   and	   its	   significant	   roles	   in	   most	   of	   the	   biological	  systems	  and	  its	  association	  with	  several	  diseases.	  An	  introduction	  to	  atom	  transition	  in	  metabolism	  and	  the	  bioenergetics	  of	  metabolism	  are	  followed.	  	  We	   also	   briefly	   present	   the	   emerging	   research	   fields	   of	   systems	   biology,	   synthetic	  biology	  and	  metabolic	  engineering	  that	  rely	  on	  the	  understanding	  of	  metabolism	  and	  for	  which	  the	  outcome	  of	  this	  thesis	  would	  have	  several	  applications.	  Finally	  we	  introduce	  and	   explain	   the	   importance	   of	   available	   biological	   and	   chemical	   databases	   and	   their	  organizations.	  
1.1 Metabolism,	  from	  metabolic	  pathways	  to	  metabolic	  networks	  
Metabolism	   is	   the	   ensemble	   of	   biological	   reactions	   that	   consecutively	   interconvert	  metabolites	  in	  the	  living	  cells	  to	  sustain	  life.	  These	  biochemical	  reactions	  are	  catalyzed	  by	   specialized	  proteins,	   called	  enzymes,	  which	   convert	  nutrient	  molecules	   to	  biomass	  building	  blocks	  and	  release	  energy	  to	  power	  different	  biochemical	  processes	  in	  the	  cell	  needed	   for	  growth	   [5].	  Metabolism	   is	  one	  of	   the	  most	   complex	  cellular	  processes	  and	  understanding	  it	  is	  crucial	  to	  many	  disciplines	  such	  as	  systems	  biology,	  biotechnology,	  medicine	  and	  pharmaceutical	  research	  for	  designing	  new	  drugs	  [6].	  For	   facilitating	   the	   study	   of	   metabolism,	   researchers	   usually	   divide	   it	   into	   two	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categories:	  catabolism	  and	  anabolism.	  They	   further	  categorize	   it	   into	  smaller	  subunits	  called	  metabolic	  pathways	  [7].	  	  Metabolic	  pathways	  are	  a	  series	  of	  enzyme-­‐catalyzed	  reaction	  steps	  which	  convert	  one	  compound	   into	   another	   through	   catabolic	   or	   anabolic	   ways.	   In	   the	   case	   of	   breaking	  down	  and	  oxidizing	   the	   large	  molecules	   (nutrient	   and	   etc.)	   into	   small	   substrates,	   this	  process	   is	   called	   catabolism.	   Catabolic	   pathways	   deliver	   the	   energy	   and	   substrates	  needed	   for	   anabolism.	  Anabolic	  pathways	  make	   use	   of	   the	   released	   energy	   and	   small	  molecules	   from	   catabolic	   reactions	   to	   produce	   molecules	   that	   construct	   the	   cell	  components	  such	  as	  proteins,	  lipids	  and	  amino	  acids	  [8].	  	  Traditionally,	  biologist	  studied	  metabolism	  by	  focusing	  on	  a	  specific	  metabolic	  pathway	  and	   investigated	   the	   different	   involved	   reaction	   steps	   and	   enzymes,	   using	   different	  approaches	  such	  as	  tracer	  experiments	  [9].	  These	  analyses	  provided	  significant	  insights	  into	  metabolism	  and	  brought	  a	  clear	  understanding	  of	  the	  structure	  and	  the	  function	  of	  canonical	   metabolic	   pathways,	   such	   as	   glycolysis	   (the	   first	   discovered	   metabolic	  pathway),	  pentose	  phosphate	  pathway,	  citric	  acid	  cycle,	  etc.	  	  However,	  it	   is	  now	  believed	  that	  the	  metabolic	  pathways	  do	  not	  function	  as	  individual	  isolated	  constituents	  and	  that	  their	  simultaneous	  function	  and	  interactions	  result	  in	  an	  extremely	   connected	   complex	   network	   [10].	   Hence,	   the	   historical	   reductionist	   and	  simplified	  approaches	  cannot	  address	  numerous	  questions	  arising	  from	  the	  study	  of	  the	  whole	  cell	  where	  the	  interactions	  of	  different	  parts	  create	  the	  emergent	  properties	  and	  behaviors.	  The	  plethora	  of	  all	  compounds,	  reactions,	  enzymes	  and	  metabolic	  pathways	  data	  along	  with	  their	  regulatory	  interactions	  which	  would	  determine	  the	  physiological	  and	  biochemical	  properties	  of	  a	   cell	   are	   integrated	   into	  metabolic	  networks.	  Metabolic	  networks	   are	   the	   backbone	   of	  metabolic	  models	   and	   are	   fundamental	   for	  metabolism	  modeling	  and	  simulations	  [11].	  	  Following	   the	   advances	   in	   genome	   sequencing	   techniques,	   the	   complete	   genome	  sequence	  is	  becoming	  available	  for	  numerous	  organisms,	  and	  thus	  the	  genomic	  data	  can	  be	   integrated	   in	   the	  metabolic	  models.	   Such	   assimilation	   results	   in	   the	   generation	   of	  more	   comprehensive	   metabolic	   models	   that	   not	   only	   explain	   the	   physiological	  properties	   of	   cell,	   but	   also	   can	   predict	   their	   behaviors.	   We	   elaborate	   more	   on	   the	  different	  modeling	  approaches	  for	  the	  metabolic	  network	  analysis	  and	  their	  significance	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in	  Chapter	  2.	  
1.2 Lipid	  metabolism	  Lipids	  are	  hydrophobic	  organic	  molecules	  that	  include	  some	  common	  compounds	  such	  as	   fats,	   oils,	   waxes,	   phospholipids	   and	   steroids	   (e.g.,	   cholesterol).	   In	   addition,	   they	  include	  a	   large	  range	  of	  compounds	  with	  special	  structures	  and	  functions.	  Lipids	  have	  several	   key	   biological	   functions	   in	   living	   cells	   such	   as	   participating	   in	   signaling	  pathways,	  acting	  as	  energy	  storage	  sources	  and	  being	  the	  structural	  components	  of	  cell	  membrane.	  Moreover,	  they	  play	  an	  important	  role	   in	  various	  diseases	  such	  as	  obesity,	  diabetes	  and	  cancer	  [12].	  Lipid-­‐associated	  disorders	  are	  metabolic	  disorders	  and	  their	  characteristic	  is	  the	  accumulation	  of	  intolerable	  amounts	  of	  lipids	  in	  some	  of	  the	  body’s	  cells	   as	   a	   reason	   of	   defects	   in	   the	   biosynthesis	   or	   biodegradations	   of	   simple	   lipids	  [13,14].	  	  The	   term	   lipidome	   refers	   to	   the	   full	   lipid	   complement	  of	   cells,	   tissues	   and	  organisms.	  Lipidomics	   –	   the	   large-­‐scale	   study	   of	   pathways	   and	   networks	   of	   cellular	   lipids	   in	  biological	   systems	   –	   aims	   to	   elucidate	   and	   characterize	   the	   lipidome	   [15,16].	   Mass	  spectrometry	  (MS)	  is	  the	  most	  commonly	  used	  analytical	  method	  in	  lipidomics	  research	  [17-­‐19].	  With	  the	  rapid	  growth	  in	  analytical	  technologies,	  in	  particular	  MS,	  vast	  amount	  of	   data	   is	   being	   generated	   for	   lipid	   structures	   [20].	   Therefore,	   there	   is	   a	   need	   for	  developing	   comprehensive	   computational	   tools	   for	   data	   mining	   and	   system	   level	  identification	  of	  lipid	  species	  and	  organizing	  them	  into	  databases	  [21].	  	  Although	  there	  are	  a	  number	  of	  ongoing	  discoveries	  in	  lipidomics,	  assisted	  by	  functional	  genomics	  and	  biophysical	  studies,	  still	  a	  large	  number	  of	  structures	  and	  functions	  need	  to	  be	  discovered	  or	  clarified	  in	  lipid	  metabolism	  [22,23].	  Due	  to	  the	  diversity	  of	  possible	  chemical	   structures	   in	   lipids,	   bioinformatics	   is	   indispensable	   for	   accelerating	   the	  discovery	   of	   novel	   structures	   and	   their	   corresponding	   biosynthetic	   and	   catabolic	  pathways.	   In	   Chapter	   5,	   we	   present	   our	   computational	   approach	   for	   the	   analysis	   of	  glycerophospholipids	   metabolism,	   a	   diverse	   and	   ubiquitous	   class	   of	   lipids	   and	   the	  results	  of	  a	  case	  study	  to	  show	  the	  applicability	  of	  our	  methods	  for	  lipid	  research.	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1.3 Atom	  transition	  in	  metabolism	  Biological	  pathways	  have	  been	  extensively	  analyzed	  with	  respect	  to	  overall	  conversions	  of	   substrates	   to	   products.	   However,	   information	   on	   atom	   transitions	   in	   metabolic	  pathways	   is	  not	  widely	  available	   in	   the	   literature	   [24].	  Reaction	  atom	  mappings	   track	  the	  positional	  changes	  of	  all	  the	  atoms	  between	  the	  substrates	  and	  the	  products	  as	  they	  undergo	   the	   chemical	   transformation	   and	   elucidate	   the	   mass	   flow	   in	   a	   biochemical	  reaction	  network	  [25].	  The	  understanding	  of	  metabolic	  reactions	  at	  the	  atomic	  level	  is	  of	  great	  importance	  as	  it	  can	  deconvolute	  the	  overlapping	  catabolic/anabolic	  pathways	  resulting	  in	  the	  observed	  metabolite	  [26].	  This	  has	  widespread	  impact	  on	  applications	  of	  systems	  biology	  such	  as	  isotope	  labelling	  experiments,	  pathway	  inference	  in	  genome	  reconstructions,	   flux	  quantification	   for	  metabolic	  engineering	  and	  strain	  development,	  and	  in	  the	  studies	  of	  metabolic	  diseases	  [27,28].	  There	   are	   two	   main	   approaches	   to	   study	   the	   atom	   transition	   through	   a	   reaction:	  experimental	  approach	  versus	  in	  silico	  approach.	  Determining	  the	  atom	  map	  of	  a	  reaction	  experimentally	  means	  to	  replace	  one	  or	  several	  atoms	  with	   radio-­‐isotopes	   or,	  more	   recently,	   stable-­‐isotopes.	  Due	   to	   the	   difference	   in	  the	  mass	   of	   isotopes,	   the	   labeling	   pattern	   of	   the	   product	   can	   be	   determined	   by	  mass	  spectrometry.	   In	   contrast,	   in	   silico	   atom	  mappings	   require	   no	   isotopes.	   Instead,	   they	  require	   chemical/biochemical	   knowledge	   about	   the	   reaction	   mechanism.	   In	   silico,	   or	  computational,	  methods	  have	  been	  developed	  to	  automatically	  generate	  atom	  maps	  for	  large	   sets	  of	   reactions.	   Still,	   isotope-­‐labeled	  metabolites	   are	   the	   standard	  approach	   to	  elucidate	   reaction	   mechanisms.	   The	   computational	   determination	   of	   reaction	  mechanisms,	  however,	  would	  be	  more	  efficient	  and	  would	  help	  to	  reduce	  the	  amount	  of	  experimental	  work.	  	  13C	  Metabolic	  Flux	  Analysis	  (13C-­‐MFA)	  [29-­‐31]	  is	  the	  standard	  approach	  to	  elucidate	  the	  reaction	   mechanisms	   as	   well	   as	   the	   particular	   distribution	   of	   fluxes	   in	   an	   organism.	  However,	   isotopic	   labelling	   experiments	   are	   costly	   and	   time-­‐consuming.	   The	  computational	   determination	   of	   reaction	  mechanisms	   is	  more	   efficient	   and	   can	   guide	  experimental	  design.	  13C-­‐MFA	  techniques	  require	  a	  description	  of	  atom	  transitions	  from	  substrates	  to	  products	  for	  each	  reaction	  in	  order	  to	  make	  predictions	  [32].	  The	  ability	  to	  track	  atoms	  through	  reaction	  pathways	  is	  inevitable	  in	  13C-­‐MFA	  studies[29,33]	  in	  order	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to:	  (i)	   find	  the	  appropriate	  position	  of	  13C	  in	  the	  tracer	  metabolite;	  and	  (ii)	  choose	  the	  best	   metabolites	   or	   biomass	   components	   to	   be	   measured	   in	   order	   to	   maximize	   the	  information	  content	  of	  flux	  observations	  in	  the	  metabolic	  network	  [34].	  	  In	  a	  comprehensive	  in	  silico	  atom-­‐level	  reconstruction	  of	  a	  metabolic	  network,	  the	  atom	  mappings	  need	   to	  be:	   (i)	  correctly	  created	  at	   the	   level	  of	   individual	  reactions,	  and	  (ii)	  connected	   in	   a	   network	   and	   conserved	   through	   all	   reactions	   steps	   from	   the	   input	  compound	  to	  the	  final	  products,	  enabling	  one	  to	  trace	  back	  the	  exact	  metabolic	  path	  of	  every	  single	  atom.	  	  More	   discussions	   about	   the	   computational	   methods	   for	   atom	   mapping	   and	   our	  contribution	   to	   the	   field	   are	   provided	   in	   Chapter	   2	   and	   we	   further	   demonstrate	   the	  results	  of	  our	  automated	  atom	  mapping	  method	  in	  Chapter	  6.	  
1.4 Bioenergetics	  of	  metabolism	  Bioenergetics	  is	  the	  crucial	  aspect	  of	  the	  metabolic	  processes	  as	  it	  concerns	  the	  energy	  production	  and	  transformations	  in	  biological	  systems	  [35].	  Bioenergetics	   is	   involved	  with	   any	   bonds	   that	   are	   broken	   or	  made	   in	   the	  molecules,	  which	  are	  part	  of	   the	  cellular	  processes.	  As	  already	  mentioned,	  metabolism	   is	  divided	  into	   two	   categories,	   and	   in	   catabolism,	   the	   breaking	   of	   nutrients	   into	   smaller	  components	   leads	   to	   the	   production	   of	   energy	   in	   different	   forms	   such	   as	   adenosine	  triphosphate	   (ATP)	   molecules.	   The	   released	   energy	   powers	   anabolism	   to	   construct	  complex	   molecules	   that	   serve	   as	   biomass	   building	   blocks	   needed	   for	   growth.	   Life	  depends	   on	   this	   energy	   flow	  and	  understanding	   the	  detailed	  mechanisms	   involved	   in	  the	  energy	  transformation	  in	  living	  organisms	  is	  a	  big	  challenge	  [36].	  The	   laws	   of	   thermodynamics	   hold	   true	   in	   the	   metabolism	   of	   a	   cell.	   Biological	  thermodynamics	  concerns	  the	  chemical	  thermodynamics	  in	  biological	  and	  biochemical	  systems.	   In	   thermodynamics,	   the	   energy	   required	   or	   released	   in	   the	   course	   of	   a	  chemical	   reaction	   is	  measured	   quantitatively	   by	   the	   change	   in	   the	   Gibbs	   free	   energy	  (ΔrG).	   ΔrG	   determines	   the	   degree	   of	   thermodynamic	   favorability	   of	   a	   reaction,	   i.e.,	   a	  negative	  ∆rG	  indicates	  that	  the	  reaction	  can	  occur	  spontaneously,	  and	  if	  ∆rG	  is	  positive,	  the	  reaction	  is	  nonspontaneous	  in	  the	  designated	  direction	  [37].	  
	  22	  
Thermodynamics	  has	  been	  applied	  in	  the	  context	  of	  biological	  systems	  to	  improve	  our	  understanding	  of	   the	  metabolism.	   It	  has	  been	  used	   to	  quantify	   the	   feasible	   ranges	   for	  the	   Gibbs	   free	   energy	   change	   of	   a	   reaction	   [38-­‐40]	   and	   to	   systematically	   assess	   the	  degree	  of	  reversibility	  of	  metabolic	  reactions	  [41].	  Such	  analysis	  requires	  a	  sufficiently	  accurate	   knowledge	   of	   the	   thermochemical	   quantities	   of	   involved	   substrates	   and	  metabolites	   [42].	   The	   number	   of	   molecules	   involved	   in	   the	   biochemical	   reactions	   is	  huge	  and	  the	  experimental	  available	  Gibbs	  free	  energies	  of	  formation	  cover	  only	  a	  small	  fraction	  of	  them	  [43,44].	  Hence,	  due	  to	  the	  scarce	  amount	  of	  available	  experimental	  data	  for	  the	  biological	  systems,	  experimental-­‐based	  thermodynamics	  analysis	  of	  metabolism	  would	   be	   limited	   to	   small	   subsections	   of	   metabolism.	   Therefore,	   methods	   for	   the	  efficient	   use	   of	   this	   minimal	   information	   and	   the	   development	   of	   reliable	   predictive	  schemes	   of	   the	   thermochemical	   quantities	   are	   compulsory	   to	   fill	   in	   the	   gaps	   in	   the	  experimental	  data	  [45-­‐47].	  	  Group-­‐Contribution	   method	   (GCM),	   a	   particularly	   useful	   tool	   for	   metabolic	   pathway	  analysis,	  is	  developed	  in	  Hatzimanikatis	  lab	  in	  2008	  to	  address	  the	  issues	  of	  the	  limited	  experimental	  information	  for	  the	  thermodynamics	  of	  biological	  systems.	  In	  this	  method,	  a	  molecule	  is	  decomposed	  into	  their	  constituent	  groups	  of	  atoms	  and	  the	  Gibbs	  energy	  of	  formation	  of	  the	  compound	  can	  be	  estimated	  as	  the	  summation	  of	  the	  properties	  of	  groups	  [48].	  Using	  GCM,	   the	  standard	  Gibbs	   free	  energy	  of	   formation	  (and	   thus,	   the	  corresponding	  free	   energy	   change	  of	   their	   reactions)	   can	  be	   estimated	  with	   sufficient	   accuracy	   for	   a	  large	  percentage	  of	  dilute	  aqueous	  solutions	  [48].	  GCMs	  are	  indispensable	  tools	  for	  the	  high	  throughput	   feasibility	  analysis	  of	  metabolites	  and	  pathways.	  However,	  since	  they	  are	  empirical	  methods,	  they	  do	  have	  their	   limitations.	  The	  coverage	  and	  the	  quality	  of	  functional	   group	   contributions	   heavily	   depend	   on	   the	   existence	   of	   relevant	  experimental	  data	  and	  on	  the	  quality	  of	  the	  data	  used	  for	  their	  determination.	  Thus,	  the	  development	   of	   alternative	   non-­‐empirical	   approaches,	   which	   could	   substitute	  experiments,	  are	  crucial	  not	  only	   for	   the	  practical	   calculations	  but	  also	   for	   the	   insight	  they	  provide.	   Such	  developments	   can	  also	  be	  used	   to	  enrich	  and	   improve	  GCMs	  or	   to	  help	  with	   consistency	   tests.	  With	   today’s	   advances	   in	  ab	   initio	   and	   density	   functional	  theory	   (dft)	   calculations	   and	   the	   availability	   of	   computational	   resources	   with	   ever	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increasing	   speed,	   the	   development	   of	   the	   above	  mentioned	   alternative	   non-­‐empirical	  approaches	  through	  quantum	  chemical	  calculations	  appear	  feasible.	  Another	   consideration	   about	   the	   experimental	   approaches	   and	   consequently	   GCM	   is	  that	  data	  -­‐	  either	  obtained	  experimentally	  or	  estimated	  through	  GCM	  –	  are	  for	  standard	  conditions	   (298.15	   K,	   101	   kPa),	   which	   is	   not	   the	   case	   in	   most	   biological	   systems.	  Adjusting	  the	  obtained	  data	  from	  GCM	  to	  the	  cellular	  conditions	  is	  therefore	  an	  essential	  step	   for	   the	   improvement	   of	   the	   results	   obtained	   through	   this	   method.	   Knowledge	  about	  the	  thermodynamics	  properties	  at	  non-­‐standard	  conditions	  is	  of	  a	  great	  interest	  for	  many	  applications	  in	  biology,	  biotechnology	  and	  medicine	  such	  as	  the	  following.	  1. The	  temperature	  of	  human	  body	  could	  change	  from	  370C	  in	  a	  healthy	  condition	  to	   400C	   in	   a	   sick	   condition.	   For	   understanding	   and	   exploring	   the	   biochemistry	   and	  molecular	   biology	   of	   human	   metabolic	   networks	   in	   both	   healthy	   and	   especially	   sick	  conditions,	   one	   needs	   to	   have	   the	   thermodynamic	   properties	   at	   biological	   conditions	  rather	  than	  standard.	  2. There	  is	  evidence	  that	  the	  metabolic	  activity	  of	  gut	  microbiota	  has	  a	  direct	  effect	  on	  human	  health.	  The	  rate	  of	  microbial	  activity	  strongly	  depends	  on	   the	   temperature,	  and	   it	   has	   been	   shown	   that	   different	   microbial	   communities	   are	   adapted	   to	   operate	  under	   different	   optimal	   temperature	   regimes.	   The	   availability	   of	   thermodynamic	  properties	  under	  relevant	  temperature	  for	  bacterial	  communities	  would	  be	  essential	  to	  understand	  the	  underlying	  mechanisms	  of	  microbiota	  and	  host	  interactions.	  	  3. Ancient	   deep-­‐sea	   hydrothermal	   systems	   provide	   an	   environment	   conducive	   to	  the	   abiotic	   synthesis	   of	   biomolecules	   that	   are	   essential	   for	   the	   emergence	   of	   life.	   The	  enormous	   biotechnological	   potential	   in	   harnessing	   the	  metabolic	   capabilities	   of	   these	  extremophiles	   can	   only	   be	   used	   with	   a	   better	   understanding	   of	   the	   metabolic	  requirements	  and	  energetics	  of	  microbial	   life	  at	   the	  edges	  of	  survivability	  [49].	   In	  this	  respect,	   reliable	   calculations	   of	   thermochemical	   properties	   of	   metabolites	   and	  biomolecules	  at	  high	  temperatures	  and/or	  high	  pressures	  are	  of	  primordial	  importance.	  	  To	  overcome	   the	   limitation	  of	  experimental-­‐based	   thermodynamics	  and	   the	  GCM,	  one	  needs	   to	   improve	   the	   GCM	   method	   to	   obtain	   thermodynamic	   predictions	   that	   are	  adjustable	   to	   any	   temperature	   and	   pressure	   based	   on	   the	   nature	   of	   the	   study.	   	   In	  Chapter	   2,	   we	   discuss	   the	   available	   methodologies	   and	   our	   recently	   introduced	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framework	   for	   estimating	   the	   thermodynamic	   properties	   for	   a	   broader	   range	   of	  metabolites	   in	   biological	   systems,	   respecting	   the	   biological	   conditions	   of	   temperature	  and	  pressure.	  Our	  introduced	  pipeline	  takes	  four	  main	  steps	  to	  do	  such	  estimations,	  and	  the	   results	   of	   the	   first	   step	   of	   the	   project	   are	   provided	   in	   Chapter	   7.	   The	   three	   other	  steps	  are	  ongoing	  projects	  and	  their	  results	  are	  not	  included	  in	  this	  thesis.	  
1.5 Systems	  biology	  	  The	  inter-­‐disciplinary	  research	  field	  of	  systems	  biology	  aims	  at	   the	  systematic	  study	  of	  metabolic	  networks	  through	  integrating	  high-­‐throughput	  ‘omics’	  experimental	  data	  into	  predictive	  mathematical	  models	  to	  provide	  holistic	  views	  of	  metabolism	  [50].	  	  Hence,	   the	   pillars	   of	   systems	   biology	   are	   the	   experimental	   techniques	   and	  computational	  methods	  to	  assess	  the	  perspective	  of	  the	  entire	  metabolic	  network	  [51].	  Opposing	  to	  the	  reductionist	  approach	  that	  study	  the	  snapshots	  of	  metabolism	  through	  single	   biological	   pathways	   analysis,	   systems	   biology,	   owing	   to	   its	   network-­‐based	  intrinsic,	   takes	   a	   systematic	   holistic	   approach	   to	   study	   instantaneously	   all	   the	  constituents	  of	  complex	  biological	  systems	  along	  with	  their	  interactions.	  The	  considerable	  advances	  already	  made	  in	  field	  of	  systems	  biology	  are	  due	  to	  the	  fast	  development	   and	   growth	   of	   high-­‐throughput	   measuring	   technologies	   such	   as	  metabolomics,	  transcriptomics	  and	  proteomics	  along	  with	  the	  emergence	  and	  advances	  of	  bioinformatics	  and	  computational	  biology	  [52].	  
1.6 Synthetic	  biology	  and	  metabolic	  engineering	  The	  origins	  of	  two	  emerging	  fields	  of	  synthetic	  biology	  and	  metabolic	  engineering,	  their	  overlaps	   and	   their	   distinctional	   disciplines	   and	   approaches	   have	   been	   clarified	   in	   a	  recent	  review	  by	  G.	  Stephanopoulos	  [53].	  	  While	  metabolic	  engineering	  seeks	  to	  customize	  the	  cell	  and	  pathway	  performance	  for	  the	   production	   of	   desired	   compounds,	   synthetic	   biology	   pursues	   this	   aim	   through	  designing	  and	  constructing	  the	  synthetic	  genetic	  circuits	  that	  regulate	  the	  performance	  of	  the	  cells	  [53,54].	  The	  new	  generations	  of	  microbial	  strains,	  called	  Synthetic	  Microbial	  Cell	  Factories,	  enable	  the	  sustainable	  production	  of	  a	  wide	  range	  of	  chemicals	  and	  fuels.	  This	  demonstrates	  the	  achievements	  being	  made	  in	  the	  last	  20	  years	  by	  the	  emergence	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and	  collaboration	  of	  multidisciplinary	  fields	  of	  metabolic	  engineering,	  systems	  biology,	  systems	  biotechnology	  and	  synthetic	  biology	  [55,56].	  In	   order	   to	   create	   efficient	  microbial	   factories	   and	   broaden	   the	   range	   of	   biosynthetic	  pathways	  for	  the	  production	  of	  both	  natural	  and	  non-­‐natural	  compounds,	  it	  is	  necessary	  to	  go	  beyond	  natural	  pathways	  by	  exploring	   the	  chemistry	  and	  synthetic	  capability	  of	  biological	  systems	  [55,56].	  	  Designing	   an	   SMCF	   has	   several	   steps,	   starting	   with	   the	   choice	   of	   the	   target	   desired	  compounds	  and	  a	  particular	  chassis	  organism.	  It	  follows	  with	  the	  further	  analysis	  of	  the	  biochemistry	  of	  the	  chosen	  organism	  to	  see	  whether	  the	  desired	  compound	  is	  native	  to	  the	   metabolism	   or	   not.	   In	   case	   of	   a	   non-­‐native	   compound,	   metabolic	   engineering	  strategies	  are	  required	  to	  design	  pathways	  for	  the	  production	  of	  the	  desired	  compound	  [57].	   After	   considering	   several	   criteria,	   the	   best	   candidate	   pathways	   are	   then	  engineered	   in	   the	   metabolic	   network	   of	   microorganisms	   that	   serve	   as	   synthetic	  platforms	  in	  synthetic	  biology.	  	  The	   complexity	   of	   biological	   chemistry	   and	   metabolism	   requires	   computational	  approaches	   that	   explore	   the	   full	   possibility	   of	   synthetic	   pathways	   towards	   target	  compounds.	  The	  de	  novo	  design	  of	  pathways	  is	  the	  key	  to	  exploit	  the	  incredible	  natural	  diversity	   of	   enzymatic	   transformations.	   Detailed	   discussions	   about	   the	   available	  methods	  for	  pathway	  design	  and	  our	  contributions	  to	  the	  field	  are	  provided	  in	  Chapter	  2.	  
1.7 Data	  organization	  in	  biological	  and	  chemical	  databases	  In	   order	   to	   take	   the	   full	   benefit	   from	   the	   wealth	   of	   extensive	   and	   rapidly	   growing	  amount	   of	   information	   produced	   through	   high-­‐throughput	   technologies	   and	  computational	   methods,	   it	   is	   crucial	   to	   systematically	   organize	   and	   catalogue	   the	  generated	  data	  into	  shared	  central	  resources	  to	  enable	  storing,	  searching	  and	  retrieving	  from	   the	   data.	   Last	   decade	   has	   been	   the	   successful	   era	   of	   such	   organized	   and	   field	  specific	   public	   data	   sources.	   Within	   the	   field	   of	   systems	   biology,	   several	   specific	  databases	   have	   been	   developed	   with	   different	   scopes,	   coverages	   and	   prioritizations,	  and	  one	  could	  broadly	  classify	   them	  to	  the	  repository	  of	  protein	  sequences	  [58,59]	  or	  metabolic	   pathway	   databases	   [60,61].	   A	   major	   challenge	   is	   to	   provide	   globally	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Chapter	  ) 	  
METHODOLOGY	  &	  THEORY	  
In	  this	  chapter	  we	  review	  the	  theory	  and	  the	  technical	  aspects	  underlying	  the	  research	  of	   this	   thesis.	   We	   emphasize	   on	   the	   “technical	   design	   elements”	   that	   were	   needed	   to	  carry	   out	   this	   research	   and	   on	   the	  methods	   that	   have	   been	   developed	   and	   applied	   to	  address	   several	  biochemical	   and	  biological	   questions	   in	   the	   context	  of	   this	   thesis.	  We	  begin	   with	   the	   computational	   methods	   for	   the	   metabolic	   network	   analysis	   and	   our	  contributions	  for	  the	  design	  of	  de	  novo	  pathways.	  We	  further	  introduce	  the	  methods	  we	  developed	   for	   the	   automated	   atom	   mapping	   of	   the	   biological	   reactions.	   In	   the	   last	  section,	   we	   describe	   a	   new	   pipeline	   for	   the	   improvement	   of	   the	   estimation	   of	   the	  thermodynamic	   properties.	   More	   details	   about	   methodologies	   are	   covered	   in	   the	  following	   chapters.	  After	   introducing	   each	  design	   element,	  we	  point	   to	   the	   chapter	   in	  which	  it	  is	  more	  elaborated	  later	  in	  the	  thesis.	  	  
2.1 Computational	  methods	  for	  metabolic	  network	  analysis	  	  Metabolic	   systems	  are	   complex	   interconnected	  networks	   that	   include	  genes,	  proteins,	  enzymes,	  metabolites	  and	  reactions.	  By	  the	  ever-­‐increasing	  availability	  of	  “omics”	  data,	  the	  size	  and	  the	  complexity	  of	  metabolic	  networks	  are	  growing	  [10].	  Such	  complex	  and	  large	   networks	   cannot	   be	   understood	   and	   analyzed	   intuitively;	   thus,	   computational	  methods	  and	  strategies	   for	   the	  reconstruction	  and	  analysis	  of	  metabolic	  networks	  are	  indispensable	   [10,62].	   Computational	   metabolic	   network	   reconstruction	   is	   a	   well-­‐established	   discipline	   in	  which	  we	   systematically	   collect	   the	   available	   data	   to	   form	   a	  knowledge-­‐based	   mathematical	   model	   of	   the	   metabolic	   network	   for	   managing	   the	  complexity	   of	   the	   biological	   systems.	   Metabolic	   network	   reconstructions	   are	   mostly	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organism	  specific	  and	  depend	  on	  the	  quality	  of	  the	  sequenced	  genome,	  thus	  differing	  in	  size	   and	  quality.	   If	   the	  metabolic	  network	   reconstruction	   is	   based	  on	   the	   full	   genome	  annotation	   of	   an	   organism,	   we	   use	   the	   term	   genome-­‐scale	   metabolic	   networks	   [63].	  These	   reconstructions	   collect	   all	   the	   relevant	   metabolic	   knowledge	   of	   the	   organisms	  and	   capture	   their	   metabolic	   capabilities	   and	   provide	   an	   in-­‐depth	   insight	   into	   their	  metabolism.	  	  
2.1.1 Genome-­‐scale	  metabolic	  models	  Genome-­‐scale	  metabolic	  models	   (GEMs)	  are	  one	  of	   the	  most	   important	  computational	  resources	   for	   the	   investigation	   of	   metabolism	   and	   have	   been	   constructed	   and	  experimentally	   verified	   for	   several	   organisms.	   The	   reconstruction	   process	   starts	  with	  collecting	  the	  relevant	  knowledge	  about	  the	  given	  organism	  from	  genome	  analysis,	  the	  databases	   of	   metabolic	   information,	   and	   its	   known	   biochemistry.	   This	   process	   is	  followed	   by	   assembling	   the	   collected	   information	   into	   a	   mathematical	   model	   which	  represents	   the	   metabolic	   network	   of	   the	   organism.	   This	   allows	   us	   to	   perform	  simulations	  and	  optimizations	  by	  using	  mathematical	  methods	  in	  order	  to	  make	  in	  silico	  predictions	  of	  metabolic	  states	  and	  generate	  hypotheses.	  Creating	  a	  GEM	  is	  a	  time-­‐consuming	  process.	  No	  procedure	  is	  yet	  available	  for	  the	  fully	  automated	   reconstruction	   of	   GEMs	   and	   still	   a	   lot	   of	   manual	   curations	   are	   required.	  However,	   numerous	   computational	   methods	   and	   protocols	   have	   been	   proposed	   to	  make	   this	   process	   semi-­‐automatic	   and	   to	   generate	   high-­‐quality	   genome-­‐scale	  models	  [64,65].	   Furthermore,	   there	   are	   repositories	   of	   publicly	   available	   reconstructed	  genome-­‐scale	  models	  for	  several	  organisms	  such	  as	  BIGG	  [66]	  and	  SEED	  [67]	  databases.	  GEMs	   are	   proven	   to	   be	   valuable	   in	   many	   applications	   in	   basic	   biological	   studies,	  metabolic	   engineering,	   biotechnology	   and	   pharmaceutical	   researches	   for	   drug	   design.	  However,	   since	   they	   are	   derived	   from	   genome	   annotations	   that	   are	   themselves	  incomplete,	   they	   may	   not	   fully	   capture	   the	   metabolic	   and	   enzymatic	   capacity	   of	   the	  organisms.	   Consequently,	   several	   metabolic	   pathways	   remain	   unknown,	   and	   many	  reactions	   are	   still	  missing	   even	   in	   known	  pathways	   and	  well-­‐studied	   organisms	   [68].	  This	   necessitates	   the	   development	   of	   higher-­‐level	   computational	   tools	   beyond	   those	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depending	  on	  the	  genome	  sequencing	  and	  annotations,	  in	  order	  to	  fill	  in	  the	  metabolic	  knowledge	  gaps	  by	  de	  novo	  prediction	  and	  the	  reconstruction	  of	  metabolic	  pathways.	  
2.1.2 In	  silico	  pathway	  design	  	  Several	   computational	   frameworks	   have	   been	   developed	   for	   the	   in	   silico	   pathway	  design	  in	  metabolic	  networks.	  The	  most	  commonly	  in	  silico	  pathway	  design	  tools	  offer	  the	   enumeration	   of	   pathways	   in	   two	  ways:	   (i)	   either	   they	   effectively	   combine	   known	  reactions	  from	  databases	  that	  lead	  to	  the	  production	  of	  a	  given	  desired	  compound	  from	  different	  organisms	  (heterologous	  pathways)	  [69-­‐71]	  or	  (ii)	  they	  construct	  the	  de	  novo	  pathways	  which	   include	  not	  only	   the	  known	  reactions	  but	  also	   the	  hypothetical	   steps	  whose	  corresponding	  enzymes	  might	  not	  actually	  exist	  in	  nature	  [6,72-­‐79].	  	  The	   algorithms	   in	   the	   first	   approach	   are	   based	   on	   the	   graph	   representation	   of	  metabolic	   networks.	   Using	   this	   graph,	   one	   can	   search	   for	   all	   the	   possible	   pathways	  between	   known	   input	   and	   output	   compounds.	   The	   source	   graph	   for	   the	   pathway	  searching	   can	   be	   either	   limited	   to	   the	   metabolic	   network	   of	   an	   organism,	   or	   extend	  beyond	  a	  specific	  organism	  and	   include	  all	  available	  known	  reactions.	  One	  of	   the	  best	  examples	  of	   such	   tools	   is	  FMM	  (From	  Metabolite	   to	  Metabolite),	   a	   computational	   tool	  for	   the	   reconstruction	   of	  metabolic	   pathways	   form	   one	   source	  metabolite	   to	   another	  target	   metabolite	   among	   different	   organisms	   [69].	   FMM	   and	   other	   similar	   methods	  [28,69-­‐71,80]	  enable	  the	  identification	  and	  the	  design	  of	  new	  metabolic	  pathways	  based	  on	  known	  reactions	  previously	  existing	  in	  the	  databases.	  Although	  there	  are	  numerous	  achievements	  in	  the	  metabolic	  engineering	  research	  through	  discovering	  heterologous	  pathways	  using	   the	  aforementioned	  tools,	  such	  reconstructed	  metabolic	  pathways	  are	  based	  on	  existing	  metabolic	  maps.	  Therefore,	   such	  methods	  are	   limited	  when	   there	   is	  no	   known	   enzymatic	   step	   for	   a	   desired	   compound	   and	   one	   has	   to	   design	   a	   de	   novo	  pathway	   for	   its	   biosynthesis	   [72].	   This	   scenario	   is	   usually	   the	   case	   when	   the	   target	  compound	  is	  a	  non-­‐native	  compound	  for	  the	  known	  chassis	  organisms.	  	  Algorithms	   of	   the	   second	   approach	   enable	   postulating	   putative	  metabolic	   pathways	  that	   are	   of	   great	   interest	   in	   synthetic	   biology.	   A	   comprehensive	   algorithm	   for	   the	   in	  
silico	  prediction	  and	  design	  and	  further	  feasibility	  evaluations	  of	  de	  novo	  pathways	  is	  a	  significant	  driver	  for	  the	  success	  of	  metabolic	  engineering	  and	  various	  such	  tools	  have	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been	  developed	  in	  the	  past	  decade	  (Table	  2.1).	  We	  will	  elaborate	  more	  on	  the	  technical	  aspects	  of	  such	  algorithms	  in	  the	  next	  section.	  	  
Table	  2-­‐1:	  Available	  de	  novo	  pathway	  reconstruction	  tools	  and	  their	  availability	  
Name	   Tool	   development	   and	  
applications	  BNICE.ch	   [6,72,81-­‐84]	  DESHARKY	   [75,85]	  ReBiT	  http://www.retro-­‐biosynthesis.com	   [78]	  Method	  developed	  with	  Cho	  et	  al.	  	   [73]	  RetroPath	  http://www.issb.genopole.fr/~faulon/retropath.php	   [74,86-­‐90]	  SimPheny	   [76]	  GEM-­‐Path	   [77]	  	  
2.1.3 Retrobiosynthesis	  for	  de	  novo	  pathways	  design	  Retrobiosynthesis,	   a	   promising	   approach	   for	   the	   de	  novo	   pathway	   design,	   is	   inspired	  from	  the	  retro-­‐evolution	  hypothesis	  proposed	  in	  1945	  by	  Norman	  Horowitz	  [91,92]	  and	  has	   its	   origins	   in	   retrosynthetic	   organic	   chemistry.	   Retrosynthetic	   analysis	   starts	   by	  defining	   a	   target	   molecule	   that	   we	   are	   interested	   to	   produce	   and	   walks	   backward	  through	   the	   known	   chemical	   transformation	   rules	   to	  modify	   the	   target	  molecule	   and	  identify	   the	   possible	   precursors	   and	   reactions	   [93,94].	   This	   basic	   concept	   of	   walking	  backwards	   from	   a	   molecule	   and	   using	   the	   biotransformation	   rules	   to	   reconstruct	  biochemical	  pathways	  is	  also	  used:	  (i)	  to	  find	  novel	  pathways	  for	  the	  biodegradation	  of	  pollutants	  [79,95]	  and	  (ii)	  in	  generating	  hypothetical	  pathways	  for	  the	  metabolites	  and	  lipids	   that	   are	   found	   in	  metabolomics	   and	   lipidomics	   studies	   but	   their	  metabolism	   is	  unknown	  [84].	  In	   retrobiosynthesis,	   the	   goal	   is	   the	   production	   of	   a	   target	   molecule	   through	   the	  enzymatic	   biotransformation	   steps	   occurring	   in	   the	   metabolic	   network	   of	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microorganisms.	   This	   analysis	   results	   in	   finding	   de	   novo	   pathways	   that	   connect	   the	  target	  molecule	   to	   either	   a	   cellular	  metabolite	   or	   to	   a	  biochemical	   feedstock	  by	  using	  natural	  or	  engineered	  enzymes.	  	  Before	   a	   de	   novo	   pathway	   could	   be	   built	   in	   the	   laboratory	   and	   integrated	   in	   a	  microorganism,	   it	   should	   first	  be	  designed	  and	  evaluated.	  While	   intuition	  and	  manual	  design	   can	   assist	   in	   postulating	   novel	   pathways,	   it	   is	   not	   sufficient	   to	   guarantee	   the	  generation	   of	   all	   the	   potentials	   and	   the	   selection	   of	   the	   most	   efficient	   ones	  [55,72,73,89,96-­‐99].	   Hence,	   the	   computational	   prediction	   tools	   are	   indispensable	   for	  retrobiosynthesis	  analysis,	  not	  only	  for	  assisting	  with	  generating	  novel	  hypotheses,	  but	  also	  for	  screening	  for	  the	  most	  efficient	  pathways.	  Computational	  frameworks	  result	  on	  the	  extensive	  generation	  of	  all	  possible	  de	  novo	   biosynthetic	  pathways	   that	  allows	   for	  the	  exploration	  of	  the	  entire	  space	  of	  feasible	  biotransformations	  in	  a	  given	  cell	  [6,72-­‐79,81].	  	  The	   combinatorial	   explosion	   is	   the	   most	   important	   risk	   associated	   with	   these	  approaches,	   since	   they	   generate	   compounds	   and	   reactions	   which	   may	   or	   may	   not	  actually	  take	  place	  in	  nature.	  Therefore,	  the	  next	  crucial	  step	  is	  to	  screen	  the	  generated	  biosynthetic	  pathways	  through	  feasibility	  studies.	  	  Following	   the	   increasing	   demand	   for	   designing	   de	   novo	   pathways	   in	   the	   metabolic	  engineering	   research,	   computational	   tools	   for	   the	   retrobiosynthetic	   analysis	   attracts	  more	  attention.	  These	  tools	  are	  becoming	  one	  of	  the	  most	  important	  steps	  for	  a	  reliable	  metabolic	  engineering	  strategy.	  BNICE.ch	   (Biochemical	   Network	   Integrated	   Computational	   Explorer)	   which	   has	   been	  developed	  by	  Hatzimanikatis	  et	  al.	  in	  2005	  [72],	  is	  a	  pioneer	  computational	  framework	  for	  the	  de	  novo	  pathway	  design	  and	  evaluation.	  	  One	  of	   the	   important	  modules	  of	  BNICE.ch	   is	   the	  retrobiosynthesis	  analysis.	  From	  our	  experience	  in	  developing	  the	  retrobiosynthesis	  framework	  of	  BNICE.ch	  and	  the	  analysis	  of	   other	   available	   tools,	  we	   propose	   a	   retrobiosynthetic	  workflow	   composed	   of	   three	  main	   steps,	   where	   each	   step	   requires	   certain	   technical	   design	   elements	   to	   be	  implemented	  (Figure	  2.1).	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Figure	  2-­‐1:	  Our	  proposed	  workflow	  for	  a	  retrobiosynthesis	   framework	  start	  with	  the	  selection	  of	  a	  
target	   molecule	   and	   results	   on	   top-­‐ranked	   synthetic	   pathways	   for	   implementation	   in	   a	   chosen	  
organism	  for	  the	  biosynthesis	  of	  the	  target	  molecule.	  	  In	  the	  next	  section,	  we	  introduce	  BNICE.ch,	  and	  we	  describe	  further	  developments	  and	  extensions	  to	  this	  framework	  that	  have	  been	  made	  during	  this	  thesis.	  The	  applications	  of	  the	  developed	  methods	  are	  demonstrated	  in	  chapters	  3	  to	  7.	  












































industrial	   projects,	   the	   results	   of	   which	   are	   cataloged	   in	   a	   web-­‐based	   database	   and	  cannot	  be	  discussed	  here	  due	  to	  confidentiality	  agreements.	  However	  a	  representative	  example	  of	  such	  analysis	  is	  available	  on	  the	  website	  (lcsb.epfl.ch/database).	  In	   the	   following	   sections,	   we	   present	   BNICE.ch,	   an	   established	   computational	  framework	   to	   design,	   evaluate,	   rank	   and	   visualize	   promising	   de	   novo	   pathways	   for	  several	  applications	  ranging	  from	  metabolic	  engineering	  to	  drug	  design.	  Below,	  we	  list	  and	  describe	  the	  technical	  design	  elements	  of	  BNICE.ch	  (Figure	  2.2).	  
2.2.1 Internal	  and	  external	  databases	  	  
2.2.1.1 Generalized	  enzymatic	  reaction	  rules	  One	   of	   the	   key	   design	   elements	   of	   BNICE.ch	   is	   a	   database	   of	   “biochemical	  transformation	  rules”.	  These	  rules	  mimic	  the	  function	  of	  enzymes	  and	  serve	  as	  in	  silico	  enzymatic	   actions.	   As	   there	   are	   a	   large	   number	   of	   characterized	   enzymes,	   one	   can	  organize	   those	   that	   perform	   similar	   reaction	  mechanisms	   into	   “generalized	  enzymatic	  
reaction	   rules”	   [72,81].	   After	   their	   introduction	   in	   BNICE.ch	   in	   2005,	   the	   concept	   of	  generalized	   reaction	   rules	   has	   been	   adopted	   by	   several	   other	   similar	   methods	  [73,74,76-­‐78].	  BNICE.ch	  has	  an	  in-­‐house	  made	  database	  of	  582	  manually	  curated	  generalized	  reaction	  rules	  that	  translate	  the	  biochemical	  knowledge	  of	  enzymatic	  reaction	  mechanisms	  into	  a	   generalized	   mathematical	   format.	   Around	   90	   percent	   of	   known	   enzyme-­‐catalyzed	  reactions	   can	  be	   represented	  by	  a	   set	   of	  291	  manually	   curated,	   bidirectional	   reaction	  rules	   that	   can	   be	   considered	   as	   “in	  silico	  enzymes”.	   Each	   of	   the	   291	   forward	   reaction	  rules	   comes	   with	   a	   reverse	   reaction	   rule	   catalyzing	   the	   opposite	   direction	   of	   the	  reaction.	  Thus,	  the	  whole	  set	  of	  reaction	  rules	  contains	  582	  forward	  and	  reverse	  rules.	  The	  generalized	  reactions	  rules	  are	  developed	  based	  on	  the	  Enzyme	  Commission	  (EC)	  classification	  of	  known	  biochemical	  reactions	  in	  enzyme	  reaction	  databases	  [100].	  The	  Enzyme	  Commission	  classification	   is	  a	  numerical	  classification	  scheme	  for	  enzymes.	   It	  uses	   a	   four-­‐digit	   number	   (EC	   number)	   that	   represents	   a	   progressively	   finer	  classification	   of	   the	   enzyme.	   If	   different	   enzymes	   (for	   instance	   from	   different	  organisms)	  catalyze	  the	  same	  reaction,	  they	  are	  assigned	  the	  same	  EC	  number.	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Figure	  2-­‐2:	  Workflow	  of	  the	  BNICE.ch	  framework	  is	  categorized	  into	  four	  main	  steps	  and	  each	  step	  










































Each	  generalized	  reaction	  rule	  has	  three	  representative	  matrices	  (Figure	  2.3):	  the	  first	  one	  is	  the	  BEM	  representation	  of	  the	  reactive	  site	  of	  substrates	  for	  a	  class	  of	  enzymes	  that	  follow	  a	  unique	  reaction	  mechanism.	  	  	  
	  
Figure	  2-­‐3:	  Example	  of	  the	  action	  of	  a	  generalized	  reaction	  rule	  on	  the	  substrate	  of	  a	  reaction	  and	  
the	  formation	  of	  products.	  The	  reaction	  rule	  matrix	  is	  added	  to	  the	  BEM	  of	  the	  reactants	  to	  produce	  





291	  rules	  in	  each	  direction.	  More	  details	  about	  the	  new	  set	  of	  generated	  reaction	  rules	  will	  be	  discussed	  in	  Chapter	  3.	  
2.2.1.2 Biological	  and	  chemical	  databases	  integrated	  in	  BNICE.ch	  A	   very	   important	   aspect	   of	   BNICE.ch	   is	   the	   information	   from	   available	   databases	  integrated	  into	  the	  framework,	  which	  allows	  us	  to	  screen	  our	  results	  against	  all	  known	  biological	   compounds	   and	   reactions.	   If	   a	   specific	   reaction	   of	   the	   database	   can	   be	  replicated	  using	  a	  generalized	  reaction	  rule,	  we	  denote	  the	  reaction	  as	  being	  "covered"	  by	  BNICE.ch.	  The	  percentage	  of	  reactions	  in	  a	  database	  that	  can	  be	  replicated	  with	  our	  reaction	  rules	  is	  called	  “coverage”,	  which	  is	  an	  important	  indicator	  for	  the	  performance	  of	  BNICE.ch	  and	  makes	  it	  distinguishable	  from	  other	  similar	  tools.	  One	  has	  to	  notice	  that	  the	  “coverage”	  is	  a	  moving	  target;	  since	  it	  depends	  on	  the	  actual	  number	  of	  “known	  reactions”	  which	  is	  not	  fixed	  and	  is	  increasing	  over	  years.	  During	  this	  thesis,	  by	  curating	  several	  new	  reaction	  rules,	  the	  coverage	  of	  BNICE.ch	  increased	  from	  48	  %	  of	  KEGG	  2008	   (~6000	   reactions)	   to	  ~90%	  of	   the	  KEGG	  2014	   (more	   than	  9000	  reactions).	  The	  most	   important	   biological	   databases	   as	   sources	   for	  metabolic	   data	   are	   the	  Kyoto	  Encyclopedia	   of	   Genes	   and	  Genomes	   (KEGG)	   [60],	   SEED	   [67,104]	   ,	  MetaCyc	   [61],	   and	  ChEBI	   [105]	   databases	   and	   their	   information	   is	   integrated	   in	   BNICE.ch.	   KEGG	   is	   a	  manually	   curated,	   reliable	   source	  of	   information	   that	   is	  used	   in	   this	  work	  as	   the	  gold	  standard	   for	  assessing	   the	  performance	  of	  our	  method	  as	  well	  as	   for	   the	  validation	  of	  reaction	   mechanisms	   through	   KEGG	   RPAIR	   database.	   KEGG	   RPAIR	   contains	   reaction	  mechanisms	  as	  well	  as	  information	  about	  atom-­‐atom	  correspondence	  [106].	  	  In	   addition	   to	   biological	   databases,	   we	   have	   integrated	   the	   enormous	   amount	   of	  information	   of	   PubChem	   database	   [107,108]	   (~2	   million	   unique	   entry	   for	   chemical	  structures)-­‐	  the	  biggest	  available	  database	  for	  compound	  structures-­‐	  in	  BNICE.ch.	  	  In	   Section	   2.2.4	  we	   elaborate	  more	   on	   how	  we	  match	   the	   generated	   compounds	   and	  reactions	  against	  the	  mentioned	  databases.	  
2.2.2 Metabolic	  network	  generation	  in	  BNICE.ch	  BNICE	   employs	   an	   automated	   network	   generation	   algorithm,	   which	   works	   in	   an	  iterative	  fashion.	  We	  use	  “generation”	  and	  “iteration”	  interchangeably	  in	  this	  work.	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Starting	  with	  a	  set	  of	  input	  molecules,	  the	  algorithm	  works	  as	  follows:	  1) Every	  molecule	   is	   checked	   for	   reactivity,	   i.e.,	   it	   is	  evaluated	   to	   find	   if	   it	  has	   the	  appropriate	   reactive	   sites	   (functionalities)	   to	   undergo	   the	   reactions	  corresponding	  to	  the	  specified	  list	  of	  reaction	  rules.	  	  2) Upon	   acting	   on	   a	   molecule,	   the	   generalized	   reaction	   rules	   recognize	   the	  biological	   reactive	  sides	  of	  molecule	  and	  apply	   the	  biotransformation	  by	  which	  the	  atoms	  and	  bonds	  rearrange	  to	  form	  the	  product.	  	  	  3) Next,	   all	   reactants	   are	   placed	   in	   a	   “reacted”	   list,	   and	   all	   products	   from	   these	  reactants	  will	  be	  placed	  in	  an	  “unreacted”	  list	  if	  they	  are	  molecules	  that	  have	  not	  been	  specified	  or	  generated	  before.	  This	  completes	  the	  first	  step	  and	  is	  defined	  as	  ‘generation	  1’.	  	  4) Each	   molecule	   in	   the	   “unreacted”	   list	   will	   be	   checked	   for	   its	   reactivity,	   the	  reaction	   rules	  will	   be	   applied,	   and	   new	   “reacted”	   and	   “unreacted”	   lists	  will	   be	  created	  for	  the	  ‘generation	  2’.	  	  5) The	   procedure	   is	   repeated	   iteratively	   and	   an	   iteration	   count	   is	   maintained	   as	  new	   molecules	   are	   created,	   keeping	   track	   of	   the	   generation	   number	   of	   each	  species,	   which	   corresponds	   to	   the	   number	   of	   steps	   required	   to	   create	   a	   given	  product	  from	  the	  original	  reactant(s).	  	  6) A	   maximum	   generation	   number	   can	   be	   specified,	   and	   thus	   the	   generation	  number	  can	  be	  used	  to	  determine	   if	  a	  given	  molecule	   from	  the	  “unreacted”	   list	  may	   react	   in	   the	   next	   generation.	   Once	   the	   generation	   number	   reaches	   the	  specified	  maximum,	  the	  newly	  created	  molecules	  are	  placed	  in	  the	  “reacted”	  list,	  which	  marks	  the	  terminal	  point	  of	  the	  reaction	  network.	  	  Being	  designed	  as	  “general”,	  the	  reaction	  rules	  are	  capable	  of	  acting	  upon	  a	  wide	  range	  of	   substrates	   in	  addition	   to	   the	   specific	  native	  ones.	  Therefore,	   repeating	   this	  process	  iteratively	   results	   in	   the	   generation	   of	   a	   biochemical	   network	   of	   all	   theoretically	  possible	   compounds	   and	   reactions,	   including	   those	   that	   have	  no	  known	  experimental	  counterpart	  (de	  novo	  compounds	  and	  reactions).	  	  Aside	   from	   the	   “number	   of	   iterations”,	   the	   number	   of	   generated	   compounds	   and	  reactions	   and	   consequently	   the	   size	   of	   the	   generated	  metabolic	   network	   depends	   on	  several	   other	   adjustable	   parameters	   that	   are	   defined	   in	   BNICE.ch	   and	  will	   be	   further	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discussed.	  
2.2.2.1 ‘Forward’	  vs.	  ‘retrobiosynthesis’	  network	  generation	  modes	  	  BNICE.ch	  has	  two	  different	  running	  modes,	  “forward”	  versus	  “retrobiosynthesis”,	  which	  allow	  us	  to	  reconstruct	  a	  metabolic	  network	  in	  two	  different	  approaches	  based	  on	  the	  nature	   of	   the	   study.	   The	   forward	   algorithm	   explores	   all	   the	   possibilities	   between	   the	  compounds	  in	  the	  “unreacted”	  list	  to	  generate	  all	  possible	  reactions	  between	  them.	  This	  running	   mode	   has	   been	   applied	   to	   reconstruct	   several	   metabolic	   networks,	   starting	  from	  a	  set	  of	  substrates	  along	  with	  the	  generalized	  reaction	  rules.	  We	  demonstrate	  the	  results	  of	   the	   forward	  running	  mode	   in	  Chapter	  4	   for	   the	  reconstruction	  of	  part	  of	   the	  lipid	   metabolism	   and	   in	   Chapter	   5	   where	   we	   reconstruct	   the	   E.coli	   core	   metabolic	  network.	  	  In	   the	  retrobiosynthetic	  algorithm,	  we	   take	  a	   slightly	  different	  approach	  based	  on	   the	  concept	   of	   retrosynthesis.	   A	   retrosynthetic	   analysis	   starts	   from	   a	   desired	   target	  compounds	  with	  the	  goal	  being	  to	  find	  all	  possible	  reactions	  steps	  (pathways)	  from	  this	  compound	   to	   potential	   substrates.	   The	   aim	   at	   each	   further	   iteration	   is	   to	   generate	   a	  reaction	  step	  that	  brings	  us	  closer	  to	  the	  potential	  substrates.	  We	  match	  the	  generated	  compounds	  in	  a	  network	  against	  the	  metabolites	  of	  the	  chosen	  organism	  and	  we	  define	  the	  potential	  substrate	  as	  any	  metabolite	  that	  is	  native	  metabolite	  for	  the	  organism	  and	  exits	  in	  the	  generated	  network	  of	  the	  target	  compound.	  	  Therefore,	   in	   the	   retrosynthetic	   mode,	   we	   allow	   the	   set	   of	   metabolites	   in	   the	  “unreacted”	   list	   in	  each	  generation	  to	  only	  react	  with	  other	  starting	  compounds	  (a.k.a.	  reactive	  starting	  compounds)	  but	  not	  with	  each	  other.	  After	  each	  generation,	   the	  new	  set	  of	  generated	  compounds	  is	  allowed	  to	  react	  with	  only	  the	  set	  of	  reactive	  compounds	  of	   previous	   generations	   in	   order	   to	   generate	   all	   possible	   biochemical	   reactions.	   This	  feature	  would	  allow	  us	  to	  always	  stay	  connected	  to	  the	  target	  compound	  through	  linear	  pathways	   of	   enzymatic	   reactions,	   and	   in	   addition,	   it	   helps	   us	   to	   explore	   more	  generations	  as	  it	  reduces	  the	  number	  of	  generated	  compounds	  and	  reactions.	  	  We	   have	   applied	   the	   retrobiosynthetic	   approach	   of	   BNICE.ch	   to	   analyze	   the	   lipid	  metabolism	   and	   to	   integrate	   the	   lipid	   structures	   from	   lipidomics	   data	   into	  metabolic	  pathways	  [84],	  which	  will	  be	  covered	  in	  Chapter	  4.	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Furthermore,	  we	  have	  successfully	  applied	  the	  retrobiosynthesis	  feature	  of	  BNICE.ch	  in	  several	   industrial	   projects	   for	   finding	   de	   novo	   pathways	   for	   the	   biosynthesis	   of	  chemicals	  with	  no	  known	  biosynthetic	  routes,	  an	  example	  of	  such	  analysis	  is	  provided	  on	  our	  website	  (lcsb.epfl.ch/database).	  
2.2.3 Pathway	  enumeration	  algorithm	  We	   analyze	   in	   further	   details	   the	   identified	   compounds	   and	   reactions	   in	   order	   to	  determine	   the	   architecture	   of	   their	   synthesis	   and	   degradation	   pathways.	   We	   use	   a	  
“pathway	  reconstruction	  algorithm“	  that	   constructs	  all	  possible	  pathways	   from	  a	  given	  substrate	  to	  the	  target	  molecule	  in	  the	  generated	  network	  of	  compounds	  and	  reactions.	  In	  general,	  the	  pathway	  reconstruction	  algorithms	  perform	  either	  a	  graph-­‐based	  search	  in	  the	  network	  or	  use	  optimization-­‐based	  methods	  to	  identify	  possible	  pathways	  from	  potential	   substrates	   for	   the	   synthesis	   of	   the	   target	   compound	   in	   the	   generated	  metabolic	  network	  [82,109,110].	  We	  implemented	  both	  features	  in	  our	  pathway	  search	  algorithm.	  	  	  
2.2.4 Pruning	  the	  generated	  data	  	  The	   in	   silico	   design	   of	   the	   de	   novo	   pathway	   risks	   a	   combinatorial	   explosion	   in	   two	  aspects.	  First,	  in	  the	  network	  generation	  process,	  the	  action	  of	  the	  generalized	  reaction	  rules	   on	   the	   compounds	   results	   in	   the	   generation	   of	   all	   possible	   compounds	   and	  reactions	   which	   may	   or	   may	   not	   actually	   take	   place	   in	   nature.	   The	   number	   of	   such	  compounds	   and	   reactions	   increases	   exponentially	   at	   every	   iteration	   of	   the	   network	  generation	   algorithm.	   Second,	   due	   to	   the	   combinatorial	   nature	   of	   the	   pathway	  enumeration	   step,	   an	   enormous	   number	   of	   pathways	   from	   a	   substrate	   to	   the	   same	  target	  compound	  are	  generated.	  Thus,	  the	  very	  important	  next	  step	  is	  the	  evaluation	  of	  proposed	   compounds,	   reactions	   and	   pathways	   and	   the	   selection	   of	   the	  most	   feasible	  enzymes,	   reactions	   and	  pathways	   to	  be	   tested	   in	   laboratory.	   In	  BNICE.ch	  we	  perform	  the	  pruning	  analysis	  by	  two	  strategies:	  (1) Qualitative	  pruning	  of	  generated	  data	  	  (2) Quantitative	  pruning	  of	  generated	  pathways	  	  
	  40	  
2.2.4.1 Qualitative	  pruning	  of	  generated	  results	  	  Qualitative	  pruning	  of	  the	  generated	  data	  is	  the	  process	  of	  surveying	  which	  portion	  of	  the	  obtained	   information	   is	  already	  known,	  which	  portion	   is	  novel,	   and	  how	  similar	   is	  the	  novel	  information	  compared	  to	  the	  known	  data,	  i.e.,	  the	  metabolites,	  reactions	  and	  pathways	  existing	   in	  the	  databases.	  These	  databases	  are	  biological,	  such	  as	  KEGG	  [60]	  and	  Metacyc	   [61],	   and	   chemical	   such	   as	  PubChem	   [111]and	  ChEBI	   [112].	   	  Qualitative	  pruning	  is	  in	  general	  independent	  of	  the	  organism	  of	  choice.	  	  By	  screening	  through	  existing	  databases,	  in	  addition	  to	  differentiating	  between	  known	  and	  novel	  knowledge,	  we	  also	  directly	  capture	  available	  biochemical	  properties	  for	  the	  compounds	  and	  reactions.	  	  
2.2.4.1.1 ‘Supervised’	  vs.	  ‘unsupervised’	  approaches	  The	   size	   of	   the	   reaction	   network	   that	   BNICE.ch	   generates	   depends	   on	   different	  constraints	  predefined	  in	  our	  algorithm.	  The	  most	  important	  factors	  that	  have	  a	  major	  effect	  on	  the	  size	  of	  the	  generated	  network	  of	  reactions	  are:	  (i) the	  number	  of	  generalized	  reaction	  rules	  and	  	  (ii) the	  allowable	  “search	  space”	  for	  the	  generated	  compounds	  and	  reactions.	  These	   are	   both	   introduced,	   as	   an	   input	   parameter	   for	   the	   algorithm	   and	   the	  consideration	   of	   these	   two	   parameters	   would	   result	   in	   a	   “supervised	   network	  
generation”	  approach	  as	  opposed	  to	  the	  “unsupervised	  network	  generation”	  approach.	  In	  a	  supervised	  network	  generation	  mode,	  based	  on	  the	  question	  we	  address,	  we	  allow	  
specific	   generalized	   reaction	   rules	   as	  opposed	   to	   all	   the	   reaction	   rules.	  An	  example	  of	  such	  approach	  is	  discussed	  in	  Chapter	  5	  where	  we	  investigate	  the	  biochemistry	  of	  E.coli	  core	   metabolic	   network.	   In	   this	   study,	   we	   only	   apply	   those	   reaction	   rules	   that	   have	  relevant	  enzymatic	  reactions	  in	  the	  core	  metabolic	  network	  of	  this	  organism.	  In	  addition	  to	  the	  selection	  of	  the	  generalized	  reaction	  rules,	  during	  this	  thesis,	  we	  have	  introduced	  the	  notion	  of	  supervised	  network	  generation	  through	  the	  adaptable	  search	  
space	   in	  the	  network	  generation	  process.	  The	  adaptable	  search	  space	  allows	  searching	  within	   a	   domain	   of	  metabolites	   and	   reactions	   that	   is	   predefined	   as	   a	   parameter.	   The	  supervision	  can	  be	  applied	   for	   the	  generated	  compounds	  or	   reactions	  or	  both	   leading	  to:	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•	  The	  selection	  of	  the	  compound	  search	  space,	  i.e.,	  at	  each	  iteration,	  we	  keep	  only	  the	  compounds	  that	  are	  part	  of	  a	  biological	  or	  chemical	  database	  or	  both	  (versus	  keeping	  all	  known	  and	  novel	  compounds	  at	  each	  iteration).	  •	  The	  selection	  of	  the	  reaction	  search	  space,	  i.e.,	  at	  each	  iteration,	  we	  allow	  only	  known	   reactions	   of	   KEGG	   or	   the	   reactions	   that	   are	   part	   of	   a	   specific	   database	  (versus	  keeping	  all	  known	  and	  novel	  reactions	  at	  each	  iteration).	  Therefore,	   at	   each	   generation	   we	   retain	   in	   the	   ‘unreacted’	   (product)	   list	   only	   the	  compounds	  and	  reactions	  that	  exist	  in	  the	  indicated	  reference	  databases.	  	  By	  introducing	  these	  three	  types	  of	  constraints	  (for	  the	  selection	  of	  the	  reaction	  rules,	  compounds	  and	  reactions),	  we	  can	  create	  different	  project-­‐specific	  supervision	  modes.	  The	   level	   of	   supervision	   is	   defined	   for	   each	   of	   the	   three	   input	   constraints,	   and	   the	  different	   levels	   range	   from	   all	   possible	   reactions	   and	   compounds	   (known	   and	   novel)	  down	  to	  pathway-­‐specific	  compounds	  and	  reactions	  only.	  	  In	  the	  case	  of	  unsupervised	  network	  generation,	  we	  apply	  all	  generalized	  reaction	  rules	  for	  the	  network	  generation	  and	  do	  not	  screen	  the	  results	  until	  the	  end	  of	  the	  job	  where	  we	  crosscheck	  against	  databases	  to	  differentiate	  the	  known	  and	  novel	  knowledge.	  	  Figure	   2.4	   is	   an	   example	   of	   three	   different	   BNICE.ch	   studies	   on	   glucose	   that	  demonstrates	  how	  the	  choice	  of	  the	  constraints	  would	  dramatically	  affect	  the	  size	  of	  the	  network.	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Figure	   2-­‐4:	   Forward	   network	   generation	   with	   BNICE.ch	   at	   three	   different	   supervision	   modes	   to	  
investigate	   the	   impact	  of	   the	   supervision	   level	   on	   the	   size	  of	   the	   generated	  network.	   The	   level	   of	  





level	  of	  supervision	  of	  reactions	  changes	  from	  only	  E.	  coli	  reactions	  in	  A,	  to	  KEGG	  reactions	  in	  B	  and	  
finally	   to	   unsupervised	   reaction	   generation	   in	   C.	   The	   inner	   circle	   shows	   the	   results	   of	   the	   first	  
iteration	   and	   the	   outer	   circle	   shows	   the	   generated	   compounds	   in	   the	   second	   iteration.	   Green	  
connections	  represent	  KEGG	  reactions,	  red	  are	  novel	  reactions	  and	  blue	  are	  E.	  coli	  reactions.	  	  In	   all	   the	   three	   examples,	   we	   used	   glucose	   as	   the	   substrate	   along	  with	   the	   set	   of	   12	  cofactors	  (NADH,	  NAD+,	  H+,	  Bicarbonate,	  CO2,	  O2,	  Water,	  ATP,	  ADP,	  Phosphate,	  Acyl-­‐CoA	  and	   ammonia)	   and	   the	   whole	   set	   of	   582	   generalized	   reaction	   rules.	   We	   ran	   the	  algorithm	   for	   two	   iterations.	   The	   supervision	   level	   for	   the	   generalized	   reaction	   rules	  and	  compounds	  is	  the	  same	  for	  the	  three	  examples.	  The	  smallest	  network	  (2.4	  A)	  shows	  the	  results	  of	  the	  reaction	  supervision	  level	  to	  only	  
E.	  coli	  reactions	  (5	  compounds	  and	  14	  reactions).	  Figure	   2.4	   B	   shows	   all	   KEGG	   reactions	   that	   are	   generated	   by	   BNICE.ch	   in	   two	  generations	  and	  contains	  20	  compounds	  and	  77	  reactions.	  The	  network	  size	  increases	  if	  we	  allow	  all	  the	  KEGG	  reactions	  (2.4	  B).	  In	  the	  last	  example	  (2.4	  C),	  all	  possible	  BNICE.ch	  reactions,	   starting	   from	   glucose	   and	   between	   the	   known	   KEGG	   compounds	   are	  explored.	  This	  reaction	  network	  includes	  161	  compounds	  and	  808	  reactions	  and	  shows	  the	   significant	   increase	   in	   the	   size	   of	   the	   network	   when	   we	   do	   not	   constraint	   the	  reaction	  level.	  Table	   2.2	   summarizes	   different	   levels	   of	   supervision	   with	   their	   corresponding	   actual	  statistics.	  For	  instance,	  if	  we	  want	  to	  work	  with	  a	  network	  of	  the	  E.	  coli	  core	  metabolism,	  we	   would	   run	   BNICE.ch	   on	   the	   supervision	   level	   “Network”,	   meaning	   that	   we	   only	  include	  specific	  reaction	  rules	  (i.e.,	  45)	  and	  we	  allow	  the	  native	  E.	  coli	  compounds	  (i.e.,	  67)	   and	   reactions	   (i.e.,	   76)	   to	   be	   produced.	   Such	   constrained	   level	   of	   supervision	   is	  especially	  important	  for	  the	  atom-­‐level	  reconstruction	  of	  metabolic	  network	  that	  will	  be	  discussed	  in	  Chapter	  6.	  	  Depending	   on	   the	   application,	   we	   may	   want	   to	   adapt	   the	   levels	   of	   supervision	  independently.	  These	   features	  allow	   the	  efficient	  arrangement	  of	   the	  results	  based	  on	  the	  knowledge	  that	  exists	  in	  databases	  and	  address	  the	  risk	  of	  combinatorial	  explosion.	  	  
Table	  2-­‐2:	  We	  defined	  5	   levels	  of	  supervision	   in	  BNICE.ch.	  The	  supervision	   level	  can	  be	  chosen	  for	  
each	   input	   constraint	   .The	   darker	   the	   color	   of	   the	   cell,	   the	   smaller	   the	   number	   of	   generalized	  
reaction	   rules	   and	   the	   search	   space	   for	   the	   generated	   compounds	   and	   reactions.	   The	   less	  
constrained	   possible	   case	   is	   to	   consider	   the	   search	   space	   of	   a	   database	   such	   as	   KEGG	   for	   the	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reconstructed	  metabolic	  networks.	   In	  this	  case,	  all	  the	  generated	  compounds	  and	  reactions	  will	  be	  
checked	   against	   KEGG,	   and	   if	   they	   exist	   in	   KEGG,	   we	   keep	   them	   with	   the	   corresponding	   KEGG	  
identification	  numbers	  (Ids).	  The	  most	  restricted	  constraint	  is	  to	  limit	  the	  choice	  of	  the	  generalized	  
reaction	   rules	  and	   the	   search	   space	   to	  a	  pathway,	  e.g.	  Glycolysis,	   and	   to	  only	  keep	   the	  generated	  
compounds	  and	  reactions	  that	  belong	  to	  this	  pathway	  at	  each	  iteration.	  We	  used	  the	  KEGG	  2014	  for	  
the	  database	   level	  of	   supervision	  and	   the	   information	   from	  the	  genome	  scale	   reconstruction	  of	  E.	  
coli,	  iJO1366	  [113]	  for	  the	  organism	  level.	  In	  the	  chapters	  3	  to	  7,	  for	  all	  the	  applications	  of	  BNICE.ch,	  
we	  present	  this	  table	  and	  we	  highlight	  the	  level	  of	  supervision	  that	  is	  used	  in	  each	  study.	  
Supervision	  level	   Input	  constraint	  
	  	   Example	   Reaction	  rules	   Compounds	   Reactions	  
Unsupervised	   -­‐	   291*2	   Unlimited	   Unlimited	  
Database	   KEGG	   291*2	   17,343	   9972	  
Organism	   E.	  coli	   150*2	   1'039	   1'387	  
Network	   Core	  metabolism	   45*2	   67	   76	  
Pathway	   Glycolysis	   10	   12	   16	  	  The	  qualitative	  pruning	   can	  be	  also	  applied	   in	   the	  pathway	  enumeration	   step.	  During	  this	   thesis	   we	   have	   also	   implemented	   the	   notion	   of	   supervised	   pathway	   enumeration	  that	  allows	  enumerating	   “a	   set	  of	  viable	  pathways”	   rather	   than	  all	  possible	  pathways.	  Applying	   this	   new	   feature,	   we	   evaluate	   pathways	   based	   on	   the	   knowledge	   of	  compounds	   and	   reactions	   in	   databases.	   For	   instance,	   we	   can	   enumerate	   only	   the	  pathways	  with	  a	  pre-­‐specified	  percentage	  of	  their	  steps	  existing	  in	  biological	  databases	  as	  known	  enzymatic	  reactions.	  
2.2.4.2 Quantitative	  pruning	  of	  generated	  pathways	  	  Once	   we	   reconstruct	   a	   metabolic	   network	   of	   compounds	   and	   reactions	   and	   further	  enumerate	  de	  novo	   pathways	   of	   interest	   and	   screen	   them	  against	   databases,	   the	   next	  step	   is	   to	   perform	   the	   feasibility	   analysis.	   Such	   analysis	   is	   performed	   in	   order	   to	  determine	   the	   suitability	   and	   the	   performance	   of	   individual	   pathways	   and	   to	  quantitatively	  prune	  the	  proposed	  pathways	  to	  a	  set	  of	  most	  biologically	  feasible	  ones.	  Quantitative	  pruning	  is	  generally	  context	  dependent	  on	  the	  chassis	  organism.	  Different	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metrics	   can	  be	   applied	   to	   evaluate	   the	   likelihood	  of	   in	  silico-­‐designed	  pathways	   to	  be	  proficiently	  implemented	  in	  an	  organism.	  One	   very	   important	   metric	   is	   the	   thermodynamics	   of	   the	   reaction	   steps	   and	  consequently	   the	  synthetic	  pathway	  which	  allows	  us	   to	  discard	  the	  pathways	  that	  are	  energetically	   unfavorable	   in	   the	   first	   place.	   To	   do	   such	   thermodynamics	   analysis,	   we	  used	   a	   Group	   Contribution	  Method	   to	   estimate	   the	   Gibbs	   free	   energy	   for	  metabolites	  and	   consequently	   the	   reactions	   [114].	   This	   method	   has	   been	   developed	   in	  Hatzimanikatis	   lab	   and	   is	   used	   in	   several	   other	   computational	   frameworks	   for	  estimating	   the	   thermodynamics	   feasibility	   of	   the	   synthetic	   pathways	   [73,76,77].	  Furthermore,	   in	   BNICE.ch,	   we	   apply	   constraint	   based	  modeling	   by	   incorporating	   the	  synthetic	  pathways	  one	  at	  the	  time	  into	  the	  genome	  scale	  model	  of	  the	  chosen	  organism	  and	   performing	   Thermodynamics	   based	   Flux	   Balance	   Analysis	   (TFBA)	   [47,115].	   This	  further	   step	   allows	   us	   to	   adjust	   the	   estimated	   Gibbs	   free	   energy	   with	   respect	   to	   the	  metabolite	   concentration,	   ionic	   strength	  and	  pH	   to	  get	   closer	   to	   in	  vivo	   conditions.	  By	  performing	  a	  TFBA	  analysis,	  we	  guarantee	  that	  the	  obtained	  pathways	  are	  feasible	  with	  respect	   to	   mass	   balance	   (stoichiometrically),	   we	   assess	   the	   network	   thermodynamic	  feasibility	   of	   generated	   pathways,	   and	   we	   thus	   quantify	   their	   overall	   effects	   on	   the	  metabolic	  profile	  of	  the	  organism	  by	  calculating	  the	  energetic	  cost	  and	  the	  change	  in	  the	  biomass	  yield	  for	  each	  molecule	  of	  the	  generated	  product	  [116,117].	  Furthermore,	  one	  of	   the	   most	   important	   outcomes	   of	   TFBA	   for	   biotechnological	   applications	   is	   the	  pruning	  and	  ranking	  of	  pathways	  based	  on	  the	  maximum	  production	  yield	  of	  the	  target	  molecule	   from	  each	   individual	   synthetic	  pathway.	   In	  Chapter	  5	  we	  elaborate	  more	  on	  the	  importance	  of	  TFBA	  analysis	  as	  a	  further	  step	  to	  quantitatively	  prune	  the	  wealth	  of	  information	  generated	  with	  BNICE.ch.	  
2.2.5 BridgIt	  analysis	  Another	   compelling	   aspect	   of	   the	   interactive	   analysis	  with	  databases	   is	   the	   structural	  similarity	  comparison	  of	  the	  substrates	  and	  products	  of	  the	  generated	  de	  novo	  reactions	  to	   the	  substrates	  and	  products	  of	   the	  known	  reactions.	  We	  can	  quantify	   the	  results	  of	  such	   a	   comparison	   by	   using	   different	   chemoinformatics	  metrics	   such	   as	   ”compounds	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fingerprints	  comparison”	  using	  “Tanimoto	  distance”	  [118],	  and	  assign	  to	  novel	  reactions	  a	  similarity	  score	  with	  respect	  to	  the	  existing	  reactions.	  	  Using	   such	   a	   metric,	   one	   can	   propose	   potential	   enzymes	   for	   the	   de	   novo	   steps	   of	   a	  pathway	   based	   on	   their	   structural	   similarities	   to	   the	   known	   reactions.	   Through	   this	  reaction	  structural	  similarity	  assessment,	  we	  can	  further	  assign	  to	  novel	  reactions	  gene	  and	   protein	   sequences	   that	   could	   be	   used	   in	   evolutionary	   protein	   engineering	   and	  computational	   protein	   design	   for	   the	   experimental	   implementation	   of	   the	   novel	  pathways.	  	  BridgIt	  has	  been	  recently	  developed	  in	  our	  lab	  as	  a	  complementary	  tool	  to	  BNICE.ch	  for	  assessing	   the	   structural	   similarity	  of	   the	   reactions.	  BridgIt	   is	  based	  on	   the	  hypothesis	  that	  chemically	  similar	  reactions	  share	  similar	  sequences,	  based	  on	  the	  “lock	  and	  key”	  principle,	  which	  is	  also	  used	  in	  the	  protein	  docking	  methods.	  The	  enzyme	  is	  considered	  as	   the	  “lock”	  and	  the	   ligand	  (molecule)	  as	  a	  “key”.	   If	  a	  molecule	  has	  the	  same	  reactive	  sites	  as	  the	  native	  substrate	  for	  a	  given	  enzyme,	  and	  similar	  surrounding	  structure,	  it	  is	  expected	   that	   the	   enzyme	   would	   catalyze	   or	   could	   evolve	   to	   catalyze	   the	   same	  transformation	  on	   this	  molecule.	  Based	  on	   this	  hypothesis,	   if	   two	  metabolic	   reactions	  have	   the	   same	   reactive	   site	   and	   similar	   surrounding	   atoms	   and	   bonds	   around	   the	  reactive	   site,	   it	   is	   highly	  plausible	   that	   these	  metabolic	   reactions	   are	   catalyzed	  by	   the	  same	  enzyme(s),	  or	  the	  corresponding	  enzymes	  share	  the	  same	  E.C.	  classification	  (up	  to	  the	  third	  class).	  Also,	  it	  is	  highly	  probable	  that	  the	  genes	  functions	  responsible	  for	  these	  reactions	  (biotransformation)	  share	  sequence	  similarity.	  The	   initial	   idea	   behind	   BridgIt	   development	   is	   to	   use	   the	   reactions’	   structural	  similarities	  as	  a	  measure	  for	  assigning	  genes	  to	  the	  hypothetical	  reactions	  generated	  in	  BNICE.ch.	  This	  method	  is	  further	  applied	  for	  finding	  and	  assigning	  protein	  sequence	  for	  the	  orphan	  reactions.	  Orphan	  reactions	  are	  enzymatic	  reactions	  that	  lack	  an	  associated	  protein	   sequence	   [119].	  Due	   to	   the	   lack	  of	   reliable	   annotations	   and	   the	  drawbacks	  of	  homology-­‐based	  predictions,	  a	  large	  part	  of	  known	  enzyme	  activities	  is	  still	  missing	  an	  associated	   gene	   sequence.	   Since	   BridgIt	   is	   not	   functioning	   based	   on	   the	   sequence	  similarity,	  and	  instead,	  takes	  into	  account	  the	  structural	  similarity	  of	  the	  reaction,	  it	  is	  a	  promising	  tool	  to	  complement	  the	  existing	  methods	  for	  assigning	  protein	  sequences	  to	  orphan	  reactions.	  
	  47	  
BridgIt	   translates	   the	   structural	   definition	   of	   a	   reaction	   to	   a	   mathematical	   form,	   so-­‐called	   a	   vector,	   and	   compares	   these	   vectors	   using	   “Tanimoto	   distance”.	   It	   has	   an	  integrated	  reference	  database	  which	  accounts	  for	  all	  KEGG	  non-­‐orphan	  reactions.	  	  It	  compares	  any	  given	  reaction	  (for	  instance	  an	  orphan	  reaction)	  with	  all	  the	  reactions	  in	   the	   reference	   database	   and	   assigns	   a	   Tanimoto	   similarity	   score	   for	   all	   the	  comparisons	  it	  does.	  The	  Tanimoto	  score	  indicates	  how	  similar	  the	  given	  reaction	  is	  to	  each	  of	   the	  reference	  reactions.	   It	  varies	  between	  0	  and	  1,	  where	  1	   is	  considered	  as	  a	  high	  similarity	  and	  0	  indicates	  no	  similarity.	  
2.2.5.1 New	  features	  of	  BridgIt	  During	  this	  thesis,	  we	  applied	  BridgIt	  in	  several	  projects	  for	  the	  further	  analysis	  of	  the	  hypothetical	   reactions	   generated	   in	   BNICE.ch.	   If	   we	   consider	   the	   de	   novo	   reactions	  generated	  with	  BNICE.ch	  as	   “theoretical	  orphan	  reactions”,	  by	  applying	  BridgIt	  we	  can	  find	  the	  most	  structurally	  similar	  known	  reaction	  along	  with	  its	  similarity	  score	  to	  the	  
de	   novo	   reaction.	   Consequently,	   we	   can	   propose	   gene	   sequences	   for	   their	   further	  practical	  implementation	  in	  metabolic	  engineering	  studies.	  	  In	  the	  course	  of	  my	  thesis,	  we	  made	  comprehensive	  case	  studies	  using	  BridgIt.	  After	  the	  analysis	  of	  the	  generated	  similarity	  scores,	  we	  came	  up	  with	  two	  different	  strategies	  to	  be	  incorporated	  in	  the	  BridgIt	  algorithm	  to	  improve	  its	  predictions.	  The	  first	  method	  is	  applicable	  for	  both	  orphan	  and	  theoretical	  orphan	  reactions,	  and	  the	  second	  approach	  is	  oriented	  for	  the	  novel	  reactions	  (theoretical	  orphan)	  that	  are	  generated	  with	  BNICE.ch	  and	  are	  associated	  with	  a	  third-­‐level	  EC	  number.	  In	  the	  first	  method	  we	  first	  exclude	  the	  cofactors	  from	  the	  generated	  reaction	  vectors	  to	   make	   a	   cofactor-­‐free	   reference	   database.	   BridgIt	   initially	   considered	   all	   the	  compounds	   in	   the	   reactions	   as	   “substrates”,	   and	   in	   the	   reactions	   in	   which	   pairs	   of	  cofactors	  with	  big	  molecular	  structures	  participate,	  for	  instance	  NAD/NAD+,	  the	  results	  were	   not	   accurate.	   Consider	   two	   reactions	   that	   both	   have	   NAD/NAD+	   in	   their	  mechanism:	   they	  would	   be	   scored	   as	   “very	   similar“	   since	   they	   share	   a	   big	   portion	   of	  their	  vector	  which	  is	  NAD/NAD+	  ,	  and	  therefore	  	  the	  biotransformation	  that	  happens	  in	  the	  course	  of	  the	  reaction	  usually	  becomes	  negligible.	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Therefore,	   we	   extracted	   from	   databases	   a	   list	   of	   molecules	   that	   are	   frequently	  considered	   as	   biological	   cofactors,	   and	   we	   incorporated	   a	   new	   feature	   to	   BridgIt,	   in	  order	   to	   exclude	   these	   cofactors	   from	   the	   reactions	   before	   constructing	   the	   reaction	  vectors.	   Therefore,	   the	   new	   feature	   of	   BridgIt	   compares	   only	   the	   biotransformations	  that	  happen	  in	  the	  course	  of	  the	  biochemical	  reaction.	  We	   incorporated	   the	   second	   feature	   for	   the	   further	   analysis	   of	   the	   novel	   reactions	  generated	  by	  BNICE.ch	  in	  order	  to	  obtain	  a	  more	  precise	  similarity	  score,	  by	  employing	  the	  wealth	  of	  information	  provided	  for	  the	  de	  novo	  generated	  reactions	  that	  is	  a	  third-­‐level	  EC	  number.	  	  Our	  new	  algorithm	  first	  looks	  at	  the	  known	  digits	  of	  the	  EC	  number	  of	  a	  novel	  reaction.	  It	  then	  extracts	  the	  reactions	  in	  the	  reference	  database	  that	  share	  a	  similar	  third-­‐level	  EC	  and	  compares	  the	  novel	  reactions	  only	  with	  them.	  	  It	  is	  also	  possible	  to	  set	  a	  predefined	  parameter	  to	  compare	  the	  novel	  reaction	  with	  all	  the	  known	  reactions	   that	   share	   the	   same	  second	  level	  EC,	   or	  with	   those	   reactions	   that	  share	   the	   same	   first	   level	   EC.	   One	   of	   the	   advantages	   of	   this	   new	   feature	   is	   its	   time	  efficiency.	  	  The	  comparison	   that	  BridgIt	  does	   for	  each	  reaction	  against	  all	   stored	  reactions	   in	   the	  reference	   database	   is	   intensively	   time	   consuming,	   and	   with	   BNICE.ch	   project	   that	  generates	   thousands	   of	   reactions,	   it	   appears	   as	   a	   limitation.	   With	   the	   new	   method	  (second	  feature),	  since	  fewer	  comparisons	  have	  to	  be	  performed,	  BridgIt	  will	  run	  much	  faster	   than	   with	   the	   original	   method.	   The	   new	   method	   excludes	   false	   positive	  comparisons	   by	   filtering	   out	   the	   reference	   reactions	   that	   have	   no	   similarity	  with	   the	  novel	  reaction	  due	  to	  the	  different	  enzyme	  class	  that	  they	  belong	  to.	  	  We	   have	   also	   investigated	   the	   performance	   of	   BridgIt,	   when	  we	   introduce	   these	   two	  features	  simultaneously.	  This	  new	  feature	   first	   filters	   the	  cofactors	   from	  the	  reactions	  and	   makes	   the	   comparison	   of	   the	   novel	   reactions	   with	   only	   the	   reactions	   that	   have	  similar	  corresponding	  EC	  classification.	  In	  Chapter	  3,	  we	  perform	  BridgIt	  analysis	  for	  a	  large	  list	  of	  novel	  reactions	  generated	  by	  BNICE.ch	  and	  we	  demonstrate	  how	  incorporating	  these	  two	  features	  improved	  BridgIt	  predictions.	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Ultimately,	   the	   result	   of	  BridgIt	   is	   a	   proposed	  known	   reaction	   along	  with	   a	   similarity	  score	   that	   can	   be	   used	   as	   scoring	   and	   ranking	   criteria	   for	   the	   evaluation	   of	   de	   novo	  pathways.	  
2.2.6 Scoring	  and	  ranking	  the	  biosynthetic	  pathways	  Reconciling	  the	  metrics	  obtained	  in	  the	  qualitative	  and	  quantitative	  pruning	  strategies	  together	   with	   the	   results	   of	   BridgIt	   analysis,	   one	   can	   define	   a	   scoring	   and	   ranking	  feature	  which	  combines	  and	  scales	  different	  factors	  and	  assigns	  an	  overall	  score	  for	  the	  prioritization	   of	   in	   silico	   generated	   pathways.	   Using	   such	   a	   score,	   the	   collection	   of	  generated	  pathways	  can	  be	  filtered	  on	  the	  basis	  of	  biochemical	  knowledge	  and	  available	  experimental	  data.	  For	   instance,	   in	   a	   retrobiosynthetic	   approach	   that	   the	   goal	   is	   to	   find	   promising	  pathways	  for	  the	  production	  of	  a	  desired	  chemical,	  such	  a	  score	  gives	  the	  capability	  to	  pinpoint	   the	   best	   candidate	   synthetic	   pathways	   that	   are	   most	   likely	   to	   produce	   the	  desired	  target	  molecule	  and	  that	  can	  be	   implemented	   in	  the	  metabolic	  network	  of	   the	  chassis	  organism.	  	  In	   BNICE.ch	  we	   rank	   the	   pathways	   based	   on	   the	   following	   individual	   scoring	  metrics	  (max	  score	  of	  1	  per	  criterion)	  to	  determine	  the	  overall	  pathway	  score	  (full	  score	  =	  5):	  	   I. Thermodynamic	  feasibility:	  1	  for	  pathways	  that	  are	  thermodynamically	  feasible	  and	  0	  otherwise	  (a	  pathway	  is	  thermodynamically	  feasible	  if	  all	  reactions	  in	  the	  overall	   pathway	   is	   thermodynamically	   feasible	   in	   the	   direction	   that	  maximizes	  product	  formation,	  we	  obtained	  this	  score	  by	  performing	  TFBA	  analysis).	  II. Pathway	  length	  score	  =	  (1	  /	  number	  of	  reactions	  in	  pathway).	  For	  practical	  reasons,	  when	  it	  comes	  to	  the	  implementation	  of	  de	  novo	  pathways,	  shorter	  pathways	  are	  preferred	  to	  longer	  ones	  since	  fewer	  steps	  need	  to	  be	  engineered	  and	  protein	  costs	  would	  be	  minimized.	  III. KEGG	  reaction	  score	  =	  (number	  of	  known	  (KEGG)	  reactions	  in	  pathway)/	  (length	  of	   the	   pathway).	   	   The	   fewer	   novel	   steps,	   the	   less	   enzyme	   engineering	   for	   the	  pathway.	  IV. Network	  feasibility	  analysis:	  maximum	  product	  yield.	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By	  embedding	  the	  novel	  pathways	  into	  the	  genome	  scale	  model	  of	  the	  organism,	  we	  can	  investigate	  the	  effect	  of	  the	  pathway	  on	  the	  original	  network.	  In	  the	  case	  of	   the	   retrobiosynthetic	   analysis,	   we	   can	   calculate	   the	  maximum	   yield	   for	   the	  production	  of	  the	  desired	  compound.	  V. Reaction	  similarity	  score	  (BridgIT	  score)	  for	  novel	  reactions,	  in	  order	  to	  evaluate	  the	  likelihood	  of	  the	  hypothetical	  generated	  reactions.	  	  Instead	   of	   calculating	   the	   overall	   score,	   one	   can	   also	   do	   the	   ranking	   of	   the	   score	   of	   a	  certain	  criterion	  as	  the	  primary	  ranking,	  and	  then	  perform	  a	  secondary	  ranking	  based	  on	   another	   criterion,	   and	   so	   forth.	   For	   instance,	   one	   approach	   can	   be	   choosing	   the	  pathways	  with	  maximum	   (or	   economically	   feasible)	   yield,	   and	   among	   them	   the	   ones	  with	   the	  minimum	   number	   of	   novel	   reactions	   as	   their	   implementation	  will	   involve	   a	  smaller	  number	  of	  engineering	  enzyme	  steps.	  	  One	  should	  be	  careful	  when	  applying	  certain	  criteria	  used	  for	  pruning	  the	  obtained	  data	  that	   it	   is	   a	   multi-­‐objective	   problem	   and	   different	   applications	   might	   give	   different	  weights	   to	   different	   criteria.	  Moreover,	   some	   of	   these	   criteria	   depend	   on	   the	   current	  technologies	   and	  although	   some	  of	   the	  pathways	   can	  be	   ruled	   currently	   as	   infeasible,	  new	  technologies	  can	  enable	  their	  realization	  in	  the	  future.	  	  	  
2.3 In	  silico	  atom	  mapped	  network	  integrated	  computational	  explorer	  So	  far	  we	  discussed	  different	  computational	  methods	  for	  the	  analysis	  of	   the	  metabolic	  reactions	   at	   the	   “metabolite”	   level,	   since	   the	  mathematical	   (graph)	   representations	   of	  metabolic	   networks	   are	   traditionally	   done	   on	   the	  metabolite	   level	   [27].	  Nevertheless,	  knowledge	  about	  the	  atom	  transition	  in	  the	  metabolic	  network	  is	  crucial	  for	  elucidating	  the	  mechanism	  of	  enzymatic	  reactions	  and	  calculating	  the	  reaction	  fluxes.	   	  During	  this	  thesis,	  we	  developed	  a	  computational	  method	  to	  introduce	  an	  additional	  level	  of	  detail	  by	  considering	  the	  track	  of	  individual	  atoms	  through	  metabolic	  reactions	  [27].	  	  Several	   algorithms	   have	   been	   developed	   to	   address	   the	   automated	   atom-­‐mapping	  problem.	  As	  comprehensively	  reviewed	  in	  [120],	  these	  algorithms	  can	  be	  classified	  into	  two	   main	   classes	   based	   on:	   (i)	   finding	   the	   maximum	   common	   substructures	   (MCS)	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between	  substrates	  and	  products	  of	  the	  reactions	  (common	  subtracted-­‐based	  methods)	  [25,121-­‐126];	  and	  	  (ii)	  optimization	  methods	  [30,126-­‐133].	  	  Both	   approaches	   rely	   on	   the	   graph	   representation	   of	   reactions	   along	  with	   the	   graph-­‐based	   pattern	   recognition.	   In	   the	   optimization-­‐based	   methods	   that	   were	   extensively	  practiced	  recently,	  one	  has	   to	  define	  a	   relevant	  objective	   function	   to	  be	  optimized	   for	  the	  atom-­‐mapping	  solution.	  The	  most	  common	  objective	   functions	   in	  automated	  atom	  mappings	  include:	  	  i. Maximizing	   the	   size	   of	   common	   subgraphs	   between	   substrates	   and	   products	  [25,122].	  	  ii. Minimizing	  the	  graph	  edge	  edit	  distance[129].	  iii. Minimizing	  the	  number	  of	  bonds	  broken	  and	  formed	  [30,125,128,130,131,133].	  However,	   even	   if	   we	   assume	   that	   the	   aforementioned	   algorithms	   do	   find	   an	   optimal	  solution,	   there	   is	  no	   guaranty	   that	   all	   enzymatic	   reactions	   follow	   the	  optimal	  way	   for	  relocating	   atoms	   from	   substrates	   to	  products	   and	   that	   the	  objective	   functions	   lead	   to	  biochemically	  relevant	  atom	  mappings.	  Furthermore,	  most	  of	  these	  algorithms	  result	  in	  a	  big	  dataset	  of	  mapped	  reactions	  since	   they	  output	  multiple	  possible	  atom	  mappings	  for	  each	  reaction.	  Therefore,	  manual	  evaluation	  is	  required	  for	  accounting	  the	  reaction	  mechanism	   in	   case	   there	   is	  more	   than	   one	   atom	  map	   reported.	   Besides,	   the	   existing	  algorithms	   provide	   atom	   mappings	   for	   a	   single	   reaction	   and	   it	   would	   be	   difficult	   to	  extend	   these	  mappings	   for	   every	  pathway	  and	   in	   every	  metabolic	  network	  of	   a	   given	  organism	  without	  extensive	  manual	  work.	  	  To	   the	   best	   of	   our	   knowledge,	   there	   is	   no	   published	   algorithm	   for	   the	   automatic	  reconstruction	  of	  the	  atom-­‐mapped	  metabolic	  network	  without	  constraints	  on	  the	  size	  of	  the	   network.	   Such	   an	   algorithm	  would	   be	   very	   useful	   in	  many	   studies,	   such	   as	   drug	  design,	   where	   knowing	   the	   fate	   of	   each	   atom	   of	   the	   candidate	   drug	   through	   the	  transformation	  pathways	   in	  human	  body	  would	  help	  to	  understand	  the	  mechanism	  of	  drug	  metabolism.	  The	  ability	  to	  trace	  the	  fate	  of	  individual	  atoms	  through	  the	  metabolic	  pathways	   is	   also	   useful	   in	  many	   applications	   of	  metabolic	   engineering	   [125,131,134]	  such	  as	   for	   the	   identification	  and	   the	  engineering	  of	  novel	  biosynthetic	   routes	   for	   the	  microbial	  production	  of	  desired	  compounds	  [28,133,135].	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During	   the	   course	   of	   this	   PhD	   thesis,	   we	   developed	   the	   “iAM.NICE”	   (in	   silico	   Atom	  Mapped	   Network	   Integrated	   Computational	   Explorer)	   framework	   for	   addressing	   the	  atom-­‐mapping	   problem.	   Our	   method	   has	   the	   capability	   to	   create	   in	   silico	   labelled	  metabolites	  as	  substrates,	  and	  to	  transfer	  the	  labels	  to	  the	  products	  according	  to	  known	  reaction	  mechanisms.	  	  We	   implemented	   the	   concept	   of	   formulating	   generalized	   enzymatic	   reaction	   rules	  developed	  in	  BNICE.ch	  [72,81]	  for	  transferring	  the	  in	  silico	  labelled	  atom	  in	  a	  substrate	  to	  a	   specific	  position	  of	  one	  of	   the	   reaction	  products.	   In	   “iAM.NICE”,	  we	  automatically	  generate	  in	  silico	   labelled	  substrates	  and	  we	  apply	  the	  enzymatic	  rules	  on	  the	   labelled	  substrates,	  which	  results	  in	  the	  generation	  of	  in	  silico	   labelled	  products	  (atom-­‐mapped	  reaction).	  KEGG	  RPAIR	   [136]	   is	  a	  manually	  curated	  database	   that	  contains	  knowledge	  on	  atom	  mapping	  stored	  in	  the	  “reactant	  pairs”	  to	  elucidate	  the	  reaction	  mechanism.	  In	  KEGG	  RPAIR,	  reactions	  are	  decomposed	  into	  reactant	  pairs	  (RPAIRs)	  which	  formulate	  a	  pairwise	  association	  between	  one	  or	  several	  groups	  of	  atoms	  from	  substrate	  to	  one	  or	  several	   groups	  of	   atoms	   in	  products,	   by	   taking	   into	   account	   the	   contribution	  of	   these	  atoms	   (main	   reactant,	   cofactor,	   etc.)	   in	   the	   reaction.	   Most	   of	   the	   automated	   atom	  mapping	  methods	  cross	  checked	  their	  atom	  mapping	  predictions	  with	  KEGG	  RPAIR	  to	  evaluate	  the	  performance	  and	  accuracy	  of	  their	  algorithm	  [26,122,125,129-­‐132,137].	  Interestingly,	   in	   our	   framework,	   the	  wealth	   of	   information	   of	   KEGG	   REACTION	   along	  with	   KEGG	   RPAIR	   is	   implemented	   for	   formulating	   the	   generalized	   reaction	   rules.	  Therefore,	   the	   performance	   of	   “iAM.NICE”	   for	   predicting	   the	   atom-­‐atom	  correspondences	   in	   the	   biological	   reactions	   and	   consequently	   metabolic	   networks	   is	  intrinsically	  validated.	  We	  further	  define	  an	  atom-­‐mapped	  metabolic	  network	  as	  a	  network	  that	  contains	  atom	  correspondence	  for	  each	  single	  reaction	  and	  for	  the	  network	  as	  a	  whole,	  meaning	  that	  an	  atom	  in	  the	  initial	  substrate	  and	  in	  its	  final	  product	  carries	  the	  same	  label.	  In	  Chapter	  6	  we	  describe	  details	  of	  our	  methodology	  and	  we	  discuss	  the	  important	  steps	  “iAM.NICE”	  takes	  to:	  
• Automatically	  map	  atoms	  from	  substrate	  to	  product	  in	  a	  single	  reaction	  
• Connect	  these	  atom-­‐mapped	  reactions	  into	  atom-­‐mapped	  metabolic	  pathways	  	  
• Integrate	  the	  atom-­‐mapped	  pathway	  in	  metabolic	  networks	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Moreover,	   we	   provide	   the	   atom-­‐mapped	   representation	   of	   all	   the	   reactions	   in	   KEGG	  database	  as	  well	  as	  an	  atom-­‐level	  representation	  of	  the	  core	  E-­‐coli	  metabolic	  network.	  Our	  results	  can	  be	  used	  for	  a	  large	  range	  of	  applications,	  starting	  from	  the	  identification	  of	   new	   metabolic	   routes	   for	   the	   microbial	   production	   of	   desired	   compounds	   to	   the	  design	  of	  the	  optimum	  labelled	  patterns	  of	  substrates,	  which	  can	  be	  a	  great	  benefit	  for	  the	  simulation	  of	  tracer	  experiments.	  
2.4 Biothermochemical	  computations	  for	  studies	  of	  metabolism	  Thermodynamics	  plays	  a	  critical	  role	  in	  studying	  the	  metabolic	  networks.	  Particularly	  in	  the	   field	  of	  de	  novo	   pathway	  design,	   it	   is	  necessary	   to	  evaluate	   the	  generated	  de	  novo	  data	  on	   the	  basis	  of	   thermodynamic	   feasibilities.	   In	   this	  section	  we	  review	  the	  exiting	  computational	   methods	   for	   estimating	   the	   thermodynamics	   properties	   and	   we	  introduce	  our	  novel	  approach	  for	  obtaining	  such	  estimations.	  As	  mentioned	  in	  Chapter	  1,	  the	  group	  contribution	  method	  (GCM)	  plays	  a	  central	  role	  in	  the	   thermodynamics	   study	  of	   the	  metabolism.	  However,	  being	  based	  on	  experimental	  data,	   this	  method	   faces	   limitations	   in	   two	   respects.	   First	   of	   all,	   experimental	   data	   are	  limited	  for	  biological	  compounds,	  especially	   for	  heavy	  metabolites	  such	  as	  aminoacids	  and	   oligopeptides,	   saccharides,	   nucleosides	   and	   their	   derivatives.	   Second,	   since	   the	  experimental	   data	   are	   obtained	   on	   ambient	   conditions,	   the	   GCM	   calculations	   and	  estimations	   based	   on	   these	   data	   hold	   true	   for	   the	   ambient	   condition	   as	   well.	   As	  described	  in	  Chapter1,	  for	  many	  applications	  and	  especially	  the	  biological	  applications,	  it	   is	   important	   to	   calculate	   the	   thermodynamic	   properties	   at	   biologically	   relevant	  conditions	   of	   temperature	   and	   pressure,	   for	   example	   at	   T=37-­‐40	   for	   the	   studies	   of	  human	  metabolism	  under	  healthy	  and	  disease	  conditions.	  	  To	  overcome	  the	  limitations	  of	  existing	  methods,	  one	  needs	  to	  improve	  the	  GCM	  method	  for	  obtaining	  predictions	  beyond	  the	  metabolites	  that	  have	  available	  experimental	  data	  and	   also	   to	   adjust	   the	   estimated	   thermodynamic	   properties	   to	   any	   temperature	   and	  pressure	   based	   on	   the	   nature	   of	   the	   study.	   To	   address	   both	   issues,	   we	   designed	   a	  pipeline	   for	   the	   thermodynamics	   analysis	   of	   metabolism,	   which	   combines	   GCM	   and	  
quantum	  chemical	  calculations	   to	   compute	   the	   thermodynamics	   properties	   for	   a	  wide	  range	  of	  biological	  compounds	  in	  adjustable	  conditions	  of	  temperature	  and	  pressure.	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2.4.1 Overview	  of	  high-­‐level	  quantum	  chemical	  calculations	  	  There	  are	  fundamental	  reasons	  for	  the	  increased	  use	  of	  quantum	  chemical	  calculations	  among	   chemists	   [138].	   The	   theories	   underlying	   calculations	   have	   now	   evolved	   to	   a	  stage	  where	  a	  variety	  of	  thermodynamic	  properties	  can	  be	  predicted.	  	  However,	   there	   is	   no	   available	  ab	   initio	  method	   for	   the	   estimation	   of	   thermodynamic	  properties	  at	  aqueous	  phase	  that	  corresponds	  to	  the	  biological	  systems.	  Current	   advances	   in	   quantum	   chemical	   calculations	   and	   the	   unprecedented	   and	   ever	  increasing	  computational	  speed	  of	  computers	  has	  made	  the	  quantum	  chemical	  methods	  the	  most	  reliable	  approach	  for	  calculation	  of	  thermochemical	  quantities	  in	  the	  ideal	  gas	  
state.	   In	  addition,	   there	  are	  already	  significant	  advances	   for	  the	  calculation/prediction	  of	   the	   corresponding	   hydration	   free	   energies	   and	   enthalpies	   in	   quantum	   calculation	  methods	  [139-­‐141].	  The	   latter	   feature	  would	  allow	  bringing	  the	  generated	  data	   in	   the	  gas	  phase	  to	  aqueous	  phase	  and	  eventually	  it	  would	  allow	  studying	  the	  thermodynamics	  of	   biological	   systems.	   Therefore,	   the	   first	   step	   is	   to	   estimate	   the	   thermodynamic	  properties	  at	  the	  gas	  phase.	  In	   a	   recent	   thorough	   review	   [142],	   the	   state-­‐of-­‐the-­‐art	   in	   quantum	   thermochemical	  calculations	   is	   compared	   with	   the	   corresponding	   group-­‐contribution	   method	   (GCM)	  approach.	   Under	   certain	   conditions,	   the	   level	   of	   accuracy	   of	   current	   quantum	  thermochemical	   predictions	   in	   the	   ideal	   gas	   state	   compares	   with	   or	   overpasses	   the	  thermochemical	   accuracy	   of	   1	   kcal/mol	   [143,144]	   for	   small	   to	   moderate	   sized	  molecules	  with	  2	  to	  10	  non-­‐hydrogen	  atoms.	  	  The	  Gaussian	  –	  n	  (Gn)	   family	  of	  quantum	  chemical	  procedures	  [144,145]	  achieves	  the	  above	   level	   of	   accuracy	   for	   moderate	   sized	   molecules	   but	   the	   accuracy	   decreases	  sharply	   for	   heavier	   molecules.	   This	   holds	   true	   for	   the	   predictions	   of	   absolute	  thermochemical	  quantities	  via	  the	  atomization	  energy	  differences.	  	  Under	   certain	   conditions,	   accurate	   predictions	   can	   be	   made	   through	   designing	  appropriate	   isodesmic	   reactions	   even	   without	   using	   high	   levels	   of	   theory	   and	  computation	   [143,144].	   In	   isodesmic	   reactions,	   bond	   types	   and	   groups	   are	   kept	   the	  same	  on	  the	  two	  reaction	  sides;	  therefore,	  any	  flaws	  in	  theory	  and	  systematic	  errors	  will	  be	   mutually	   compensated.	   This	   makes	   the	   isodesmic	   reaction	   approach	   a	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computationally	   efficient	   way	   to	   calculate	   the	   enthalpies	   and	   Gibbs	   free	   energies	   of	  formation	  for	  relatively	  large	  molecules	  with	  tens	  or	  more	  heavy	  atoms	  [145,146].	  The	  key	  prerequisite	   in	   an	   isodesmic	   reaction	  approach	   is	   the	   availability	  of	   accurate	  thermochemical	   information	   on	   all	   other	   reactants	   and	   products	   beside	   the	   studied	  molecule.	  A	  lot	  of	  work	  has	  been	  done	  in	  this	  respect	  for	  the	  development	  of	  extensive	  thermochemical	  databases	  [147-­‐149].	  Metabolic	  reactions	  take	  place	  in	  aqueous	  environments	  where	  metabolites	  often	  exist	  as	   ions.	   Significant	   advances	   have	   been	   made	   in	   the	   field	   of	   gas-­‐phase	   ion	  thermochemistry,	   both	   experimentally	   and	   computationally	   [150-­‐157].	   In	   a	   recent	  review[158],	   standard	   values	   for	   gas-­‐phase	   basicities	   and	   proton	   affinities	   were	  recommended	  for	  the	  20	  (protein)	  aminoacids.	  Gas	  phase	  acidities	  for	  these	  aminoacids	  were	  also	  reported	  in	  recent	  studies	  [157,159].	  Yet,	  heats	  and	  free	  energies	  of	  formation	  of	  ionic	  forms	  are	  rarely	  reported.	  	  There	   have	   also	   been	   some	   studies	   on	   the	   gas-­‐phase	   quantum	   thermochemistry	   of	  saccharides	   and	   nucleosides,	   but	   not	   as	   extensive	   as	   for	   aminoacids.	   Reliable	  experimental	   thermochemical	   data	   for	   these	   classes	   of	   metabolites,	   especially	  nucleosides,	  are	  rare.	  	  
2.4.2 Computational	  tools	  used	  for	  high-­‐level	  quantum	  calculations	  Hereby	  we	   describe	   the	   computational	   tools	   we	   used	   for	   the	   calculation	   of	   heat	   and	  Gibbs	   free	   energy	   of	   aforementioned	   heavy	  metabolites	   in	   the	   gas	   phase.	   The	   heavy	  metabolites	   of	   interest	   in	   this	   work	   are	   fairly	   flexible	   and	   exist	   in	   a	   vast	  conformational/isomerization	   space,	   which	   makes	   their	   detailed	   theoretical	  computations	  a	  challenging	  task	  [160].	  For	   the	   conformer	   search,	   we	   used	   the	   COSMOconfX	   suite	   (Cosmologic	   GmbH,	  Germany)	  and	   the	  Conformer	  Analysis	   application	  of	   Spartan	  14	   suite	   (Wavefunction,	  USA)	  –	  a	  Monte	  Carlo	  /	  Molecular	  Mechanics	  algorithm.	  The	  first	  gross	  selection	  of	  the	  prevailing	  conformers	  was	  screened	  further	  down	  to	  a	   few	  conformers	  by	  performing	  energy	   calculations	   with	   progressively	   increasing	   basis	   set.	   We	   reinserted	   some	  conformers	  with	   extensive	   intramolecular	   hydrogen	  bonding,	  which	  were	   rejected	  by	  the	   above	   search	   algorithm	   into	   the	   pool	   for	   further	   calculations	   at	   a	   higher	   level.	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Whenever	  available,	  we	  inserted	  optimal	  geometries	  from	  literature	  into	  the	  pool	  at	  this	  stage.	   The	   prevailing	   conformers	   were	   subject	   to	   further	   geometry	   optimization	   at	  progressively	   higher	   levels	   until	   the	   most	   stable	   conformer	   was	   identified.	   We	  performed	   further	   calculations	   for	   the	   isodesmic	   reactions	   with	   the	   most	   stable	  conformer	  or	  with	  the	  few	  (less	  than	  five)	  prevailing	  conformers.	  	  We	  did	  Quantum	  chemical	   calculations	   at	   the	  DFT-­‐D3	   level	  with	  Grimme’s	  dispersion	  correction	   (D3	   London	   dispersion	   correction)	  with	   Becke–Johnson	   damping	   [161]	   as	  implemented	   in	   TURBOMOLE	   suite[162]	   with	   the	   resolution	   of	   the	   identity	   RI-­‐J	  approximation[163].	   Geometry	   optimization	   and	   vibrational	   frequency	   analysis	   were	  done	   with	   the	   Becke-­‐3-­‐Lee-­‐Yang-­‐Parr	   (B-­‐3LYP)	   3-­‐	   parameter	   hybrid	   functional	   with	  Becke’s	  popular	  nonlocal	  exchange	   functional	  and	  Lee/Yang/Parr	  nonlocal	  correlation	  functional	   [164,165]	   with	   the	   def2-­‐TZVP	   (Karlsruhe	   segmented	   contracted	   triple-­‐z	  valence	   quality	   plus	   polarization)	   basis	   set	   [162].	   All	   geometry-­‐optimization	   /	  frequency	   calculations	   were	   performed	   with	   TURBOMOLE	   v.	   6.5	   suites	   (Cosmologic	  GmbH,	   Germany).	   Using	   this	   geometry,	   we	   conducted	   single	   point	   energy	   (SPE)	  calculations	   at	   a	   higher	   level	   in	   two	   alternative	  ways:	   First,	   the	   generalized	   gradient	  approximation	  (GGA)	  B97-­‐D	  density	  functional	  [166,167]	  was	  used	  with	  the	  quadruple	  z-­‐valence	  quality	  def2-­‐QZVPD	  basis	  set	  as	  implemented	  in	  TURBOMOLE	  suite	  with	  the	  above	   Grimme’s	   D3	   dispersion	   correction.	   We	   did	   the	   SPE	   calculations	   for	   all	  compounds	   considered,	   neutral	   or	   ionic.	   Second,	  we	   used	   the	   Chai	   and	  Head-­‐Gordon	  ωB97X-­‐D	   long-­‐range	   corrected	   hybrid	   density	   functional	   [168]	   with	   the	   6-­‐311++G(2df,2p)	  basis	   set,	   as	   implemented	   in	  Gaussian	  09	  and	   in	  Spartan	  14	   suites	  of	  programs.	  Calculations	  at	  the	  second	  level	  were	  done	  on	  selected	  metabolites.	  	  We	  performed	  vibrational	   frequency	  calculations	  in	  order	  to	  verify	  that	  the	  structures	  were	   minima	   and,	   also,	   to	   obtain	   the	   zero	   point	   vibrational	   energy	   (ZPE)	   and	   the	  thermal	   corrections	   to	   the	   enthalpy,	   Hv,	   and	   free	   energy,	   Gv.	  We	   calculated	   the	   latter	  quantity	  from	  the	  entropy	  change	  through	  the	  classical	  equation:	  ΔfG	  =	  ΔfH	  –	  TΔfS	  The	  entropy	  term	  in	  the	  heavy	  metabolites	  is	  dominated	  by	  their	  many	  low	  frequencies	  [169],	   which	   are	   usually	   poorly	   approximated	   in	   the	   quantum	   thermochemical	  
	  57	  
calculations,	   therefore	   the	   “normal-­‐mode”	   approximation	  may	   not	   be	   valid	   for	   heavy	  and	  flexible	  molecules.	  More	   details	   of	   the	   methods	   we	   applied	   and	   the	   isoseismic	   reactions	   we	   design	   to	  calculate	   the	   thermodynamics	   properties	   for	   the	   heavy	   metabolites	   along	   with	   our	  results	  will	  be	  comprehensively	  discussed	  in	  Chapter	  7.	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Chapter	  ) 	  
ATLAS	  of	  BIOCHEMISTRY	  
How	  the	  known	  biochemistry	  evolves	  if	  we	  apply	  the	  generalized	  enzyme	  reaction	  





SUMMARY	  In	  this	  chapter	  we	  introduce	  the	  most	  comprehensive	  database	  of	  all	  the	  biochemically	  plausible	  reactions	  that	  can	  be	  generated	  using	  BNICE.ch	  based	  on	  the	  known	  biochemistry	  introduced	  in	  the	  KEGG	  database.	  This	  extension	  of	  KEGG	  reaction	  database	  includes	  ~128000	  reactions	  that	  can	  connect	  two	  or	  more	  KEGG	  metabolites,	  Approximately	  5300	  reactions	  out	  of	  ~128000	  are	  the	   KEGG	   reactions	   whereas	   the	   rest	   are	   hypothetical	   novel	   reactions	   that	   have	   never	   been	  reported	   to	   occur	   in	   nature.	   We	   applied	   the	   BridgIt	   method,	   an	   extension	   to	   BNICE.ch,	   to	  evaluate	   the	   structural	   similarity	   of	   the	   hypothetical	   proposed	   reactions	   to	   the	   known	   KEGG	  reactions.	  	  Furthermore,	   to	   validate	   the	   consistency	   of	   our	   results	   with	   the	   known	   biochemistry,	   we	  compared	  the	  2	  versions	  of	  KEGG	  database,	  KEGG2012,	  and	  KEGG2014.	  Interestingly,	  81	  novel	  reactions	   that	   BNICE.ch	   discovered	   based	   on	   the	   KEGG2012	   database	   appeared	   as	   known	  reactions	  in	  the	  2014	  version.	  This	  finding	  validates	  the	  consistency	  of	  the	  BNICE.ch	  generalized	  
reaction	  rules	  with	  the	  enzymatic	  reaction	  rules	  that	  nature	  follows.	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3.1 Introduction	  Our	  knowledge	  about	  the	  metabolism,	  even	  for	  the	  most	  studied	  model	  organisms	  such	  as	  E.	  coli	  and	  S.	  cerevisiae	  is	  not	  complete,	  and	  none	  of	  the	  available	  metabolic	  network	  reconstructions	  for	  any	  organism	  is	  considered	  complete	  and	  without	  knowledge	  gaps	  [170].	  The	  Kyoto	  Encyclopedia	  of	  Genes	  and	  Genomes	  (KEGG)	  database	  [60],	  known	  as	  the	  most	  complete	  source	  of	  metabolic	  data,	  increases	  its	  size	  and	  number	  of	  enzymatic	  reactions	   in	   each	   yearly	   updated	   release,	  which	   demonstrates	   that	   numerous	   not	   yet	  characterized	  enzymatic	  reactions	  are	  still	  to	  be	  found	  in	  nature.	  To	   the	  best	   of	   our	   knowledge,	   there	   is	   no	   available	  database	   that	   accounts	   for	  all	   the	  
theoretically	  possible	  enzymatic	  reactions,	  which	  are	  connecting	  known	  compounds	  and	  that	  are	  based	  on	  the	  known	  biochemistry.	  Such	  information	  would	  be	  of	  great	  interest	  not	   only	   for	   filling	   the	   knowledge	   gaps	   in	  metabolic	   networks,	   but	   also	   for	  metabolic	  engineering	  studies	  where	  the	  discovery	  of	  novel	  reactions	  is	  an	  important	  mission.	  The	  question	  that	  arises	  is:	  how	  the	  known	  biochemistry	  evolves	  if	  we	  apply	  the	  generalized	  enzyme	  reaction	  rules	  against	  all	  the	  currently	  known	  compounds?	  We	  address	   this	  question	  by	  applying	   the	   concept	  of	  generalized	  reaction	  rules	  within	  the	  computational	  framework	  BNICE.ch.	  Since	  the	  BNICE.ch	  reaction	  rules	  are	  based	  on	  the	  Enzymatic	   Commission	   (EC)	   classification	   system,	   every	   novel	   reaction	   generated	  with	  BNICE.ch	  was	  associated	  to	  a	  third-­‐level	  EC	  number,	  which	  defines	  a	  biochemically	  relevant	   reaction	   mechanism	   for	   novel	   reactions.	   With	   BNICE.ch	   we	   reconstructed	  ~90%	  of	   known	   reproducible	  KEGG	   reactions,	   and	   discovered	  more	   than	   123’000	  de	  
novo	   reactions	   involving	   two	   or	  more	   known	   KEGG	   compounds.	  We	   organized	   these	  results	   in	   a	   database,	   named	   “ATLAS	   of	   biochemistry”	   that	   comprises	   all	   the	  hypothetically	   possible	   enzymatic	   reactions	   between	   any	   two	   KEGG	   compounds,	   or	  more	  if	  required	  by	  the	  reaction	  mechanism.	  	  Since	  de	  novo	  reactions	  are	  theoretical	  orphan	  reactions,	  we	  applied	  BridgIt	  (Chapter	  2)	  for	  each	  of	  these	  reactions	  to	  find	  candidate	  genetic	  sequences	  that	  code	  for	  an	  enzyme	  that	  is	  potentially	  capable	  to	  catalyze	  the	  novel	  reaction.	  We	  applied	  different	  running	  modes	  of	  BridgIt	  and	  we	  extensively	  compared	  the	  results	  of	  different	  approaches.	  We	  analyzed	  our	  results	  with	  respect	   to	   two	  different	  versions	  of	   the	  KEGG	  database,	  KEGG	   2012	   and	   KEGG	   2014	   and	  we	   investigated	   if	   any	   of	   our	   predicted	   hypothetical	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reactions	  in	  KEGG	  2012	  became	  known	  in	  KEGG	  2014.	  Remarkably,	  we	  found	  81	  novel	  reactions	  that	  BNICE.ch	  predicts	  based	  on	  KEGG	  2012	  are	  reported	  as	  known	  enzymatic	  reactions	   in	   KEGG.	   This	   finding	   validated	   the	   consistency	   of	   our	   generalized	   reaction	  rules	   with	   the	   acknowledged	   biochemistry,	   and	   demonstrated	   that	   our	   proposed	  hypothetical	  enzymatic	  reactions	  are	  an	  important	  complement	  of	  the	  known	  cataloged	  biochemistry.	  
3.2 Methods	  The	   modules	   and	   methodologies	   of	   BNICE.ch	   have	   been	   extensively	   discussed	   in	  Chapter	   2.	   As	   described	   previously,	   BNICE.ch	   performance	   depends	   on	   a	   set	   of	  parameters	  that	  we	  predefine	  for	  each	  study.	  Here	  we	  list	  the	  input	  parameters	  that	  we	  used	   in	   this	   Chapter,	   and	  we	   also	   describe	   the	   procedural	   steps	  we	   took	   to	   build	   the	  “Atlas	  of	  Biochemistry”.	  
3.2.1 Preprocessing	  of	  KEGG	  compounds	  and	  reactions	  	  The	  KEGG	  database	  keeps	  growing	  in	  size:	  In	  1999,	  it	  accounted	  for	  5’207	  reactions	  and	  5’645	   compounds.	   In	   2004,	   there	   were	   5’799	   reactions	   and	   10’739	   compounds.	   In	  December	   2014,	   KEGG	   stored	   9’972	   reactions	   and	   17’343	   chemical	   compounds,	   and	  both	  categories	  keep	  growing	  with	  every	  new	  release.	  The	  continuous	  discovery	  of	  new	  
biochemistry	  indicates	  that	  our	  knowledge	  about	  metabolism	  is	  far	  from	  being	  complete,	  and	   that	   there	   is	   a	   remarkable	   potential	   for	   the	   discovery	   of	   new	   metabolic	  functionalities.	  	  For	  a	  reaction	  to	  be	  reconstructed	  in	  BNICE.ch	  we	  require	  a	  defined	  molecular	  structure	  for	   each	   of	   involved	   compounds.	   A	   structural	   definition	   of	   compounds	   is	   needed	   to	  create	  the	  corresponding	  bond	  electron	  matrices	  (BEM)	  as	  discussed	   in	  Chapter	  2.	  On	  the	   other	   hand,	   polymers	   being	   a	   repetition	   of	   monomers	   that	   already	   exist	   in	   the	  database	  do	  not	  add	  any	  useful	   information	   to	  our	  study.	  Therefore,	  we	  preprocessed	  the	  KEGG	  compounds	  and	  excluded	  from	  our	  input	  data	  all	  compounds	  that:	  i. Do	  not	  have	  a	  structural	  definition	  ii. Describe	  the	  polymer	  structures	  Similarly,	  we	  parsed	  all	  the	  KEGG	  reactions	  and	  excluded:	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i. Reactions	  with	  uncompleted	  molecular	  description	  of	  the	  reactants	  and	  products	  ii. Reactions	  that	  involve	  polymers	  iii. Reactions	  that	  are	  stoichiometric	  unbalanced	  After	  we	  removed	  the	  compounds	  and	  reactions	  that	  did	  not	  meet	  the	  above	  mentioned	  criteria,	  we	  ended	  up	  with	  a	  parsed	  KEGG	  database	  that	  consists	  of	  14’549	  compounds	  and	  5914	  reactions.	  
3.2.2 Reconstructing	  KEGG	  reactions	  and	  predicting	  de	  novo	  reactions	  In	   this	   section,	   we	   present	   a	   pipeline	   for	   reconstructing	   the	   latest	   coverage	   of	   KEGG	  
reaction	   database.	   We	   used	   the	   following	   two	   approaches	   to	   perform	   the	  reconstruction:	  In	  the	  first	  approach,	  we	  applied	  all	  the	  generalized	  reaction	  rules	  one	  at	  a	  time,	  to	  all	  KEGG	  compounds.	  We	  used	   the	  supervision	   level	   that	  allowed	  all	  possible	  reactions	   (known	   and	   novel)	   but	   only	   KEGG	   compounds	   (Table	   3.1).	   The	  procedure	  was	  as	  follows:	  	  1. Apply	  a	  reaction	  rule	  to	  all	  KEGG	  compounds	  and	  for	  only	  one	  iteration.	  2. Screen	  the	  output	  against	  the	  KEGG	  database	  and	  save	  the	  results	  3. Switch	  to	  the	  next	  rule	  and	  go	  to	  Step	  1.	  	  4. Stop	  when	  all	  582	  reaction	  rules	  are	  covered.	  	  As	   a	   result	   of	   this	   procedure	   we	   got	   two	   lists	   of	   reactions:	   KEGG	   covered	  (reconstructed)	  reactions	  and	  de	  novo	  reactions.	  	  In	   the	   second	   approach,	   we	   identified	   those	   KEGG	   reactions	   that	   were	   not	  reconstructed	  after	  1st	  iteration	  of	  BNICE.ch,	  and	  we	  performed	  further	  analysis	  with	   these	   reactions	   (~12	   %	   of	   the	   reconstructable	   KEGG	   reactions).	   In	   our	  pipeline,	  we	  read	  these	  reactions	  one	  by	  one,	  extracted	  the	   involved	  substrates	  and	  cofactors	  and	  put	  them	  in	  the	  list	  of	  “starting	  compounds”.	  We	  then	  applied	  all	   the	   generalized	   reaction	   rules	   simultaneously	   for	   three	   iterations	   to	  investigate	   can	  BNICE.ch	   replicate	   these	   reaction	  mechanisms	   in	   several	   steps.	  These	  identified	  steps	  represent	  a	  “multi-­‐step	  reaction	  mechanism”.	  The	  level	  of	  supervision	  in	  this	  approach	  was	  the	  same	  as	  described	  in	  Table	  3.1.	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The	   results	   of	   these	   two	   studies	   allowed	   us	   to	   explore	   all	   possible	   enzymatic	  
reactions	  (known	  and	  novel)	  between	  KEGG	  compounds.	  	  
Table	  3-­‐1:	  The	  level	  of	  supervisions	  that	  is	  applied	  in	  this	  study	  for	  the	  generalized	  reaction	  rules,	  
compounds	  and	  reactions.	  
Supervision	  level	   Input	  constraint	  
	  	   Example	  
Reaction	  
rules	   Compounds	   Reactions	  
Unsupervised	   -­‐	  
	  
Unlimited	   Unlimited	  
Database	   KEGG	   291*2	   14'549	   	  
Organism	   	   	   	   	  
Network	   	   	   	   	  
Pathway	   	   	   	   	  
	  
3.2.3 BridgIt	  Analysis	  The	  concept	  behind	  the	  development	  of	  BridgIt	   framework	   is	   thoroughly	  discussed	   in	  Chapter	   2.	   In	   this	   section,	   we	   applied	   the	   BridgIt	   method	   to	   assess	   the	   chemical	  similarity	  of	   the	  hypothetical	  generated	  reactions	   to	   the	  known	  KEGG	  reactions	  and	   to	  propose	  candidate	  genetic	  sequences	  for	  them.	  	  Based	  on	  the	  assumption	  that	  enzymes	  with	  similar	  structure	  catalyze	  similar	  reactions,	  the	  BridgIt	  algorithm	  proposes	  a	  genetic	  sequence	  for	  the	  novel	  reactions,	  together	  with	  a	  score	  that	  indicates	  the	  similarity	  of	  the	  novel	  reaction	  to	  the	  known	  reaction.	  BridgIt	  also	  indicates	  in	  which	  organism	  the	  similar	  enzyme	  can	  be	  found,	  which	  is	  important	  in	  metabolic	  engineering	  studies.	  We	  applied	  the	  four	  different	  modes	  of	  BridgIt	  as	  discussed	  in	  Chapter	  2:	  i. BridgIt_Cofactors	  ii. BridgIt_EC	  iii. BridgIt_CO_EC	  iv. BridgIt_original	  And	   we	   investigated	   the	   impact	   of	   the	   introduced	   features	   on	   the	   performance	   of	  BridgIt	  and	  its	  predictions.	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3.3 Results	  and	  discussions	  We	   generated	   a	   repository	   of	   all	   possible	   enzymatic	   reactions	   between	   KEGG	  compounds.	  This	  collection	  is	  a	  valuable	  source	  of	  information	  for	  the	  biochemical	  and	  biological	   studies	   and	   its	   characteristics	   and	   significance	   will	   be	   presented	   and	  discussed	  in	  the	  following	  sections.	  
3.3.1 KEGG	  reactions	  covered	  by	  BNICE	  	  ~	  90%	  of	  all	  KEGG	  reactions	  were	  reconstructed	  using	  the	  generalized	  reaction	  rules	  of	  BNICE.ch.	   There	   are	   1’261	   reactions	   in	   KEGG	   database	   that	   have	   no	   assigned	   EC	  number,	  which	  means	  that	  there	  is	  no	  known	  reaction	  mechanism	  for	  these	  reactions.	  Since	   BNICE	   reports	   the	   EC	   number	   up	   to	   the	   third	   level,	   we	   can	   propose	   EC	  classification	  and	  therefore	  reaction	  mechanisms	  for	  some	  of	  the	  reactions	  missing	  the	  EC	  number.	  We	  could	  identify	  the	  first	  three	  EC	  identifiers	  for	  178	  KEGG	  reactions.	  For	  134	   reactions	   the	   classification	   was	   unambiguous,	   meaning	   that	   there	   was	   only	   one	  suggested	   EC	   classification.	   For	   remaining	   44	   reactions	   two	   or	   more	   EC	   suggestions	  were	   reported.	   In	   most	   of	   the	   cases	   the	   suggestions	   were	   similar,	   i.e.	   out	   of	   the	   46	  ambiguous	   classifications	   only	   10	   reported	   different	   classifiers	   for	   the	   first	   EC	   level.	  Table	   3.2	   shows	   an	   example	   of	   KEGG	   reactions	   without	   corresponding	   EC	   number	  together	  with	  the	  third	  level	  EC	  number	  that	  BNICE.ch	  proposes	  for	  these	  reactions.	  	  
	  
Table	  3-­‐2:	  Two	  examples	  of	  KEGG	  reactions	  without	  a	  corresponding	  EC	  numbers	  and	  the	  suggested	  
EC	  number	  by	  BNICE.ch.	  An	  unambiguous	  EC	  suggestion	  is	  in	  white,	  whereas	  reactions	  with	  two	  or	  
more	  suggested	  EC	  numbers	  are	  highlighted	  in	  red.	  	  The	   entire	   list	   of	   KEGG	   reactions	  with	   EC	   suggestions	   can	   be	   found	   in	   the	   Appendix,	  Table	  A1.	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3.3.2 Multi-­‐step	  reactions	  An	   example	   of	   a	  multi-­‐step	   reaction	   that	   is	   reconstructed	  with	   BNICE.ch	   is	   shown	   in	  Figure	  3.1.	  Part	  A	  shows	  the	  description	  of	  a	  KEGG	  reaction	  with	  unidentified	  enzyme	  and	  mechanism.	  In	  Part	  B,	  using	  BNICE.ch,	  we	  propose	  a	  two-­‐step	  reaction	  mechanism	  to	  carry	  out	  the	  biotransformation.	  The	  first	  step	  is	  a	  known	  KEGG	  reaction,	  but	  in	  the	  reverse	  direction	  and	  the	  second	  step	  is	  a	  novel	  reaction.	  Interestingly,	  for	  the	  first	  step	  we	   propose	   two	   reaction	  mechanism,	   one	   is	   the	   same	   as	   the	   known	   reaction	   on	   the	  reverse	   direction	   (3.5.1A1(rev))	   and	   the	   other	   one	   is	   a	   class	   6	   enzyme	   that	  BNICE.ch	  proposes	  for	  this	  reaction	  (6.3.1.A1).	  	  
	  
Figure	   3-­‐1:	   A	   two-­‐step	   reaction	   of	   KEGG	   database	   that	   do	   not	   have	   a	   corresponding	   enzyme	   for	  
catalyzing	   it	   (A)	  and	  using	  BNICE.ch,	   in	   (B)	  we	  proposed	  a	  two-­‐steps	  reactions	  that	  has	  one	  known	  
KEGG	  reactions	  (step	  1)	  and	  one	  novel	  reaction	  (step	  2)	  to	  describe	  the	  biotransformation.	  









biological	   compounds	   to	   be	   interconverted	   by	   a	   relatively	   small	   number	   of	   reaction	  mechanisms.	  	  
3.3.4 Validating	  the	  action	  of	  generalized	  reaction	  rules	  To	  validate	  the	  consistency	  of	  mechanisms	  of	  the	  generated	  hypothetical	  reactions	  with	  the	   known	   biochemistry,	   we	   investigated	   if	   any	   of	   the	   novel	   reactions	   that	   BNICE.ch	  generated	  on	  the	  basis	  of	  KEGG	  2012	  became	  known	  in	  the	  more	  recent	  versions	  of	  the	  KEGG	  database	  and	  we	  used	  KEGG	  2014	  for	  this	  comparison.	  	  Between	   the	   two	   releases	   KEGG	   2012	   and	   KEGG	   2014,	   691	   reactions	  were	   added	   to	  KEGG	  reaction	  database.	  From	  this	  set	  of	  added	  reactions	  we	  removed	  all	  incomplete	  or	  unbalanced	   reactions,	   as	   well	   as	   the	   reactions	   that	   contained	   compounds	   with	  undefined	   structure.	   We	   also	   removed	   reactions	   that	   could	   not	   possibly	   be	  reconstructed	  by	  BNICE	  because	  they	  involved	  new	  compounds	  that	  were	  not	  present	  in	   KEGG	   2012,	   but	   were	   added	   later	   to	   KEGG	   2014.	   After	   this	   preprocessing,	   the	  remaining	  data	  set	  of	  new	  entries	  of	  KEGG	  2014	  contained	  236	  reactions.	  	  We	  then	  generated	   the	  set	  of	  novel	  reactions	  on	   the	  basis	  of	  KEGG	  2012	  reaction	  and	  compound	   databases	   and	   compared	   it	   with	   the	   236	   new	   entries	   of	   KEGG	   2014.	  Interestingly,	   we	   predicted	   81	   of	   these	   236	   reactions.	   Even	   more	   strikingly,	   for	   67	  reactions	   the	   EC	   numbers	   that	   have	   been	   assigned	   by	   BNICE.ch	   matched	   the	   EC	  numbers	  in	  KEGG	  2014.	  For	  8	  reactions	  BNICE.ch	  proposed	  an	  alternative	  classification,	  whereas	   for	   the	   remaining	   6	   reactions	   KEGG	   2014	   was	   lacking	   an	   EC	   identifier	   and	  BNICE.ch	  proposed	  an	  EC	  number	  up	  to	  the	  3rd	  level	  for	  these	  reactions.	  The	  list	  of	  81	  reactions	  with	  their	  EC	  numbers	  is	  presented	  in	  Appendix	  Table	  A2.	  
3.3.5 BridgIT	  analysis	  of	  novel	  reactions	  We	  performed	  4	  studies	  using	  4	  different	  methods	  of	  BridgIt	  to	  analyze	  the	  structural	  similarity	   of	   ~123,000	   novel	   reactions	   predicted	   by	   BNICE.ch	   to	   the	   known	   KEGG	  reactions.	  We	  compared	  BridgIt	  performance	  for	  two	  criteria:	  i. The	   distribution	   of	   the	   highest	   similarity	   score	   that	   each	   method	   predicts	  	  (Figure	  3.2)	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ii. The	  closest	  KEGG	  reaction	  that	  the	  4	  methods	  assign	  to	  the	  novel	  reactions.	  For	  this	   criterion,	  we	   compared	   combinations	   of	   pairs	   of	   the	   4	  methods	   across	   six	  different	  EC	  classes.	  (Figure	  3.3)	  The	  distribution	  of	  the	  highest	  score	  was	  quite	  different	  across	  4	  methods	  (Figure	  3.2).	  As	   we	   applied	   4	   methods	   in	   the	   order	   of	   increasing	   constraints	   (i.e.	   from	  BridgIt_original	   to	   BridgIt_CO_EC)	   the	   number	   of	   high	   scores	   (close	   to	   1)	   gradually	  decreased.	  The	  BridgIt_original	  method	  predicted	  high	  scores	  (close	  to	  1)	  for	  the	  largest	  number	  of	  the	  novel	  reactions,	  whereas	  BridgIT_CO_EC	  predicted	  the	  smallest	  number	  of	  high	  scores.	  The	  accuracy	  of	  these	  methods	  can	  be	  tested	  against	  the	  BLAST	  similarity	  scores	   of	   these	   reactions.	   However,	   the	   preliminary	   results	   and	   verifications	   of	   the	  individual	  examples	  suggested	  that	  BridgIT_CO_EC	  had	  the	  higher	  accuracy.	  
	  
Figure	  3-­‐2:	  the	  distribution	  of	  the	  highest	  similarity	  score	  that	  different	  methods	  of	  BridgIt	  assign	  to	  
the	  123,000	  novel	  reactions.	  	  
	  We	   compared	   combinations	   by	   pairs	   of	   4	   BridgeIt	   methods	   across	   six	   different	   EC	  classes	   to	   gain	   more	   insight	   about	   their	   performance	   (Figure	   3.3).	   For	   example,	   the	  comparison	  of	  BridgIT_EC_CO	  and	  BridgIt_EC	  methods	  indicated	  that	  for	  the	  EC	  class	  1,	  their	   predictions	   were	   ~30%	   similar,	   whereas	   for	   the	   EC	   class	   4	   their	   predictions	  coincided	  in	  more	  than	  70%	  (Figure	  3.3).	  
BridgIt_CO_EC,, BridgIt_EC,, BridgIt_CO,, BridgIt_original,,
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Figure	  3-­‐3:	  Comparing	  the	  similarity	  of	  the	  closet	  KEGG	  reaction	  that	  each	  method	  predicts	  for	  novel	  
reactions.	  The	  first	  comparison	  is	  between	  BridgIT_EC_CO	  and	  BridgIt_EC	  methods	  (EC/CO_VS_EC).	  
The	  color	  coding	  of	  the	  bars	  is	  according	  to	  the	  EC	  level	  1	  number.	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NICELips	  
How	  to	  bridge	  the	  gap	  between	  the	  enoous	  available	  knowledge	  from	  lipidomics	  studies	  and	  the	  limited	  knowledge	  on	  lipid	  metabolism?	  
	  
	  
SUMMARY	  In	   this	   chapter,	  we	   introduce	  a	   computational	  approach,	   called	  NICELips	   (Network	   Integrated	  Computational	   Explorer	   for	   Lipidomics),	   based	   on	   the	   formulation	   of	   generalized	   enzymatic	  reaction	   rules	   for	   lipid	  metabolism.	  Our	   approach	   employs	   the	   generalized	   rules	   to	   postulate	  novel	   pathways	   of	   lipid	   metabolism.	   It	   further	   integrates	   all	   discovered	   lipids	   in	   biological	  networks	  of	  enzymatic	  reactions	  that	  consist	  their	  biosynthesis	  and	  biodegradation	  pathways.	  We	   illustrate	   the	   utility	   of	   our	   approach	   through	   a	   case	   study	   of	  bis(monoacylglycero)phosphate	   (BMP),	   a	   biologically	   important	   glycerophospholipid	   with	  immature	   synthesis	   and	   catabolic	   route(s).	   Using	  NICELips,	  we	  were	   able	   to	   propose	   various	  synthesis	  and	  degradation	  pathways	  for	  this	  compound	  and	  several	  other	  lipids	  with	  unknown	  metabolism	  like	  BMP,	  and	  in	  addition	  several	  alternative	  novel	  biosynthesis	  and	  biodegradation	  pathways	   for	   lipids	  with	  known	  metabolism.	  NICELips	  has	  potential	   applications	   in	  designing	  therapeutic	   interventions	   for	   lipid-­‐associated	   disorders	   and	   in	   the	   metabolic	   engineering	   of	  model	  organisms	  for	  improving	  the	  bio-­‐based	  production	  of	  lipid-­‐derived	  fuels	  and	  chemicals.	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4.1 Introduction	  One	   of	   the	   most	   functionally	   and	   structurally	   important	   classes	   of	   lipids	   is	  glycerophospholipids.	   They	   constitute	   the	   majority	   of	   the	   common	   lipid	   class	   called	  phospholipids	  and	  can	  be	  found	  in	  almost	  all	  organisms	  as	  they	  are	  the	  building	  blocks	  of	  cell	  membranes	  [171,172].	  Glycerophospholipids	  contain	  a	  polar	  head	  and	  a	  glycerol	  core	  with	   fatty	   acids	   attached	   to	   the	   glycerol	  moiety	   [173].	   They	   are	   subdivided	   into	  distinct	  subclasses,	  based	  on	  the	  nature	  of	  the	  polar	  head	  group	  at	  the	  sn-­‐3	  position	  of	  the	  glycerol	  backbone	  [174]	  (Figure	  4.1).	  	  
	  
Figure	  4-­‐1:	  General	  structure	  of	  glycerophospholipids.	   In	  most	  glycerophospholipids	  the	  phosphate	  
(on	  sn-­‐3	  position)	  is	  one	  of	  the	  following	  polar	  head	  groups:	  serine,	  choline,	  ethanolamine,	  glycerol,	  
or	  inositol	  (designated	  X	  at	  right).	  The	  Acyl	  chains	  are	  shown	  with	  “R”	  in	  the	  n-­‐2	  and	  sn-­‐1	  positions	  
and	  can	  have	  different	  length	  and	  degrees	  of	  saturation.	  
	  One	   of	   the	   major	   limitations	   in	   lipidomics	   and	   more	   generally	   in	   metabolomics	  experiments	   is	   the	   identification	   of	   unknown	   compounds	   due	   to	   the	   lack	   of	  comprehensive	  integrated	  reference	  databases	  [21,175,176].	  	  Until	   recently,	   there	   were	   few	   specialized	   databases	   focusing	   on	   lipids	   analysis	   and	  classifications.	  In	  2007,	  LIPID	  MAPS	  Structure	  Database	  (LMSD)	  became	  available	  [175].	  LMSD	   is	   a	   comprehensive	   database	   for	   lipid	   structures	   that	   currently	   contains	   over	  40,000	   different	   classified	   structures	   and	   their	   corresponding	   physicochemical	  information.	   However,	   a	   comprehensive	   database	   of	   lipid	   structure	   is	   not	   enough	   to	  fully	  understand	  their	  multiple	  biological	  roles	  in	  cell	  biology	  and	  pathology.	  To	  further	  clarify	   their	   functions	   and	   the	   enzymes	   related	   to	   their	  metabolism,	   it	   is	   essential	   to	  organize	   them	   in	   the	  context	  of	  biological	  pathways	  and	  derive	   their	  associations	  and	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interactions	  with	  enzymes	  and	  other	  lipids.	  	  For	   the	   representation	   of	   lipids	   pathways,	   KEGG	   (Kyoto	   Encyclopedia	   of	   Genes	   and	  Genomes)	   [60]	   is	   the	  most	  comprehensive	  database	  available	   for	  small	  molecules	  and	  contains	  biological	  pathway	  maps	  for	  different	  parts	  of	  lipid	  metabolism.	  However,	  lipid	  biological	  pathways	  in	  KEGG	  are	  limited	  to	  general	  lipid	  species	  and	  do	  not	  include	  all	  the	   lipid	   structures	   available	   through	   LMSD.	   Therefore,	   the	   growth	   rate	   of	   these	   two	  databases	   is	  different	  and	  this	  results	   in	   the	  creation	  of	  a	  big	  knowledge	  gap	  between	  them.	  The	   aforementioned	   needs	   and	   limitations	   in	   lipids	   bioinformatics	   motivated	   us	   to	  develop	   a	   computational	   framework,	   NICELips	   (Network	   Integrated	   Computational	  Explorer	  for	  Lipidomics),	  to	  generate	  associations	  between	  KEGG	  and	  LMSD	  databases	  and	   to	   enrich	   our	   knowledge	   of	   lipid	   metabolism.	   NICELips	   consists	   of	   several	  components	  integrated	  into	  a	  workflow	  and	  it	  is	  the	  first	  tool	  to	  provide	  an	  efficient	  and	  consistent	   procedure	   for	   linking	   lipid	   compound	   databases,	   such	   as	   LMSD,	   with	  pathway	  databases,	  such	  as	  KEGG.	  The	  central	  component	  involves	  the	  generation	  and	  reconstruction	   of	   lipid	   structures	   integrated	   in	   metabolic	   reactions.	   Within	   this	  component	  we	  identify	  all	  the	  known	  enzymatic	  reactions	  of	  lipid	  metabolism	  in	  KEGG	  database,	  and	  we	  formulate	  the	  generalized	  reaction	  rules	  for	  lipid	  reactions	  based	  on	  the	   molecular	   signatures	   of	   known	   enzymatic	   reactions.	   We	   then	   use	   BNICE.ch	  framework	  to	  apply	  the	  generalized	  reaction	  rules	  through	  three	  different	  schemes	  that	  differ	   on	   the	   level	   of	   supervision	   procedure	   (detailed	   description	   of	   the	   method	   is	  discussed	  in	  Chapter	  2).	  	  In	  this	  work	  we	  focused	  on	  the	  “Glycerophospholipid	  metabolism”.	  In	  each	  of	  the	  three	  different	   schemes,	   we	   investigated	   a	   specific	   research	   question	   about	   the	  glycerophospholipid	  structures	  and	  metabolism.	  In	  the	  first	  scheme,	  we	  reconstructed	  a	  comprehensive	  network	  of	  glycerophospholipid	  metabolism	   that	   includes	   all	   the	   known	   reported	   structures	   and	   reactions	   in	   their	  corresponding	   KEGG	   map.	   In	   addition	   we	   incorporated	   many	   novel	   compounds	   and	  reactions	  that	  have	  not	  been	  previously	  reported	  in	  databases.	  In	  order	  to	  facilitate	  the	  identification	   of	   novel	   compounds	   and	   assess	   the	   biochemical	   similarity	   between	   the	  novel	  and	  known	  compounds,	  we	  adapted	  and	   implemented	  a	  subgraph	   isomorphism	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classification	  algorithm	  to	  classify	  these	  compounds	  based	  on	  the	  existing	  classification	  scheme	   for	   glycerophospholipids.	   The	   structural	   similarity	   among	   the	   members	  provides	   an	   insight	   on	   the	   functions	   of	   the	   novel	   compounds	   and	   enzyme	   specificity	  involved	  in	  their	  biosynthetic	  and	  catabolic	  pathways.	  Our	  classification	  method	  is	  also	  coupled	  with	  a	  scoring	  algorithm	  in	  order	  to	  assess	  the	  similarity	  of	  compounds	  in	  each	  group	  with	  the	  introduced	  general	  substructural	  pattern.	  The	  scoring	  algorithm	  assigns	  a	  value	  between	  0	  and	  1	  to	  each	  compound,	  and	  helps	  us	  to	  assign	  priority	  in	  the	  study	  of	  novel	  compounds.	   If	  we	  allow	  all	   the	  novel	  compounds	   to	  be	  kept	   in	   the	  generated	  reactions	  network,	  it	   limits	  the	  number	  of	  iterations	  that	  we	  can	  run	  BNICE.ch	  since	  it	  generates	  too	  many	  compounds	  and	  causes	  the	  combinatorial	  explosion.	  	  In	   the	   second	  scheme,	  we	   repeated	   the	   same	  procedure	  as	   in	   the	   first	   scheme,	  but	  we	  constrained	  the	  “level	  of	  compound	  supervision”	  to	  only	  the	  KEGG	  compounds,	  in	  order	  to	  explore	  all	  the	  possible	  reactions	  between	  only	  the	  known	  lipid	  structures.	  In	  the	  third	  mode,	  we	  applied	  the	  retrobiosynthesis	  algorithm	  of	  BNICE.ch	  that	  uses	  the	  reaction	  rules	  against	  LMSD	  structures	  to	  identify	  their	  metabolic	  and	  catabolic	  reaction	  pathways.	   We	   illustrate	   the	   efficacy	   and	   usefulness	   of	   our	   approach	   in	   the	   study	   of	  bis(monoacylglycero)phosphate	   (BMP)	   metabolism.	   BMP	   has	   two	   glycerol	   subunits	  linked	  by	  a	  phosphodiester	  group	  and	  it	   is	  a	  structural	  isomer	  of	  phosphatidylglycerol	  (PG).	  The	  endosomes	  are	  highly	  enriched	  in	  BMP,	  where	  it	  can	  amount	  up	  to	  70%	  of	  the	  total	   phospholipids	   of	   the	   endosomal	   membrane	   [177].	   BMP	   is	   important	   for	   the	  structural	   and	   functional	   integrity	   of	   the	   late	   endosomes.	   Interestingly,	   BMP	   is	   also	   a	  unique	  lipid	  due	  to	  its	  stereochemical	  configuration	  different	  from	  that	  of	  other	  animal	  glycerophospholipids.	   Despite	   numerous	   studies,	   we	   still	   miss	   essential	   knowledge	  concerning	   its	   properties,	   and	   biosynthetic	   and	   catabolic	   pathways.	   Based	   on	   the	  experimental	   evidence,	  BMP	   is	   synthesized	   from	   its	   structural	   isomer,	   (PG).	  After	   the	  removal	  of	  one	  fatty	  acid	  from	  the	  sn-­‐2	  position,	  lysophosphatidylglycerol	  is	  produced	  as	  next	  intermediate	  that	  then	  undergoes	  a	  transacylation	  reaction	  [178].	  The	  results	  of	  the	  retrosynthesis	  experiment	  suggest	  various	  synthesis	  and	  degradation	  pathways	  for	  this	  compound.	  Our	   studies	   here	   demonstrate	   how	   NICELips	   can	   provide	   a	   full	   overview	   of	   all	   lipid	  species	  in	  the	  cell,	  and	  particularly	  in	  the	  context	  of	  metabolic	  pathways	  that	  comprise	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all	   the	   chemical	   interactions	   and	   transformations	   between	   lipid	   compounds	   and	  enzymes.	   The	   results	   of	   this	  work	   have	   important	   implications	   for	   discovering	   novel	  therapeutic	   approaches	   for	   lipid-­‐associated	   disorders,	   through	   proposing	   novel	  biosynthetic	   and	   biodegradation	   pathways	   to	   alternate	   the	  metabolism	   of	   genetically	  defective	   lipids.	  On	   the	  other	  hand,	   exploring	   the	   entire	   space	  of	   feasible	   reactions	   in	  lipid	  metabolism	  will	  open	  up	  opportunities	  for	  generating	  de	  novo	  reactions	  to	  design	  and	   engineer	   new	   strains	   for	   the	   bio-­‐based	   production	   of	   lipids-­‐derived	   fuels	   and	  chemicals.	  
4.2 Methods	  The	  development	  of	  the	  NICELips	  framework	  is	  an	  extension	  of	  BNICE.ch	  [72]	  tailored	  for	  lipid	  metabolism.	  NICELips	  specifically	  consists	  of	  two	  main	  algorithms	  of	  BNICE.ch	  and	   several	   auxiliary	   functions	   for	   further	   analysis	   of	   the	   obtained	   results.	   BNICE.ch	  methodologies	  are	  extensively	  discussed	  in	  Chapter	  2.	  The	  two	  main	  algorithms	  of	  BNICE.ch	  are	  applied	  in	  this	  study:	  (i) Forward	  network	  reconstruction	  algorithm	  	  To	   reconstruct	   the	   KEGG	   glycerophospholipid	   metabolism	   using	   specific	  generalized	  reaction	  rules	  relevant	  to	  this	  pathway	  	  (ii) Retrobiosynthesis	  algorithm	  	  To	   integrate	   the	   lipid	   structures	   from	   LMSD	   database	   into	   metabolic	  pathways	  and	  link	  them	  through	  known	  and	  hypothetical	  reactions	  by	  using	  the	  reaction	  rules.	  	  A	  flowchart	  of	  the	  different	  steps	  of	  the	  NICELips	  framework	  is	  illustrated	  in	  Figure	  4.2	  and	  will	  be	  discussed	  in	  the	  following	  sections.	  
4.2.1 Generalized	  reaction	  rules	  in	  glycerophospholipid	  metabolism	  The	   KEGG	   pathway	   of	   glycerophospholipid	   metabolism	   was	   used	   as	   a	   reference	   to	  develop	  the	  generalized	  enzymatic	  reaction	  rules	  for	  this	  study.	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Figure	  4-­‐2:	  The	  NICELips	  framework	  for	  investigating	  lipid	  metabolism	  using	  three	  different	  schemes.	  
All	   the	   three	   schemes	   start	   with	   a	   KEGG	   pathway	   that	   we	   want	   to	   study	   (glycerophospholipid	  
metabolism	   in	   this	   study).	   We	   extract	   the	   generalized	   enzyme	   reaction	   rules	   relevant	   for	   the	  
pathway	   under	   study	   and	   we	   reconstruct	   different	   levels	   of	   reactions	   networks	   based	   on	   the	  







































Table	   4-­‐1:	   The	   set	   of	   enzyme	   rules	   involved	   in	   known	   glycerophospholipid	   pathways,	   in	   the	  
parenthesis	  the	  specific	  reaction	  rules	  used	  in	  this	  study	  are	  shown.	  The	  alphanumeric	  classification	  
of	   the	  rules	  corresponds	  to	  differences	   in	  cofactors	  and	  substrate	  structure	   (e.g.,	   linear	  vs.	  cyclical	  
structures).	   For	  each	   rule	   an	  example	   reaction	  with	  associated	  EC	  nomenclature	  and	   the	   required	  
cofactors	  are	  given.	  
	  In	   developing	   the	   rule	   2.7.8,	   we	   studied	   all	   the	   4th	   level	   reactions	   in	   EC	   2.7.8	   class	  (designated	  as:	  “Transferases	  for	  other	  substituted	  phosphate	  groups”)	   in	  which	  there	  are	   37,	   4th	   level	   reactions	   (numbered	   from	   2.7.8.1	   to	   2.7.8.37).	   The	   37	   4th	   level	   EC	  numbers	  correspond	   to	  51	  specific	  KEGG	  reaction	   IDs.	  By	  carefully	   investigating	   their	  mechanism,	   we	   found	   out	   that	   in	   24	   out	   of	   51	   reactions,	   the	   reactive	   sites	   of	   the	  substrates	  share	  common	  structures.	  Consequently,	  we	  developed	  the	  general	  reaction	  rule	  2.7.8A1	  for	  replicating	  the	  24	  reactions	  having	  exact	  match	  of	  reactive	  sites	  of	  their	  substrates.	  	  
Enzyme	  rule	   Reaction	  name	   EC	   Required	  cofactor	  
1.1.1	  (1.1.1A1)	   Oxidoreductases	  with	  NAD+	  or	  NADP+	  as	  
acceptor	  
1.1.1.8	   H+,	  NAD+	  or	  NADP+	  




2.3.1	  (2.3.1F1)	   Transferring	  groups	  other	  than	  
aminoacyl	  groups	  
2.3.1.15	   Acyl-­‐CoA	  
2.7.1	  (2.7.1A1)	   Phosphotransferases	  with	  an	  alcohol	  
group	  as	  acceptor	  
2.7.1.32	   ATP	  
2.7.7	  (2.7.7A1)	   Nucleotidyltransferases	   2.7.7.41	   Cytidine	  triphosphate	  
2.7.8	  (2.7.8A1)	   Transferases	  for	  other	  substituted	  
phosphate	  groups	  
2.7.8.5	   __	  
3.1.1	  (3.1.1A1)	   Carboxylic-­‐ester	  hydrolases	   3.1.1.52	   Water,	  O2	  
3.1.3	  (3.1.3A2)	   Phosphoric-­‐monoester	  hydrolases	   3.1.3.27	   Phosphate	  
3.1.4	  (3.1.4A1)	   Phosphoric-­‐diester	  hydrolases	   3.1.4.3	   Water	  
3.6.1	  (3.6.1A1)	   In	  phosphorus-­‐containing	  anhydrides	   3.6.1.26	   Water	  
4.1.1	  (4.1.1A3)	   Carboxy-­‐lyases	   4.1.1.65	   CO2	  
4.3.1	  (4.3.1A3)	   Ammonia-­‐lyases	   4.3.1.7	   Ammonia	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Out	   of	   these	   24	   KEGG	   reactions,	   11	   reactions	   belong	   to	   the	   glycerophospholipid	  metabolism.	   For	   the	   remaining	   27	   reactions	  we	   further	   developed	   2	   additional	   rules	  (2.7.8A2	  and	  2.7.8B1),	  which	  do	  not	  appear	  in	  the	  glycerophospholid	  metabolism.	  The	  joined	  set	  of	  the	  2.7.8	  rules	  is	  able	  to	  reproduce	  all	  the	  currently	  known	  reactions	  that	  could	   be	   classified	   as	  members	   of	   the	   EC	   2.7.8	   class.	   Many	   rules	   require	   specific	   co-­‐factors	  or	  other	  small	  molecules	  for	  their	  function	  (Table	  4.1).	  	  In	   order	   to	   reproduce	   all	   the	   reactions	   involved	   in	   the	   KEGG	   pathway	   of	  glycerophospholipid	  metabolism,	  we	  found	  that	  at	  least	  12	  generalized	  enzyme	  reaction	  rules	  were	  required	  (Table	  4.1).	  	  
4.2.2 Forward	  network	  generation	  within	  NICELips	  We	  employ	  the	  forward	  network	  generation	  algorithm	  to	  replicate	  the	  known	  pathway	  of	   glycerophospholipid	   metabolism	   as	   found	   in	   KEGG.	   Next,	   we	   apply	   an	   automatic	  search	  into	  KEGG	  database	  to	  identify	  which	  of	  the	  generated	  compounds	  and	  reactions	  are	  novel	  and	  which	  already	  exist	  in	  KEGG.	  	  	  The	   initial	   set	   of	   starting	   compounds	   consisted	   of	   4	   core	   compounds	   (sn-­‐glycerol-­‐3-­‐phosphate,	  serine,	  choline,	  and	  inositol)	  and	  12	  cofactors	  (NADH,	  NAD+,	  H+,	  Bicarbonate,	  CO2,	   O2,	   Water,	   Cytidine	   triphosphate	   (CTP),	   Phosphate,	   Acyl-­‐CoA,	   S-­‐Adenosylmethionine	   and	   ammonia),	   and	   the	   set	   of	   the	   12	   generalized	   reaction	   rules	  (Table	  4.1).	  	  We	  ran	   the	  algorithm	  with	   two	  different	   levels	  of	   supervisions.	   In	   the	   first	   approach	  we	   investigated	   the	   glycerophospholipid	   metabolism	   with	   supervision	   only	   on	   the	  generalized	   enzyme	   rules	   that	   describe	   the	   known	   glycerophospholipid	   pathway	   in	  KEGG.	   As	   for	   the	   search	   space	   of	   compounds	   and	   reactions,	   we	   didn’t	   apply	   any	  constraint	  (Table	  4.2).	  We	  wanted	  to	  understand	  after	  how	  many	  number	  of	  iterations	  the	  combinatorial	  explosion	  occurs	  for	  the	  compounds	  (known	  and	  novel)	  and	  for	  the	  reactions	  (known	  and	  novel).	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Table	  4-­‐2:	  Applied	  levels	  of	  supervision	  for	  the	  analysis	  of	  the	  Scheme	  1.	  	  
Supervision	  level	   Input	  constraint	  
	  	   Example	   Reaction	  rules	   Compounds	   Reactions	  
Unsupervised	   -­‐	  
	  
Unlimited	   Unlimited	  
Database	   	   	   	   	  
Organism	   	   	   	   	  
Network	   	   	   	   	  
Pathway	   Glycerophosphplipid	   12*2	   33	   69	  	  Since	   one	   of	   the	  main	   objectives	   of	   NICELips	   is	   to	  make	   associations	   between	   LMSD	  compounds	  and	  known	  metabolites	   found	   in	  KEGG	  database,	  we	  do	  not	   include	  novel	  compounds	   in	   the	   second	   approach.	   We	   investigated	   how	   the	   reaction	   network	   of	  glycerophospholipid	   will	   evolve	   if	   we	   explored	   all	   the	   possible	   reactions	   between	  known	  compounds	  of	  KEGG.	  Will	  it	  converge	  after	  a	  certain	  point?	  	  To	  answer	  this	  question,	  we	  applied,	  the	  supervision	  on	  the	  level	  of	  compounds	  rather	  than	   the	   supervision	   of	   the	   generalized	   reaction	   rules.	   As	   for	   the	   search	   space	   of	   the	  compounds,	   we	   only	   allowed	   the	   KEGG	   compounds	   to	   be	   included	   in	   our	   network	  (Table	  4.3).	  	  
Table	  4-­‐3:	  Applied	  levels	  of	  supervision	  for	  the	  analysis	  of	  the	  Scheme	  2&3.	  Supervision	  level	   Input	  constraint	  
	  	   Example	   Reaction	  rules	   Compounds	   Reactions	  
Unsupervised	   -­‐	   	   Unlimited	   Unlimited	  Database	   KEGG	   	   14'549	   5914	  
Organism	   	   	   	   	  
Network	   	   	   	   	  
Pathway	   Glycerophosphplipid	   12*2	   33	   69	  	  
4.2.2.1 Automatic	  classification	  and	  scoring	  	  For	   the	   rapid	   and	   automatic	   classification	   of	   the	   compounds	   dataset	   generated	   by	  NICELips,	  we	   established	   a	   subgraph	   isomorphism	   algorithm,	   coupled	  with	   a	   scoring	  algorithm.	   Exploiting	   the	   fact	   that	   NICELips	   uses	   a	   graph	   representation	   of	   the	  compound	   structures,	   we	   used	   a	   chemistry-­‐based	   approach	   by	   introducing	   a	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classification	   algorithm	   based	   on	   subgraph	   isomorphism,	   in	   which	   the	   novel	  compounds	   are	   classified	   through	   comparison	   with	   characteristic	   substructures	   of	  these	   subclasses.	   More	   precisely,	   we	   used	   the	   existing	   classification	   scheme	   for	  glycerophospholipids	  in	  which	  seven	  main	  classes	  are	  distinguished	  by	  a	  base	  structure	  in	  each	  class.	  	  Identifying	  the	  key	  features	  of	  the	  base	  structures,	  we	  generated	  template	  (sub)graphs	  (substructures)	  for	  different	  classes	  and	  used	  them	  to	  classify	  thousands	  of	  novel	  compounds	  predicted	  with	  NICELips,	  using	  our	  proposed	  algorithm.	  Several	  methods	  for	  (sub)graph	  matching	  are	  found	  in	  literature	  [179-­‐181].	  We	  adapted	  and	   used	   the	   efficient	   VF2	   (sub)graph	   matching	   algorithm	   introduced	   in	   [182].	   In	  (sub)graph	  isomorphism	  literature,	  the	  VF2	  algorithm	  [183]	  is	  known	  to	  be	  one	  of	  the	  fastest	   and	   most	   accurate	   algorithms	   proposed	   so	   far.	   Its	   effectiveness	   is	   shown	  especially	  when	  applied	   to	   large	   graphs,	   and	   it	   is	  well	   established	   that	   this	   algorithm	  outperforms	   other	   existing	   subgraph	   isomorphism	   algorithms	   such	   as	   Ullmann,	   SD,	  Nauty	  and	  VF	  algorithms.	  Basically,	  a	  subgraph-­‐matching	  algorithm	  is	  provided	  with	  a	  subgraph	  Gy	  of	  base	  structure	  y	  (i.e.,	  any	  of	  the	  substructures	  depicted	  in	  Table	  3),	  and	  a	  graph	   GX	   of	   the	   compound	   X	   found	   using	   NICELips.	   The	   VF2	   algorithm	   searches	   the	  structure	   of	   GX,	   and	   if	   GY⊂GX	   	   (i.e.,	   if	   graph	   GX	   contains	   the	   subgraph	   Gy),	   places	   the	  compound	  X	  in	  the	  class	  defined	  by	  the	  substructure	  Y.	  Using	   this	   method,	   based	   on	   the	   structural	   similarity,	   all	   novel	   compounds	   can	   be	  classified	  into	  the	  glycerophospholipid	  subclasses.	  	  The	  analysis	  of	  the	  large	  number	  of	  novel	  compounds	  was	  facilitated	  by	  the	  application	  of	  a	  scoring	  algorithm.	  In	  this	  algorithm,	  for	  each	  class	  we	  introduced	  the	  key	  feature	  of	  the	   class	   (characteristic	   substructures)	   as	   the	   reference	   structure	   and	   the	   other	  members	   of	   the	   class	   were	   ranked	   according	   to	   their	   similarity	   to	   the	   reference	  structure	  of	  the	  class.	  The	  scoring	  is	  based	  on	  2D	  similarity	  measures.	  Each	  compound	  is	  coded	  in	  a	  vector,	  called	  fingerprint,	  which	  codes	  the	  characteristic	  of	  the	  structure	  of	  a	  compound.	   Then,	   based	   on	   the	   comparison	   between	   two	   fingerprints,	   a	   similarity	  coefficient	   is	   computed,	  which	   gives	   us	   a	   similarity	   score.	  Different	  methods	   exist	   for	  creating	  fingerprints	  and	  calculating	  the	  similarity	  coefficient.	  We	  hereby	  elaborate	  on	  our	  choice	  of	  the	  two	  methods.	  For	  the	  similarity	  coefficient,	  the	  choice	  of	  the	  Tanimoto	  coefficient	   (also	   called	   Jaccard	   statistic)	   is	   a	   recommended	   choice	   in	   chemical	  
	  79	  
information	   by	   various	   studies.	   Therefore,	   we	   used	   this	  measure	   of	   similarity	   in	   our	  work.	  The	  choice	  of	  the	  fingerprint	  method	  has	  to	  be	  deduced	  depending	  on	  its	  suitability	  to	  represent	   structural	   information	   for	   a	   set	   of	   compounds	   of	   interest.	   The	   Wild	   and	  Blankey	   [184]	  study	  evaluated	   the	  suitability	  of	  different	  2D	   fingerprints	   to	  represent	  structural	  information.	  They	  conclude	  that	  fingerprints	  that	  use	  a	  predefined	  dictionary	  of	   structural	   features	   outperform	   fingerprints	   derived	   from	   structural	   paths	   in	  compounds	  when	  comparison	  is	  done	  to	  larger	  data	  sets	  with	  less	  well-­‐defined	  clusters.	  However,	   fingerprints	   that	  encode	  structures	  obtain	  better	   results	   to	  discriminate	   the	  differences	  between	  closely	  related	  series.	  After	  performing	  tests	  on	  different	  molecules	  insight	  classes	  and	  across	  classes,	  we	  use	  for	  the	  scoring	  MACCS	  fingerprint.	  These	  well-­‐established	   structural	   keys	   are	   encoded	  using	   a	   set	   of	   166	  public	   keys	   defined	   in	   the	  MDL	   documentation,	   implemented	   in	   OpenBabel	   [185].	   The	   MACCS	   method	   is	   a	  valuable	   tool	   in	   the	   selection	   and	   prioritization	   of	   compounds	   from	   large	   compound	  collections.	  
4.2.3 Retrobiosynthesis	  algorithm	  within	  NICELips	  In	   the	   third	   approach,	   we	   applied	   the	   retrobiosynthesis	   algorithm	   for	   LMSD	  glycerophospholipids.	  We	  validated	  the	  efficiency	  of	  our	  approach	  for	  linking	  KEGG	  and	  LMSD	   databases	   through	   the	   study	   of	   a	   biologically	   important	   lipid	   compound,	  bis(monoacylglycero)phosphate	   (BMP),	   	   which	   does	   not	   exist	   in	   KEGG	   database	   but	  exists	   in	   LMSD.	   The	   level	   of	   supervision	   applied	   in	   this	   study	   is	   exactly	   as	   Table	   4.3	  shows.	  
4.2.4 Pathway	  enumeration	  algorithm	  To	  take	   full	  advantage	  of	   the	  wealth	  of	   information	  generated	   in	  both	  approaches,	  we	  apply	   our	   pathway	   reconstruction	   algorithm	   to	   analyze	   and	   evaluate	   the	   generated	  compounds	  and	  pathways.	  The	  pathway	  search	  algorithm	  identifies	  all	  linear	  pathways	  between	  a	  defined	   starting	   compound	  and	   target	   compound,	   and	  provides	   insight	   for	  the	  pathways	  required	  for	  the	  synthesis	  and	  catabolism	  of	  different	  lipid	  compounds.	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4.2.5 Thermodynamic	  studies	  of	  the	  generated	  pathway	  In	  order	  to	  prune	  the	  set	  of	  novel	  synthesis	  and	  catabolic	  pathways	  and	  to	  evaluate	  their	  relative	   feasibility,	   we	   performed	   a	   thermodynamic	   feasibility	   analysis	   based	   on	   the	  thermodynamics-­‐based	   metabolic	   flux	   analysis	   (TMFA/TFBA)	   [47,186,187].	   The	  standard	   Gibbs	   free	   energy	   of	   reactions	   is	   estimated	   using	   the	   group	   contribution	  method	  for	  biological	  compounds	  [48,188].	  	  
4.3 Results	  and	  discussion	  We	   used	   NICELips	   to	   study	   the	   important	   class	   of	   lipids	   associated	   with	   the	  glycerophospholipid	  metabolism.	  One	  of	  the	  main	  challenges	  is	  the	  construction	  of	  a	  full	  comprehensive	  database	  of	   compounds,	   reactions	  and	  pathways	   for	   lipid	  metabolism.	  The	   huge	   gap	   between	   the	   two	  most	   commonly	   used	   databases	   for	   lipids,	   KEGG	   and	  LMSD,	   is	   growing	   rapidly	   due	   to	   advancement	   of	   mass	   spectrometry	   methods.	   The	  ability	  of	  our	  approach	   to	  generate	  and	  assemble	  a	   complete	  virtual	  database	  of	   lipid	  compounds	   and	   pathways,	   allows	   the	   concurrent	   filling	   of	   the	   gap	   between	   the	   two	  databases.	  We	  applied	  NICELips	  framework	  to:	  (i)	   explore	   the	   diversity	   of	   structures	   in	   glycerophospholipids	   and	   classify	   the	   novel	  generated	   compounds,	   (ii)	   generate	   a	   reaction	   network	   for	   glycerophospholipid	  metabolism	   to	   Expand	   KEGG	   metabolic	   pathway	   and	   (iii)	   link	   KEGG	   and	   LMSD	  databases	   through	   the	   study	   of	   a	   biologically	   important	   lipid	   compound,	  bis(monoacylglycero)phosphate	   (BMP),	   	   which	   doesn’t	   exist	   in	   KEGG	   database	   but	  exists	  in	  LMSD.	  In	  the	  following	  paragraphs	  we	  explore	  the	  insight	  that	  we	  gained	  from	  NICELips	  in	  each	  of	  these	  applications.	  
4.3.1 Exploring	  glycerophospholipid	  metabolism	  We	   explored	   the	   diversity	   of	   structures	   and	   reactions	   in	   glycerophospholipid	  metabolism	   by	   applying	   NICELips	   without	   any	   constraints	   on	   the	   search	   space	   for	  compounds	  and	  reactions.	  This	  resulted	   in	   the	  generation	  of	  a	  network	  of	  all	  possible	  compounds	  and	  reactions	  based	  on	  the	  enzymatic	  rules	  of	  glycerophospholipids.	  After	  nine	  iterations	  the	  produced	  network	  includes	  4,497	  compounds	  and	  20,874	  reactions	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4.3.1.1 NICELips	  vs.	  KEGG	  and	  LMSD	  We	  compared	  the	  generated	  results	  (compounds	  and	  reactions)	  with	  KEGG	  database	  in	  which	   there	   are	   nomenclatures	   for	   both	   compounds	   in	   the	   form	   of	   their	   chemical	  formulas	   and	   structures	   and	   reactions.	   The	   KEGG	   glycerophospholipid	   pathway	  includes	   33	   compounds	   and	   69	   reactions.	   In	   our	   generated	   dataset,	   there	   are	   74	  compounds	  and	  68	  reactions	  which	  fully	  cover	  the	  33	  compounds	  and	  69	  reactions	  of	  the	   KEGG	   glycerophospholipid	   pathway	   (Table	   4.4).	   There	   exist	   also	   other	   KEGG	  compounds	  and	  reactions	  not	  assigned	  in	  the	  glycerophospholipid	  map	  (specifically	  25	  compounds	   and	   13	   reactions),	   some	   of	   which	   are	   assigned	   to	   other	  metabolic	  maps,	  while	   few	  of	   them	  are	  not	  assigned	   to	  any	  metabolic	  map	  of	   the	  KEGG	  database.	  This	  result	   highlights	   an	   important	   utility	   of	   our	   framework,	   which	   is	   the	   postulation	   of	  enzyme-­‐based	   hypothetical	   reactions	   that	   can	   link	   compounds	   to	   reactions	   and	  integrate	  them	  into	  existing	  metabolic	  maps.	  In	  LMSD	  database,	  several	   fatty	  acid	  compositions	  have	  been	  described	   for	   lipids.	  The	  huge	  diversity	  in	  the	  LMSD	  database	  comes	  mainly	  from	  the	  variation	  of	  attached	  acyl	  chains	  “fatty	  acids”	  in	  terms	  of	  length,	  number	  and	  position	  of	  double	  bonds.	  	  In	  our	  framework	  and	  in	  consistency	  with	  KEGG	  database,	  fatty	  acid	  substructures	  are	  all	   represented	   with	   a	   common	   group	   name	   (called	   “R”);	   thus	   we	   assume	   a	   unified	  substructure	  and	  do	  not	  consider	  the	  different	  modifications	  of	  the	  acyl	  chains	  in	  lipid	  structures.	   If	   one	   ignores	   the	   acyl	   chain	   variations,	   then	   LMSD	   contains	   a	   limited	  number	  of	  distinguishable	  structures	  of	  glycerophospholipids.	  More	  precisely,	  we	  could	  identify	  62	  unique	  structures	  in	  this	  database.	  We	  then	  compared	  our	  generated	  dataset	  with	  LMSD	  and	  we	  observed	   that	   our	  dataset	   includes	  51	   structures	   (82%	  out	   of	   the	  total	  unique	  structures	  in	  LMSD).	  The	  remaining	  structures	  that	  NICELips	  were	  not	  able	  to	  generate	  were	  due	  to	  the	  following	  reasons:	  	  (i) The	   molecule	   contained	   head	   groups	   that	   required	   other	   starting	  compounds,	  such	  as	  sugars,	  not	  in	  the	  KEGG	  map,	  and	  	  (ii) The	   reactions	   involved	   biotransformations	   that	   were	   not	   captured	   by	   our	  current	  set	  of	  generalized	  reaction	  rules.	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Table	  4-­‐4:	  Statistics	  of	  compounds	  and	  reactions	  generated	  in	  the	  first	  scheme,	  after	  9	  iterations	  of	  
NICELips	  algorithm.	  Iteration	   Reactions	  predicted	  (cumulative)	   Of	  which	  in	  KEGG	   Compounds	  predicted	  (cumulative)	   Of	  which	  in	  KEGG	  1	  2	  3	  4	  5	  6	  7	  8	  9	  
3	  15	  62	  141	  247	  446	  949	  3,054	  20874	  
3	  8	  18	  26	  32	  42	  49	  57	  68	  
21	  36	  62	  88	  123	  186	  329	  889	  4497	  
20	  30	  41	  44	  50	  58	  65	  70	  74	  Total	   20,874	   68	   4,497	   74	  
	  Given	  that	  the	  rules	  we	  used	  in	  this	  study	  are	  based	  on	  the	  enzyme	  reactions	  in	  known	  glycerophospholipid	   pathways,	   this	   finding	   suggests	   a	   broader	   class	   of	   enzymes	   are	  involved	   in	  glycerophospholipid	  metabolism.	  This	   is	  an	  observation	   that	  has	  not	  been	  acknowledged	  before	   in	   the	   classification	  of	   glycerophospholipid	  metabolism.	  Overall,	  these	  results	  demonstrate	  the	  very	  good	  match	  of	  our	  dataset	  with	  the	  data	  in	  LMSD.	  
4.3.1.2 Classification	  and	  scoring	  of	  the	  compound	  dataset	  Unlike	  other	  classes	  of	  biomolecules	  that	  can	  be	  considered	  as	  mere	  permutations	  on	  a	  common	   and	   finite	   set	   of	   monomers	   (e.g.,	   proteins	   and	   oligonucleotides),	   complex	  lipids,	  such	  as	  glycerophospholipids,	  are	  composites	  of	  a	  wide	  range	  of	  building	  blocks	  that	   can	   give	   rise	   to	   a	   huge	   array	   of	   combination.	   These	   combinations	   cannot	   be	  predicted	  by	  simple	  inspection	  of	  the	  precursor	  molecules	  because	  they	  are	  the	  product	  of	  a	  large	  number	  of	  biochemical	  transformations.	  The	  diversity	  in	  molecular	  structure	  was	  extremely	  higher	  in	  our	  datasets,	  since	  we	  explored	  computationally	  the	  diversity	  of	  glycerophospholipid	  structures	  using	  all	  the	  possible	  enzyme-­‐reaction	  rules	  involved	  in	  the	  synthesis	  of	  these	  groups.	  Common	  glycerophospholipids	  of	  mammalian	  tissues	  can	  be	   classified	   according	   to	   the	   following	  head	   group	   components:	   1)	   phosphate	   in	  Glyceropyrophosphates	   (PPA);	   2)	   glycerol	   unit	   in	   Glycerophosphoglycerols	   (PG);	   3)	  serine	   group	   in	   Glycerophosphoserines	   (PS);	   4)	   choline	   in	   Glycerophosphocholines	  (PC);	   5)	   ethanolamine	   in	   Glycerophosphoethanolamines	   (PE);	   6)	   six-­‐carbon	   sugar	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inositol	   in	   Glycerophosphoinositol	   (PI);	   7)	   Cytidine	   5'-­‐diphosphate	   in	   CDP-­‐Glycerols	  (CDP-­‐Glycerol).	  
Table	  4-­‐5:	  Results	  of	  the	  classification	  of	  the	  novel	  compounds	  in	  7	  classes	  based	  on	  their	  structural	  
similarities	  to	  the	  known	  lipid	  structures.	  
	  	  In	   order	   to	   tackle	   the	   diversity	   of	   the	   generated	   molecular	   structures,	   we	   first	  constructed	   a	   classifier	   to	   classify	   4,497	   compounds	   belonging	   to	   seven	   different	  structural	  classes,	  based	  on	  the	  chemical	  structures	  of	  the	  known	  compounds	  using	  the	  subgraph	  isomorphism	  technique	  described	  in	  section	  5.2.2.1.	  	  	  
	  84	  
Table	  4-­‐6:	  A	  closer	   look	  the	  compounds	  of	  the	  PG	  class	  shows	  that	  two	  different	  stereoisomers	  of	  
bis(monoacylglycero)phosphate	   is	   generated	   as	   a	   novel	   compound	   in	   this	   study	   and	   is	   correctly	  
classified	  in	  the	  PG	  class,	  with	  a	  high	  similarity	  score	  of	  0.84	  .	  




























	  We	  next	   compared	   the	   compounds	   in	   the	  generated	  datasets	  with	   those	   in	  KEGG	  and	  LMSD.	   In	   order	   to	   organize	   the	   groups	   in	   a	   controlled	  manner	   that	  will	   facilitate	   the	  comparison,	  we	  merged	  13	   classes	  of	  LMSD	  with	   the	   same	  head	  groups	  and	  came	  up	  with	  7	  different	  structural-­‐based	  classes,	  plus	  one	  containing	  “other	  structures”,	  similar	  to	   LMSD.	  The	   inspection	  of	   the	   summary	  of	   classification	   results	   (Table	  4.5)	   suggests	  that	   there	   are	  many	   structures	   in	  different	   classes	  not	   existing	   in	  KEGG,	  which	  either	  exist	  in	  other	  databases	  such	  as	  LMSD,	  or	  do	  not	  exist	  in	  any	  current	  lipid	  database.	  In	   our	   method	   of	   classification	   we	   have	   devised	   for	   each	   compound	   a	   scoring	   value	  between	   0	   and	   1.	   This	   scoring	   value	   shows	   the	   structural	   similarity	   between	   all	   the	  members	  of	  the	  group	  and	  the	  general	  pattern	  used	  for	  classification,	  while	  helping	  us	  to	   assign	   priority	   in	   the	   study	   of	   novel	   compounds.	   In	   other	   words,	   for	   each	   novel	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compound,	  a	  score	  closer	  to	  1	  accounts	  for	  higher	  similarity	  to	  known	  compounds	  and	  higher	   likelihood	   for	   its	   existence.	  One	   can	   arbitrarily	   define	   threshold	   values	   for	   the	  score	  and	  select	  all	  compounds	  from	  a	  class,	  with	  a	  score	  beyond	  a	  particular	  threshold,	  for	   more	   analysis.	   Selecting	   compounds	   according	   to	   the	   scores	   provides	   us	   with	   a	  manageable	   number	   of	   novel	   compounds	   for	   further	   studies	   on	   biosynthesis	   and	  catabolic	  pathway	  association	  with	  these	  novel	  compounds.	  Hereby	  we	  show	  the	  results	  of	   our	   case	   study	   for	   a	   lipid	   compound	   that	   does	   not	   exist	   in	   KEGG:	  bis(monoacylglycero)phosphate	  (BMP)	  found	  in	  the	  PG	  class	  with	  the	  similarity	  score	  of	  0.848.	  Examples	  of	  our	  scoring	  results	  are	  shown	  in	  Table	  4.6.	  	  
4.3.2 Expansion	  of	  the	  glycerophospholipid	  KEGG	  pathway	  The	   KEGG	   pathway	   map	   of	   glycerophospholipid	   includes	   33	   compounds	   and	   69	  reactions.	   After	   20	   iterations	   of	   our	   algorithm,	   the	   number	   of	   generated	   compounds	  converged	   to	   383	   (all	   KEGG	   compounds)	   and	   the	   number	   of	   generated	   reactions	  converged	  to	  3787.	  Out	  of	  the	  3787	  generated	  reactions,	  251	  reactions	  corresponded	  to	  KEGG	  reactions	  as	  shown	  in	  Figure	  4.3.	  Within	  the	  generated	  results,	  we	  recovered	  all	  the	   33	   compounds	   and	   69	   reactions	   as	   reported	   in	   the	   KEGG	   glycerophospholipids	  pathways.	   We	   believe	   that	   the	   fact	   that	   NICELips	   finds	   all	   the	   previously	   curated	  compounds	  and	  reactions	  in	  KEGG	  is	  an	  implicit	  validation	  of	  the	  NICELips	  framework	  for	  the	  study	  of	  lipid	  metabolism.	  Interestingly,	  many	  of	  these	  KEGG	  compounds	  and	  reactions	  have	  not	  been	  previously	  associated	  with	  the	  glycerophospholipids	  pathway	  in	  KEGG	  database.	  This	  observation	  demonstrates	  how	  our	  method	  can	  now	  link	  the	  KEGG	  pathway	  of	  glycerophospholipids	  with	  the	  other	  KEGG	  pathways	  and	  also	  propose	  metabolic	  pathways	  for	  reactions	  that	  are	  not	  associated	  with	  any	  metabolic	  pathways	  in	  KEGG	  database.	  	  Our	   results	   also	   proposed	   several	   shorter	   alternative	   pathways	   including	   novel	   steps	  for	  the	  synthesis	  of	  biologically	  important	  lipids	  in	  glycerophospholipid	  metabolism.	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Figure	   4-­‐3:	   (a)	   Compounds	   generated	   through	   the	   reconstruction	  of	   glycerophospholipid	   pathway	  
using	  NICELips.	  The	  number	  of	  compounds	  increases	  in	  each	  iteration.	  (b)	  Total	  number	  of	  reactions	  
and	  KEGG	  reactions	  generated	  in	  each	  iteration.	  
	  
4.3.2.1 Reconstruction	  and	  enumeration	  of	  novel	  pathways	  We	  applied	  the	  pathway	  search	  algorithm	  to	  find	  alternative	  pathways	  for	  the	  synthesis	  and	  biodegradation	  of	  known	   lipids.	  We	  started	  with	  a	  defined	  substrate	  and	  a	   target	  lipid,	  and	  we	  applied	  the	  algorithm	  to	  reconstruct	  all	  linear	  connections	  between	  them.	  The	  starting	  compound	  we	  used	   in	   this	  study	   is	  sn-­‐glycerol-­‐3-­‐phosphate,	  which	   is	   the	  substrate	  we	  also	  used	  for	  the	  reconstruction	  of	  the	  KEGG	  map	  of	  glycerophospholipids	  (see	   above).	   We	   chose	   as	   target	   compound	   the	   phosphatidylglycerol	   (PG),	   which	   is	  known	   to	   be	   the	   substrate	   of	   bis(monoacylglycero)phosphate	   (BMP)	   biosynthesis.	  There	   is	   only	   one	   known	   de	   novo	   pathway	   for	   PG	   biosynthesis	   which	   is	   a	   4-­‐step	  pathway	   starting	   from	   sn-­‐glycerol-­‐3-­‐phosphate	   (Figure	   4.4).	   Interestingly,	   we	   find	  hundreds	  of	  novel	  pathways,	  which	  are	  even	  shorter	  than	  the	  native	  pathway	  in	  KEGG	  database	  (representative	  shorter	  pathways	  are	  shown	  in	  Figure	  4.4).	  



























































Figure	  4-­‐4:	  The	  native	  de	  novo	  pathway	  for	  PG	  biosynthesis	  as	  is	  found	  in	  KEGG	  is	  shown	  in	  black	  
arrows.	  Based	  on	  our	  results	  we	  propose	  several	  alternative	  shorter	  pathways	  with	  length	  1	  (in	  red	  
arrows),	  length	  2	  (in	  blue	  arrows)	  and	  length	  3	  (in	  green	  arrows).	  The	  pathways	  presented	  here	  are	  
chosen	  based	  on	  the	  thermodynamics	  feasibility	  results	  and	  we	  present	  the	  most	  feasible	  pathways	  
for	  each	  length.	  
	  BMP,	   the	   structural	   isomer	  of	  phosphatidylglycerol	   (PG)	   is	  one	  of	   the	  most	   intriguing	  structures	  of	  phospholipids	  discovered	  to	  date	  [189].	   It	  exhibits	  an	  unusual	  sn-­‐1:sn-­‐1’	  stereo	  configuration,	  based	  on	  the	  position	  of	  the	  phosphate	  moiety	  in	  its	  two	  glycerol	  units.	   Based	   on	   the	   positions	   of	   fatty	   acids	   on	   the	   glycerol	   molecule,	   two	   different	  isomers	  have	  been	  reported	  for	  BMP,	  the	  2,2’-­‐dioleoyl	  form	  and	  the	  3,3’-­‐isomer.	  	  We	  carried	  out	  24	  iterations	  of	  the	  retrosynthesis	  algorithm	  using	  the	  set	  of	  12	  reaction	  rules,	  starting	  compounds	  and	  cofactors	  (mentioned	  in	  section	  2.2),	  plus	  BMP.	  After	  24	  iterations	  the	  number	  of	  compounds	  (all	  KEGG	  compounds)	  converged	  to	  208	  and	  the	  number	  of	  reactions	  converged	  to	  505	  (out	  of	  which	  101	  reactions	  are	  KEGG	  reactions)	  as	  shown	  in	  Figure	  4.5.	  We	  found	  that	  the	  minimum	  number	  of	  steps	  for	  the	  synthesis	  of	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Figure	   4-­‐5:	   The	   results	   of	   the	   retrosynthesis	   algorithm	   applied	   for	   BMP.	   (a)	   shows	   the	   iterative	  
generation	  of	  compounds	  and	  (b)	  shows	  the	  total	  number	  and	  KEGG	  reactions	  generated	  for	  each	  
iteration.	  	  BMP	  from	  PG	  is	  4,	  and	  it	  involves	  7	  lipid	  compounds	  (Figure	  4.6).	  Moreover,	  we	  found	  shorter	  pathways	  from	  other	  known	  lipid	  compounds	  that	  could	  lead	  to	  BMP.	  As	  shown	  in	   Figure	   4.6,	   BMP	   is	   one	   step	   away	   from	   the	   known	   compounds	   reported	   in	   KEGG	  database.	  After	  a	  one-­‐step	  reaction	  with	  water	  as	  a	  cofactor	  (a	  novel	  reaction	  that	  does	  not	   exist	   in	   KEGG),	   BMP	   is	   degraded	   to	   “2-­‐Acyl-­‐sn-­‐glycerol	   3-­‐phosphate”	   and	   “2-­‐Acylglycerol”.	   “2-­‐Acyl-­‐sn-­‐glycerol	   3-­‐phosphate”	   is	   a	   lipid	   compound	   associated	   with	  glycerophospholipid	  pathway	  in	  KEGG	  database.	  “2-­‐Acylglycerol”	  is	  a	  KEGG	  compound	  which	  is	  not	  associated	  with	  any	  reported	  metabolic	  pathway.	  	  
	  
Figure	  4-­‐6:	  Out	  of	  hundreds	  of	  generated	  reactions	  for	  BMP	  metabolic	  network,	  hereby	  we	  present	  
couples	  of	  thermodynamically	  feasible	  pathways.	  In	  the	  set	  of	  required	  generalized	  reaction	  rules	  for	  
reconstruction	  of	  the	  KEGG	  pathway	  of	  glycerophospholipids,	  “3.1.4A1”	  is	  the	  only	  enzyme	  rule	  that	  
can	   react	   with	   BMP	   (first	   iteration	   showed	   in	   black	   arrow	   in	   the	   figure).	   In	   the	   second	   iteration	  




























































glycerophospholipid	  metabolism	   is	   generated.	   In	   the	   third	   iteration	   (showed	   in	   green	   arrow),	   sn-­‐
Glycerol	   3-­‐phosphate	   is	   generated	   through	   another	   reaction.	   And	   finally,	   in	   the	   fifth	   iteration	  
(showed	  in	  purple	  arrow),	  phosphatidylglycerol	  (PG),	  which	  is	  supposed	  to	  be	  the	  substrate	  for	  BMP	  
biosynthesis	  is	  produced.	  	  Interestingly	   our	   results	   propose	   a	   possible	   integration	   of	   this	   lipid	   to	  glycerophospholipid	   pathway.	   Thus,	   based	   on	   the	   results	   obtained,	   we	   are	   able	   to	  propose	   alternate	   candidate	   synthesis	   and	   degradation	   pathways	   for	   BMP	   with	  different	  lengths	  and	  biophysical	  properties.	  We	   observed	   that	   not	   all	   of	   the	   LMSD	   compounds	   are	   one	   step	   away	   from	   KEGG	  compounds.	   As	  mentioned	   in	   section	   4.2,	  we	   can	   exclude	   novel	   compounds	   from	   the	  generated	   network,	   and	   this	   results	   in	   smaller	   network	   that	   includes	   only	   the	   KEGG	  compounds.	   For	   the	   LMSD	   compounds	   that	   are	   not	   one	   step	   away	   from	   the	   KEGG	  compounds,	   we	   allow	   all	   novel	   and	   known	   compounds	   in	   each	   generation,	   and	   we	  obtain	   networks	   that	   have	   both	   novel	   and	   KEGG	   compounds.	   The	   novel	   compounds	  serve	   as	   intermediates	   to	   connect	   the	   LMSD	   compounds	   to	   the	   KEGG	   metabolic	  pathways.	  
4.3.4 Thermodynamic	  feasibility	  studies	  We	   employed	   the	   group	   contribution	   method	   to	   estimate	   the	   standard	   Gibbs	   free	  energy	  (Δ°Gr)	   for	  all	   the	  reactions	  generated	  using	  the	  NICELips	  framework	  (Table	  2).	  Δ°Gr	  is	  estimated	  in	  the	  range	  of	  +28.49	  KJ	  to	  -­‐35.64	  KJ	  for	  93%	  of	  3497	  reactions	  in	  the	  reconstructed	  networks	  of	   glycerophospholipid	  metabolism.	  The	  Δ°Gr	   for	  64%	  of	  505	  reactions	   in	   the	   networks	   of	   the	   retrosynthesis	   of	   BMP	   is	   estimated	   in	   the	   range	   of	  +13.37	   KJ	   to	   -­‐35.64	   KJ.	   We	   were	   not	   able	   to	   estimate	   the	   energies	   for	   some	   of	   the	  reactions	   due	   to	   groups	   in	   the	   substrates	   or	   products	   for	   which	   thermodynamic	  information	  was	  not	  available.	  To	  further	  analyze	  the	  predicted	  alternative	  pathways,	  we	  performed	  thermodynamics	  analysis	  for	  the	  results	  of	  the	  pathway	  search	  algorithm.	  Δ°Gr	  of	  the	  overall	  pathway	  can	  be	  computed	  by	  the	  sum	  of	  Δ°Gr	  of	  the	  individual	  reactions	  in	  the	  pathway.	  If	  Δ°Gr	  of	  the	  overall	   pathway	   is	   negative	  we	   consider	   it	   as	   a	   thermodynamically	   feasible	   pathway.	  According	  to	  this	  calculation,	  all	  the	  representative	  pathways	  in	  this	  study	  (Figure	  4.4	  &	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Figure	  4.6)	  were	  found	  to	  be	  thermodynamically	  feasible.	  
	  
Table	  4-­‐7:	  A	  summary	  of	  results	  of	  thermoynamics	  feasibility	  studies	  for	  reconstructed	  network	  of	  
glycerophospholipids	  and	  the	  analysis	  of	  the	  reaction	  network	  of	  retrosynthesis	  of	  BMP.	  
Reconstructed	  network	  of	  glycerophospholipid	  
	  
Reaction	  network	  of	  retrosynthesis	  of	  BMP	  
Range	  of	  ΔGr	   #	  of	  reactions	   %	  in	  KEGG	   Range	  of	  	  ΔGr	   #	  of	  reactions	   %	  in	  KEGG	  
ΔGr	  <	  0	   664	   44.6%	   ΔGr	  <	  0	   154	   43%	  
ΔGr	  =	  0	   2231	   5.4%	   ΔGr	  =	  0	   36	   2%	  
ΔGr	  >	  0	   601	   45.3%	   ΔGr	  >	  0	   129	   53%	  
ΔGr	   is	   not	  
estimated	  
291	   4.7%	   ΔGr	   is	   not	  
estimated	  
	  
186	   2%	  
	  We	   also	   observed	   that	   the	   standard	   Gibbs	   free	   energy	   for	   almost	   50%	   of	   the	   KEGG	  reactions	  is	  positive	  (Table	  4.7).	  This	  indicates	  that	  the	  concentrations	  of	  the	  substrates	  and	  products	   in	   the	  system	  play	  a	  critical	   role	   in	  determining	   the	   feasibility	   in	  vivo	  as	  the	  Gibbs	  free	  energy	  of	  reaction	  has	  to	  be	  negative	  in	  order	  for	  the	  reactions	  to	  operate	  in	   the	   direction	   of	   the	   synthesis	   of	   important	   compounds.	   However,	   this	   entails	  knowledge	   of	   in	   vivo	   concentration	   ranges	   and	   network	   thermodynamic	   feasibility	  analysis.	  Therefore,	  having	  positive	  values	  for	  the	  standard	  Gibbs	  energy	  of	  reactions	  of	  the	   network	   is	   not	   enough	   for	   discarding	   them	   as	   thermodynamically	   infeasible	  reactions	  and	  there	  are	  other	  parameters	  that	  should	  be	  taken	  into	  account.	  
4.4 Conclusions	  Due	   to	   the	   importance	  of	   lipids	   in	   cellular	  physiology	  and	  pathology	  as	  well	   as	   to	   the	  recent	   interest	   of	   the	   biotechnology	   community	   for	   understanding	   their	   role	   as	  resources	  for	  alternative	  fuels	  and	  chemicals,	  the	  study	  of	  lipids	  has	  emerged	  as	  a	  major	  research	  area.	  A	  computational	  framework,	  NICELips,	  was	  developed	  to	  investigate	  lipid	  metabolism.	   In	   this	   work,	   we	   demonstrated	   the	   utility	   of	   NICELips	   for	   studying	  glycerophospholipid	   metabolism.	   Our	   results	   emphasize	   the	   wealth	   of	   novel	   lipid	  structures	  and	  biosynthesis	  and	  the	  abundance	  of	  catabolic	  reactions	  that	  are	  yet	  to	  be	  discovered.	  We	  demonstrated	  our	  approach	  by	  reporting	  an	  interesting	  lipid	  compound	  that	  does	  not	  appear	  in	  KEGG:	  the	  bis(monoacylglycero)phosphate	  (BMP).	  
	  91	  
By	  reconstructing	  the	  KEGG	  pathways	  of	  lipid	  metabolism,	  our	  results	  indicated	  several	  shorter	   alternative	   pathways	   for	   lipids	   synthesis	   than	   those	   found	   in	   KEGG.	   The	  significant	  advantage	  of	  NICELips	  is	  that	  all	  the	  generated	  compounds	  are	  automatically	  organized	  into	  pathways	  of	  reactions,	  i.e.,	  we	  can	  easily	  identify	  the	  reactions	  in	  which	  the	  compounds	  have	  participated.	  This	   is	  a	  unique	  property	   that	  enables	  us	   to	  search	  for	   pathways	   based	   on	   the	   desired	   compounds,	   as	   a	   result	   of	   the	   generation	   of	   a	  network	  of	  all	  compounds	  and	  reactions.	  	  The	  retrosynthesis	  analysis	  using	  NICELips	  links	  all	  the	  reported	  structures	  for	  lipids	  in	  LMSD	   to	   the	   metabolic	   pathways	   in	   KEGG,	   and	   thus	   offers	   a	   great	   potential	   for	  proposing	  synthesis	  and	  catabolic	  pathways	  for	  many	  lipids	  in	  LMSD.	  	  Due	   to	   the	   large	   number	   of	   novel	   pathways	   discovered	   for	   different	   compounds,	   we	  should	   next	   develop	   criteria	   for	   identifying	   and	   ranking	   of	   pathways	   that	   are	   more	  feasible	   in	  vivo.	  Such	  ranking	  will	   further	  guide	  the	  research	  in	  targeted	  lipidomics	  for	  the	   experimental	   identification	   of	   pathways	   around	   lipids	   of	   interest,	   for	   which	  information	  about	  their	  synthesis	  and	  catabolic	  routes	  is	  still	  missing.	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Chapter	  ) 	  
SUPER	  E.	  coli	  
How	   to	   discover	   and	   assess	   the	   full	   enzymatic	   and	   metabolic	   capabilities	   of	   an	  organism?	  
	  










5.1 Introduction	  Genome-­‐scale	   metabolic	   (GEM)	   reconstructions	   capture	   the	   known	   metabolic	  capabilities	   of	   organisms,	   and	   they	   have	   been	   used	   in	   many	   metabolic	   engineering	  studies	   that	   have	   provided	   important	   insights	   into	   complex	   biochemical	   networks.	  However,	   these	   studies	   rely	   on	   known	   biochemical	   reactions,	   and	   they	   may	   fail	   to	  exploit	   full	   metabolic	   potential	   of	   studied	   and	   engineered	   microorganisms	   as	   they	  neglect	  novel	  metabolic	  reactions,	  i.e.	  the	  reactions	  that	  are	  currently	  unknown	  to	  exist	  in	  the	  studied	  microorganisms.	  	  The	   metabolic	   network	   of	   Escherichia	   coli	   is	   one	   of	   the	   best-­‐characterized	   reaction	  networks	   in	   biology	   and	   several	   GEMs	   for	   different	   strains	   with	   different	   sizes	   have	  been	  developed	  for	   this	  microorganism	  since	  2000	  [190].	  Nevertheless,	  even	   for	  well-­‐studied	  organisms	  such	  as	  E.	  coli,	  there	  are	  still	  significant	  knowledge	  gaps	  and	  missing	  biotransformation	  steps	  to	  be	  characterized	  [170].	  	  In	  the	  last	  decade,	  tremendous	  efforts	  were	  invested	  on	  developing	  systematic	  methods	  for	  the	  prediction	  and	  de	  novo	  design	  of	  novel	  pathways	  [99].	  Most	  of	  the	  studies	  have	  focused	  on	   retrobiosynthesis	   tools	   to	   identify	  de	  novo	   pathways	   for	   the	  production	  of	  target	   molecules	   in	   a	   specific	   organism	   [74-­‐77,82,191].	   However,	   these	   strategies	  explore	   novel	   pathways	   only	   around	   the	   chemistry	   of	   the	   target	   structure	   and	   they	  neglect	  the	  potential	  evolution	  of	  metabolism.	  However,	  applying	  these	  methods	  with	  a	  new	  perspective	  can	  help	  us	  to	   investigate	  a	  more	   fundamental	   questions:	   what	   is	   the	   utmost	   metabolic	   capacity	   of	   an	   organism	  such	  as	  E.	  coli,,	  and	  what	  are	  the	  metabolic	  functionalities	  that	  allow	  us	  achieving	  this?	  The	   answer	   to	   this	   question	   will	   provide	   a	   full	   list	   of	   all	   possible	   metabolites	   and	  metabolic	  reactions	  in	  the	  organism.	  	  In	   this	   study,	   we	   introduce	   a	   systematic	   computational	   workflow	   for	   exploring	   the	  metabolic	   capacity	   of	   a	   given	  microorganism.	  Our	   approach	   combines	   the	   knowledge	  from	   genome	   scale	   models	   with	   a	   rule-­‐based	   network	   reconstruction	   algorithm	   and	  results	   in	   a	   new	   generation	   of	   model	   organisms,	   so	   called	   “super	   organisms”	   with	  expanded	  metabolic	  capabilities.	  
	  The	  workflow	  has	  three	  main	  components	  (Figure	  5.1):	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(i) We	  employ	  the	  BNICE.ch	  framework,	  which	  is	  able	  to	  generate	  every	  possible	  biochemical	   reaction	   from	  a	  given	   set	  of	   generalized	  enzyme	   reaction	   rules	  and	  a	  set	  of	  starting	  compounds;	  BNICE	  generates	  a	  super	  metabolic	  network	  that	  explores	   the	  metabolic	  capability	  of	   the	  organism	  by	   introducing	  many	  novel	  reactions.	  (ii) In	  order	  to	  identify	  the	  functionality	  of	  these	  novel	  reactions	  and	  to	  examine	  their	  feasibility	  for	  implementation	  purposes,	  we	  embed	  the	  novel	  reactions	  into	   the	  genome	  scale	  model	  of	  E.	  coli	   and	  we	  use	  a	  computational	  pipeline	  (composed	  of	  FBA,	  TFBA,	  and	  MILP	  optimization)	  to	  identify	  sets	  of	  reactions	  that	  can	  increase	  a	  desired	  metabolic	  property	  such	  as	  the	  biomass	  yield	  on	  glucose.	  	  (iii) We	  further	  investigate	  the	  structural	  similarity	  of	  the	  novel	  reactions	  to	  the	  known	   enzymatic	   reactions.	   We	   used	   this	   similarity	   metric	   for	   the	  identification	  of	  candidate	  gene	  sequences	  for	  the	  novel	  reactions.	  	  	  Starting	  from	  the	  known	  biochemistry	  of	  E.	  coli	  metabolism,	  we	  investigated	  how	  many	  novel	   reactions	   can	   be	   identified	   and	   if	   these	   reactions	   can	   give	   extra	   metabolic	  potential	   to	   this	   organism	   for	   industrial	   application	   in	   the	   production	   of	   fuels	   and	  chemicals.	   Interestingly,	   we	   found	   that	   there	   exist	   reactions	   in	   the	   generated	   super	  metabolic	  network	  that	  can	  increase	  the	  maximum	  theoretical	  biomass	  yield	  on	  glucose.	  This	   work	   allows	   for	   the	   first	   time	   the	   full	   exploration	   of	   theoretical	   metabolic	  capabilities	  of	  an	  organism	  through	  the	  addition	  of	  metabolic	  functionalities.	  	  
5.2 Methods	  The	  proposed	  workflow	   consists	   of	   several	   computational	   steps	   (Figure	   5.1),	   and	   the	  details	   of	   each	   step	  will	   be	   discussed	   in	   the	   following	   sections.	   Though	  we	   apply	   the	  workflow	  to	  construct	  the	  expanded	  metabolic	  network	  of	  E.	  coli,	  it	  can	  be	  used	  for	  any	  other	  organism.	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5.2.1 Construction	  of	  a	  “super”	  metabolic	  network	  The	   reconstruction	   of	   a	   “super”	   metabolic	   network	   of	   E.	   coli	   is	   accomplished	   using	  BNICE.ch	  computational	  framework	  [72].	  	  	  
Figure	   5-­‐1	   :	   The	   workflow	   for	   generating	   the	   “super	   E.	   coli”	   metabolic	   network	   that	   contains	  
thousands	  of	  non-­‐native	  enzymatic	   reactions	   (known	  and	  novel)	   and	  evaluating	   the	   impact	  of	   the	  
novel	  steps	  to	  the	  enzymatic	  profile	  and	  metabolic	  capacity	  of	  this	  organism.	  

























































We	  focused	  on	  the	  central	  carbon	  metabolism	  since	  the	  breakdown	  of	  nutrients	  and	  the	  major	   part	   of	   carbon	  modification	   and	   energy	  metabolism	   is	   carried	   out	   in	   the	   core	  carbon	   metabolism.	   In	   addition,	   most	   of	   the	   metabolite	   targets	   for	   the	   metabolic	  engineering	  studies	  belong	  to	  the	  core	  carbon	  metabolism.	  Therefore,	  in	  our	  analysis	  we	  considered	   5	   central	   metabolism	   subsystems	   glycolysis,	   pentose	   phosphate	   pathway,	  citric	   acid	   cycle,	   glyoxylate	   cycle	   and	   pyruvate	   metabolism,	   together	   with	   the	  biosynthesis	   pathways	   for	   glycerol	   and	   the	   amino	   acids	   close	   the	   central	   carbon	  metabolism:	  glutamate,	  glutamine,	  aspartate,	  asparagine,	  alanine	  and	  serine.	  	  
	  
Figure	  5-­‐2	  :	  The	  core	  metabolic	  network	  of	  E.	  coli	  contains	  67	  compounds	  including	  14	  cofactors.	  The	  
compounds	  are	  connected	  by	  76	  enzymatic	  reactions	  which	  are	  attributed	  to	  one	  of	  the	  subsystems:	  
Glycolysis	   (blue),	  Pyruvate	  pathway	  (green),	  TCA	  cycle	  (red),	  Pentose	  phosphate	  pathway	  (orange),	  
Glyoxylate	  pathway	  (violet),	  or	  additional	  pathways	  accounting	  for	  the	  biosynthesis	  of	  some	  amino	  
acids	  or	  glycerol	  (light	  blue).	  We	  used	  the	  latest	  genome-­‐scale	  metabolic	  model	  iJO1366	  [170,192]	  for	  E.	  coli	  K-­‐12	  as	  a	  reference	   for	   extraction	  of	   known	   core	   enzymatic	   reactions	  discovered	   so	   far	   for	   this	  organism.	  The	  resulting	  network	  included	  67	  compounds	  (including	  14	  cofactors)	  and	  76	  reactions	  (Figure	  5.2).	  	  We	   needed	   45	   generalized	   reaction	   rules	   to	   reproduce	   these	   76	   known	   enzymatic	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reactions	   using	   BNICE.ch.	   Since	   the	   directional	   feasibility	   of	   the	   reactions	   is	   further	  assessed	  through	  the	  TFBA	  analysis,	  we	  included	  the	  enzymatic	  reaction	  rules	  for	  both	  reaction	   directionalities	   (forward	   and	   reverse).	   Therefore,	   we	   applied	   90	   (45*2)	  reaction	  rules	  to	  reconstruct	  the	  core	  carbon	  metabolism	  of	  E.	  coli.	  	  We	  used	  the	  “forward	  network	  reconstruction	  mode”	  of	  BNICE.ch,	  we	  left	  unconstrained	  the	   “number	   of	   iteration”	   for	   the	   system,	   and	   we	   allowed	   the	   network	   generation	  algorithm	  to	  run	  till	  the	  number	  of	  compounds	  and	  reactions	  converge,	  i.e.	  till	  no	  more	  compounds	  and	  reactions	  could	  be	  generated.	  	  We	  were	  interested	  to	  investigate	  how	  many	  hypothetical	  reactions	  could	  evolve	  from	  the	   known	   biochemistry	   of	   E.	   coli.	   Therefore,	   we	   allowed	   only	   biologically	   known	  compounds	  to	  be	  selected	  as	  a	  part	  of	  the	  network,	  and	  we	  did	  not	  put	  any	  constraint	  on	  the	  reactions,	  which	  resulted	  on	  the	  generation	  of	   thousands	  of	  novel	  reactions	   in	   the	  reconstructed	   metabolic	   network	   of	   this	   organism.	   Table	   5.1	   shows	   the	   level	   of	  supervision	  we	  applied	  in	  this	  study.	  	  	  
Table	  5-­‐1:	  The	  supervision	  level	  for	  the	  reactions	  rules	  is	  on	  the	  network	  level,	  for	  the	  compounds	  
on	  the	  database	  (KEGG)	  level	  and	  there	  was	  no	  constraint	  for	  the	  reactions	  and	  all	  the	  possible	  
reactions	  (known	  and	  novel)	  are	  allowed	  in	  the	  network	  generation	  process	  
Supervision	  level	   Input	  constraint	  
	  	   Example	  
Reaction	  
rules	   Compounds	   Reactions	  
Unsupervised	   -­‐	  
	  
Unlimited	   Unlimited	  
Database	   KEGG	   	   14549	   	  
Organism	   	   	   	   	  
Network	   Core	  metabolic	  network	  of	  E.	  coli	  	   45*2	   67	   76	  
Pathway	   	   	   	   	  
5.2.2 Integration	  of	  novel	  reactions	  in	  genome	  scale	  model	  To	   further	   analyze	   the	   thousands	   of	   hypothetical	   enzymatic	   reactions	   generated	   by	  BNICE.ch,	  we	  developed	  tools	  and	  frameworks	  to	  study	  their	  impact	  on	  the	  metabolism	  of	   E.	   coli.	   The	   genome	   scale	   metabolic	   reconstruction	   of	   E.	   coli	   iJO1366	   [192]	   was	  utilized	   as	   the	   reference	   model	   for	   integrating	   the	   novel	   generated	   reactions	   in	   the	  context	  of	  metabolic	  model,	   and	   further	   for	  performing	   in	  silico	  analyses	   such	  as	  Flux	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Balance	  Analysis	  (FBA),	  yield	  calculations	  and	  gap	  filling.	  	  
E.	   coli	   genome	   scale	   network	   includes	   2585	   reactions	   and	   1807	   metabolites	   across	  cytoplasm,	   periplasmic	   space	   and	   growth	   media,	   and	   can	   grow	   on	   different	   carbon	  sources	   under	   aerobic	   and	   anaerobic	   conditions	   [192].	   Since	   all	   the	   generated	   novel	  reactions	  are	  around	  the	  central	  carbon	  metabolism,	  we	  integrated	  them	  into	  the	  E.	  coli	  metabolic	  network	  as	  cytoplasmic	  enzymatic	  reactions.	  We	  call	  the	  genome	  scale	  model	  with	   the	   integrated	  new	  reactions	   the	  “de	  novo	  E.	  coli	  metabolic	  network”	  and	  we	  will	  use	  this	  term	  in	  the	  next	  sections.	  
5.2.3 Identifying	  sets	  of	  reactions	  that	  increase	  the	  biomass	  yield	  in	  E.	  coli	  network	  We	   performed	   Flux	   Balance	   Analysis	   (FBA)	   to	   investigate	   if	   the	   novel	   proposed	  reactions	   increase	   the	   yield	   of	   biomass	   production.	   By	   performing	   a	   Flux	   Variability	  Analysis	   (FVA)	   on	   the	   extended	   metabolic	   network	   with	   the	   integrated	   de	   novo	  reactions,	  we	  observed	  that	  there	  was	  not	  a	  unique	  set	  of	  reactions	  that	  would	  increase	  the	   biomass	   yield.	   Hence,	   we	   developed	   an	   iterative	   method	   for	   identifying	   sets	   of	  reaction(s)	  that	  increase	  the	  yield,	  and	  we	  have	  determined	  all	  possible	  combinations	  of	  novel	   reactions	   responsible	   for	   this	   increase.	   We	   outline	   the	   developed	   method	   as	  follows:	  i) Split	  the	  reactions	  in	  de	  novo	  network	  into	  forward	  and	  reverse	  reactions	  ii) Add	  binary	  use	  variables	  for	  each	  of	  the	  novel	  reactions	  iii) Formulate	  the	  problem	  as:	  Max	   𝑧! 	  s.t.	  𝑆. 𝑣 = 0	  𝑣!"# ≤ 𝑣! ≤ 𝑣!"#	  𝑣!,! + 𝑣!,! + 𝐾𝑧! ≤ 𝐾	  𝑧! 	  –	  binary	  variable	  associated	  with	  the	  reaction	  i	  S	  –	  stoichiometric	  matrix	  of	  the	  network	  v	  –	  flux	  vector	  and	  𝑣!"#	  	  ,	  lower	  and	  𝑣!"#  upper	  bound	  for	  the	  reaction	  fluxes	  K	  –	  large	  arbitrary	  constant	  to	  enforce	  the	  thermodynamic	  constraint	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We	  have	   also	   included	   constraints	   to	  prevent	   the	   simultaneous	  usage	  of	   forward	   and	  reverse	  reactions;	  hence	  either	  forward	  or	  reverse	  direction	  can	  be	  active.	  	  iv) However,	   this	   formulation	   will	   generate	   only	   one	   solution,	   and	   we	   have	  already	  determined	   there	   is	  more	   than	  1	  set	  of	   reactions	   that	   increases	   the	  yield.	   To	   enumerate	   all	   possible	   sets,	   we	   have	   created	   a	   constraint	   that	  prevents	   the	   solver	   from	   choosing	   the	   same	   solution,	   and	   we	   have	  exhaustively	  enumerated	  all	  possible	  sets.	  	  
5.2.4 Thermodynamic-­‐Based	  Flux	  Balance	  Analysis	  (TFBA)	  We	   did	   not	   have	   any	   experimental	   evidence	   about	   the	   kinetic	   (ir)reversibility	   of	   the	  possible	  biotransformations,	  and	  thus	  we	   integrated	  novel	  reactions	   into	   the	  native	  E.	  
coli	  network	   as	   bidirectional	   reactions.	   Since	   thermodynamic	   properties	   of	   reactions	  affect	  their	  directionalities,	  we	  tested	  the	  feasibility	  of	  the	  sets	  of	  reactions	  integrated	  in	  the	  E.	  coli	   genome	  scale	  network	  under	   thermodynamic	  constraints.	  For	   this	  purpose,	  we	   utilized	   the	   formulation	   of	   Thermodynamics-­‐based	   Metabolic	   Flux	   Analysis	  (TMFA/TFBA)	  [47],	  which	  uses	  Group	  Contribution	  Method	  (GCM)	  [27]	  to	  estimate	  the	  standard	   Gibbs	   free	   energy	   of	   formation	   of	   metabolites,	   and	   builds	   a	   Mixed	   Integer	  Linear	  Programming	  (MILP)	  problem	  to	  incorporate	  the	  thermodynamic	  constraints	  in	  metabolic	   networks.	   We	   applied	   these	   constraints	   [48,193,194],	   and	   we	   verified	   the	  thermodynamic	  feasibility	  of	  the	  proposed	  novel	  reaction	  sets	  and	  their	  impact	  on	  the	  yield	  of	  biomass	  accumulation.	  	  
5.2.5 Gap-­‐filling	  analysis	  by	  using	  novel	  reactions	  in	  E.	  coli	  network	  There	  are	  knowledge	  gaps	  in	  the	  latest	  proposed	  genome	  scale	  reconstruction	  (GEM)	  of	  
E.	  coli	   [170].	  This	   is	  due	  to	   the	  missing	  enzymatic	   functions,	  which	  were	  not	  captured	  during	  gene	  to	  reaction	  association	  (GPRs)	  and	  the	  gap	  filling	  analysis.	  We	  have	  utilized	  BNICE.ch	  generated	  reactions	  to	  identify	  possible	  gap	  filling	  reactions	  for	  the	  dead-­‐end	  (blocked)	  metabolites	  in	  E.	  coli	  metabolic	  network.	  We	  performed	  the	  dead-­‐end	  analysis	  of	  the	  de	  novo	  generated	  metabolic	  network,	  and	  we	  reported	  the	  metabolites	  that	  were	  dead-­‐ends	   in	   the	   native	   network	   but	   connected	   to	   the	   metabolism	   in	   the	   enlarged	  network.	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5.2.6 BridgIt	  analysis	  In	   Chapter	   2	   we	   described	   the	   methodologies	   behind	   the	   BridgIt	   framework	   and	   in	  Chapter	   3	   we	   demonstrated	   its	   efficiency	   on	   finding	   the	   structurally	   similar	   known	  reactions	  to	  the	  hypothetical	  generated	  reactions	  of	  BNICE.ch.	  	  
5.3 Results	  and	  discussions	  We	   explored	   how	   the	   metabolic	   network	   of	   E.coli	   evolves	   within	   the	   known	  biochemistry	  if	  we	  apply	  the	  aforementioned	  90	  generalized	  enzymatic	  reaction	  rules	  to	  glucose	  as	  a	  starting	  substrate	  along	  with	  the	  set	  of	  relevant	  cofactors.	  We	  also	  analyzed	  how	  the	  generated	  hypothetical	  reactions	  affect	  the	  known	  metabolic	  network	  of	  E.	  coli	  and	  how	  these	  reactions	  are	  changing	  the	  enzymatic	  profile	  of	  this	  network.	  
5.3.1 E.	  coli	  super	  metabolic	  network	  reconstruction	  The	  network	  generation	  algorithm	  converged	  after	  16	  iterations	  resulting	  in	  a	  network	  of	   565	   compounds	   and	   7804	   reactions.	   975	   out	   of	   7804	   generated	   reactions	   were	  already	   reported	   in	   KEGG	   database	   (Figures	   5.3	   &	   5.4).	   The	   algorithm	   reconstructed	  successfully	  67	  compounds	  and	  76	  reactions	  that	  exist	  in	  the	  core	  metabolic	  network	  of	  
E.	  coli	  (see	  Section	  5.2.1),	  and	  even	  more	  striking	  was	  that	  we	  obtained	  additional	  native	  
E.	  coli	  compounds	  and	  reactions	  (Figures	  5.3	  &	  5.4).	  This	  demonstrated	  that	  the	  utilized	  generalized	  reaction	  rules	  could	  be	  used	  to	  explain	  the	  biochemistry	  of	  the	  other	  parts	  of	  E.	  coli	  metabolism.	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Figure	  5-­‐3:	  Total	  number	  of	  generated	  compounds	  (all	  KEGG	  compounds)	  after	  16	   iterations	  along	  
with	   the	   numbers	   of	   generated	   native	   E.coli	   compounds.	   After	   16	   iterations,	   the	   number	   of	  
compounds	  converged	  to	  565.	  
	  
Figure	  5-­‐4:	  Total	  number	  of	  reactions,	  KEGG	  reactions	  and	  E.coli	  native	  reactions	  generated	  in	  each	  
iteration	  through	  the	  reconstruction	  of	  core	  metabolism	  of	  E.coli.	  The	  total	  number	  of	  reactions	  
converged	  to	  7804	  after	  16	  iterations.	  
	  
5.3.2 Characteristics	  of	  de	  novo	  metabolic	  network	  of	  E.	  coli	  	  After	  integrating	  the	  generated	  compounds	  and	  reactions	  into	  the	  genome	  scale	  model	  of	   E.	   coli,	   the	   overall	   number	   of	   metabolites	   in	   the	   extended	   network	   increased	   by	  
!!!!!!#!of!iterations 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
!!!!!!Total!#!of!reactions 0 18 80 197 553 1119 1730 2419 3268 4266 5247 6010 6714 7441 7780 7801 7804
!!!!!!KEGG!reactions 0 9 26 62 164 322 438 545 648 752 839 892 930 953 965 973 975





















!!!!!!#!of!iterations 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
!!!!!Total!#!of!compounds 19 28 45 83 159 223 277 334 393 439 478 513 540 555 562 564 565




















20.4%	   to	   2176	   compounds,	   whereas	   the	   number	   of	   reactions	   (7804)	   almost	   tripled	  compared	  to	  the	  native	  model.	  362	  out	  of	  565	  generated	  metabolites	  and	  470	  out	  of	  the	  7804	  generated	  reactions	  were	  already	  native	  for	  E.	  coli.	  	  Since	   reactions	   in	   the	   metabolic	   models	   are	   considered	   as	   bidirectional	   unless	   the	  kinetic	  irreversibility	  is	  observed	  experimentally,	  we	  added	  to	  the	  expanded	  model	  the	  forward	   and	   reverse	   reactions	   of	   the	   same	   BNICE.ch	   biotransformation	   as	   one	  bidirectional	  reaction.	  We	  ended	  up	  with	  the	  expanded	  model	  with	  6454	  reactions	  and	  2176	  metabolites.	  	  One	  of	  our	  main	  goals	  in	  this	  study	  was	  to	  investigate	  the	  possible	  contributions	  of	  the	  proposed	  novel	  reactions	  to	  the	  E.	  coli	  metabolism	  and	  to	  determine	  if	  these	  reactions	  could	   be	   used	   to	   fill	   in	   some	  missing	   functions	   in	   the	   current	   functional	   annotation.	  Firstly,	  we	  tested	  the	  de	  novo	  metabolic	  network	  for	  its	  capacity	  to	  accumulate	  biomass	  precursors.	   Wild	   type	   E.	   coli	   grows	   with	   a	   specific	   growth	   rate	   of	   0.99	   1/hr	   with	   a	  glucose	  uptake	  	  of	  10mmol/gDWhr	  under	  aerobic	  conditions.	  	  To	   assess	   the	   impact	   of	   the	   novel	   introduced	   hypothetical	   reactions	   to	   the	  metabolic	  network	   of	   E.	   coli,	   we	   performed	   Flux	   balance	   Analysis	   (FBA)	   on	   the	   de	   novo	   E.	   coli	  network	   and	  we	   obtained	   a	   specific	   growth	   rate	   of	   1.46	   1/hr	   under	   the	   same	  media	  composition,	  which	  corresponds	  to	  46%	  increase	  in	  the	  biomass	  yield	  compared	  to	  the	  wild	  type	  E.	  coli.	  
5.3.3 Sets	  of	  reactions	  that	  increase	  the	  biomass	  yield	  We	  performed	  a	  Flux	  Variability	  analysis	  (FVA)	  on	  the	  de	  novo	  metabolic	  network,	  and	  we	  found	  out	  that	  there	  were	  no	  individual	  novel	  reaction(s)	  whose	  addition	  to	  the	  E.	  
coli	  network	  would	  increase	  the	  biomass	  yield	  on	  glucose.	  This	  implied	  that	  there	  were	  alternative	   set(s)	   of	   reactions	   that	   were	   responsible	   for	   this	   increase	   in	   the	   yield.	   In	  order	   to	   determine	   these	   different	   sets	   of	   reactions,	   we	   applied	   our	   framework	   (See	  Section	  2.2.1),	  and	  we	  identified	  all	  possible	  sets	  that	   increase	  the	  yield	  in	  the	  de	  novo	  network	  (Table	  5.2).	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Table	  5-­‐2:	  Total	  number	  of	  generated	  sets	  of	  reactions	  that	  increase	  the	  yield	  in	  FBA,	  and	  the	  
number	  of	  those	  that	  are	  network	  thermodynamically	  feasible	  and	  that	  increase	  the	  yield	  in	  the	  
TFBA	  analysis	  as	  well.	  	  
Length	   #	  of	  generated	  sets	   #	  of	  TFBA	  feasible	  
2	   136	   7	  
3	   6705	   1075	  
4	   4200	   1677	  
5	   7	   4	  
Total	   11048	   2763	  	  We	  found	  that	  11048	  different	  sets	  of	  reactions	  with	  lengths	  2,	  3,	  4	  and	  5	  could	  increase	  the	  yield	  to	  at	  least	  90%	  of	  the	  theoretical	  optimum	  yield	  (1.3	  1/hr	  specific	  growth	  rate	  with	  10	  mmol/gDWhr	  glucose	  uptake	  rate).	  These	  11046	  sets	  were	  composed	  of	  only	  1140	  reactions	  (~15	  percent	  of	  the	  total),	  	  and	  135	  of	  them	  were	  known	  KEGG	  reactions	  whereas	  the	  others	  were	  novel	  reactions	  proposed	  by	  BNICE.ch.	  
5.3.4 TFBA	  of	  E.	  coli	  metabolic	  network	  along	  with	  different	  sets	  of	  reactions	  After	  populating	  all	  possible	  combinations	  of	  the	  novel	  reactions	  that	  increase	  the	  yield,	  we	   have	   tested	   them	   under	   thermodynamic	   constraints	   to	   investigate	   if	   the	  bioenergetics	   would	   allow	   those	   biotransformations	   to	   operate	   in	   the	   favorable	  direction.	  	  We	  integrated	  the	  identified	  sets	  one	  at	  a	  time	  into	  the	  E.	  coli	  native	  metabolic	  network,	  and	  we	  have	  performed	  the	  TFBA	  analysis	  of	  so	  obtained	  extended	  metabolic	  networks.	  The	  highest	  specific	  growth	  we	  obtained	  with	  these	  extended	  networks	  was	  1.39	  1/hr	  under	  aerobic	  conditions,	  with	  10	  mmol/gDWhr	  glucose	  uptake.	  The	  first	  obvious	  result	  was	   that	   due	   to	   the	   thermodynamic	   constraints	   the	   highest	   specific	   growth	   rate	  decreased	   from	  1.46	  1/hr	   to	  1.39	  1/hr.	  Even	   though	  some	   identified	  sets	  of	   reactions	  were	   thermodynamically	   feasible,	   some	   reactions	   that	   belonged	   to	   the	   native	  metabolism	  were	  not	  thermodynamically	  feasible	  in	  the	  direction	  that	  was	  imposed	  by	  the	   integrated	   sets	   of	   novel	   reactions.	   As	   a	   result,	   we	   observed	   a	   drop	   in	   the	   yield	  compared	   to	   FBA	   results.	   On	   the	   other	   hand,	   8285	   identified	   sets	   were	  thermodynamically	  infeasible	  in	  the	  increasing	  yield	  direction	  (Table	  5.2)..	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During	  the	  analysis	  of	  some	  sets,	  we	  could	  not	  conclude	  the	  main	  reason	  for	  the	  biomass	  yield	   increase	   at	   a	   first	   glance,	   and	  we	   performed	   further	   analysis	   to	   understand	   the	  behavior	  of	  the	  de	  novo	  network.	  	  We	   built	   de	   novo	  models	   with	   the	   sets	   that	   increase	   the	   yield	   to	   the	   highest	   with	  thermodynamic	  constraints,	  and	  performed	  TFBA	  simulations	  to	  observe	  the	  behavior	  of	  the	  de	  novo	  network.	  By	  analyzing	  these	  models,	  we	  concluded	  that	  the	  yield	  increase	  is	  mostly	  related	  to	  ATP,	  which	  states	  that	  the	  limiting	  metabolite	  for	  the	  biomass	  yield	  is	  ATP,	  rather	  than	  any	  other	  biomass	  building	  block.	  The	  detailed	  study	  of	  these	  sets	  is	  an	  ongoing	  project	  and	  it	  is	  subject	  to	  further	  analysis.	  	  
5.3.5 Analysis	  of	  dead-­‐end	  metabolites	  In	  the	  de	  novo	  metabolic	  network	  of	  E.coli,	  we	  had	  a	  closer	  look	  to	  the	  metabolites	  that	  are	   “dead	   end	   metabolites”	   in	   the	   native	   model	   of	   E.	   coli	   and	   we	   investigated	   their	  connectivity	  in	  the	  new	  generated	  network	  in	  attempt	  to	  identify	  the	  new	  reaction	  steps	  that	  connect	  them	  to	  the	  other	  metabolites	  in	  the	  network.	  In	   total,	   there	   were	   208	   dead-­‐end	   metabolites	   in	   iJO1366	   which	   represent	   the	  knowledge	  gaps	   in	   this	  model	   reconstruction	   [170].	  Nine	  metabolites	   that	  were	  dead-­‐end	   in	   the	   native	   model	   got	   connected	   with	   the	   other	   metabolites	   of	   the	   de	   novo	  metabolic	  network	  through	  the	  novel	  reactions	  of	  BNICE.ch	  (Table	  5.3).	  	  
Table	  5-­‐3:	  List	  of	  metabolites	  that	  were	  dead-­‐end	  metabolites	  in	  the	  native	  E.	  coli	  and	  are	  not	  dead-­‐
end	  in	  the	  de	  novo	  metabolic	  network.	  The	  reaction	  steps	  that	  could	  connect	  these	  metabolites	  to	  
the	  native	  metabolites	  are	  novel	  hypothetical	  reactions	  generated	  by	  BNICE.ch.	  
Metabolites	  that	  are	  not	  dead-­‐end	  in	  
the	  de	  novo	  metabolic	  network	  
#	  of	  reactions	  could	  connect	  the	  
metabolites	  to	  the	  native	  metabolites	  	  
#	  of	  Novel	  
reactions	  
2,3-­‐dioxo-­‐l-­‐gulonate	   3	   3	  
2,5-­‐diketo-­‐d-­‐gluconate	   2	   2	  
2-­‐phosphoglycolate	   2	   2	  
4-­‐hydroxy-­‐l-­‐threonine	   5	   5	  
p1,p5-­‐bis(5-­‐adenosyl)	  pentaphosphate	   11	   11	  
1-­‐aminopropan-­‐2-­‐ol	   72	   72	  
1-­‐deoxy-­‐d-­‐xylulose	   10	   10	  
gamma-­‐hydroxybutyrate	   15	   15	  
oxalate	   17	   17	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5.3.6 BridgIt	  analysis	  Since	  in	  this	  analysis	  we	  explored	  all	  the	  possible	  enzymatic	  reactions	  of	  E.	  coli	  on	  the	  basis	  of	  its	  known	  biochemistry	  (the	  network	  includes	  only	  known	  compounds),	  the	  set	  of	  generated	  novel	  reactions	  were	  a	  subset	  of	  the	  hypothetical	  reactions	  we	  reported	  in	  Chapter	  3.	  Therefore	  their	  detailed	  analysis	  is	  discussed	  in	  Chapter	  3.	  Hereby,	  in	  order	  to	   compare	   different	   sets	   of	   reactions	   and	   to	   rank	   them	   based	   on	   their	   structural	  similarities	   to	   the	   known	   reactions,	   we	   reported	   an	   “average	   BridgIt	   score”	   for	   the	  reactions	  in	  each	  set.	  	  
5.4 Conclusions	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Chapter	  ) 	  
iAM.NICE!	  
What	  is	  the	  fate	  of	  each	  atom	  from	  nutrients	  into	  metabolic	  universe?	  
	  
SUMMARY	  In	   this	   chapter,	  we	   introduce	   a	   computational	   framework,	   “iAM.NICE”	   (in	  silico	  Atom	  Mapped	  Network	   Integrated	   Computational	   Explorer),	   for	   the	   atom-­‐level	   reconstruction	   of	   metabolic	  networks	  from	  the	  in	  silico	  labeled	  substrates,	  which	  allows	  tracking	  the	  fate	  of	  atoms	  through	  the	  reconstructed	  metabolic	  network.	  The	  originality	  of	  “iAM.NICE”	  is	  twofold.	  First,	  it	  is	  to	  our	  knowledge	   the	   first	   automated	   atom-­‐mapping	   algorithm	   that	   is	   derived	   from	   the	   underlying	  enzymatic	  biotransformation	  mechanism;	  and	  second,	  its	  application	  is	  not	  limited	  to	  individual	  reactions	   and	   it	   can	   be	   used	   for	   the	   reconstruction	   of	   atom-­‐mapped	  metabolic	   networks.	  We	  illustrate	  the	  effectiveness	  of	  our	  method	  through	  the	  reconstruction	  of	  atom-­‐mapped	  reactions	  of	  KEGG	  database.	  Furthermore,	  we	  provide	  an	  example	  of	  an	  atom-­‐level	  representation	  of	  core	  metabolic	  network	  of	  E.	  coli	   to	   show	  how	  a	   comprehensive	  atom	   level	  metabolic	   analysis	   can	  guide	  the	  experimental	  design	  to	  obtain	  more	  precise	  biological	  information.	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6.1 Introduction	  The	   automated	   identification	   of	   atom	   transitions	  within	   a	   reaction	   pathway	   is	   a	   very	  challenging	   task	   since	   the	   degree	   of	   complexity	   of	   metabolic	   networks	   dramatically	  increases	  when	  we	   transit	   from	  metabolite-­‐level	   studies	   to	  atom-­‐level	   studies.	  Despite	  being	  studied	  extensively	  in	  various	  approaches,	  the	  field	  of	  atom	  mapping	  of	  metabolic	  networks	   is	   lacking	   an	   automated	   approach,	   which	   accounts	   for	   the	   information	   of	  
reaction	  mechanism	  for	  atom	  mapping	  and	  is	  extendable	  from	  atom-­‐mapped	  reactions	  to	  
atom-­‐mapped	  reaction	  networks.	  	  In	   a	   reliable	   in	   silico	   atom-­‐level	   reconstruction	   of	   a	   metabolic	   network	   the	   atom	  mappings	  need	   to	  be:	   (i)	  correctly	  created	  at	   the	   level	  of	   individual	  reactions,	  and	  (ii)	  connected	   in	   a	   network	   and	   conserved	   through	   all	   reactions	   steps	   from	   the	   input	  compound	  to	  the	  final	  products,	  enabling	  one	  to	  trace	  back	  the	  exact	  metabolic	  path	  of	  every	  single	  atom.	  To	  do	  so,	  we	  developed	  the	  “iAM.NICE”	  framework	  for	  addressing	  the	  atom-­‐mapping	  problem.	  In	  this	  study,	  we	  provide	  the	  atom-­‐mapped	  representation	  of	  all	  the	  reactions	  in	  KEGG	  database	  as	  well	  as	  an	  atom-­‐level	  representation	  of	  core	  E-­‐coli	  metabolic	  network.	  Our	  results	  can	  be	  used	  for	  a	  large	  range	  of	  applications,	  starting	  from	  the	  identification	  of	  new	   metabolic	   routes	   for	   the	   microbial	   production	   of	   desired	   compounds	   to	   the	  interpretation	   of	   the	   optimum	   labelled	   patterns	   of	   substrates,	   which	   can	   be	   a	   great	  benefit	  for	  the	  simulation	  of	  tracer	  experiments.	  
6.2 Methods	  
6.2.1 In	  silico	  atom	  labelling	  	  In	   the	   “iAM.NICE”	   framework,	   molecules	   are	   represented	   in	   the	   form	   of	   a	   Bond-­‐Electron-­‐Matrix	  (BEM)	  that	  describes	  the	  electron	  bonds	  between	  the	  atoms	  [101]	  and	  we	   store	   this	   information	   as	   a	   molfile	   [195].	   Our	  method	   allows	   us	   to	   automatically	  label	  all	  the	  atoms	  of	  a	  molecule,	  with	  the	  exception	  of	  hydrogen	  atoms.	  In	  our	  in	  silico	  labelling	   studies	   we	   adopted	   the	   annotation	   used	   in	   stable	   isotope	   13C	   labelling	  experiments.	  For	  the	  cases	  where	  we	  needed	  to	  trace	  the	  fate	  of	  more	  than	  one	  labelled	  atom,	   we	   used	   14C,	   15C,	   etc.	   Though	   all	   the	   examples	   shown	   in	   this	   work	   represent	  
	  109	  
carbon	   labelling,	   the	   same	   principle	   can	   be	   applied	   for	   the	   annotation	   of	   other	   atom	  types.	  	  Within	  the	  “iAM.NICE”	  framework,	  we	  can	  label	  substrate	  molecules	  in	  many	  distinctive	  ways	   by	   altering	   the	   number	   of	   labelled	   atoms	   and	   their	   positions.	  However,	   in	   this	  study	  we	  will	  focus	  on	  the	  following	  cases:	  	  1) Fully	  labelled	  molecules:	  fully	  labelled	  molecule	  means	  that	  all	  labelled	  atoms	  in	  a	   molecule	   have	   distinct	   labels,	   whereas	   in	   stable	   isotope	   13C	   labelling	  experiments	   all	   labelled	   atoms	   have	   the	   same	   label.	   We	   use	   such	   labelled	  molecules	  to	  construct	  atom-­‐maps	  of	  individual	  reactions;	  here,	  the	  atoms	  of	  the	  starting	   compound(s)	   are	   labelled,	  with	   the	   exception	   of	   hydrogen	   atoms,	   and	  the	   result	   of	   their	   transition	   through	   a	   biochemical	   transformation	   can	   be	  observed	  in	  the	  atom-­‐mapped	  reaction	  product.	  	  2) Single	   atom	   labelled	   molecules:	   we	   use	   these	   molecules	   to	   construct	   atom-­‐mapped	  pathways	  and	  metabolic	   reaction	  networks;	  here,	   a	   single	  atom	  of	   the	  starting	  compound	  is	  labelled,	  and	  the	  fate	  of	  this	  atom	  can	  be	  observed	  through	  a	  sequence	  of	  reactions.	  Figure	   6.1	   shows	   an	   example	   of	   in	   silico	   carbon-­‐labelled	   glucose	   and	   the	   comparison	  between	   different	   isotopomers	   of	   glucose.	   The	   term	   isotopomer	   comes	   from	   isotope	  isomers,	   and	   it	   describes	   different	   isotopic	   compositions	   of	   the	   same	   compound.	   An	  important	   characteristic	   of	   “iAM.NICE”	   is	   that	   it	   considers	   different	   isotopomers	   as	  different	  compounds,	  enabling	  the	  differentiation	  between	   isotopomers	  and	  hence	  the	  reconstruction	  of	  atom-­‐mapped	  networks.	  	  Depending	   on	   the	   purpose	   of	   the	   in	   silico	   labeling	   study,	   we	   choose	   a	   different	  isotopomer	   as	   starting	   compound.	   Unlabeled	   glucose	   is	   compared	   with	   fully	   carbon	  labeled	  and	  different	  C-­‐labeled	  glucose	  based	  on	   the	  position	  of	   the	   labeled	  carbon.	   If	  we	  want	   to	   follow	  a	   specific	  atom	  of	   the	   starting	  compound	   through	   the	  network,	  we	  choose	   13C-­‐single	   labeled	  glucose.	  C1	   to	  C6	  specify	   the	  position	  of	   the	   labeled	  atom	   in	  the	  molecule.	  	  Note	  that	  we	  can	  also	  use	  a	  fully	  labelled	  molecule	  in	  sequences	  of	  reactions.	  However,	  with	   all	   the	   atoms	   being	   labelled,	   as	   the	   size	   of	   metabolic	   network	   increases	   the	  generated	   atom-­‐mapped	   network	   becomes	   prohibitively	   complex	   for	   any	   practical	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purpose.	   Thus,	   we	   use	   the	   single	   atom	   labelled	   molecules	   to	   study	   the	   metabolic	  networks.	  
	  
Figure	   6-­‐1:	   Depending	   on	   the	   purpose	   of	   the	   in	   silico	   labeling	   study,	   we	   choose	   a	   different	  
isotopomer	   as	   starting	   compound.	   Unlabeled	   glucose	   is	   compared	   with	   fully	   carbon	   labeled	   and	  
different	   C-­‐labeled	   glucose	   based	   on	   the	   position	   of	   the	   labeled	   carbon.	   If	   we	   want	   to	   follow	   a	  
specific	  atom	  of	  the	  starting	  compound	  through	  the	  network,	  we	  choose	  13C-­‐single	  labeled	  glucose.	  
C1	  to	  C6	  specify	  the	  position	  of	  the	  labeled	  atom	  in	  the	  molecule.	  
6.2.2 Atom-­‐mapped	  reactions:	  transferring	  labelled	  substrates	  to	  labelled	  products	  As	  already	  discussed	  in	  Chapter	  3,	  the	  generalized	  enzymatic	  reaction	  rules	  were	  initially	  developed	  in	  BNICE.ch	  with	  the	  aim	  of	  discovering	  de	  novo	  alternative	  biosynthesis	  and	  biodegradation	  pathways,	  and	  their	  potential	  has	  been	  demonstrated	  in	  several	  studies	  [72,82,84].	  	  Contrary	  to	  their	  application	  in	  our	  previous	  studies,	  in	  this	  study,	  for	  the	  first	  time	  we	  applied	   the	   generalized	   reaction	   rules	   not	   for	   generating	   novel	   information,	   but	   for	  introducing	   another	   level	   of	   information	   to	   the	   existing	   knowledge	   of	   metabolism.	  Specifically,	   we	   added	   detailed	   information	   about	   the	   atom	   transition	   to	   the	   known	  metabolic	   networks	   by	   reconstructing	   the	   known	   enzymatic	   reactions	   at	   the	   atomic	  level.	  For	  this	  purpose,	  we	  adjusted	  the	  BNICE	  algorithms,	  and	  we	  also	  formulated	  new	  algorithms	   for	   the	  atom-­‐mapped	  reconstruction	  of	  enzymatic	  reactions,	  pathways	  and	  metabolic	  network.	  Our	   algorithm	   read	   the	   KEGG	   reactions,	   one	   by	   one,	   extracted	   the	   substrates	   and	  checked	  them	  against	  a	   list	  of	  cofactors	  given	  as	  a	  parameter	  and	  after	   identifying	  the	  cofactors,	   it	  automatically	  regenerated	  the	   in	  silico	   labelled	  non-­‐cofactors	  substrate	  by	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successively	  labelling	  their	  carbon	  atoms.	  In	  case	  of	  having	  more	  than	  one	  substrate,	  the	  successive	  manner	  continues	  after	  labelling	  the	  first	  substrate	  (Figure	  7.3,	  EC	  Class2).	  In	  order	   to	  generate	  atom-­‐mapped	  reactions,	   “iAM.NICE”	   transfers	   the	   label(s)	   from	  a	  substrate	  to	  a	  product	  by	  taking	  into	  account	  the	  information	  about	  the	  rearrangements	  of	   the	   chemical	   bonds	   derived	   from	   the	   generalized	   reaction	   rules.	   This	   way,	   we	  generate	   the	   product	   structure	   from	   the	   substrate	   structure	   by	   rearranging	   bonds,	  while	   conserving	   the	   information	   about	   the	   positions	   of	   atoms.	   Figure	   6.2	   shows	   an	  example	  of	  atom-­‐mapped	  reaction	  along	  with	   the	  BEM	  of	   representation	  of	   substrate,	  products	   and	   the	  matrix	   representation	  of	   the	   corresponding	  generalize	   reaction	   rule	  for	   carrying	   out	   such	   an	   enzymatic	   reaction.	   The	   colour	   codes	   help	   to	   clarify	   the	  different	   corresponding	   parts	   of	   BEM	   and	   reaction	   rule	   matrix.	   According	   to	   the	  mechanism	  predefined	  in	  the	  reaction	  rule,	  the	  13C	  __	  14C	  bond	  breaks	  and	  two	  products	  form.	  The	  cofactor	  of	  the	  reaction	  (NADPH)	  rearranges	  the	  electrons	  as	  described	  in	  the	  reaction	  rule	  to	  generate	  a	  double	  bond	  instead	  of	  13C	  __	  O	  and	  15C	  __	  O	  which	  results	  on	  the	   formation	   of	   labelled	   CO2	   and	   pyruvate	   as	   the	   products	   with	   specified	   carbon	  position	  being	  conserved	  based	  on	  the	  mechanism	  of	  the	  reaction.	  	  
6.2.3 Atom-­‐mapped	  pathways	  and	  networks	  In	  our	  proposed	  approach,	  the	  atom-­‐mapped	  pathways	  and	  networks	  are	  reconstructed	  in	  an	  iterative	  manner.	  In	  the	  first	  iteration	  of	  the	  procedure,	  we	  apply	  the	  generalized	  reaction	  rules	  on	  a	  starting	  in	  silico	  labelled	  substrate.	  If	  one	  of	  the	  generalized	  reaction	  rules	  recognizes	  the	  reactive	  site	  in	  the	  labelled	  substrate,	  the	  reaction	  rule	  rearranges	  the	   bonds	   according	   to	   its	   distinct	   reaction	  mechanism.	   This	  way,	  we	   obtain	   a	   set	   of	  atom-­‐mapped	   reactions	   together	   with	   their	   labelled	   products.	   The	   labelled	   products	  obtained	  in	  the	  first	  iteration	  are	  the	  substrates	  for	  the	  second	  iteration.	  As	  a	  result,	  the	  labelled	  products	   of	   the	   second	   iteration	   are	   two	   steps	   away	   from	   the	   initial	   labelled	  substrates	  and	  they	  contain	  the	  information	  about	  the	  fate	  of	  each	  atom	  after	  these	  two	  reaction	  steps.	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Figure	  6-­‐2:	  BEM	  representation	  of	  an	  atom-­‐mapped	  example	  reaction:	  The	  generalized	  reaction	  rule	  
recognizes	  the	  reactive	  site	   (red)	  of	   the	  substrate.	  Next,	   the	  reaction	  rule	  matrix,	  which	  stores	  the	  
bond	  changes	  for	  every	  pair	  of	  atoms,	  is	  added	  to	  the	  substrate	  matrix	  (green)	  at	  the	  reactive	  site.	  
The	  resulting	  product	  matrix	  contains	  the	  BEM	  of	  the	  products:	  CO2	  (light	  blue)	  and	  Pyruvate	  (dark	  
blue).	  We	  iterate	  the	  steps	  of	  the	  procedure	  till	  we	  reconstruct	  studied	  pathways	  or	  networks.	  This	  way,	  we	  can	  trace	  the	  fate	  of	  every	  single	  atom	  from	  the	  first	  substrate	  to	  the	  final	  product,	   i.e.	   we	   eventually	   obtain	   a	   comprehensive	   atom	   level	   reconstruction	   of	  metabolic	  pathways	  or	  metabolic	  networks.	  An	   important	   feature	   of	   “iAM.NICE”	   is	   that	   the	   existing	   metabolic	   data	   in	   biological	  databases	  is	  integrated	  into	  our	  framework	  and	  is	  organized	  within	  different	  categories	  and	   levels	   such	   as	   compounds,	   reactions,	   pathways,	   organisms,	   etc.	   This	   allows	   us	   to	  screen	   the	  obtained	  results	  against	  all	  known	  biological	  knowledge	   in	  different	   levels.	  Detailed	  explanations	  on	  the	  different	  levels	  of	  supervision	  and	  their	  importance	  for	  the	  “i.AM.NICE”	  framework	  are	  provided	  in	  Chapter	  2.	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6.3 Results	  and	  discussion	  In	   the	   following	   we	   present	   a	   proof	   of	   concept	   for	   the	   atom	   mapping	   of	   enzymatic	  reactions,	   pathways	   and	   metabolic	   networks	   using	   “iAM.NICE”,	   we	   continuously	  elaborate	   on	   the	   computational	   and	   methodological	   concepts	   associated	   with	   this	  approach,	   and	   we	   illustrate	   the	   application	   of	   the	   proposed	   method	   for	   the	   atom	  mapping	  of	  the	  E.coli	  central	  carbon	  metabolism.	  
6.3.1 Atom	  mapping	  for	  single	  enzymatic	  reactions	  We	  used	  our	   framework	   to	   reconstructed	  atom-­‐mapped	  KEGG	  reactions	   (version	   July	  2014).	  We	   used	   fully	   carbon	   labeled	   KEGG	  molecules	   (Section	   6.2.1)	   as	   inputs	   to	   the	  algorithm	  together	  with	  all	  the	  generalize	  reaction	  rules.	  Upon	  acting	  on	  a	  molecule,	  the	  generalized	   reaction	   rules	   automatically	   identify	   the	   biological	   reactive	   sides	   of	  molecule	  and	  apply	  the	  biotransformation	  by	  which	  the	  atoms	  and	  bonds	  rearrange	  to	  form	   the	   product.	   We	   show	   an	   example	   of	   a	   carbon	   mapped	   reaction	   for	   every	  enzymatic	   class	   of	   the	   Enzyme	   Commission	   (EC)	   classification	   system[196]	   in	   Figure	  6.3.	  	  
6.3.2 Atom	  mapping	  for	  metabolic	  pathways	  Biological	   pathways	   are	   a	   combination	   of	   several	   enzymatic	   reactions	   occurring	   in	   a	  sequence.	  “iAM.NICE”	  not	  only	  accurately	  maps	  atoms	  for	  individual	  reactions,	  but	  also	  extends	   these	   atom-­‐mapped	   reactions	   to	   atom-­‐mapped	   metabolic	   pathways	   and	  eventually	   the	   metabolic	   networks.	   In	   the	   following	   sections	   we	   presented	   the	  properties	  and	  utility	  of	  our	  approach	  by	  studying	  the	  central	  carbon	  pathways.	  Central	  carbon	   metabolism	   takes	   different	   enzymatic	   steps	   to	   convert	   sugars	   into	   metabolic	  precursors,	  which	  are	  used	  downstream	  to	  form	  the	  entire	  biomass	  of	  the	  cell.	  While	  in	  this	  study	  we	  focus	  on	  mapping	  carbon	  atoms,	  our	  method	  can	  be	  used	  to	  map	  atoms	  of	  all	  elements	  with	  the	  exception	  of	  Hydrogen.	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Figure	  6-­‐3:	  An	  example	  of	  a	  carbon	  atom-­‐mapped	  reaction	  is	  given	  for	  each	  EC	  class.	  Carbon	  atoms	  
in	  the	  substrates	  are	   labelled	  from	  13C	  upwards,	  and	  every	  carbon	  isotope	  present	  on	  the	  reactant	  
side	  reappears	  on	  the	  product	  side.	  In	  the	  case	  of	  more	  than	  one	  substrate,	  e.g.	  the	  example	  of	  EC	  
class	   2,	   the	   carbon	   labels	   are	   enumerated	   sequentially	   for	   all	   the	   substrates.	   The	   molecular	  
structures	  of	  cofactors	  that	  do	  not	  participate	  in	  carbon	  transfer	  are	  not	  shown.	  We	  show	  below	  the	  
reaction	  arrows	  the	  KEGG	  Id	  and	  the	  name	  of	  the	  catalysing	  reaction	  rule.	  
6.3.2.1 Atom-­‐mapped	  Glycolysis	  Glycolysis	   is	   a	  metabolic	  pathway	   that	   converts	   glucose	   to	   acetyl-­‐CoA	  and	  with	   a	   few	  variations,	  occurs	  in	  roughly	  all	  organisms.	  To	  generate	  the	  atom-­‐mapped	  glycolysis,	  we	  constrained	  the	  scope	  of	  the	  search	  space	  of	  compounds	  and	  reactions	  to	  the	  pathway	  level	   (Section	   7.2.3,	   Table	   7.1)	   and	   we	   performed	   10	   iterations	   since	   the	   glycolysis	  pathway	   is	   a	   sequence	   of	   10	   enzymatic	   reaction	   steps,	   one	   should	   be	   careful	   that	   in	  some	   steps	   more	   than	   one	   reaction	   occurs	   which	   makes	   in	   total	   16	   reactions	   in	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glycolysis	  (Figure	  6.4).	  Since	  the	  entry	  point	  to	  glycolysis	  starts	  is	  D-­‐glucose,	  we	  used	  as	  inputs	  for	  our	  algorithm	  the	  fully	  carbon-­‐labelled	  glucose	  and	  the	  set	  of	  9	  cofactors	  that	  are	  required	  to	  reconstruct	  all	  the	  reaction	  steps	  in	  glycolysis	  (Figure	  6.4)	  
	  
Figure	   6-­‐4:	   Glycolysis	   pathway	   reconstructed	   from	   a	   fully	   carbon-­‐labelled	   glucose.	   Reactions	   are	  
numbered	   from	   1	   to	   16,	   connecting	   the	   22	   compounds	   and	   isotopomers.	   Boxes	   show	   the	   atom-­‐
mapped	  molecular	  structures	  of	  the	  produced	  isotopomers	  for	  a	  selection	  of	  metabolites.	  




































































































this	  example,	   the	  first	  metabolite	  generated	  from	  glucose	  was	  glucose-­‐6-­‐phosphate.	   In	  the	   second	   iteration,	   the	   generalized	   reaction	   rules	   were	   applied	   to	   glucose-­‐6-­‐phosphate,	  which	   resulted	   in	   the	   generation	   of	   fructose-­‐6-­‐phosphate.	   This	   procedure	  was	  continued	  until	  acetyl-­‐CoA	  and	  CO2	  were	  produced	  and	  all	  the	  reactions	  in	  the	  list	  of	  glycolysis	  were	   reconstructed	   along	  with	   their	   atom	  maps	   (Figure	   6.4).	   The	   resulting	  network	   had	   22	   compounds	   (including	   9	   pairs	   of	   isotopomers)	   connected	   by	   16	  reactions.	  The	   isotopomer	  pairs	   resulted	   from	   the	  branching	   that	  occurred	   in	   reaction	  5,	  where	  fructose-­‐6-­‐phosphate	   was	   split	   into	   glycerone-­‐phosphate	   and	   glyceraldehyde3-­‐phosphate,	   both	   carrying	  differently	   labelled	   carbon	   atoms.	  Glycerone-­‐phosphate	  was	  further	  transformed	  into	  a	  second	  isotopomer	  of	  glyceraldehyde3-­‐phosphate.	  The	  rest	  of	   the	   labelled	   pathway	   contained	   two	   parallel	   sequences	   of	   compounds,	  where	   each	  sequence	  followed	  a	  different	  labelling	  pattern.	  We	   ended	   up	   with	   two	   isotopomers	   of	   acetyl-­‐CoA	   and	   CO2,	   with	   each	   molecule	  containing	  a	  subset	  of	  the	  initial	  isotope	  labels	  of	  the	  starting	  compound.	  Interestingly,	  the	   two	   carbon	   atoms	   giving	   CO2	  were	   initially	   present	   at	   the	   3rd	   and	   4th	   position	   in	  glucose,	   while	   the	   other	   atoms	   of	   glucose	   ended	   up	   in	   acetyl-­‐CoA.	   This	   example	  demonstrated	  how	  we	   could	   trace	  back	   the	   itinerary	  of	   each	   single	   atom	   through	   the	  pathway.	   Other	   carbon-­‐mapped	   biological	   pathways	   such	   as	   citrate	   cycle,	   pentose	  phosphate	   and	   pyruvate	   pathways	   can	   be	   replicated	   in	   the	   same	   manner	   and	  encompassed	   as	   a	   central	   carbon	  metabolism	   together	   and	   are	   presented	   in	   the	   next	  part.	  	  
6.3.3 Atom	  mapped	  E.	  Coli	  core	  metabolic	  network	  In	   order	   to	   demonstrate	   the	   efficiency	   of	   “iAM.NICE”	   in	   reconstructing	   atom	   level	  metabolic	  networks,	  we	  mapped	  the	  carbon	  atoms	  of	  a	  core	  metabolic	  network	  of	   the	  
E.coli	   core	   metabolism	   introduced	   in	   section	   5.2.1,	   Figure	   5.2.	   The	   network	   was	   a	  manually	  curated	  subset	  of	   the	  genome-­‐scale	  metabolic	  model	   iJO1366	   for	  E.	  coli	  K-­‐12	  MG1655	  [113],	  and	  it	  covered	  glycolysis/gluconeogenesis,	  pentose	  phosphate	  pathway,	  pyruvate	  metabolism,	  Tricarboxylic	  Citric	  Acid	  (TCA)	  cycle	  and	  glyoxylate	  metabolism,	  as	  well	  as	  the	  biosynthesis	  pathways	  for	  glycerol.	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We	   constrained	   the	   scope	   of	   the	   search	   space	   of	   compounds	   and	   reactions	   to	   the	  network	   level,	   i.e.	   to	   the	  core	  metabolism	  of	  E.	  coli	   (Table	  6.1),	  we	  used	  as	   inputs	  13C-­‐single	   labelled	  glucose	   together	  with	  14	  cofactors	   involved	   in	   core	  E.	  coli	  metabolism,	  and	   we	   studied	   the	   flow	   of	   labelled	   carbon	   atom	   through	   the	   metabolic	   network.	  Starting	   from	   a	   glucose	   molecule	   we	   performed	   16	   iteration	   steps	   to	   cover	   every	  reaction	  by	  iterative	  network	  reconstruction.	  	  
Table	  6-­‐1:	  The	  level	  of	  supervision	  that	  we	  applied	  for	  the	  reconstruction	  of	  the	  atom-­‐mapped	  core	  
metabolic	  network	  of	  E	   .coli	   is	  at	   the	  network	   level	   for	   the	  generalized	   reaction	   rules,	   compounds	  
and	  reactions	  
Supervision	  level	   Input	  constraint	  
	  	   Example	  
Reaction	  
rules	   Compounds	   Reactions	  
Unsupervised	   -­‐	  
	   	  
	  
Database	   	   	   	   	  
Organism	   	   	   	   	  
Network	   Core	  metabolic	  network	  of	  E.	  coli	   45*2	   67	   76	  
Pathway	   	   	   	   	  	  We	  repeated	  this	  procedure	  six	  times	  where	  in	  each	  repetition	  we	  changed	  the	  position	  of	  the	   labelled	  carbon	  atom	  in	  the	  13C-­‐single	   labelled	  glucose	  molecule,	   i.e.	  we	  used	  as	  inputs	   carbon-­‐labelled	   glucose	   C1,	   C2,	   C3,	   C4,	   C5	   and	   C6	   (Figure	   6.1).	   This	   way,	   we	  generated	  six	  different	  atom-­‐mapped	  networks.	  	  	  We	  analyzed	   the	  6	  resulting	  atom-­‐mapped	  metabolic	  networks,	  and	  we	  observed	   that	  the	  size	  of	  networks	  (graphs),	  in	  terms	  of	  number	  of	  isotopomers	  (nodes	  of	  the	  graph)	  and	   number	   of	   reactions	   (edges	   of	   the	   graph),	   was	   changing	   depending	   on	   which	  labelled	  glucose	  molecule,	  C1	   to	  C6,	  was	  used	  as	   the	   input.	   In	   fact,	   the	  position	  of	   the	  labelled	   atom	   in	   the	   labelled	   glucose	   molecule	   affected	   how	   the	   labelled	   atom	   was	  propagating	   through	   the	   network,	   and	   therefore	   how	   many	   isotopomers	   were	  generated.	  We	  identified	  four	  properties	  that	  gave	  rise	  to	  the	  differences	  in	  the	  size	  of	  the	  labelled	  metabolic	  networks:	  I. Loss	   of	   13C	   to	   CO2	   during	   the	   course	   of	   a	   reaction	   reduces	   the	   number	   of	  isotopomers.	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II. Production	  of	  labelled	  acetyl-­‐CoA	  increases	  the	  number	  of	  isotopomers.	  	  III. Presence	   of	   the	   label	   in	   the	   glycerol	   pathway	   increases	   the	   number	   of	  isotopomers.	  	  IV. Labelled	   pyruvate	   originating	   from	   the	   pentose-­‐phosphate	   pathway	   increases	  the	  number	  of	  isotopomers.	  	   	  
Figure	  6-­‐5:	  Altering	  the	  position	  of	  the	  label	  (from	  C1	  to	  C6)	  influences	  the	  size	  of	  the	  network.	  The	  
barplot	  in	  Panel	  A	  shows	  numbers	  of	  compounds	  (blue)	  and	  reactions	  (red)	  for	  different	  positions	  of	  
labelled	  carbon	  atom.	  The	  table	  in	  Panel	  B	  presents	  the	  number	  of	  isotopomers	  and	  reactions	  that	  
are	  produced	  over	  16	   iterations,	  for	  each	  of	  6	  atom-­‐mapped	  networks	  (i.e.	   for	  altered	   inputs	  from	  
C1	  to	  C6).	  Red	  cells	  (or	  alternatively	  green	  cells)	  in	  Panel	  B	  show	  that	  the	  corresponding	  property	  if	  
satisfied	  reduces	  (or	  increases)	  the	  network	  size	  by	  promoting	  (or	  impeding)	  the	  generation	  of	  new	  
















C1 C2 C3 C4 C5 C6
Number/of/compounds 67 237 225 151 273 258 196
Number/of/reactions 100 526 567 274 684 754 417
Generations 16 16 16 16 16 16 16
13C/in/Glycerol A no no no yes yes/ yes
PP/pathway/gives/labeled/pyruvate A no no no yes yes yes
label/goes/to/AcetylACoA A yes yes no yes yes yes
















Figure	   6-­‐6:	   Section	   of	   the	   atom-­‐mapped	   E.	   coli	   core	   metabolism	   is	   presented	   for	   single	   in	   silico	  
labelled	   carbon	   of	   glucose,	   changing	   from	  C1	   to	   C6.	   Red	   dots	   indicate	   the	   positions	   of	   13C	   arising	  
from	  the	  initial	  labelled	  glucose	  and	  conserved	  in	  the	  pathway.	  Varying	  the	  position	  of	  the	  labelled	  
carbon	  atom	  on	  glucose	  results	  in	  different	  citrate	  isotopomers,	  which	  are	  highlighted	  for	  each	  case.	  
Dotted	  lines	  represent	  the	  combination	  of	  several	  reactions	  steps	  that	  do	  not	  affect	  the	  position	  of	  
labelled	   carbon.	   The	   number	   on	   the	   bottom	   of	   each	   compound	   corresponds	   to	   its	   entry	   in	   the	  
generated	  network	  (graph	  node).	  	  
6.4 Conclusions	  	  In	   this	   study,	  we	   presented	   a	   novel,	   systematic	   approach	   capable	   of	   reproducing	   the	  known	  metabolic	  knowledge	  with	  an	  extra	  level	  of	  information	  -­‐	  the	  atom-­‐mapped	  data.	  We	  performed	  the	  atom	  mapping	  of	  biological	  reactions,	  pathways	  and	  networks	  using	  enzymatic	   reaction	   rules	   that	   reflect	   a	   biochemical	   reality,	   therefore	   chemical	   and	  biological	  validity	  of	  the	  reported	  atom-­‐mapped	  reactions	  are	  guaranteed.	  	  We	   demonstrated	   our	   results	   through	   the	   reconstruction	   of	   an	   atom-­‐level	  representation	   of	   the	   E.	   coli	   core	   metabolism	   and	   we	   elucidated	   the	   flow	   of	   single	  carbon	   atoms	   through	   the	   network	   starting	   from	   glucose	   as	   the	   carbon	   source.	  Furthermore,	  we	  analysed	  the	  generated	  atom-­‐mapped	  networks	  from	  different	  aspects	  such	  as	  the	  growth	  in	  number	  of	   isotopomers	  or	  the	  loss	  of	  the	  isotopic	  tracer	  to	  CO2.	  This	   information	  is	  very	  useful	   for	  optimizing	  the	  design	  of	  13C-­‐MFA	  experiments.	  The	  result	  of	  this	  study	  shows	  precisely	  which	  part	  of	  metabolism	  is	  contributing	  more	  for	  the	  production	  of	  biomass	  building	  blocks.	  Our	   focus	   in	   this	   study	   was	   on	   the	   analysis	   of	   carbon	   flow	   through	   the	   metabolic	  pathways,	  nevertheless	  similar	  studies	  exploring	  the	  metabolic	  fate	  of	  atoms	  other	  than	  carbon	   could	   reveal	   new	   insights	   into	   the	   internal	   organization	   of	   metabolism.	   The	  proposed	  method	  allows	  also	  reconstructing	   the	  atom-­‐mapped	  metabolic	  networks	   in	  an	  extended	  search	  space.	  This	  way,	  for	  example,	  we	  could	  consider	  all	  KEGG	  reactions	  for	   a	   reconstructed	   E.	   coli	   network	   and	   study	   how	   the	   integration	   of	   reactions	   non-­‐native	  to	  E.coli,	  but	  which	  exist	  in	  other	  organisms,	  would	  affect	  the	  carbon	  flow	  in	  the	  network.	   In	   addition,	   integrating	   novel	   pathways	   generated	   by	   the	   original	   BNICE.ch	  framework	   in	   the	   search	   space	   could	   further	   increase	   the	   potential	   of	   this	   type	   of	  studies.	  Such	  results	  may	  subsequently	  be	  used:	  (i)	  for	  applications	  in	  synthetic	  biology;	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Chapter	  ) 	  
THERMODYNAMICS	  of	  METABOLISM	  
How	  energetics	  constraint	  biochemistry?	  	  
	  
	  
SUMMARY	  In	   this	   chapter	  we	  present	  a	   coherent	  and	  unified	  developed	   framework	   for	   the	  estimation	  of	  thermodynamics	   of	   metabolism	   and	   the	   rationalization	   of	   feasibility	   analysis	   of	   metabolic	  pathways.	  This	  work	  is	  the	  first	  phase	  of	  an	  on	  going	  project	  on	  thermodynamics	  of	  metabolism	  using	  GCM	  methods	  coupled	  with	  the	  quantum	  thermochemical	  calculations.	  	  	  The	   lack	   of	   the	   available	   ab	   initio	   methods	   for	   the	   direct	   calculation	   of	   thermodynamic	  properties	   at	   aqueous	   solutions	   (which	   correspond	   to	   biological	   systems)	   limits	   their	  applications	   in	   biological	   studies.	   To	   address	   this	   limitation,	   our	   proposed	   pipeline	   first	  calculates	  the	  thermodynamic	  properties	  in	  the	  gas	  phase	  and	  the	  results	  of	  this	  study	  coupled	  with	   the	   corresponding	   hydration/solvation	   results	   (on	   going	   project	   based	   on	   this	   chapter)	  would	  result	  in	  the	  desired	  thermochemical	  quantities	  in	  aqueous	  solutions.	  In	   this	   chapter	   we	   introduce	   our	   methods	   and	   present	   our	   results	   for	   the	   estimation	   of	  thermodynamic	   properties	   for	   a	   wide	   range	   of	   metabolites.	   Furthermore,	   we	   compare	   our	  calculations	   with	   reliable	   experimental	   measurements	   and	   predictive	   calculations	   from	   the	  literature,	  when	  available.	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7.1 Introduction	  Intrinsic	  properties	  of	  metabolites	  from	  gas-­‐phase	  quantum	  chemical	  calculations	  form	  the	  basis	  for	  understanding	  their	  behaviour	  in	  more	  complex	  systems	  such	  as	  proteins,	  nucleic	  acids	  and	  polysaccharides.	  Remarkable	  progress	  is	  made	  for	  small	  to	  moderate-­‐sized	   compounds	   with	   up	   to	   ten	   non-­‐hydrogen	   atoms.	   However,	   the	   biochemical	  compounds	   in	  metabolic	  pathways	  such	  as	  aminoacids	  and	  oligopeptides,	  saccharides,	  nucleosides	  and	  their	  derivatives,	  often	  exceed	  this	  molecular	  size	  limit.	  For	  the	  heavier	  metabolites,	   we	   further	   need	   computational	   information	   since	   reliable	   experimental	  information	  for	  them	  is	  rather	  limited	  and	  often	  non-­‐existing.	  Most	  of	  the	  compounds	  of	  interest	   in	   this	   work	   are	   solid	   /	   crystalline	   at	   ambient	   conditions	   with	   high	   melting	  points	   and	   very	   low	   vapour	   pressures	   and,	   thus,	   are	   elusive	   to	   direct	   gas-­‐phase	  measurements.	  	  Most	  often,	  the	  standard	  heat	  of	  formation	  of	  these	  compounds	  in	  the	  gaseous	  state	  are	  obtained	   by	   combining	   the	   heats	   of	   formation	   in	   the	   pure	   solid	   state	   (typically,	   from	  heats	   of	   combustion)	   and	   the	   heat	   of	   sublimation	   (typically,	   by	   extrapolation	   from	  values	   obtained	   at	   significantly	   higher	   temperatures	   –	   if	   the	   compounds	   are	   not	  decomposed).	   Both	   of	   these	   typical	   experimental	   measurements,	   however,	   require	  extreme	  care	  as	  they	  are	  prone	  to	  significant	  experimental	  errors	  [197].	  Therefore,	  for	  many	  of	  the	  heavy	  metabolites	  described	  above,	  the	  basic	  thermochemical	  quantities	  in	  the	   ideal	   gas	   state	   still	   resist	   an	   experimental	   determination	   with	   the	   acceptable	  “chemical	  accuracy”	  of	  1	  kcal/mol.	  Attempts	   to	  develop	  predictive	  group	  contribution	  methods	  based	  on	  experimental	  results	  for	  smaller	  molecules	  [198,199]	  are	  not	  always	  successful	   for	   the	   above	   types	   of	   metabolites	   and	   require	   significant	   improvements	  [200].	   Thus,	   today	   there	   is	   much	   interest	   in	   accurate	   theoretical	   calculations	   of	  thermodynamic	  quantities	  of	  these	  metabolites.	  	  	  Moreover,	  most	  of	  the	  thermodynamic	  studies	  in	  the	  literature	  are	  confined	  to	  ambient	  conditions.	   Their	   extension	   to	   remote	   temperatures	   and	   pressures	   requires	   accurate	  knowledge	   of	   additional	   properties	   relevant	   to	   the	   interaction	   of	   the	   studied	  metabolites	  with	   their	   neighbouring	  molecules.	  Heat	   capacities,	   thermal	   expansivities	  and	  isothermal	  compressibilities	  are	  among	  the	  properties	  that	  must	  be	  known	  for	  such	  an	   extension.	   In	   addition,	   the	   effect	   of	   external	   conditions	   on	   solvation	   phenomena,	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primarily	  hydration	  phenomena,	   is	   of	   key	   importance	   in	   the	   evolution	  of	   biochemical	  reactions	   and	   processes	   at	   remote	   conditions.	   This	   includes	   metabolite	   dissociation,	  ligand-­‐binding,	   protein	   folding,	   and	   ion	   distributions.	   In	   this	   regard,	   molecular	  thermodynamics,	  which	  combines	  quantum	  chemical	  calculations	  with	  classical	  mixture	  thermodynamics	   and	   equation-­‐of-­‐state	   approaches	   for	   extrapolation	   to	   high	  temperatures	   and	   pressures,	   can	   be	   used	   for	   understanding	   the	   metabolism	   of	  microorganisms,	   not	   only	   at	   ambient	   conditions	   but	   also	   at	   extreme	   conditions	   of	  temperature	  and	  pressure	  [201-­‐210].	  In	   this	   chapter,	  we	   introduce	  our	  cohesive	  approach	   for	   the	  reliable	  estimation	  of	   the	  basic	   thermochemical	   quantities	   of	   metabolites,	   biomolecules	   and	   associated	  biochemical	   reactions	   over	   an	   extended	   range	   of	   external	   conditions	   of	   temperature	  and	   pressure.	   As	   for	   the	   results,	   we	   focus	   on	   quantum	   chemical	   calculations	   of	  enthalpies	   and	   free	   energies	   of	   formation	   in	   gas	   phase	   via	   isodesmic	   reactions	   of	   key	  metabolites,	   such	   as	   aminoacids/oligopeptides,	   oligosaccharides,	   and	   nucleotides	  /nucleosides,	   for	  which	   experimental	   information	   is	   difficult	   to	   obtain.	   	   The	   obtained	  quantum	  chemical	  calculations	  complement	  the	  available	  thermochemical	  compilations	  and	  form	  the	  basis	  for	  the	  expansion	  and	  testing	  of	  subsequent	  developments.	  	  
7.2 Methods	  
7.2.1 Accounting	  for	  conformers,	  anomers	  and	  tautomers	  In	  figure	  7.1,	  we	  compared	  the	  most	  stable	  structures	  obtained	  for	  methionine,	  glutamic	  acid	   and	   valine	   with	   the	   corresponding	   structures	   proposed	   in	   [157],	   and	   the	   most	  stable	  structure	  for	  open	  chain	  glucose	  with	  the	  corresponding	  structures	  proposed	  in	  [211].	  The	  differences	   in	  the	  calculations	  are	  not	  significant	   in	  the	  case	  of	  aminoacids.	  What	  is	  worth	  pointing	  out	  is	  the	  different	  stabilizing	  factors	  in	  the	  two	  cases.	  As	  is	  clear	  from	  the	  figure,	  the	  second	  row	  structures	  (this	  work)	  exhibit	  intramolecular	  hydrogen	  bonding	  that	   includes	   the	  relatively	  strong	  OH-­‐-­‐-­‐	  NH	  bond.	   In	  contrast,	   the	  upper	  row	  structures	   do	   not	   exhibit	   such	   intramolecular	   hydrogen	   bonds	   and	   appear	   as	   less	  compact	  structures.	  Based	  on	  these	  properties	  we	  expect	  that	  the	  upper	  row	  structures	  prevail	   at	   higher	   temperatures	  while	   the	   lower	   row	   structures	   be	   dominant	   at	   lower	  temperatures.	   In	   the	   case	   of	   glucose	   chains,	   we	   observe	   that	   both	   structures	   are	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stabilized	   by	   four	   intramolecular	   hydrogen	   bonds	   of	   the	   same	   OH-­‐-­‐-­‐	   O	   type	   and	   the	  difference	   in	   the	  calculations	   is	  not	  negligible.	  The	  right	  structure	  (this	  work)	   is	  more	  stable	  by	  ca.	  9	  kJ/mol.	  The	  reason	   for	   this	  difference	  resides	  on	   the	  more	  cooperative	  character	   of	   hydrogen	   bonding	   in	   the	   right	   structure	   (four	   vs.	   three	   consecutive	  hydrogen	  bonds)[212]	  and	  the	  relatively	  open	  structure	  (free	  terminal	  OH).	  	  	  
A	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  B	  








	   	  
Figure	   7-­‐1:	  A:	   Comparison	   of	  most	   stable	   structures	   for	  methionine,	   glutamic	   acid	   and	   valine	  with	   the	   corresponding	   structures	  proposed	  by	  Stover	  et	   al.[157].	  B:	   Comparison	  of	   the	  most	  stable	  structure	  of	  glucose	  chain	  with	  the	  corresponding	  literature	  structure[211].	  From	   the	   thermodynamic	   point	   of	   view,	   the	   pertaining	   value	   for	   the	  metabolite	   is	   an	  
average	   over	   the	   conformer	   population	   considered	   coexisting	   at	   equilibrium.	   This	  averaging	  is	  done	  by	  adopting	  the	  classical	  Boltzmann	  distribution	  equation	  [213]:	  	  










fraction	   at	   equilibrium,	   and	   similarly	   for	   the	   Gibbs	   free	   energy	   of	   formation.	   Using	  equation	  (8.1),	  we	  observe	  that	  this	  contribution	  falls	  rapidly	  as	  the	  conformer’s	  Gibbs	  free	  energy	  of	   formation	  departs	  from	  its	   lowest	  value	  in	  the	  conformer	  set,	  or,	  as	  the	  relative	   Gibbs	   free	   energy	   of	   formation	   departs	   from	   zero	   (Figure	   7.2).	   Note	   that	   the	  relative	   Gibbs	   free	   energy	   corresponds	   to	   the	   difference	   of	   Gibbs	   free	   energy	   of	  formation	   of	   conformer	   i	   from	   the	   corresponding	   quantity	   of	   the	   global	  minimum	   or	  most	  stable	  conformer,	  i.e.	  	  𝛥∆!𝐺! = 𝛥!𝐺! − 𝛥!𝐺!"#	  	   	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  (7.2)	  	  Thus,	  although	  the	  heat	  of	  formation	  of	  some	  conformers	  may	  depart	  by	  as	  much	  as	  30	  kJ/mol	   from	   the	   corresponding	   lowest	   value,	   the	   so-­‐calculated	   average	   heat	   of	  formation	  differs	  by	  less	  than	  4.0	  kJ/mol	  from	  the	  lowest	  conformer’s	  value.	  	  	  The	  above	  conformer	  distribution	  analysis	  is	  valid	  as	  long	  as	  the	  conformer	  population	  is	  known	  sufficiently	  well.	  Omitting	  conformers	  near	   the	  global	  minimum	  may	   lead	  to	  significant	   errors.	   However,	   omitting	   all	   conformers	   above	   the	   usual	   cut-­‐off	   of	   1	  kcal/mol	   in	  relative	  Gibbs	  free	  energy	  may	  also	   introduce	  a	  non-­‐negligible	  error	  since	  the	  omitted	  conformers	  may	  be	  numerous.	  Another	  source	  of	  error	  is	  the	  fact	  that	  Gibbs	  free	   energies	   of	   formation	   are	   not	   usually	   known	  with	   high	   precision	   and	   the	   above	  averaging	  is	  then	  done	  with	  the	  overall	  energy.	  	  
 
Figure	   7-­‐2:	   The	   mole	   fraction	   of	   conformers	   at	   equilibrium	   as	   a	   function	   of	   the	   corresponding	  
relative	  Gibbs	  free	  energy	  of	  formation	  for	  aspartic	  acid.	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  In	   the	   case	   of	   conformers	  with	   extensive	   intramolecular	   hydrogen	   bonding,	   which	   is	  often	  the	  case	  with	  heavy	  metabolites,	  this	  error	  may	  not	  be	  negligible	  either.	  The	   situation	  may	   be	   different	   in	   the	   case	   of	   tautomers.	   As	   figure	   7.3	   shows,	   for	   the	  calculation	   of	   the	   thermochemical	   quantities	   for	   inosine,	   as	   an	   example,	  we	   need	   the	  corresponding	  quantities	  for	  hypoxanthine.	  Hypoxanthine	  may	  be	  found	  in	  7	  tautomeric	  forms	  including	  the	  enol	  form	  of	  6-­‐hydroxypurine.	  	  	  
NH1	   NH2	  






Figure	  7-­‐3:	  The	  tautomers	  of	  hypoxanthine	  	  	  These	  structures	  correspond	  to	  a	  well-­‐known	  isomer	  population	  for	  which	  equation	  (1)	  may	   be	   applied	   unequivocally.	   One	  may	   argue	   that	   some	   of	   these	   tautomers	   are	   not	  relevant	   since	   the	   ribose	   group	   occupies	   one	   site	   in	   inosine.	   However,	   regarding	  hypoxanthine	   itself,	   its	   average	   thermochemical	   quantities	   may	   still	   be	   obtained	   by	  applying	   equation	   (1),	   leading	   to	   a	   value	   of	   just	   0.4	   kJ/mol	   higher	   than	   the	   heat	   of	  formation	  of	  the	  most	  stable	  conformer,	  NH4.	  The	  situation	  in	  tautomers	  of	  nucleosides	  or	   histidine	   is	   different	   since	   some	   of	   them	   may	   be	   favored	   (stabilized)	   by	   strong	  intramolecular	   hydrogen	   bonds.	   The	   averaging	   results	   for	   guanine	   and	   cytosine	   are	  similar.	  Although	  one	  may	  infer	  from	  this	  discussion	  that	  the	  thermochemical	  quantities	  of	  the	  most	  stable	  tautomer	  are	  good	  approximations	  for	  the	  corresponding	  quantities	  for	  the	  metabolite,	   the	  knowledge	  of	  these	  quantities	  for	  the	   less	  stable	  tautomers	  are	  also	  important.	  	  The	  case	  of	  sugar	  anomers	  with	  open	  and	  cyclic	  structures	  is	  again	  different.	  The	  results	  through	   detailed	   sugar	   puckering	   analyses[211,214]	   show	   that	   particular	   puckering	  geometries	   may	   be	   favoured	   in	   various	   glycobiology	   processes	   over	   the	   usual	   low	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energy	   equatorial	   4C1	   conformation	   and,	   thus,	   a	   detailed	   knowledge	   of	   the	   puckering	  landscape	  is	  crucial	  for	  understanding	  these	  processes.	  Thus,	   it	   makes	   more	   sense	   to	   focus	   on	   the	   thermochemical	   quantities	   of	   the	   global	  minimum	   in	   each	   class	   of	   structures	   (open	   chain,	   furanoses,	   pyranoses)	   and	   use	   the	  above	   puckering	   analyses	   for	   the	   averaging	   via	   equation	   (8.1).	   However,	   considering	  the	  reported	  range	  and	  the	  distribution	  of	  enthalpy	  differences	  in	  the	  above	  puckering	  analyses,	   it	   is	   clear	   that	   the	   thermochemical	   quantities	   of	   sugars	   do	   not	   deviate	  significantly	  from	  the	  corresponding	  quantities	  of	  the	  global	  minimum	  in	  each	  case.	  	  	  
7.2.2 Selection	  of	  isodesmic	  reactions	  for	  calculation	  of	  heats	  and	  Gibbs	  free-­‐energies	  of	  




Glycerol	  –	  conformer	  #1	  
	  	  	  	  
	  
	  
Glycerol	  –	  conformer	  #2	  
	  
Ethylene	  glycol	  –	  conformer	  #1	  
	  	  	  
Ethylene	  glycol	  -­‐	  conformer	  #2	  
Figure	   7-­‐4:	   Conformers	   of	   glycerol	   and	   ethylene	   glycol	  with	   and	  without	   intramolecular	   hydrogen	  




Table 7-1:	   The	   predicted	   thermochemical	   quantities	   for	   glycerol	   based	   on	   quantum	   chemical	  calculations	  at	  the	  DFT-­‐D3/B3LYP/def2-­‐TZVPD	  level.	  	  	  
Table	  7-­‐2:	  The	  isodesmic	  reactions	  for	  neutral	  metabolites	  
Metabolite	   Isodesmic	  Reaction	  
Aminoacids	  /	  dipeptides	  
H2NCHRCOOH	   H2NCHRCOOH	  (Gly)	  +	  CH3R	  =>	  H2NCHRCOOH	  +	  CH4	  	  
Arginine	  (Arg)	   Gly+guanidine+butylamine	  =>	  Arg	  +	  CH4	  +	  NH3	  
Histidine	  (His)	   Gly+imidazole+propane	  =>	  His+2	  CH4	  
Proline	  (Pro)	   pyrrolidine+acetic	  acid	  =>	  Pro+	  CH4	  
Tryptophan	  (Try)	   Gly+indol+propane	  =>	  Try+2	  CH4	  
Alanylalanine	  (AlaAla)	   2Ala	  +CH3NH2	  =>	  AlaAla	  +	  CH3OH	  +	  NH3	  
Alanylglycine	  (AlaGly)	   Ala	  +	  Gly	  +	  CH3NH2	  =>	  AlaGly	  +	  CH3OH	  +	  NH3	  
Alanylphenylalanine	  (AlaPhe)	   Ala	  +	  Phe	  +	  CH3NH2	  =>	  AlaPhe	  +	  CH3OH	  +	  NH3	  
Glycylglycine(GlyGly)	   2Gly	  +	  CH3NH2	  =>	  GlyGly	  +	  CH3OH	  +	  NH3	  
Glycerol	  
conformer	  
Heat	   of	   reaction	  
(kJ/mol)	  
Heat	   of	   formation	  
(kJ/mol)	  
Free	  energy	  of	  formation	  (kJ/mol)	  
Predicted	   Experim.	   Predicted	   Experim.	  
Isodesmic	  reaction	  A	  
#1	   -­‐62.0	   -­‐583.7	   -­‐577.91,	   -­‐
582.82	  
-­‐445.8	   -­‐4482	  
#2	   -­‐48.5	   -­‐570.0	   	   -­‐435.6	   	  
Isodesmic	  reaction	  B,	  ethylene	  glycol	  conformer	  #1	  
#1	   -­‐4.9	   -­‐582.6	   -­‐577.91,	   -­‐
582.82	  
-­‐446.0	   -­‐4482	  
#2	   +8.7	   -­‐569.1	   	   -­‐435.7	   	  
Isodesmic	  reaction	  B,	  ethylene	  glycol	  conformer	  #2	  
#1	   -­‐22.9	   -­‐617.7	   -­‐577.91,	   -­‐
582.82	  
-­‐462.3	   -­‐4482	  
#2	   -­‐9.3	   -­‐604.1	   	   -­‐452.0	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Phenylalanylglycine	  (PheGly)	   Gly	  +	  Phe	  +	  CH3NH2	  =>	  PheGly	  +	  CH3OH	  +	  NH3	  
Glycylvaline	  (GlyVal)	   Gly	  +	  Val	  +	  CH3NH2	  =>	  GlyVal	  +	  CH3OH	  +	  NH3	  
Leucylglycine	  (LeuGly)	   Leu	  +	  Gly	  +	  CH3NH2	  =>	  LeuGly	  +	  CH3OH	  +	  NH3	  
Saccharides	  
αD-­‐Glucose	  (αDGl)	   3HOCH2CH2OH+tetrahydropyran(THP)	  =>	  αDGl	  +	  CH3OH	  +	  2C2H6	  	  	  
βD-­‐Glucose	  (βDGl)	   3HOCH2CH2OH	  +	  THP	  =>	  βDGl	  +	  CH3OH	  +	  2C2H6	  	  	  
Glucose	  –	  chain	  (GlCh)	   3HOCH2CH2OH	  +	  C2H6	  +	  CH3CHO	  =>	  GlCh	  +	  CH3OH	  +	  3CH4	  	  	  
2-­‐deoxy-­‐D-­‐Glucose	  (2-­‐deGl)	   2HOCH2CH2OH	  +	  THP	  =>	  2-­‐deGl	  +	  CH4	  +	  C2H6	  
βD	  –Galactose	  (βDGal)	   3HOCH2CH2OH	  +	  THP	  =>	  βDGal	  +	  CH3OH	  +	  2C2H6	  	  	  
βD	  –Mannose	  (βDMan)	   3HOCH2CH2OH	  +	  THP	  =>	  βDMan	  +	  CH3OH	  +	  2C2H6	  	  	  
βD	  –Ribose	  (βDRib)	   2HOCH2CH2OH	  +	  THF	  =>	  βDRib	  +	  CH4	  +	  C2H6	  
αD-­‐Ribofuranose	  (αDRib)	   2HOCH2CH2OH	  +	  THF	  =>	  αDRib	  +	  CH4	  +	  C2H6	  
2–deoxyD-­‐ribose(2-­‐deRib)	   2HOCH2CH2OH	  +	  THF	  =>	  2-­‐deRib	  +	  CH3OH	  +	  C2H6	  	  	  
Fructose-­‐chain	  (FrCh)	   3HOCH2CH2OH	  +	  CH3COCH3	  =>	  FrCh	  +	  CH3OH	  +	  2CH4	  	  	  
βD-­‐Fructopyranose	  (βDFrp)	   3HOCH2CH2OH	  +	  THP	  =>	  βDFrp	  +	  CH3OH	  +	  2C2H6	  	  	  
βD-­‐Fructofuranose	  (βDFr)	   3HOCH2CH2OH	  +	  THF	  =>	  βDFr	  +	  CH3CH2OH	  +	  2CH4	  	  	  
βD–Xylofuranose	  (βDXyf)	   3HOCH2CH2OH	  +	  THF	  =>	  βDXyf	  +	  CH3CH2OH	  +	  CH3OH	  +	  C2H6	  	  	  
βD–Xylopyranose	  (βDXyp)	   2HOCH2CH2OH	  +	  THP	  =>	  βDXyp	  +	  2	  C2H6	  	  	  
αD–Xylopyranose	  (αDXyp)	   2HOCH2CH2OH	  +	  THP	  =>	  αDXyp	  +	  2	  C2H6	  	  	  
Sucrose	  	   βDGl	  +	  βDFr	  	  	  +	  CH3COCH3	  =>	  Sucrose	  +	  2	  CH3OH	  
Maltose	  	   2βDGl	  	  +	  CH3COCH3	  =>	  Maltose	  +	  2	  CH3OH	  
Nucleobases/Nucleosides	  
6-­‐Hydroxypurine	   Adenine	  +	  CH3OH	  =>	  6-­‐Hydroxypurine	  +	  CH3NH2	  
Adenosine	   Adenine	  +	  βDRib	  +	  CH3NH2	  =>	  Adenosine	  +	  CH3OH	  +	  NH3	  
2-­‐Deoxyadenosine	   Adenine	   +	   2-­‐deRib	   +	   CH3NH2	   =>	   2-­‐Deoxyadenosine	   +	   CH3OH	   +	  
NH3	  
2,3-­‐Dideoxyadenosine	   Adenosine	  +	  2	  CH4	  =>	  2,3-­‐Dideoxyadenosine	  +	  2	  CH3OH	  
Inosine	   Hypoxanthine	  +	  βDRib	  +	  CH3NH2	  =>	  Inosine	  +	  CH3OH	  +	  NH3	  
Guanosine	   Guanine	  +	  βDRib	  +	  CH3NH2	  =>	  Guanosine	  +	  CH3OH	  +	  NH3	  
Cytidine	  	   Cytosine	  +	  βDRib	  +	  CH3NH2	  =>	  Cytidine	  +	  CH3OH	  +	  NH3	  
Thymidine	   Thymine	  +	  βDRib	  +	  CH3NH2+	  CH4	  =>	  Thymidine	  +	  2CH3OH	  +	  NH3	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Deoxythymidine	   Thymine	  +	  THF+	  CH3NH2+	  CH3CH2OH	  =>	  Deoxythymidine	  +	  2CH4	  
+	  NH3	  
Uridine	  	   Uracil+	  βDRib	  +	  CH3NH2	  =>	  Uridine	  +	  CH3OH	  +	  NH3	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7.2.3 Thermochemical	  calculations	  for	  neutral	  metabolites	  We	  calculated	  the	  heats	  and	  Gibbs	  free	  energies	  of	  the	  isodesmic	  reactions	  (Table	  7.2)	  at	  298.15	  K	  and	  ambient	  pressure.	  We	  added	  ZPE	  (zero	  point	  vibrational	  energy)	  to	  SPE	  together	  with	  the	  thermal	  corrections	  for	  the	  enthalpy	  or	  the	  Gibbs	  free	  energy	  for	  each	  reactant	  or	  product.	  This	  results	  in	  their	  total	  enthalpy,	  H0,	  and	  Gibbs	  free	  energy,	  G0:	  	  H0	  	  =	  SPE	  +	  αZPE	  +	  Hv	   	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  (7.3)	  and	  G0	  	  =	  SPE	  +	  αZPE	  +	  Gv	   	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  (7.4)	  	  The	  scaling	  factor,	  α,	  has	  values	  close	  to	  1.	  In	  this	  work	  it	  was	  set	  equal	  to	  0.975.	  	  The	  heat	  of	  a	  reaction:	   ν1	  R1	  +	  ν2	  R2	  	  =>	  ν3	  R3+	  ν4	  R4	  can	  	  then	  be	  obtained	  in	  the	  usual	  manner	  as	  ΔrH0	  =	  ν3	  H03	  +	  ν4	  H04	  -­‐	  ν1	  H01	  +	  ν2	  H02	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  (7.5)	  A	  similar	  approach	  can	  be	  used	  for	  the	  free	  energy	  of	  the	  same	  reaction,	  ΔrG0.	  We	  can	  also	  derive	  the	  same	  result	  from	  the	  heats	  of	  formations	  of	  reactants	  and	  products,	  or:	  ΔrH0	  =	  ν3	  ΔfH03	  	  	  +	  ν4	  ΔfH04	  -­‐	  ν1	  ΔfH01	  +	  ν2	  ΔfH02	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  (7.6)	  and	  similarly	  for	  ΔrG0.	  Calculation	  of	  the	  standard	  heats	  and	  free	  energies	  of	  formation	  of	  a	  metabolite	  requires	  accurate	  knowledge	  of	   the	   corresponding	  properties	   for	   all	   reactants	   and	  products	  of	  the	  isodesmic	  reaction.	  By	  replacing	  the	  known	  quantities	  we	  can	  use	  equation	  (7.6)	  in	  order	   to	   obtain	   the	   unknown	   heat	   of	   formation	   	   (similarly	   the	   unknown	   Gibbs	   free	  energy	  of	  formation)	  of	  the	  studied	  metabolite.	  The	  existing	  compilations[147-­‐149,215]	  provide	  reliable	  data	  for	  these	  computations,	  which	  are	  summarized	  in	  Appendix	  Table	  A3	  for	  the	  compounds	  that	  participate	  in	  our	  isodesmic	  reactions.	  
7.2.4 Thermochemical	  calculations	  for	  ionic	  metabolites	  Gas	  phase	  acidities,	  gas	  phase	  basicities	   (GB)	  and	  proton	  affinities	   (PA)	  are	   important	  elements	  for	  understanding	  the	  acid-­‐base	  behavior	  of	  heavy	  metabolites	  not	  only	  in	  the	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gas	  phase	  but	  also	   in	  aqueous	  solutions	  and	  numerous	  biological	  processes	  [216,217].	  The	   extensive	   experimental	   and	   theoretical	   research	   over	   several	   decades	   has	   led	   to	  reliable	   compilations	   of	   the	   above	   properties,	   especially	   for	   aminoacids	  [150,152,153,157,158].	  For	  this	  case,	  one	  can	  use	  these	  experimental	  data	  to	  estimate	  heats	  and	  free	  energies	  of	  formation	  of	  protonated	  and	  deprotonated	  aminoacids	  if	  the	  corresponding	  quantities	   for	   the	  neutral	   species	  are	  available.	  On	   the	  other	  hand,	  one	  can	   perform	   the	   same	   level	   of	   quantum	   thermochemical	   calculations	   as	   described	   in	  section	   8.2.1,	   and	   use	   appropriate	   isodesmic	   reactions	   in	   order	   to	   estimate	   the	  thermochemical	  quantities	  of	  the	  ionic	  metabolites.	  We	  have	  followed	  both	  approaches	  and	  we	  compare	  the	  results	  in	  the	  next	  section.	  In	  order	  to	  clarify	  the	  computations,	  we	  first	  recall	  the	  definitions	  of	  gas	  phase	  acidity,	  GB,	  and	  proton	  affinity,	  PA.	  	  	  Let	  reaction	  C	  be	  the	  protonation	  reaction	  of	  metabolite	  M	  :	  M	  (g)	  +	  H+	  (g)	  =>	  MH+	  (g)	   	   	   	   	   	   	   	   	   (C)	  and	  reaction	  D	  the	  deprotonation	  reaction	  for	  the	  same	  metabolite:	  M	  (g)	  =>	  [M-­‐H]-­‐	  (g)	  +	  H+	  (g)	   	   	   	   	   	   	   	   	   (D)	  The	  gas-­‐phase	  basicity	  of	  metabolite	  M	   is	   equal	   to	   the	  negative	  of	   the	   standard	  Gibbs	  free	  energy	  change	  of	  reaction	  C,	  i.e.,	  GB	  (M)	  =	  -­‐ΔrG0C’	   	   	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  (7.7)	  and	   its	  proton	  affinity	   is	  equal	   to	   the	  negative	  of	   the	  standard	  enthalpy	  change	  of	   the	  same	  reaction	  C,	  i.e.,	  PA	  (M)	  =	  -­‐ΔrH0C	   	   	  	  	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  (7.8)	  The	  standard	  Gibbs	  free	  energy	  change	  of	  the	  deprotonation	  reaction	  D	  is	  the	  gas-­‐phase	  acidity	  of	  metabolite	  M,	  i.e.,	  ΔGacid	  (M)	  =	  ΔrG0D	   	   	   	   	   	  	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  (7.9)	  and	  similarly	  for	  the	  enthalpy:	  ΔHacid	  (M)	  =	  ΔrH0D	   	   	   	   	  	   	   	   	   	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  (7.10)	  	  Calculations	   of	   gas	   phase	   acidities	   of	   aminoacids	   are	   typically	   done	   via	   the	   isodesmic	  reaction	  E	  	  Aminoacid	  +	  CH3COO-­‐	  =>	  [Aminoacid	  –H]-­‐	  +	  CH3COOH	   	  	  	  	  	  	  	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  (E)	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  and	   by	   anchoring	   the	   calculations	   to	   the	   known	   gas	   phase	   acidity	   for	   acetic	   acid	  [152,156,159].	  Alternatively,	   one	  may	  use	  benzoic	  acid	   in	   the	   isodesmic	   reaction	  E	  or	  even	  glycine	  as	  there	  exist	  consensus	  values	  for	  it	  [152],	  namely	  ΔGacid	  (Gly)	  =	  1403.5	  ±	  1.5	  kJ/mol	  and	  ΔHacid	  (Gly)	  =	  1433.5	  ±	  1.5	  kJ/mol.	  	  Our	   calculations	   for	  ΔGacid	  and	  ΔHacid	   for	  glycine	   (1404.1	  and	  1434.4,	   respectively)	   fall	  within	   the	   consensus	   range	   and	  were	  used	  as	   a	  basis	   for	   the	   calculation	  of	   heats	   and	  free	  energies	  of	  formation	  of	  our	  deprotonated	  metabolites.	  For	  this	  purpose,	  however,	  we	  also	  need	  values	  for	  the	  heat	  and	  free	  energy	  of	  formation	  of	  deprotonated	  glycine	  itself.	  	  These	  quantities	  require	  the	  knowledge	  of	  corresponding	  values	  for	  proton	  (H+)	  or	   any	   other	   cation.	   The	   adopted	   standard	   thermochemical	   values	   for	   proton	   in	   this	  work,	  ΔfG0(g,	  H+)	  =	  1513	  kJ/mol	  and	  ΔfH0(g,	  H+)	  =	  1533	  kJ/mol,	  	  were	  recommended	  by	  Truhlar	  et	  al	  [218]	  and	  were	  obtained	  by	  using	  the	  electron	  convention	  and	  the	  Fermi-­‐Dirac	   statistics	   (not	   the	   Boltzmann	   statistics).	   Thus,	   the	   heat	   of	   formation	   of	  deprotonated	  glycine	  (cf.	  reaction	  D)	  is:	  	  ΔfH	  (glycine-­‐,	  g)	  =	  ΔHacid	  (Gly)	  -­‐	  ΔfH0(g,	  H+)	  +	  ΔfH	  (glycine,	  g)	  	  =	  -­‐491	  kJ/mol	  and,	   similarly,	   ΔfG	   (glycine-­‐,	   g)	   =	   -­‐409	   kJ/mol.	   The	   thermochemical	   quantities	   of	   all	  other	   aminoacids	   can	   be	   obtained	   either	   directly	   as	   with	   glycine	   or	   through	   the	  isodesmic	  reaction	  Aminoacid	  +	  glycine-­‐	  =>	  [Aminoacid	  –	  H]-­‐	  +	  glycine	   	  	  	  	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (F)	  We	  further	  obtain	  the	  thermochemical	  quantities	  for	  the	  protonated	  metabolites	  in	  the	  same	  way.	  
7.3 Results	  and	  discussion	  
7.3.1 Thermochemical	  properties	  of	  neutral	  metabolites	  in	  ideal	  gas	  phase	  We	   calculated	   the	   gas-­‐phase	   standard	   heats	   and	   Gibbs	   free	   energies	   of	   formation	   of	  neutral	  metabolites	  and	  compared	  our	  estimations	  with	  available	  literature	  data,	  both,	  experimental	  and	  computational	  (Table	  7.3).	  In	  general,	  our	  calculations	  for	  aminoacids	  fall	  within	   the	   range	   of	   literature	   values.	   They	   are	   also	   in	   agreement	  with	   the	   recent	  calculations	  by	  Stover	  et	  al	  [157].	  On	  average,	  the	  discrepancy	  between	  the	  two	  sets	  of	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calculations	   via	   isodesmic	   reactions	   is	   less	   than	   1	   kcal/mol.	   Our	   calculations	   are	   on	  average	   more	   negative,	   most	   probably	   due	   to	   the	   fact	   that	   our	   reference	   value	   for	  glycine	  (-­‐391.7	  kJ/mol),	  which	  seems	  to	  be	  more	  widely	  accepted	  [148,200,219,220],	  	  is	  lower	  than	  the	  value	  adopted	  by	  Stover	  et	  al	  [157]	  by	  almost	  7	  kJ/mol.	  Considering	  this	  different	  reference	  value,	  the	  two	  sets	  of	  calculations	  are	  well	  in	  accordance.	  However,	  our	  calculations	  still	  remain	  on	  average	  more	  negative	  than	  their	  G3-­‐MP2	  calculations.	  Stover	  et	  al.	  do	  not	  report	  Gibbs	  free	  energies	  of	  formation	  for	  comparison.	  Due	  to	  these	  discrepancies	  caused	  by	  the	  differences	  in	  the	  adopted	  reference	  values,	  we	  also	  report	  in	  Table	  7.3	  the	  heats	  and	  free	  energies	  of	  the	  isodesmic	  reactions	  that	  are	  not	  affected	  by	  such	  reference	  values.	  	  
Table	   7-­‐3:	   Estimated	  standard	   thermochemical	  properties	   (ideal	  gas	  phase)	  of	  neutral	  metabolites	  
from	   isodesmic	   reactions	   (Table	   7.2).	   Geometry	   optimization	   and	   frequency	   calculations	   at	   DFT-­‐
D3/B3LYP/def2-­‐TZPV(D)	   level	   and	   energy	   (SPE)	   calculations	   at	   DFT-­‐D3/B97-­‐d/def2-­‐QZPVD	   level.	  
Values	  in	  parentheses	  were	  calculated	  at	  the	  same	  geometry	  but	  with	  SPEs	  at	  the	  DFT/ωB97X-­‐d/6-­‐
311++G(2df,2p)	  level.	  All	  quantities	  are	  given	  in	  kJmol-­‐1.	  
	  
Metabolite	  
ΔrG	   ΔfG	   ΔrH	   ΔfH	  
estimated	   literature	  
Aminoacids	  	  
Alanine	  	   -­‐16.4	   -­‐298.0	  
(-­‐298.0)	  
-­‐21.0	   -­‐421.9	  
(-­‐422.0)	  
-­‐415.9a	   ,	   -­‐421.3a	   	   	   -­‐
414.7g,	   -­‐435.5c,	   	   	   -­‐
415.9h,	  -­‐419.4b	  
Arginine	  	   -­‐42.0	   -­‐129.9	   -­‐63.4	   -­‐398.9	   -­‐389.1a	   ,-­‐395.8a,	   -­‐
380.6b	  
Asparagine	  	   -­‐10.8	   -­‐411.4	  
(-­‐409.0)	  
-­‐35.9	   -­‐612.0	  
(-­‐610.0)	  
-­‐591.8a	   ,	   -­‐610a,	   	   	   	   	   -­‐
593.8b	   	   -­‐609.1c,	   	   	   	   -­‐
590.5h	  
Aspartic	  acid	  	   -­‐5.5	   -­‐621.8	  
(-­‐622.7)	  
-­‐19.6	   -­‐790.2	  
(-­‐791.1)	  
-­‐786.6a	   ,-­‐793.3a,	   	   -­‐
804.4c,	  	  -­‐786.7h,	  	   	   	  -­‐
787.8b	  
Cysteine	  	   -­‐18.3	   -­‐272.8	   -­‐33.3	   -­‐396.5	   -­‐378.2a,	   -­‐395a,	   	   	   	   	   -­‐
378.1h,	   	   	   	   	   	   	   	   	   	   	   	   	   -­‐
382.6n,	  	  	  -­‐	  397.1n	  
Glutamic	  acid	  	   -­‐21.4	   -­‐631.0	  
(-­‐633.6)	  
-­‐26.1	   -­‐819.0	  
(-­‐821.7)	  
-­‐807a	  ,	  -­‐815.9a,	  	  	  	  	  	  -­‐
825.0c,	   -­‐807.4h,	   	   	   -­‐
810.7b	  
Glutamine	  	   -­‐14.1	   -­‐395.8	   -­‐26.9	   -­‐626.0	   -­‐629.7c,	   -­‐621.7a	   	   	   	   -­‐
611.2h,	  -­‐618.1b	  
Glycine	  	   	   -­‐300.1e	   	   -­‐391.7	   -­‐391.7e.	  	   -­‐392.1f,	   	   	   -­‐
390.4k	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Histidine	  	   -­‐56.9	   -­‐87.6	   -­‐75.9	   -­‐289.9	   -­‐221.8h,-­‐271.1a	   ,	   	   -­‐
267.6b	  ,	  -­‐289.5i	  
Isoleucine	  	   -­‐16.0	   -­‐279.7	  
	  (-­‐282.5)	  
-­‐22.8	   -­‐493.5	  
(-­‐496.3)	  
-­‐486.6a,	   -­‐493.3a,	   	   -­‐
487.1b,	   	   -­‐499.6c,	   	   	   -­‐
486.8h	  
Leucine	  	   -­‐17.0	   -­‐280.6	  
(-­‐282.7)	  
-­‐24.5	   -­‐495.2	  
(-­‐497.3)	  
-­‐486.6	   a,-­‐494.1a,	   	   -­‐
489.7b,	  	  -­‐501.8c,	  	   	   	  -­‐
486.8f,	   -­‐486.8h,	   	   	   -­‐
4875	  
Lysine	  	   -­‐13.6	   -­‐205.9	   -­‐28.5	   -­‐458.8	   -­‐443.5a	   ,	   -­‐451.5a,	   	   -­‐
443.4h,	  -­‐444.2b	  
Methionine	  	   -­‐16.2	   -­‐248.0	  
(-­‐246.8)	  
-­‐28.1	   -­‐427.8	  
(-­‐426.4)	  
-­‐412.1a,	   -­‐428.9a,	   	   -­‐
426.5b,	  	  -­‐412.1h	  
Phenylalanine	  	   -­‐23.3	   -­‐142.2	  
(-­‐139.0)	  
-­‐36.3	   -­‐323.5	  
(-­‐320.4)	  
-­‐302.1a	   ,-­‐322.6a,	   	   -­‐
319.6c,	   	   -­‐312.9f,	   	   	   -­‐
302h,	  -­‐318.4b	  
Proline	  	   -­‐12.4	   -­‐221.8	   -­‐29.8	   -­‐391.1	   -­‐373.2a	   ,	   -­‐387a,	   	   	   	   -­‐
366.2f,l,	   	   -­‐373.3h,	   	   -­‐
385.5m	  
Serine	  	   -­‐16.0	   -­‐433.5	  
(-­‐433.6)	  
-­‐29.5	   -­‐581.5	  
(-­‐580.0)	  
-­‐567.8	   a,-­‐578.2a,	   	   -­‐
567.8h,	  	  -­‐578.4b	  
Threonine	  	   -­‐16.5	   -­‐439.5	  
(-­‐439.9)	  
-­‐30.2	   -­‐620.0	  
	  (-­‐620.3)	  
-­‐603.8a	   ,-­‐618.8a,	   	   -­‐
620.9c,	   	   -­‐603.7h,	   	   	   -­‐
616.0b	  
Tryptophan	  	   -­‐43.6	   	  -­‐29.8*	   -­‐58.0	   	  -­‐246.9	   -­‐217.2a	   ,-­‐249.4a,	   	   -­‐
215h,	  	  	  	  	  -­‐238.1b	  




-­‐27.8	   -­‐489.0	  
(-­‐487.0)	  
-­‐482a	  ,	  -­‐490.4a,	  	  	  	  	  
-­‐498.5c,	   -­‐481.9h,	   	   	   -­‐
489.2b	  
Valine	  	   -­‐11.9	   -­‐282.2	  
	  (-­‐283.4)	  
-­‐21.3	   -­‐472.6	  
(-­‐473.9)	  
-­‐466.1a	  ,	  -­‐472.4a,	  	  
-­‐481.2c,	   -­‐455.2f,	   	   	   -­‐
466.1h,	   -­‐468.7b,	   	   	   -­‐
455.2j	  
Dipeptides	  
Alanylalanine	  	   -­‐15.1	   -­‐400.2	   -­‐18.4	   -­‐635.1	  
	  
-­‐648.3c,	  -­‐623.7h	  
Alanylglycine	  	   -­‐10.3	   -­‐397.6	   -­‐13.9	   -­‐600.4	   -­‐588.2c	  
Alanylphenylalanine	  	   3.2	   	  -­‐226.1	   4.8	   	  -­‐514.0	   -­‐534.9b,	   	   -­‐532.4c	   ,	   -­‐	  
509.7h	  
Glycylglycine	  	   -­‐11.0	   -­‐400.4	   -­‐15.6	   -­‐571.8	  
	  
-­‐528c,	  -­‐571.9h	  
Phenylalanylglycine	   -­‐15.1	   -­‐246.5	   -­‐10.0	   -­‐498.0	   -­‐500.9b	  
Glycylvaline	  	   -­‐9.8	   -­‐381.3	  
(-­‐378.4)	  
-­‐15.0	   -­‐652.2	  
(-­‐649.3)	  
-­‐633.8c,	   	   	   	   	   	   	   	   	   -­‐
647.9h	  
Leucylglycine	  	   -­‐15.5	   	  -­‐385.4	   -­‐22.6	   	  -­‐682.4	   -­‐652.2c	  
Nucleobases	  /	  Nucleosides	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  aStover	  2012[157]	   ;	   bT1	   (G3-­‐MP2)	   (Spartan14,	  Wavefunction);	   cDomalski	  and	  Hearing	  1993[199];	   dDorofeeva	   2010[221];	   eGoos	   database[148];	   fPedley	   1994[222];	   gNgauv	  
Hypoxanthine	   -­‐21.8	   172.8	   -­‐21.5	   38.0	   	  
6-­‐Hydroxypurine	   19.5	   194.6	   15.4	   59.5	   72.6b	  
	  
Adenosine	  	   -­‐21.2	   -­‐123.0	  
(-­‐128.7)	  
-­‐31.6	   -­‐481.6	  
(-­‐487.4)	  
-­‐472.7b	  
2-­‐Deoxyadenosine	  	   29.3	   18.2	  
(20.3)	  
40.1	   -­‐315.2	  
(-­‐313.3)	  
-­‐288.1b	  
2,3-­‐Dideoxyadenosine	   60.9	   161.6	   77.0	   -­‐151.9	   -­‐139.9b	  
Inosine	  	   -­‐12.0	   -­‐310.5	  
(-­‐305.8)	  
-­‐22.0	   -­‐659.7	  
(-­‐655.1)	  
-­‐646.4b	  
Guanosine	  	   -­‐12.1	   -­‐298.9	   -­‐22.5	   -­‐682.2	   -­‐664.2b	  
Uridine	  	   -­‐5.6	   -­‐675.3	   -­‐14.2	   -­‐991.5	   -­‐989.5b	  
Thymidine	  	   30.2	   -­‐521.6	  
(-­‐523.2)	  
30.6	   -­‐856.8	  
(-­‐858.5)	  
	  
Deoxythymidine	   -­‐83.4	   -­‐373.8	   -­‐111.4	   -­‐691.5	   -­‐684.2b	  
Saccharides	  
Cytidine	   -­‐12.7	   -­‐433.7	   -­‐18.9	   -­‐764.2	   -­‐768.9b	  
αD-­‐Glucose	   -­‐74.5	   -­‐837.5	   -­‐91.2	   -­‐1115.0	   	  
βD-­‐Glucose	  	   -­‐74.6	   -­‐836.6	  	  
	  
-­‐89.1	   -­‐1112.8	   -­‐1040.1e	  
-­‐1113.5b	  
Glucose	  –	  chain	  	   -­‐78.0	   -­‐836.7	  	  
	  
-­‐109.1	   -­‐1102.5	   -­‐1016.2e	  
-­‐1095.5b	  
2-­‐Deoxy-­‐D-­‐Glucose	   -­‐79.6	   -­‐682.7	   -­‐97.3	   -­‐941.9	   -­‐949.6b	  
βD	  –Galactose	  	   -­‐71.0	   -­‐833.0	   -­‐87.2	   -­‐1110.9	   -­‐1111.5b	  
βD	  –Mannose	   -­‐72.2	   -­‐834.2	   -­‐88.1	   -­‐1111.8	   	  
βD-­‐Fructopyranose	   -­‐89.1	   -­‐851.1	  
(-­‐856.3)	  





-­‐216.2	   -­‐934.8	   -­‐146.0	   -­‐1112.5	   -­‐1039.3e	  
	  
Fructose-­‐chain	   -­‐32.8	   -­‐828.6	  
(-­‐829.0)	  
-­‐60.5	   -­‐1093.2	  
(-­‐1095.3)	  
-­‐1113.3b	  
βD	  –Ribose	  	   -­‐79.6	   -­‐682.1	   -­‐100.1	   -­‐902.9	   	  
αD-­‐Ribofuranose	   -­‐78.5	   -­‐681.0	   -­‐102.2	   -­‐905.0	   -­‐907.9b	  
2-­‐deoxy-­‐D-­‐
Ribofuranose	  
-­‐56.9	   -­‐547.5	   -­‐71.1	   -­‐747.6	   	  
βD-­‐Xylofuranose	   -­‐59.1	   -­‐684.5	  
(-­‐572.4)	  
-­‐76.6	   -­‐907.5	  
(-­‐911.1)	  
-­‐918.5b	  
βD-­‐Xylopyranose	   -­‐72.0	   -­‐693.7	   -­‐84.8	   -­‐920.1	   	  
αD-­‐Xylopyranose	   -­‐72.6	   -­‐694.3	   -­‐86.6	   -­‐921.9	   	  
Sucrose	  	   45.9	   	  -­‐1419.2	   33.2	   	  -­‐1985.2	   	  
Maltose	  	   3.9	   	  -­‐1459.2	   -­‐1.3	   	  -­‐2013.2	   -­‐1838.4e	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Sabbah	   1977[220];	   hSagadeev	   2010[223],	   iRiffet	   [213],	   jNIST-­‐JANAF	   [224],	   kNgauv	  [220],	  lSabbah	  [225].	  mContineanu[226].	  nRibeiro	  da	  Silva	  2010[227].	  	  	  Table	   7.3	   shows	   some	   inconsistencies	   between	   our	   calculations	   and	   the	   literature	  values.	   Direct	   comparison	  with	   the	   GCM	   predictions[199]	   cannot	   be	  made	   since	   they	  have	   used	   an	   erroneous	   value	   for	   glycine	   (-­‐375.3	   kJ/mol).	   The	   consistency	   with	   the	  composite	  T1	  method	  (Spartan	  14	  database	  –	  Wavefunction)	  is	  very	  good	  in	  the	  case	  of	  PheGly	  but	  poor	  in	  the	  case	  of	  AlaPhe.	  However,	  our	  calculations	  for	  this	  latter	  dipeptide	  are	  in	  good	  agreement	  with	  the	  recent	  estimation	  by	  Sagadeev	  [200].	  The	  literature	  on	  saccharides	  and	  nucleosides	  is	  not	  as	  rich	  as	  that	  of	  aminoacids.	  The	  focus	  on	  saccharides	  is	  on	  the	  more	  stable	  furanose	  or	  pyranose	  closed	  ring	  structures	  [211,214].	  Their	  capacity	  to	  form	  multiple	  intramolecular	  hydrogen	  bonds,	  as	  shown	  in	  the	   previous	   section	   is	   contributing	   significantly	   to	   their	   stability	   and	   cannot	   be	  overlooked	   in	   selecting	   isodesmic	   reactions	   for	   their	   formation.	   There	   are	   very	   few	  literature	  data	   to	   compare	  with	   our	   calculations.	  Our	   calculations	   are	   consistent	  with	  the	  composite	  T1	  predictions	  (Spartan14	  dbase	  –	  Wavefunction)	  but	  we	  see	  noticeable	  differences	   with	   the	   reported	   ATcT	   values[148].	   However,	   the	   discrepancies	   are	   too	  large	   (over	  70	  kJ/mol)	   to	  be	  attributed	   to	  erroneous	  calculations	  either	  via	   isodesmic	  reactions	   (our	   calculations)	   or	   via	   composite	   G3-­‐MP2	   method	   (Spartan	   14).	   This	   is	  probably	  one	  of	  the	  very	  few	  cases	  to	  be	  reconsidered	  in	  ATcT	  compilation.	  	  The	  nucleosides	  share	  features	  from	  nucleotides,	  especially	  tautomerism,	  and	  from	  the	  saccharide	  bD-­‐ribose,	  especially	  the	  flexibility	  for	  intramolecular	  hydrogen	  bonding.	  As	  shown	   in	   figure	   5,	   guanosine	   can	   form	   the	   strong	   OH	   –N	   hydrogen	   bonds	   with	   the	  guanine	  ring	  as	  well	  as	  the	  OH—O	  hydrogen	  bonds	  with	  ribose.	  	  In	  uridine,	  the	  prevailing	  hydrogen	  bond	  is	  of	  the	  OH—O	  type	  with	  the	  carbonyl	  oxygen	  of	   the	  uracil	  ring.	  This	  hydrogen	  bonding	  capacity	   is	  a	  significant	  stabilizing	   factor	   for	  the	   nucleoside	   conformers	   and	   an	   adequate	   conformational	   search	   cannot	   overlook	  them.	  For	   nucleosides,	   we	   made	   a	   thorough	   comparison	   in	   Table	   4	   with	   composite	   T1	  calculations	  (Spartan	  14	  database	  –	  Wavefunction).	  The	  observed	  discrepancy	  between	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Spartan	  14	  and	  our	  estimations	  for	  adenosine,	  guanosine,	  inosine	  and	  derivatives	  is,	  in	  part,	  stemming	  from	  the	  fact	  that	  for	  adenine	  base,	  Spartan	  14	  database	  gives	  a	  heat	  of	  formation	  of	  276.3	  kJ/mol,	  which	  is	  significantly	  higher	  than	  the	  ATcT	  database	  value	  of	  225.7	  kJ/mol,	  while	  for	  guanine	  it	  gives	  a	  value	  of	  44.09	  kJ/mol,	  which	  is	  again	  higher	  than	   the	  ATcT	  value	   of	   16	   kJ/mol.	   	   The	   inconsistencies	   for	   the	   other	  nucleobases	   are	  significantly	  smaller	  as	  shown	  in	  the	  calculations.	  
7.3.2 Thermochemical	  properties	  of	  ionized	  metabolites	  in	  ideal	  gas	  phase	  In	   the	   majority	   of	   metabolites,	   the	   populations	   of	   species	   in	   the	   gas	   phase	   are	  dominated	   by	   the	   neutral	   as	   they	   are	  much	  more	   stable	   than	   the	   ionized	   structures.	  However,	   we	   also	   considered	   ionized	   structures,	   as	   this	   will	   contribute	   to	   our	  understanding	  of	  their	  hydration	  that	  will	  be	  important	  in	  the	  next	  phases	  of	  the	  project	  for	  bringing	  the	  gas	  phase	  estimation	  to	  aqueous	  phase,	  which	  is	  the	  case	  for	  biological	  systems.	  Our	  main	  focus	  on	  ionic	  structures	  is	  on	  aminoacids	  for	  which	  we	  considered	  both	   protonation	   and	   deprotonation	   reactions.	   In	   Table	   7.4	   we	   report	   the	   gas-­‐phase	  acidities	   (reaction	   enthalpies	   and	   Gibbs	   free	   energies)	   for	   aminoacids	   as	   well	   as	   the	  standard	   enthalpies	   and	   Gibbs	   free	   energies	   of	   formation	   of	   the	   deprotonated	  aminoacids.	  The	  agreement	  of	  our	   calculations	  with	   literature	  data	   is	   satisfactory.	  We	  can	  however	  observe	  noticeable	  differences	  such	  as	  for	  the	  case	  of	  ΔGacid	  for	  methionine	  (18	  kJ/mol).	  The	   formation	  quantities	  are	  all	  negative	  but	   there	  are	  no	   literature	  data	  for	  comparison.	  	  
	  
Table	   7-­‐4:	   Estimated	   gas-­‐phase	   acidities	   and	   standard	   thermochemical	   properties	   of	   ionic	  




ΔfG	   ΔrG	  
(ΔGacid)	  




Alanine	  	   -­‐411	   1400	   1400a,	  
1398.5c	  
-­‐524	   1431	   1432a,b	  
1425±8.8	  
Arginine	  	   -­‐273	   1356	   1347a,	  
1359.5c	  
-­‐532	   1388	   1381a,	  1387b	  
1389±13	  
Asparagine	  	   -­‐572	   1353	   1354a,	  
1359c	  
-­‐760	   1385	   1386a,	  1384b	  
1388±13	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Cysteine	  	   -­‐411	   1374	   1369a	  
1364c	  
















Glutamine	  	   -­‐558	   1351	   1347a,	  
1359c	  
-­‐777	   1382	   1378a,b	  
1388±13	  
Glycine	  	   -­‐409	   1404	   1403a,	  
1402c	  
-­‐491	   1434	   1435a,	  1434b	  
1433d	  
Histidine	  	   -­‐252	   1348	   1345a,	  
1356c	  
-­‐447	   1377	   1376a,	  1374b	  
1385±13	  
Isoleucine	  	   -­‐394	   1399	   1396a,	  
1388.5c	  
-­‐601	   1426	   1426a,b	  
1418±13	  
Leucine	  	   -­‐395	   1398	   1395a,	  
1390c	  
-­‐602	   1427	   1424a,	  1428b	  
1419±13	  
Lysine	  	   -­‐329	   1390	   1380a	  
1383c	  
-­‐576	   1416	   1410a,	  1415b	  
1412±13	  
Methionine	  	   -­‐356	   1403	   1385a,	  
1376c	  
-­‐534	   1427	   1418a,	  1412b	  
1405±13	  
Phenylalanine	  	   -­‐268	   1388	   1384a,	  
1379c	  
-­‐433	   1424	   1416a,	  1417b	  
1408±13	  
Proline	   -­‐341	   1394	   1394a	  
1395c	  
-­‐499	   1425	   1425a,	  1430b	  
1430±13	  
Serine	   -­‐583	   1363	   1363a,c	   -­‐722	   1393	   1392a,b	  
1392±13	  
Threonine	   -­‐592	   1360	   1359a,	  
1360.5c	  
-­‐763	   1390	   1390a,	  1397b	  
1390±13	  
Tryptophan	   -­‐155	   1388	   1390a,	  
1380.5c	  
-­‐358	   1422	   1423a,	  1422b	  
1410±13	  
Tyrosine	   -­‐415	   1386	   1382a	  
1378.5c	  
-­‐602	   1420	   1415a,	  1419b	  
1408±13	  
Valine	   -­‐398	   1391	   1394a,	  
1391c	  
-­‐577	   1427	   1425a,	  1430b	  
1420±13	  aStover	  2012[157]	   ;	   bJones	   et	   al	   2007[159]	  ;cO’Hair	  1995[150],	   dBouchoux	  2011[158].	  *Deprotonated	  side	  carboxyl.	  	  	  In	   Table	   7.5	   we	   report	   the	   gas-­‐phase	   basicities	   and	   proton	   affinities	   for	   aminoacids,	  adenosine	  and	  βD-­‐Glucose	  as	  well	  as	  the	  standard	  enthalpies	  and	  Gibbs	  free	  energies	  of	  formation	  of	  the	  protonated	  metabolites.	  The	  latter	  quantities	  were	  obtained	  from	  the	  GBs	  and	  PAs	   recommended	   in	   the	   literature	  and	   the	   corresponding	  quantities	   for	   the	  neutral	   metabolites	   from	   Table	   7.3.	   We	   observe	   that	   our	   calculations	   conform	   with	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literature	  data	  in	  general.	  The	  obtained	  formation	  quantities	  are	  in	  most	  cases	  positive	  but	  no	  obvious	  conclusions	  can	  be	  drawn	  out	  of	  their	  values.	  
Table	  7-­‐5:	  Estimated	  standard	  thermochemical	  quantities	  (ideal	  gas	  phase)	  of	  ionic	  metabolites	  from	  
corresponding	  properties	  for	  neutral	  metabolites	  (Table	  7.3)	  and	  their	  recommended	  basicities	  (GB)	  
and	  proton	  affinities	  (PA)a.	  Values	  in	  parenthesis	  are	  our	  GB	  and	  PA	  calculations	  at	  the	  same	  level	  of	  
theory	  as	  in	  Table	  4.	  All	  quantities	  are	  given	  in	  kJmol-­‐1.	  
Metabolite	   GBa	   ΔfG0	   PAa	   ΔfH0	  
Alanine	  	   868	  
(872)	  













Asparagine	  	   905	   196.6	   942	   -­‐21.0	  
Aspartic	  acid	  	   882	   9.2	   920	   -­‐177.2	  
Cysteine	  	   870	  
(874)	  
370.2	   903	  
(905)	  
233.5	  
Glutamic	  acid	  	   908	   -­‐26.0	   947	   -­‐233.0	  
Glutamine	  	   935	   182.2	   975	   -­‐68.0	  
Glycine	  	   854	  
(854)	  
358.9	   887	  
(887)	  
254.3	  
Histidine	  	   947	   475.5	   979	   264.1	  
Isoleucine	  	   885	  
(884)	  
348.3	   919	  
(921)	  
120.5	  
Leucine	  	   883	  
(885)	  
349.4	   916	  
(920)	  
121.8	  
Lysine	  	   952	  
(948)	  
355.1	   994	  
(990)	  
80.2	  
Methionine	  	   899	  
(910)	  
366.2	   938	  
(945)	  
167.5	  
Phenylalanine	  	   892	  
(896)	  
478.9	   930	  
(929)	  
279.5	  
Proline	   908	   383.2	   942	   200.0	  














Tryptophan	   909	   574.2	   945	   341.1	  
Tyrosine	   895	   329.6	   933	   111.0	  
Valine	   881	  
(887)	  
349.8	   915	  
(920)	  
145.4	  
Adenosine	   945b	   445	   979b	   72.4	  
βD-­‐Glucose	   786.6c	   -­‐111.1	   810.3c	   -­‐392.2	  	  aBouchoux	  2012[158],	  bBouchoux	  2008[156],	  cJebber	  1996[228].	  *Main	  chain	  –NH2	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Appendix	  Table	  A4	   summarizes	   the	  derived	   formation	  quantities,	   together	  with	   some	  formation	   quantities	   from	   the	   literature	   and	   shows	   a	   good	   consistency	   between	   our	  calculations	  and	  literature	  values.	  The	  formation	  quantities	  for	  all	  three	  types	  of	  species	  (neutral,	   protonated,	   deprotonated)	   follow	   similar	   trends.	   This	   is	   better	   visualized	   in	  figures	   7.5	   and	   figure	   7.6.	   Figure	   7.5	   shows	   that	   the	   free	   energies	   of	   formation	   of	  protonated	   and	   deprotonated	   aminoacids	   vary	   linearly	   with	   the	   free	   energy	   of	  formation	  of	   the	  neutral	  aminoacids.	  The	  parameters	  of	   the	  straight	   lines	  are	  given	   in	  Appendix	  Table	  A5.	  The	  two	  lines	  in	  figure	  7.5	  are	  almost	  parallel	  with	  a	  slope	  close	  to	  one.	  The	  deviations	  from	  the	  straight	   line	  are	  mainly	  due	  to	  aminoacids	  having	  strong	  protonation	  sites	  other	   than	   the	  common	   -­‐NH2	  group	   in	   the	  main	  chain.	  As	  expected,	  the	  best	  example	  is	  arginine	  (Arg1	  in	  figure	  7.5)	  with	  the	  strong	  basic	  guanidine	  site.	  We	  also	   indicate	   in	   figure	   the	   free	   energy	   of	   formation	   of	   arginine	   protonated	   on	   the	  common	   –NH2	   group	   (Arg2	   in	   figure	   7.5),	   which	   is	   now	   closer	   to	   the	   linear	  approximation.	  	  Similar	   comments	   can	   be	   made	   for	   the	   enthalpy	   of	   formation	   of	   protonated	   and	  deprotonated	  aminoacids	  (figure	  7.6).	  	  Figures	  7.5	  and	  7.6	  are	  useful	  for	  rationalizing	  acidities	  and	  basicities	  of	  aminoacids	  and	  their	  derivatives.	   It	   is	  also	  worth	  mentioning	   that	  one	  of	   the	  other	  protonated	  species	  (adenosine)	  has	  its	  formation	  quantities	  close	  to	  the	  straight	  lines	  in	  these	  figures.	  The	  other	  protonated	  species	  (βD-­‐glucose),	  however,	  deviates	  from	  the	  lines	  to	  some	  extent.	  This	  diverse	  behavior	  requires	  some	  explanation.	  Equation	  8.7	  may	  be	  rewritten	  as	  follows:	  GB	  (M)	  =	  ΔfG0(M)	  +	  ΔfG0(H+)	  -­‐	  ΔfG0(MH+)	  	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  (7.7a)	  Or	  ΔfG0(MH+)	  =	  ΔfG0(M)	  +	  ΔfG0(H+)	  -­‐	  GB	  (M)	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  (7.11)	  	  If	  R	  is	  the	  reference	  compound	  of	  the	  isodesmic	  reaction,	  which	  is	  often	  used	  to	  replace	  for	  the	  ΔfG0(H+),	  equation	  (8.11)	  can	  be	  rewritten	  as:	  ΔfG0(RH+)	  =	  ΔfG0(R)	  +	  ΔfG0(H+)	  -­‐	  GB	  (R)	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  (7.12)	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Figure	   7-­‐5:	   Formation	   free	   energy	   of	   protonated	   and	   deprotonated	  aminoacids	   vs.	   the	   formation	  
free	  energy	  of	  their	  neutral	  counterparts	  
	  
Figure	  7-­‐6:	  Formation	  enthalpies	  of	  protonated	  and	  deprotonated	  aminoacids	  vs.	  the	  formation	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  A	  linear	  relationship	  (figure	  7.5)	  in	  the	  form	  of	  ΔfG0(MH+)	  =	  sΔfG0(M)	  +	  I	  =	  sΔfG0(M)	  +	  [ΔfG0(RH+)	  -­‐	  sΔfG0(R)]	  	  or	  ΔfG0(MH+)	  =	  ΔfG0(RH+)	  +	  s[ΔfG0(M)	  -­‐	  ΔfG0(R)]	   	   	   	   	   	  	  	  	  	  	  	  	  	  (7.14)	  implies	  that:	  sΔfG0(M)	  =	  ΔfG0(M)	  +	  sΔfG0(R)	  -­‐	  ΔfG0(R)	  +	  GB	  (R)	  -­‐	  GB	  (M)	  	  	   	   	   	  	  	  	  	  	  	  	  	  (7.15)	  which	  can	  be	  restated	  as:	  (s-­‐1)ΔfG0(M)	  =	  (s-­‐1)ΔfG0(R)	  +	  GB	  (R)	  -­‐	  GB	  (M)	   	   	   	   	   	  	  	  	  	  	  	  	  	  (7.16)	  i.e.,	  	  GB	  (M)	  =	  GB	  (R)	  +	  (s-­‐1)[ΔfG0(R)	  -­‐	  ΔfG0(M)]	  	   	   	   	   	   	  	  	  	  	  	  	  	  	  (7.17)	  	  Equation	  7.14	  or	  equivalently	  equation	  7.17	  implies	  that	  the	  constant	  (intercept)	  term	  of	   the	   above	   linear	   relationship	   is	   dictated	   by	   the	   corresponding	   thermochemical	  quantities	   of	   the	   reference	   compound.	   Amines	   are	   often	   used	   to	   anchor	   gas	   phase	  basicities	  of	  aminoacids	  while	  for	  saccharides	  a	  more	  appropriate	  reference	  compound	  would	  be	  an	  alcohol.	  Proton	  affinities	  and	  gas-­‐phase	  acidities	  can	  be	  treated	  in	  a	  similar	  way.	  Figures	  7.7	  and	  7.8	  are	  analogous	  to	  figures	  7.5	  and	  7.6	  with	  the	  difference	  of	  enhanced	  scales	   in	   order	   to	   accommodate	   the	   reference	   compounds	   as	   well.	   Parameters	   and	  statistics	   of	   the	   linear	   fittings	   are	   shown	   in	   Appendix	   Table	   A6.	   As	   can	   be	   observed,	  there	   is	   now	  much	   better	   linear	   fit	   in	   all	   cases.	   Classes	   of	   compounds	   anchored	   to	   a	  given	  reference	  fall	  on	  a	  straight	  line	  passing	  through	  reference	  compounds.	  Sugars,	  as	  an	   example,	   fall	   on	   the	   lines	   passing	   through	   alcohols.	   Aminoacids,	   amines,	   and	  nucleobases	   fall	  on	  nearly	   the	  same	   lines.	  The	   lines	   in	  each	  graph	  are	  almost	  parallel.	  This	   feature	   is	   particularly	   useful	   for	   a	   quick	   qualitative	   estimation	   of	   the	   formation	  quantities	   of	   ions	   or,	   equivalently,	   the	   gas-­‐phase	   acidities	   and	   basicities	   from	   the	  formation	  quantities	  of	  neutral	   counterparts.	  We	  emphasize	   the	  point	   that	   these	   lines	  are	   for	   a	   qualitative	   estimation	   of	   gas	   phase	   acidities	   and	   basicities.	   As	   pointed	   out	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above,	   the	   very	   same	   neutral	   metabolite	   may	   exhibit	   different	   acid/base	   strength	  depending	   on	   its	   protonation/deprotonation	   sites.	   Thus,	   the	   observed	   scatter	   in	   the	  figures	  was	  expected.	  Nevertheless,	   the	   straight	   lines	  of	   figures	  7.7	  and	  7.8	  are	  useful	  tools	  in	  discussing	  gas-­‐phase	  acidities	  and	  basicities.	  	  
 
Figure	   7-­‐7:	   Formation	   free	   energies	   of	   protonated	   and	   deprotonated	   compounds	   (including	  
aminoacids)	   vs.	   the	   formation	   enthalpy	   of	   their	   neutral	   counterparts.	   The	   lines	   are	   linear	   fits	  
(parameters	  and	  statistics	  are	  shown	  in	  Appendix	  Table	  A5).	  
	  
 
Figure	   7-­‐8:	   Formation	   enthalpies	   of	   protonated	   and	   deprotonated	   compounds	   vs.	   the	   formation	  
enthalpy	  of	  their	  neutral	  counterparts.	  The	  lines	  are	  linear	  fits	  (parameters	  and	  statistics	  are	  shown	  
in	  Appendix	  Table	  A6).	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Chapter	  ) 	  
CONCLUSIONS	  &	  PRESPECTIVES	  
Cellular	  modification	   for	   designing	   reliable	   synthetic	  microbial	   cell	   factories	   (SMCFs)	  lies	  at	  the	  heart	  of	  metabolic	  engineering.	  This	  is	  a	  multidiscipline	  process	  that	  entails	  numerous	  challenges	  and	  cannot	  be	  carried	  out	   intuitively,	  which	  necessitates	  the	  use	  of	  several	  computational	  methods	  and	  tools.	  With	   the	  work	  we	   put	   forward	   in	   this	   thesis,	   we	   outlined	   the	   significance	   of	   several	  computational	   disciplines	   such	   as	   computational	   biochemistry,	   bioinformatics,	  computational	   biology,	   cheminformatics,	   constraint-­‐based	   modeling,	   process	  engineering,	   mathematical	   optimization,	   databases,	   etc.	   for	   the	   profitability	   and	   the	  progress	  of	  systems	  biology	  and	  in	  particular	  the	  metabolic	  engineering	  studies.	  	  After	   introducing	  several	  principal	  milestones	  of	  computational	  metabolic	  engineering	  concepts	   in	  Chapetr	   2,	  we	  described	   the	  details	  of	  our	  developed	  methodologies	  and	  their	   potential	   biochemical	   and	   biomedical	   applications	   and	   they	   could	   contribute	   in	  gaining	  novel	  biological	  and	  biochemical	  insights.	  	  We	   presented	   in	   Chapter	   3	   our	   results	   from	   the	   computational	   investigation	   of	   the	  entire	   space	   of	   enzymatic/metabolic	   possibilities	   for	   the	   design	   of	  de	  novo	  metabolic	  pathways,	   irrespective	   of	   the	   choice	   of	   the	   organism.	   We	   discovered	   that	   around	  120’000	   new	   biochemical/enzymatic	   reactions	   could	   evolve	   from	   the	   known	  biochemistry.	  We	  further	  compared	  the	  structural	  similarities	  of	  the	  hypothetical	  novel	  reactions	   with	   those	   already	   existing	   in	   the	   metabolic	   databases	   and	   cataloged	   our	  findings	  in	  a	  web-­‐based	  tool.	  In	  Chapter	   4,	   due	   to	   the	   importance	  of	   lipids	   in	   cellular	  physiology	  and	  pathology	  as	  well	  as	  recent	  interest	  for	  their	  role	  as	  resources	  for	  alternative	  fuels	  and	  chemicals,	  we	  had	  a	  closer	  look	  to	  lipid	  metabolism	  and	  applied	  several	  computational	  methods	  to	  get	  new	   insights	   about	   the	   structural	   diversities	   and	   metabolic	   functions	   of	   this	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metabolism.	  We	   introduced	   the	   computational	  pipeline	  NICELips	  used	   for	  elaborating	  our	   knowledge	   on	   lipid	   metabolism.	   The	   results	   of	   our	   case	   studies	   prove	   the	  effectiveness	  of	  NICELips	  for	  integrating	  the	  lipid	  species	  having	  unknown	  metabolism	  (obtained	  in	  lipidomics	  studies)	  into	  metabolic	  pathways.	  Broadening	  the	  application	  of	  NICELips	  to	  all	  the	  subsections	  of	  lipid	  metabolism	  will	  result	  in	  the	  establishment	  of	  a	  new	   repository	   of	   lipid	   information	   with	   potential	   applications	   in	   the	   design	   of	   new	  therapeutical	  approaches	  for	  lipid	  related	  disorders.	  In	   Chapter	   5	   we	   investigated	   the	   metabolic	   network	   of	   E.coli	   one	   of	   the	   most	   well	  studied	   chassis	   microorganisms.	   Enormous	   effort	   has	   been	   spent	   to	   discover	   all	   the	  metabolic	   potential	   of	   this	   organism	   for	   the	  microbial	   production	   of	   native	   and	   non-­‐native	   compounds.	   While	   several	   ongoing	   research	   studies	   focus	   on	   all	   fronts	   to	  discover	   new	   insights,	   a	   computational	   strategy	   to	   discover	   the	   full	   theoretical	  enzymatic	  potential	  of	  this	  or	  any	  given	  organism	  was	  missing.	  	  In	  addressing	  so,	  we	  developed	  “super	  E.	  coli”,	  an	  artificial	  reconstruction	  of	  the	  E.	  coli	  metabolic	   network	   with	   all	   possible	   new	   functionalities	   and	   extra	   metabolic	  capabilities,	  discovered	  on	  the	  basis	  of	  its	  known	  biochemistry.	  The	  metabolic	  network	  of	  “super	  E.	  coli”	   fulfills	  major	  objectives	  such	  as	   increasing	  the	  yield	  through	  biomass	  production	  and	  in	  addition,	  encompassing	  the	  synthetic	  capacity	  for	  the	  biosynthesis	  of	  several	  heterologous	  compounds.	  We	  can	  envision	   that	  our	  approach	  will	  provide	   the	  blueprints	  of	  new	  organisms	  able	  to	  efficiently	  convert	  low	  value	  compounds	  into	  every	  possible	  specialty	  and	  commodity	  chemical.	  In	   Chapter	   6	   we	   took	   one	   step	   beyond	   the	   conventional	   analyses	   of	   metabolism,	   in	  which	   the	  metabolic	  network	   is	   represented	  as	  a	  graph	  of	  metabolites	   interconnected	  with	  biological	   reactions.	  We	  developed	   the	   computational	   framework	   “iAM.NICE”	   for	  complementing	  the	  metabolic	  networks	  by	  accounting	  for	  all	  atom	  transitions	  from	  the	  substrates	  to	  the	  products.	  We	  demonstrated	  our	  results	  through	  the	  reconstruction	  of	  an	  atom-­‐level	  representation	  of	  the	  E.	  coli	  core	  metabolism	  and	  we	  elucidated	  the	  mass	  flow	   through	   the	   network.	   The	   results	   of	   this	   study	   and	   the	   further	   application	   of	  “iAM.NICE”	   for	   the	  atom-­‐level	   reconstruction	  of	  other	  biological	  networks	  rather	   than	  those	   discussed	   in	   this	   work	   could	   provide	   detailed	   predictions	   for	   guiding	   the	   13C	  Metabolic	  Flux	  Analysis.	  We	  believe	  that	  the	  ability	  to	  accurately	  track	  the	  moments	  of	  atoms	  in	  the	  metabolic	  networks	  opens	  up	  new	  opportunities	  for	  revealing	  hidden	  parts	  of	   metabolism	   and	   for	   generating	   hypotheses	   regarding	   the	   alternative	   or	   missing	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pathways	   in	   metabolism	   with	   high	   potential	   applications	   in	   metabolic	   engineering	  studies.	  Metabolism	  centers	  on	  the	  bioenergetics	  of	  cellular	  processes,	  and	  in	  our	  last	  research	  project	  of	  this	  thesis	  in	  Chapter	  7,	  we	  focused	  on	  the	  thermodynamics	  of	  metabolism	  in	  order	   to	   address	   the	   existing	   constraints	   and	   limitations	   for	   obtaining/estimating	   the	  thermodynamics	   properties	   of	   metabolite	   and	   consequently	   the	   metabolic	   reactions.	  We	  proposed	   a	   sound	  pipeline	   for	   the	   accurate	   estimation	   of	   several	   thermodynamic	  properties	  for	  a	  broad	  range	  of	  metabolites.	  Furthermore,	  we	  proposed	  a	  new	  approach	  for	   adjusting	   the	   measured/calculated/estimated	   thermodynamics	   properties	   to	   any	  temperature	   and	   pressure,	   rather	   than	   the	   standard	   ones	   which	   do	   not	   hold	   true	  especially	   in	   biological	   systems.	   In	   this	   work,	   we	   focused	   our	   attention	   on	   the	  estimation	  of	   thermodynamic	  properties	  of	  heavy	  metabolites	   in	   the	  gas	  phase.	   In	   the	  future,	   applying	   the	   concept	   of	   the	   thermodynamic	   cycles	   coupled	   with	   the	   data	  obtained	   in	   this	   thesis,	   we	   can	   provide	   estimated	   thermodynamic	   values	   for	   the	  metabolites	   in	   aqueous	   solutions	   (the	   same	   as	   for	   biological	   systems),	   which	   are	  adjustable	  to	  relevant	  temperature,	  and	  pressure	  conditions	  based	  on	  the	  nature	  of	  the	  study.	  	  We	  close	  this	  thesis	  by	  highlighting	  the	  fundamental	  position	  of	  the	  computational	  tools	  and	   approaches	   in	   systems	   biology	   and	   in	   the	   success	   of	   its	   pioneer	   research	   field,	  metabolic	   engineering.	   During	   this	   PhD	   work,	   we	   contributed	   to	   the	   field	   of	  computational	   systems	   biology	   through	   developing	   new	   tools	   and	   methods	   for	  enhancing	   our	   understanding	   of	   metabolic	   networks.	   This	   work	   can	   lead	   to	   the	  discovery	   of	   new	   insights,	   the	   generation	   of	   new	  hypotheses	   and	   the	   design	   of	   novel	  strategies	  toward	  the	  ultimate	  goal	  of	  metabolic	  engineering:	  to	  be	  able	  to	  produce	  any	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APPENDIX	  
Table	   A1:	   Proposed	   EC	   classification	   number	   up	   to	   the	   third	   level	   by	   BNICE.ch	   for	   178	   KEGG	  
reactions	  that	  are	  missing	  an	  EC	  number.	  The	  three	  columns	  show	  the	  KEGG	  reaction	  identifier,	  the	  
reaction	  rule(s)	  catalyzing	  the	  reaction	  and	  the	  suggested	  EC	  number	  for	  each	  reaction.	  Reactions	  for	  
which	  two	  or	  more	  EC	  numbers	  are	  suggested	  are	  colored	  in	  light	  red.	  
KEGG	  ID	   Reaction	  rules	   Suggested	  EC	  number	  
R00091	   |1.8.1B1(rev)|1.8.1B1	   1.8.1.-­‐	  
R00270	   |3.5.1A1(rev)|3.5.1A1|6.3.1A1(rev)|6.3.1A1	   3.5.1.-­‐	  |	  	  6.3.1.-­‐	  
R00598	   |2.1.1A5(rev)|2.1.1A5|2.1.1A1(rev)	   2.1.1.-­‐	  	  
R00683	   |2.1.1A5(rev)|2.1.1A5	   2.1.1.-­‐	  	  
R00744	   |1.2.1A2(rev)|1.2.1A2	   1.2.1.-­‐	  	  
R01339	   |2.6.1A1(rev)	   2.6.1.-­‐	  	  
R02343	   |1.1.1A1(rev)|1.1.1A1|1.2.1B1(rev)|1.2.1B1	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R02344	   |1.1.1A1(rev)|1.1.1A1|1.2.1B1(rev)|1.2.1B1	   1.1.1.-­‐	  |	  1.2.1.-­‐	  
R02583	   |4.2.1A1(rev)|4.2.1A1|4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6	   4.2.1.-­‐	  	  
R02659	   |3.1.1A1(rev)|3.1.1A1	   3.1.1.-­‐	  	  
R02798	   |4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6	   4.2.1.-­‐	  	  
R02801	   |4.2.1A1(rev)|4.2.1A1|4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6	   4.2.1.-­‐	  	  
R02856	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R03082	   |1.2.1D3(rev)	   1.2.1.-­‐	  	  
R03128	   |5.3.2A1(rev)|5.3.2A1	   5.3.2.-­‐	  |	  5.3.2.-­‐	  	  
R03249	   |1.5.1A1(rev)|1.5.1A1	   1.5.1.-­‐	  |	  1.5.1.-­‐	  	  
R03250	   |3.5.3A1(rev)|3.5.3A1	   3.5.3.-­‐	  |	  3.5.3.-­‐	  	  
R03314	   |1.5.1A1(rev)|1.5.1A1	   1.5.1.-­‐	  |	  1.5.1.-­‐	  	  
R03383	  
|3.1.2A1(rev)|3.1.2A1|3.3.1A1|6.2.1A1(rev)|6.2.1A1|6.2.1B1(rev)|6.2.1B1|6.
2.1C1(rev)|6.2.1C1|6.2.1D1(rev)|6.2.1D1	   3.1.2.-­‐	  |	  3.3.1.-­‐	  |	  6.2.1.-­‐	  	  
R03506	   |1.1.1D1(rev)|1.1.1D1|1.2.1A1(rev)|1.2.1A1	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R03507	   |1.1.1A1(rev)|1.1.1A1|1.2.1B1(rev)|1.2.1B1	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R03694	  
|4.2.1A1(rev)|4.2.1A1|4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6|4.2.1C1(re
v)|4.2.1C1	   4.2.1.-­‐	  	  
R03695	  
|3.1.2A1(rev)|3.1.2A1|3.3.1A1|6.2.1A1(rev)|6.2.1A1|6.2.1B1(rev)|6.2.1B1|6.
2.1C1(rev)|6.2.1C1|6.2.1D1(rev)|6.2.1D1	   3.1.2.-­‐	  |	  3.3.1.-­‐	  |	  6.2.1.-­‐	  	  
R03758	  
|1.1.1B2(rev)|1.1.1B2|4.1.1A2(rev)|4.1.1A2|4.1.1A3(rev)|4.1.1A3|4.1.1A6(re
v)|4.1.1A6|4.1.1A7(rev)|4.1.1A7|4.2.1A4(rev)	   1.1.1.-­‐	  |	  4.1.1.-­‐	  |	  4.2.1.-­‐	  	  
R03863	   |1.1.1A1(rev)|1.1.1A1|1.2.1B1(rev)|1.2.1B1	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R03864	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R03892	   |5.3.2A1(rev)|5.3.2A1|5.3.2A2(rev)|5.3.2A2	   5.3.2.-­‐	  	  
R03897	  
|4.2.1A1(rev)|4.2.1A1|4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6|4.2.1C1(re
v)|4.2.1C1	   4.2.1.-­‐	  	  
R04269	   |2.6.1A1(rev)	   2.6.1.-­‐	  	  
R04416	   |4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6|4.2.1C1(rev)|4.2.1C1	   4.2.1.-­‐	  	  
R04443	   |1.5.1A1(rev)|1.5.1A1	   1.5.1.-­‐	  	  
R04446	   |1.5.1A1(rev)|1.5.1A1	   1.5.1.-­‐	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R04453	   |1.2.1A2(rev)|1.2.1A2	   1.2.1.-­‐	  	  
R04593	   |3.1.1A1	   3.1.1.-­‐	  	  
R04646	   |2.4.1D1(rev)|2.4.1A1(rev)|2.4.1B1(rev)|2.4.1C1(rev)	   2.4.1.-­‐	  	  
R04875	   |3.5.1A1	   3.5.1.-­‐	  	  
R04876	   |1.1.1A1(rev)|1.2.1B1(rev)	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R04918	  
|4.1.1A1(rev)|4.1.1A1|4.1.1A6(rev)|4.1.1A6|4.1.1A7(rev)|4.1.1A7|4.2.1A4(re
v)	   4.1.1.-­‐	  |	  4.2.1.-­‐	  	  
R04987	   |1.14.13A1(rev)|	   1.14.13.-­‐	  	  
R04999	   |3.1.1A1	   3.1.1.-­‐	  	  
R05056	   |5.3.3A1(rev)|5.3.3A1|5.3.3A2(rev)|5.3.3A2	   5.3.3.-­‐	  	  
R05057	   |5.3.3A1(rev)|5.3.3A1|5.3.3A2(rev)|5.3.3A2|5.3.3A3(rev)|5.3.3A3	   5.3.3.-­‐	  	  
R05058	   |5.3.3A1(rev)|5.3.3A1|5.3.3A2(rev)|5.3.3A2	   5.3.3.-­‐	  	  
R05080	   |2.4.1E1(rev)|2.4.1A1(rev)|2.4.1B1(rev)|2.4.1C1(rev)	   2.4.1.-­‐	  	  
R05107	   |2.4.1A1|2.4.1E1(rev)|2.4.1A1(rev)|2.4.1B1(rev)|2.4.1C1(rev)	   2.4.1.-­‐	  	  
R05108	   |2.4.1C1|2.4.1E1(rev)|2.4.1A1(rev)|2.4.1B1(rev)|2.4.1C1(rev)	   2.4.1.-­‐	  	  
R05119	   |1.2.1A1(rev)|1.2.1A1	   1.2.1.-­‐	  	  
R05125	   |5.3.3A1(rev)|5.3.3A1|5.3.3A2(rev)|5.3.3A2	   5.3.3.-­‐	  	  
R05232	   |1.1.1A1(rev)|1.1.1A1|1.2.1B1(rev)|1.2.1B1	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R05250	   |1.14.13A1(rev)|	   1.14.13.-­‐	  	  
R05303	   |2.1.1A5(rev)|2.1.1A5|2.1.1A1(rev)	   2.1.1.-­‐	  	  
R05445	   |3.8.1A2(rev)|3.8.1A2	   3.8.1.-­‐	  	  
R05471	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R05477	   |3.8.1A2(rev)|3.8.1A2	   3.8.1.-­‐	  	  
R05478	   |4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6|4.2.1C1(rev)|4.2.1C1	   4.2.1.-­‐	  	  
R05515	   |1.1.1A1(rev)|1.1.1A1|1.2.1B1(rev)|1.2.1B1	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R05535	   |4.5.1A1(rev)|4.5.1A1	   4.5.1.-­‐	  
R05543	   |4.2.1A2|4.2.1A6	   4.2.1.-­‐	  	  
R05569	   |3.5.99A1(rev)|3.5.99A1	   3.5.99.-­‐	  	  
R05609	   |5.3.3A1(rev)|5.3.3A1|5.3.3A2(rev)|5.3.3A2	   5.3.3.-­‐	  	  
R05656	   |5.5.1A5(rev)|5.5.1A5	   5.5.1.-­‐	  	  
R05659	   |4.2.1A1(rev)|4.2.1A1|4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6	   4.2.1.-­‐	  	  
R05677	   |3.5.1A1|6.3.1A1(rev)	   3.5.1.-­‐	  |	  6.3.1.-­‐	  	  
R05694	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R05856	   |4.2.1A6(rev)|4.2.1A6	   4.2.1.-­‐	  	  
R05866	   |1.14.13A5(rev)|1.14.13A5	   1.14.13.-­‐	  	  
R05870	   |2.3.1F1(rev)|2.3.1D1|2.3.1D1(rev)	   2.3.1.-­‐	  	  
R05881	   |2.1.1A4(rev)|2.1.1A5(rev)|2.1.1A5|2.1.1A1(rev)	   2.1.1.-­‐	  	  
R06418	   |5.3.3A1(rev)|5.3.3A1|5.3.3A2(rev)|5.3.3A2|5.3.3A3(rev)|5.3.3A3	   5.3.3.-­‐	  	  
R06428	   |4.2.1A1(rev)|4.2.1A1|4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6	   4.2.1.-­‐	  	  
R06429	   |1.3.1A2(rev)|1.3.1A2	   1.3.1.-­‐	  	  
R06430	   |1.3.1A2(rev)|1.3.1A2	   1.3.1.-­‐	  	  
R06432	   |2.1.1A1|2.1.1A1(rev)	   2.1.1.-­‐	  	  
R06434	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R06472	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R06473	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	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R06474	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R06475	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R06592	   |4.2.3A2(rev)|4.2.3A2	   4.2.3.-­‐	  	  
R06593	   |4.2.1A1(rev)|4.2.1A1|4.2.1A6(rev)|4.2.1A6	   4.2.1.-­‐	  	  
R06594	   |1.1.1A1(rev)|1.1.1A1|1.2.1B1(rev)|1.2.1B1	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R06627	   |2.1.1A4(rev)|2.1.1A5(rev)|2.1.1A5|2.1.1A1(rev)	   2.1.1.-­‐	  	  
R06629	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R06665	   |4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6	   4.2.1.-­‐	  	  
R06685	   |3.1.1A1	   3.1.1.-­‐	  	  
R06686	   |4.1.1A6(rev)|4.1.1A6|4.1.1A7(rev)|4.1.1A7	   4.1.1.-­‐	  	  
R06752	   |1.14.15A1(rev)|1.14.15A1	   1.14.15.-­‐	  	  
R06774	   |2.1.1A5(rev)|2.1.1A5|2.1.1A1(rev)	   2.1.1.-­‐	  	  
R06830	  
|1.1.1B2(rev)|1.1.1B2|4.1.1A2(rev)|4.1.1A2|4.1.1A3(rev)|4.1.1A3|4.1.1A6(re
v)|4.1.1A6|4.1.1A7(rev)|4.1.1A7|4.2.1A4(rev)	   1.1.1.-­‐	  |	  4.1.1.-­‐	  |	  4.2.1.-­‐	  	  
R06866	   |4.1.1A6(rev)|4.1.1A6|4.1.1A7(rev)|4.1.1A7	   4.1.1.-­‐	  	  
R06867	   |2.4.1E1(rev)|2.4.1A1(rev)|2.4.1B1(rev)|2.4.1C1(rev)	   2.4.1.-­‐	  	  
R06968	   |3.5.99A1(rev)|3.5.99A1	   3.5.99.-­‐	  	  
R06997	   |2.3.1F1(rev)|2.3.1D1|2.3.1D1(rev)	   2.3.1.-­‐	  	  
R07009	   |5.5.1A5(rev)|5.5.1A5	   5.5.1.-­‐	  	  
R07010	   |5.5.1A5(rev)|5.5.1A5	   5.5.1.-­‐	  	  
R07011	   |5.5.1A5(rev)|5.5.1A5	   5.5.1.-­‐	  	  
R07012	   |5.5.1A5(rev)|5.5.1A5	   5.5.1.-­‐	  	  
R07016	   |1.14.13A5(rev)|1.14.13A5	   1.14.13.-­‐	  	  
R07058	   |1.1.1A1(rev)|1.1.1A1|1.2.1B1(rev)|1.2.1B1	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R07067	   |4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6|4.2.1C1(rev)|4.2.1C1	   4.2.1.-­‐	  	  	  
R07073	   |5.5.1A5(rev)|5.5.1A5	   5.5.1.-­‐	  	  
R07074	   |5.5.1A5	   5.5.1.-­‐	  	  
R07076	   |5.5.1A5	   5.5.1.-­‐	  	  
R07086	   |5.5.1A5(rev)|5.5.1A5	   5.5.1.-­‐	  	  
R07095	   |4.2.1A6	   4.2.1.-­‐	  	  
R07101	   |4.2.1A6	   4.2.1.-­‐	  	  
R07124	   |3.1.2A1|3.3.1A1|6.2.1A1(rev)|6.2.1B1(rev)|6.2.1C1(rev)|6.2.1D1(rev)	   3.1.2.-­‐	  |	  6.2.1.-­‐	  	  
R07427	   |5.3.3A3(rev)|5.3.3A3	   5.3.3.-­‐	  	  
R07428	   |1.1.1A1(rev)|1.1.1A1|1.2.1B1(rev)|1.2.1B1	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R07474	   |1.14.15A1(rev)|1.14.15A1	   1.14.15.-­‐	  	  
R07497	   |5.3.3A3(rev)|5.3.3A3	   5.3.3.-­‐	  	  
R07506	   |1.3.1A2(rev)|1.3.1A2	   1.3.1.-­‐	  	  
R07576	   |4.2.1A1	   4.2.1.-­‐	  	  
R07707	   |5.5.1A5(rev)|5.5.1A5	   5.5.1.-­‐	  	  
R07708	   |4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6	   4.2.1.-­‐	  	  
R07922	   |2.1.1A4(rev)|2.1.1A5(rev)|2.1.1A5|2.1.1A1(rev)	   2.1.1.-­‐	  	  
R07986	  
|4.2.1A1(rev)|4.2.1A1|4.2.1A2(rev)|4.2.1A2|4.2.1A6(rev)|4.2.1A6|4.2.1C1(re
v)|4.2.1C1	   4.2.1.-­‐	  	  
R07991	   |4.2.1A1	   4.2.1.-­‐	  	  
R07992	   |4.2.1A1	   4.2.1.-­‐	  	  
R08024	   |4.2.1A1	   4.2.1.-­‐	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R08061	   |3.6.1A1(rev)|3.6.1A1	   3.6.1.-­‐	  	  
R08062	   |3.6.1A1(rev)|3.6.1A1	   3.6.1.-­‐	  	  
R08063	   |3.6.1A1(rev)|3.6.1A1	   3.6.1.-­‐	  	  
R08064	   |3.6.1A1(rev)|3.6.1A1	   3.6.1.-­‐	  	  
R08069	   |3.1.3A1(rev)|3.1.3A1	   3.1.3.-­‐	  	  
R08070	   |3.1.3A1(rev)|3.1.3A1	   3.1.3.-­‐	  	  
R08071	   |3.1.3A1(rev)|3.1.3A1	   3.1.3.-­‐	  	  
R08079	   |3.1.3A1(rev)|3.1.3A1	   3.1.3.-­‐	  	  
R08128	   |2.4.1A1|2.4.1E1(rev)|2.4.1A1(rev)|2.4.1B1(rev)|2.4.1C1(rev)	   2.4.1.-­‐	  	  
R08145	   |6.3.5A1(rev)|6.3.5A1	   6.3.5.-­‐	  	  
R08148	   |1.14.13A5(rev)|1.14.13A5	   1.14.13.-­‐	  	  
R08152	   |3.3.2A1(rev)|3.3.2A1	   3.3.2.-­‐	  	  
R08153	   |3.3.2A1(rev)|3.3.2A1	   3.3.2.-­‐	  	  
R08154	   |2.7.1A1(rev)|2.7.1A1|2.7.8A1	   2.7.1.-­‐	  |	  2.7.8.-­‐	  	  
R08251	   |3.5.1A1|6.3.1A1(rev)	   3.5.1.-­‐	  |	  6.3.1.-­‐	  	  
R08279	   |4.2.1A1	   4.2.1.-­‐	  	  
R08289	   |4.2.1A1	   4.2.1.-­‐	  	  
R08309	   |4.3.2A1	   4.3.2.-­‐	  	  
R08311	   |3.5.1A1	   3.5.1.-­‐	  	  
R08328	  
|4.1.1A1(rev)|4.1.1A1|4.1.1A6(rev)|4.1.1A6|4.1.1A7(rev)|4.1.1A7|4.2.1A4(re
v)	   4.1.1.-­‐	  |	  4.2.1.-­‐	  	  
R08451	   |3.5.1A1	   3.5.1.-­‐	  	  
R08492	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R08494	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R08561	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R08562	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R08563	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R08590	   |1.1.1A1(rev)|1.2.1B1(rev)	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R08591	   |5.3.2A1(rev)|5.3.2A1|5.3.2A2(rev)|5.3.2A2	   5.3.2.-­‐	  	  
R08861	   |1.1.1A2(rev)|1.1.1A2|1.2.1B2(rev)|1.2.1B2	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R08870	   |2.3.3A1(rev)|2.3.3A1|2.3.3B1(rev)|2.3.3B1	   2.3.3.-­‐	  	  
R08871	   |2.3.1D3(rev)|2.3.1F1(rev)	   2.3.1.-­‐	  	  
R08874	   |3.5.1A1|6.3.1A1(rev)	   3.5.1.-­‐	  |	  6.3.1.-­‐	  	  
R08876	   |3.5.1A1|6.3.1A1(rev)	   3.5.1.-­‐	  |	  6.3.1.-­‐	  	  
R09170	   |5.5.1A5(rev)|5.5.1A5	   5.5.1.-­‐	  	  
R09172	   |5.5.1A5(rev)|5.5.1A5	   5.5.1.-­‐	  	  
R09175	   |5.5.1A5(rev)|5.5.1A5	   5.5.1.-­‐	  	  
R09179	   |5.5.1A5	   5.5.1.-­‐	  	  
R09253	   |4.3.1A3(rev)|4.3.1A3	   4.3.1.-­‐	  	  
R09259	   |4.1.2A2	   4.1.2.-­‐	  	  
R09260	   |4.1.2A2	   4.1.2.-­‐	  	  
R09261	   |4.1.2A2	   4.1.2.-­‐	  	  
R09273	   |3.1.1A1	   3.1.1.-­‐	  	  
R09276	   |1.13.11A1(rev)|1.13.11A2(rev)|1.13.11A2	   1.13.11.-­‐	  	  
R09278	   |4.1.1A6(rev)|4.1.1A6|4.1.1A7(rev)|4.1.1A7	   4.1.1.-­‐	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R09282	   |4.2.1A1(rev)|4.2.1A1|4.2.1A6(rev)|4.2.1A6|4.2.1C1(rev)|4.2.1C1	   4.2.1.-­‐	  	  
R09312	   |1.6.5A1(rev)|1.6.5A1	   1.6.5.-­‐	  	  
R09337	   |3.1.1A1	   3.1.1.-­‐	  	  
R09342	   |4.2.1A1(rev)|4.2.1A1|4.2.1A6(rev)|4.2.1A6	   4.2.1.-­‐	  
R09377	   |3.5.4A1(rev)|3.5.4A1	   3.5.4.-­‐	  	  
R09779	   |3.5.1A1|6.3.1A1(rev)|6.3.2A1(rev)	   3.5.1.-­‐	  |	  6.3.1.-­‐	  |	  6.3.2.-­‐	  	  
R09850	   |2.7.4B1	   2.7.4.-­‐	  	  
R09854	   |2.3.1F1(rev)	   2.3.1.-­‐	  	  
R10013	   1.5.1A1|	   1.5.1.-­‐	  	  
R10212	   1.2.3B1|	   1.2.3.-­‐	  	  
R10458	   2.1.1A5|	   2.1.1.-­‐	  	  
R10459	   1.1.1A1(rev)|1.2.1B1(rev)|	   1.1.1.-­‐	  |	  1.2.1.-­‐	  	  
R10638	   2.4.1A1|	   2.4.1.-­‐	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Table	  A2:	  List	  of	  81	  reactions	  that	  BNICE.ch	  proposed	  them	  as	  “novel	  reactions”	  based	  on	  theKEGG	  
2012	  database	  and	  they	  are	  reported	  as	  “known	  reactions”	  in	  KEGG	  2014	  database.	  It	  shows	  the	  
capability	  of	  BNICE.ch	  for	  prediction	  reactions	  that	  follow	  known	  biochemistry	  rules.	  
	  
KEGG	  
reaction	   Equation	   EC	  number	   Reaction	  rule	  
R10013	   C20279<=>C00001+C16138	  
	  
1.5.1A1|	  
R10021	   C00003+C03448<=>C00004+C00080+C03037	   1.1.1.327	   1.1.1A1|1.2.1B1|	  
R10037	   C00029+C18796<=>C00015+C08334	   2.4.1.63	   2.4.1A1|	  
R10042	   C00004+C00007+C00080+C01407<=>C00001+C00003+C00146	   1.14.13.0	   1.14.13A2|	  
R10043	   C00004+C00007+C00080+C00146<=>C00001+C00003+C00090	   1.14.13.0	   1.14.13A2|	  
R10044	   C00005+C00007+C00080+C07160<=>C00001+C00006+C20321	   1.14.13.160	   1.14.13A7|	  
R10046	   C00001+C05841<=>C00121+C00253	   3.2.2.3	   3.3.1A1|	  
R10051	   C00001+C20320<=>C20324	   3.7.1.18	   3.7.1A1|	  
R10052	   C00003+C04411<=>C00004+C00011+C00080+C00233	   1.1.1.85	   1.1.1.A9|	  
R10075	   C00006+C20325<=>C00005+C00080+C20308	   1.3.1.92	   1.3.1A2|	  
R10078	   C20329<=>C00001+C11887	   1.14.13.109	   4.2.1A6|	  
R10084	   C00001+C20331<=>C20332	   1.14.99.36	   3.3.2A1|	  
R10093	   C00002+C20345<=>C00008+C00129	   2.7.4.26	   2.7.4A1|2.7.4B1|	  
R10094	   C00026+C20350<=>C00025+C20351	   2.6.1.94	   2.6.1A1(rev)|	  
R10096	   C00029+C02627<=>C00015+C20353	   2.4.1.284	   2.4.1A1|	  
R10101	   C00001+C00007+C15987<=>C00027+C00218+C00232	   1.5.3.21	   1.4.3A1|	  
R10102	   C00001+C00007+C15987<=>C00027+C00067+C00334	   1.5.3.19	   1.4.3A1|	  
R10103	   C00001+C00007+C20361<=>C00027+C00218+C19567	   1.4.3.24	   1.4.3A1|	  
R10105	   C00001+C00006+C19567<=>C00005+C00080+C19569	   1.2.1.83	   1.2.1A2|	  
R10110	   C00007+C19789<=>C20367	   1.13.11.64	   1.13.11A2|	  
R10114	   C00006+C12448<=>C00005+C00080+C20371	   1.1.1.334	   1.1.1A2|1.2.1B2|	  
R10116	   C00005+C00080+C20372<=>C00006+C20373	   1.1.1.100	   1.1.1A2(rev)|1.2.1B2(rev)|	  
R10117	   C20373<=>C00001+C20374	   4.2.1.59	  
4.2.1A1|4.2.1A2|4.2.1A6|4.2.1C1(r
ev)|	  
R10118	   C00005+C00080+C20374<=>C00006+C20375	   1.3.1.10	   1.3.1A2(rev)|	  
R10120	   C00005+C00080+C20376<=>C00006+C20377	   1.1.1.100	   1.1.1A2(rev)|1.2.1B2(rev)|	  
R10121	   C20377<=>C00001+C20378	   4.2.1.59	  
4.2.1A1|4.2.1A2|4.2.1A6|4.2.1C1(r
ev)|	  
R10122	   C00005+C00080+C20378<=>C00006+C19846	   1.3.1.10	   1.3.1A2(rev)|	  
R10125	   C00003+C09849<=>C00004+C00080+C09848	   1.1.1.0	   1.1.1A1|1.2.1B1|	  
R10128	   C00003+C09131<=>C00004+C00080+C20379	   1.1.1.332	   1.1.1A1|1.2.1B1|	  
R10130	   C00006+C17580<=>C00005+C00080+C17581	   1.1.1.329	   1.1.1A2|1.2.1B2|	  
R10134	   C00001+C20383<=>C00191+C20380	   3.1.1.93	   3.1.1A1|3.2.1A1|	  
R10153	   C00025<=>C05574	   5.4.3.9	   5.4.3A1|	  
R10161	   C00003+C00100<=>C00004+C00080+C00894	   1.3.1.95	   1.3.1A1|	  
R10172	   C01209+C01944<=>C00010+C00011+C05753	   2.3.1.207	   2.3.1D2|	  
R10178	   C00022+C00334<=>C00041+C00232	   2.6.1.96	   2.6.1A1(rev)|	  
R10179	   C00048+C00334<=>C00037+C00232	   2.6.1.96	   2.6.1A1(rev)|	  
R10180	   C00022+C00078<=>C00041+C00331	   2.6.1.99	   2.6.1A1(rev)|	  
R10181	  
C00005+C00007+C00080+C00331<=>C00001+C00006+C00011+
C00954	   1.14.13.168	   1.14.13A3|	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R10190	   C00003+C03187<=>C00004+C00080+C00688	  
1.1.1.339|1
.1.1.344	   1.1.1A1|1.2.1B1|	  
R10208	   C01271<=>C00001+C00693	   4.2.1.59	   4.2.1A1|4.2.1A2|4.2.1A6|	  
R10212	   C00001+C00007+C14279<=>C00027+C01546	  
	  
1.2.3B1|	  
R10221	   C00003+C00345<=>C00004+C00011+C00080+C00199	  
1.1.1.343|1
.1.1.351	   1.1.1.A9|	  
R10222	   C00003+C02489<=>C00004+C00080+C00161	   1.1.1.345	   1.1.1A1|1.2.1B1|	  
R10232	   C00001+C17325<=>C00014+C00868	   3.5.4.35	   3.5.4A1|6.3.4A1(rev)|	  
R10235	   C00001+C01344<=>C00009+C06196	   3.6.1.64	   3.6.1A1|	  
R10250	   C00019+C10453<=>C00021+C10454	   2.1.1.146	   2.1.1A5|	  
R10251	   C00019+C16930<=>C00021+C10452	   2.1.1.146	   2.1.1A5|	  
R10253	   C00024+C00590<=>C00010+C20225	   2.3.1.0	   2.3.1D1|2.3.1D1(rev)|	  
R10308	   C00003+C01500<=>C00004+C00080+C01499	   1.1.1.347	   1.1.1A1|1.2.1B1|	  
R10332	   C00003+C01217<=>C00004+C00080+C05927	   1.5.1.47	   1.5.1B1|	  
R10343	   C00033+C00091<=>C00024+C00042	   2.8.3.18	   2.8.3A1(rev)|	  
R10412	   C00003+C01126<=>C00004+C00080+C03461	   1.1.1.354	   1.1.1A1|1.2.1B1|	  
R10448	   C00019+C00805<=>C00021+C12305	   2.1.1.274	   2.1.1A5|	  
R10458	   C00019+C00688<=>C00021+C11460	  
	  
2.1.1A5|	  
R10459	   C00004+C00080+C11460<=>C00003+C12481	  
	  
1.1.1A1(rev)|1.2.1B1(rev)|	  
R10466	   C00001+C05933<=>C00077+C07044	   3.5.3.25	   3.5.4A1|	  
R10472	   C00019+C10343<=>C00021+C01448	   2.1.1.283	   2.1.1A5|	  
R10473	   C00024+C00556<=>C00010+C15513	   2.3.1.224	   2.3.1D1|2.3.1D1(rev)|	  
R10474	   C00024+C02394<=>C00010+C12299	   2.3.1.224	   2.3.1D1|2.3.1D1(rev)|	  
R10491	   C00019+C14155<=>C00021+C14153	   2.1.1.95	   2.1.1A5|	  
R10492	   C00019+C14156<=>C00021+C14154	   2.1.1.95	   2.1.1A5|	  
R10520	   C00003+C00092<=>C00004+C00080+C01236	   1.1.1.363	   1.1.1A1|1.2.1B1|	  
R10523	   C00019+C00135<=>C00021+C03298	   2.1.1.44	   2.1.1A5|	  
R10524	   C00019+C03298<=>C00021+C04259	   2.1.1.44	   2.1.1A5|	  
R10528	   C00006+C02489<=>C00005+C00080+C00161	   1.1.1.272	   1.1.1A2|1.2.1B2|	  
R10547	   C00001+C12213<=>C00009+C12212	   3.1.3.92	   3.1.3A1|	  
R10555	   C01151<=>C01182	   5.3.1.29	   5.3.1A3|	  
R10561	   C00002+C01107<=>C00008+C00009+C00011+C20345	   4.1.1.0	   4.1.1C1|	  
R10600	   C00024+C00490<=>C00033+C00531	   2.8.3.0	   2.8.3A1(rev)|	  




R10615	   C00001+C00006+C00577<=>C00005+C00080+C00258	   1.2.1.89	   1.1.1D2|1.2.1A2|	  
R10638	   C00029+C00561<=>C00015+C00844	  
	  
2.4.1A1|	  
R10639	   C00029+C00844<=>C00015+C08325	  
	  
2.4.1A1|	  
R10687	   C00001+C12270<=>C00025+C01042	   3.4.17.21	   3.5.1A1|6.3.1A1(rev)|	  
R10696	   C00001+C09821<=>C09825	   3.7.1.21	  
4.2.1A1(rev)|4.2.1A2(rev)|4.2.1A6(
rev)|	  
R10699	   C00047+C01092<=>C01037+C04076	   2.6.1.105	   2.6.1A1(rev)|	  
R10701	   C00001+C10434<=>C00493+C01197	   3.1.1.0	   3.1.1A1|	  
R10703	   C00003+C01845<=>C00004+C00080+C00207	   1.1.1.0	   1.1.1A1|1.2.1B1|	  
R10705	   C00001+C17530<=>C00033+C00132	   3.1.1.0	   3.1.1A1|	  
R10707	   C00024+C01209<=>C00010+C00011+C05744	   2.3.1.180	   2.3.1D2|	  
R10709	   C00019+C17570<=>C00021+C16695	   2.1.1.295	   2.1.1A5|	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Table	  A3:	  Thermochemical	  data	  for	  the	  reactants	  of	   isodesmic	  reactions	  of	  Table	  7.2	  that	  are	  used	  
for	  the	  calculation	  of	  thermodynamic	  properties	  for	  the	  heavy	  metabolites	  in	  the	  gas	  phase	  
Compound	   ΔfH	  /	  kJ	  mol
-­‐1	   ΔfG	  /	  kJ	  mol
-­‐1	  
Methane	   -­‐74.52	   -­‐50.49	  
Ethane	   -­‐83.85	   -­‐31.92	  
Propane	   -­‐104.68	   -­‐24.39	  
n-­‐Butane	   -­‐125.79	   -­‐16.7	  
isoButane	   -­‐134.18	   -­‐20.76	  
n-­‐Pentane	   -­‐146.76	   -­‐8.813	  
isoPentane	   -­‐153.6	   -­‐14.05	  
Methanol	   -­‐200.94	   -­‐162.32	  
Ethanol	   -­‐234.95	   -­‐167.85	  
1-­‐Propanol	   -­‐255.2	   -­‐159.9	  
2-­‐Propanol	   -­‐272.7	   -­‐173.47	  
1-­‐Butanol	   -­‐274.6	   -­‐150.3	  
Ethylene	  glycol	   -­‐387.5	   -­‐302.6	  
p-­‐Ethylphenol	   -­‐144.05	   -­‐21.58	  
Acetaldehyde	   -­‐166.2	   -­‐132.8	  
Acetone	   -­‐215.7	   -­‐151.3	  
Acetic	  acid	   -­‐432.25	   -­‐374.6	  
Propanoic	  acid	   -­‐453.5	   -­‐366.7	  
Butanoic	  acid	   -­‐475.8	   -­‐360.0	  
Dimethyl	  ether	   -­‐183.94	   -­‐112.8	  
Methylamine	   -­‐19.38	   32.07	  
Dimethylamine	   -­‐18.45	   68.39	  
Propylamine	  	   -­‐70.1	   41.7	  
Butylamine	  	   -­‐91.9	   49.3	  
Pentylamine	  	   -­‐113.2	   57.3	  
Ammonia	   -­‐45.57	   -­‐16.4	  
Benzene	   82.88	   129.6	  
Ethylbenzene	   29.92	   130.73	  
Tetrahydrofuran	  (THF)	   -­‐182.5	   -­‐79.69	  
Tetrahydropyran	  (THP)	   -­‐224.28	   -­‐80.37	  
Acetamide	  	   -­‐238.3	   -­‐159.53	  
Propanamide	   -­‐259.0	   -­‐151.05	  
Butanamide	   -­‐282.0	   -­‐132.13	  
Imidazole	   131.5	   192.75	  
Indole	  	   156.6	   237.3	  
Pyrrolidine	  	   -­‐3.6	   114.7	  
Guanidine	   27.95	   95.94	  
Methyl	  propyl	  sulfide	   -­‐82.3	   17.93	  
Adenine	  	   225.7	   348.67	  
Guanine	   16	   184.49	  
Cytosine	   -­‐69.5	   50.24	  
Uracil	   -­‐301.5	   -­‐198.35	  
Thymine	   -­‐338	   -­‐192.27	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Table	   A4:	   Thermochemical	   quantities	   of	   neutral,	   deprotonated,	   and	   protonated	   aminoacids.	  







neutral	   deprotonated	   protonated	   neutral	   deprotonated	   protonated	  






Arginine	  	   -­‐129.9	   -­‐273	   389.8	   -­‐398.9	   -­‐532	   99.7	  
Asparagine	  	   -­‐411.4	   -­‐572	   196.6	   -­‐612.0	   -­‐760	   -­‐21.0	  
Aspartic	  acid	  	   -­‐621.8	   -­‐830	   9.23	   -­‐790.2	   -­‐991	   -­‐177.2	  
Cysteine	  	   -­‐272.8	   -­‐411	   370.2	   -­‐396.5	   -­‐525	   233.5	  
Glutamic	  acid	  	   -­‐631.0	   -­‐812	   -­‐26.0	   -­‐819.0	   -­‐997	   -­‐233.0	  
Glutamine	  	   -­‐395.8	   -­‐558	   182.2	   -­‐626.0	   -­‐777	   -­‐68.0	  
























Lysine	  	   -­‐205.9	   -­‐329	   355.1	   -­‐458.8	   -­‐576	   80.2	  
Methionine	  	   -­‐248.0	   -­‐356	   366.2	   -­‐427.8	   -­‐534	   167.5	  
Phenylalanine	  	   -­‐142.2	   -­‐268	   478.9	   -­‐323.5	   -­‐433	   279.5	  






Serine	   -­‐433.5	   -­‐583	   201.5	   -­‐581.5	   -­‐722	   39.5	  
Threonine	   -­‐439.5	   -­‐592	   187.5	   -­‐620.0	   -­‐763	   -­‐6.0	  
Tryptophan	   	  -­‐29.8	   -­‐155	   574.2	   	  -­‐246.9	   -­‐358	   341.1	  
Tyrosine	   -­‐288.4	   -­‐415	   329.6	   -­‐489.0	   -­‐602	   111.0	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   Free	  energy	  of	  formation	  (Fig.	  7.5)	   Enthalpy	  of	  formation	  (Fig.	  7.6)	  
R2	   0.953	   	   0.943	   	  
Intercept	   589.0	   SD	  =	  15.8	   583.7	   SD	  =	  27.9	  
Slope	   0.925	   SD	  =	  0.047	   0.976	   SD	  =	  0.055	  
Deprotonated	  Aminoacids	  
R2	   0.984	   	   0.986	   	  
Intercept	   -­‐105.3	   SD	  =	  10.8	   -­‐64.5	   SD	  =	  15.7	  
Slope	   1.107	   SD	  =	  0.032	   1.131	   SD	  =	  0.031	  
Protonated	  Aminoacids	  and	  References	  
	   ΔfG0	  	  (Line	  C,	  Fig.	  7.7)	   	  ΔfH0	  	  (Line	  F,	  Fig.	  7.8)	  
R2	   0.983	   	   0.983	   	  
Intercept	   605.4	   SD	  =	  6.1	   594.6	   SD	  =	  9.48	  
Slope	   0.971	   SD	  =	  0.022	   0.999	   SD	  =	  0.023	  
Deprotonated	  Aminoacids	  and	  References	  
	   ΔfG0	  	  (Line	  B,	  Fig.	  7.7)	   	  ΔfH0	  	  (Line	  E,	  Fig.	  7.8)	  
R2	   0.988	   	   0.989	   	  
Intercept	   -­‐113.5	   SD	  =	  7.0	   -­‐-­‐77.8	   SD	  =	  11.3	  
Slope	   1.067	   SD	  =	  0.022	   1.098	   SD	  =	  0.024	  
Protonated	  Sugars	  and	  References	  
	   ΔfG0	  	  (Line	  I,	  Fig.	  7.7)	   ΔfH0	  	  (Line	  L,	  Fig.	  7.8)	  
R2	   0.993	   	   0.996	   	  
Intercept	   759.0	   SD	  =	  13.7	   750.9	   SD	  =	  17.8	  
Slope	   1.031	   SD	  =	  0.038	   1.021	   SD	  =	  0.033	  
Deprotonated	  Sugars	  and	  References	  
	   ΔfG0	  	  (Line	  H,	  Fig.	  7.7)	   ΔfH0	  	  (Line	  K,	  Fig.	  7.8)	  
R2	   0.988	   	   0.992	   	  
Intercept	   62.4	   SD	  =	  25.7	   65.9	   SD	  =	  27.3	  
Slope	   1.160	   SD	  =	  0.042	   1.117	   SD	  =	  0.034	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